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Heart	   failure,	  defined	  as	   the	   inability	  of	   the	  heart	   to	  pump	  enough	  blood	  to	  
supply	   the	   metabolic	   demands	   of	   the	   body,	   affects	   more	   than	   23	   million	   people	  
worldwide	  with	  total	  annual	  costs	  in	  2013	  of	  $32	  billion	  in	  the	  US	  alone.	  	  In	   in	  vitro	  
and	   in	   vivo	   models	   of	   failing	   hearts,	   HNO	   has	   been	   shown	   to	   improve	   both	  
vasorelaxation	   and	   myocardial	   contractility	   via	   unique	   mechanisms	   leading	   to	  
enhanced	   intracellular	  Ca2+	  cycling.	   	  Due	   to	   its	   inherent	  reactivity	  as	  a	  biologically	  
relevant	   reactive	   intermediate,	  HNO	  must	   be	   generated	   in	   situ	   through	   the	   use	   of	  
donor	  compounds,	  but	  very	  few	  physiologically	  useful	  HNO	  donors	  exist.	   	  HNO,	  an	  
“aldehyde	  mimetic”,	  was	  used	  as	  a	  reagent	  to	  synthesize	  a	  variety	  of	  HNO	  donors	  in	  
what	   can	   be	   considered	   an	   N-­‐selective	   HNO-­‐aldol	   reaction	   in	   up	   to	   quantitative	  
yields	  with	  bimolecular	  rate	  constants	  reaching	  8	  ×	  105	  M–1s–1.	  	  The	  hydroxylamino–
X	  (HAX)	  general	  class	  of	  HNO	  donors,	  where	  X	  is	  based	  on	  Meldrum’s	  acid	  (HAMA),	  
barbituric	   acid	   (HABA),	   or	   pyrazolone	   (HAPY),	   is	   capable	   of	   releasing	   HNO	  
quantitatively	   under	   nonenzymatic,	   physiological	   conditions,	   with	   the	   rate	   and	  
amount	  of	  HNO	  released	  being	  dependent	  mainly	  on	  the	  nature	  of	  the	  carbon-­‐based	  
leaving	  group.	  	  Experimental	  and	  computational	  investigations	  suggest	  that	  the	  HNO	  
release	  rate	  correlates	  with	  HAX	  and	  X–H	  pKa.	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§ 1.1	  	  Chemistry	  of	  Nitroxyl	  (HNO)	  
1.1.1 Nitroxyl	  (HNO)	  and	  Related	  Nitrogen	  Oxides	  
Endogenous	   nitric	   oxide	   (NO)	   generation	   in	   mammalian	   systems	   was	  
discovered	   more	   than	   25	   years	   ago.1-­‐3	   	   As	   a	   result	   of	   this	   significant	   finding,	   a	  
fundamentally	   new	   paradigm	   in	   mammalian	   cell	   signaling	   emerged.	   	   That	   is,	   a	  
specific	  biological	  function	  could	  be	  highly	  regulated	  through	  the	  use	  of	  small,	  freely	  
diffusible,	  and	  reactive	  molecules.	  	  NO,	  a	  diatomic	  radical	  known	  previously	  only	  as	  
a	   noxious	   environmental	   pollutant,	   is	   now	   known	   for	   its	   capability	   of	   regulating,	  
among	   other	   things,	   smooth	  muscle	   relaxation	   and	  platelet	   adhesion/aggregation.	  	  
For	   their	   discoveries	   concerning	  NO	  as	   a	   signaling	  molecule	   in	   the	   cardiovascular	  
system,	   Robert	   F.	   Furchgott,	   Louis	   J.	   Ignarro,	   and	   Ferid	  Murad	  were	   awarded	   the	  
Nobel	  Prize	  in	  Medicine	  in	  1998.4	  	  
In	   certain	   aerobic,	   biological	   environments,	   NO	   can	   react	   to	   form	   other	  
oxidized	   species,	   specifically	   nitrogen	   dioxide	   (NO2),	   peroxynitrite	   (ONOO–),	   and	  
nitrite	   (NO2–),	   which	   are	   all	   regarded	   as	   important	   biological	   effectors,	   cellular	  
toxins,	  and/or	  cellular	  signaling	  agents.5	  	  As	  the	  biological	  fate	  of	  NO	  is	  thought	  to	  be	  
primarily	  oxidative,	  research	  has	  been	  focused	  more	  on	  nitrogen	  oxide	  species	  with	  
higher	  oxidation	  states.	   	  Thus,	  the	  one-­‐electron	  reduced,	  protonated	  redox	  partner	  
to	  NO,	  nitroxyl	  (HNO),	  has	  received	  significantly	  less	  attention.	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As	   it	   turns	   out,	   HNO	   chemistry	   is	   significantly	   more	   complicated	   when	  
compared	  to	  the	  chemistry	  of	  other	  nitrogen	  oxides.	  	  At	  neutral	  pH	  in	  the	  absence	  of	  
chemical	   traps,	  HNO	  efficiently	   dimerizes	   (k	   =	   8	   ×	   106	  M-­‐1s-­‐1)	   to	   hyponitrous	   acid	  
(HON=NOH),	  which	  subsequently	  dehydrates	  to	  nitrous	  oxide	  (N2O).6	   	  Thus,	  unlike	  
all	   other	   commonly	   studied	   nitrogen	   oxides	   shown	   in	   Table	   1-­‐1,	   HNO	   cannot	   be	  
used	  directly;	  donor	  molecules	  are	  required	  for	  the	  generation	  of	  HNO	  in	  situ.	  
	  
Table	  1-­‐1.	  	  Nitroxyl	  (HNO)	  and	  Related	  Nitrogen	  Oxides	  
Compound	   Structure	   Oxidation	  State	   Endogenous?	  
nitrate	   NO3–	   +5	   Yes	  
nitrogen	  dioxide	   NO2	   +4	   Yes	  
nitrite	   NO2–	   +3	   Yes	  
nitric	  oxide	   NO	   +2	   Yes	  
nitroxyl	   HNO	   +1	   Maybe	  
nitrogen	   N2	   0	   Yes	  
hydroxylamine	   NH2OH	   -­‐1	   Yes	  
ammonia	   NH3	   -­‐3	   Yes	  
	  
	   Much	   of	   the	   recent	   interest	   in	   HNO	   has	   been	   catalyzed	   by	   research	  
suggesting	  that	   it	  may	  be	  a	  novel	   therapeutic	  of	  heart	   failure.7-­‐11	   	  The	  discovery	  of	  
endogenous	   HNO	   generation	   in	   mammalian	   systems	   has	   yet	   to	   be	   unequivocally	  
demonstrated.	  	  Given	  its	  inherent	  reactivity,	  one	  of	  the	  most	  important	  issues	  in	  the	  
field	  is	  developing	  a	  specific	  and	  sensitive	  detector	  or	  trap	  for	  HNO	  in	  vivo	  in	  order	  
to	   fully	   understand	   the	   biology	   of	   HNO.	   	   Such	   a	   discovery	   would	   imply	   that	  
regulation	   pathways	   for	   this	   biologically	   relevant	   reactive	   intermediate	   might	  
already	  exist,	   relieving	  many	   toxicology	   issues	  regarding	  HNO	  as	  a	  potential	  heart	  
failure	   therapeutic.	   	   Indeed,	   there	   are	   several	   possible	   biosynthetic	   pathways	   to	  
HNO	  (Scheme	  1-­‐1).12	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Scheme	  1-­‐1.	  	  Possible	  Biosynthetic	  Pathways	  to	  HNOa	  
	  
aL-­‐NHA	   =	   N-­‐hydroxy-­‐L-­‐arginine;	   nNOS	   =	   neuronal	   nitric	   oxide	   synthase;	   SOD	   =	  
superoxide	   dismutase;	   THB	   =	   tetrahydrobiopterin.	   	   Adapted	   from	   Wrobel,	   A.	   T.;	  
Johnstone,	  T.	  C.;	  Liang,	  A.	  D.;	  Lippard,	  S.	  J.;	  Rivera-­‐Fuentes,	  P.	  J.	  Am.	  Chem.	  Soc.	  2014,	  
136,	  467–4705.	  	  	  
	  
	   NO	   is	   generated	   from	   a	   family	   of	   enzymes	   known	   as	   the	   nitric	   oxide	  
synthases	  (NOS),	  which	  convert	  arginine	  to	  citrulline	  and	  NO	  in	  the	  presence	  of	  the	  
cofactor	   tetrahydrobiopterin	   (THB).13,14	   	   Isolated	   neuronal	   NOS	   produces	   HNO	  
instead	  of	  NO	  in	  the	  absence	  of	  THB.14	   	  Other	  possible	  redox	  pathways	  include	  the	  
oxidation	  of	  hydroxylamine	  (NH2OH),15	  the	  reduction	  of	  NO2–,16	  or	  the	  reduction	  of	  
NO17	   with	   heme-­‐containing	   proteins.	   	   In	   addition,	   NO	   and	   HNO	   has	   been	  
demonstrated	   to	   interconvert	   in	   the	   presence	   of	   superoxide	   dismutase	   (SOD).18	  	  
Lastly,	  nitrosothiols,	  such	  as	  the	  smallest	  derivative,	  HSNO,	  can	  serve	  as	  HNO	  donors	  
upon	  disulfide	   formation	  with	   an	   additional	   thiol.19	   	   Taken	   together,	   these	   results	  
are	   promising	   indicators	   that	   the	   endogenous	   generation	   of	   HNO	   is	   highly	   likely,	  
thus	  providing	  motivation	  to	  those	  in	  the	  field	  pursuing	  improved	  methods	  for	  the	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1.1.2	  	  HNO	  Reactivity	  and	  Fundamental	  Chemical	  Properties	  
	   HNO	   is	   a	   triatomic	   molecule,	   yet	   its	   structural	   simplicity	   belies	   the	  
complexity	  of	  some	  of	  its	  fundamental	  chemical	  properties.	  	  As	  described	  above	  and	  
shown	   in	   Scheme	   1-­‐2,	   dimerization	   and	   subsequent	   N2O	   formation	   precludes	  
straightforward	  experimentation	  on	  HNO.	  	  	  
	  
Scheme	  1-­‐2.	  	  HNO	  Reactivity	  with	  HNO	  
	  
	  
Controversy	   surrounding	   the	   pKa	   of	   HNO	   led	   to	   some	   of	   the	   original	  
dismissiveness	  of	  HNO	  as	  a	  biologically	  relevant	  species.	  	  Since	  the	  pKa	  of	  HNO	  was	  
originally	  reported	  to	  be	  ca.	  4.7	  based	  on	  pulse	  radiolysis	  experiments,	  the	  nitroxyl	  
anion	  (NO–)	  was	  expected	  to	  dominate	  at	  physiological	  pH.20	  	  Ellison	  and	  co-­‐workers	  
demonstrated	   that	   NO–	   is	   bound	   by	   only	   ca.	   0.6	   kcal/mol	   relative	   to	   electron	  
detachment	  suggesting	  that	  it	  should	  be	  readily	  oxidized	  to	  NO	  under	  physiological	  
conditions.21	   	   However,	   the	   biological	   properties	   of	   NO	   and	   HNO	   appear	   to	   be	  
different.7-­‐11,	  22-­‐27	   	  For	  example,	  Paolocci,	  Kass,	  and	  co-­‐workers	  at	  the	  JHU	  School	  of	  
Medicine	   reported	   increased	   level	   of	   cGMP,	   which	   leads	   to	   enhanced	   relaxation,	  
following	   administration	   of	   the	   NO	   donor,	   diethylamine	   diazeniumdiolate	  
(DEA/NO).	   	   Yet,	   administration	   of	   the	   HNO	   donor,	   Angeli’s	   salt	   (AS),	   does	   not	  
provide	   increased	   levels	  of	   cGMP.7,8	   	  Rather,	   in	  models	  of	  heart	   failure,	  defined	  as	  
the	  inability	  of	  the	  heart	  to	  pump	  enough	  blood	  to	  supply	  the	  metabolic	  demands	  of	  
the	   body,	   AS-­‐derived	   HNO	   has	   been	   shown	   to	   improve	   both	   vasorelaxation	   and	  
HNO    +    HNO [HON=NOH] N2O    +    H2O
8 x 106 M-1s-1
. .
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myocardial	   contractility	   via	   unique	  mechanisms	   leading	   to	   enhanced	   intracellular	  
Ca2+	  cycling.28	  
In	  addition,	  the	  reactivity	  of	  HNO	  with	  thiols	  is	  distinct	  from	  that	  of	  NO	  with	  
thiols.29,30	  	  One	  of	  the	  hallmarks	  of	  HNO	  biological	  chemistry	  is	  the	  highly	  thiophilic	  
property	  of	  HNO,	  forming	  sulfinamides	  or	  disulfides	  depending	  on	  the	  concentration	  
of	  thiol	  (Scheme	  1-­‐3a),	  whereas	  NO	  requires	  dioxygen	  (O2)	  for	  reactivity	  with	  thiols,	  
the	  end	  products	  of	  which	  are	  nitrosothiols	  (Scheme	  1-­‐3b).	  
	  
Scheme	  1-­‐3.	  	  HNO	  Versus	  NO	  Reactivity	  with	  Thiols	  
	  
	   	  
	   Due	  to	  these	  reports	  of	  HNO	  reactivity	  at	  physiological	  pH,	  the	  validity	  of	  the	  
pKa	  value	  was	  called	  into	  question.	  	  At	  the	  time	  of	  the	  original	  pKa	  measurement,	  the	  
spin	  states	  of	  the	  HNO/NO–	  system	  were	  ignored.	  	  NO–	  is	  isoelectronic	  with	  O2	  and,	  
like	  O2,	   has	   a	   triplet	   ground	   state.31	   	   Thus,	   simple	  protonation	  of	   3NO–	   is	   formally	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been	  clarified;	  a	  value	  of	  approximately	  11.4	  has	  been	  obtained	  by	  several	  methods,	  
confirming	  that	  HNO	  is	  the	  physiologically	  relevant	  protonation	  state.6,33,34	  	  	  
	   HNO	   is	   capable	   of	   serving	   as	   either	   an	   oxidant,	   as	   demonstrated	   by	   its	  
propensity	  to	  react	  with	  thiols,	  or	  as	  a	  reductant.	  	  For	  example,	  HNO	  reduces	  metals	  
including	   iron	   (Fe),35-­‐38	   copper	   (Cu),39,40	   and	   manganese	   (Mn)41,42	   via	   reductive	  
nitrosylation.	  	  Also,	  the	  H–NO	  bond	  strength	  is	  only	  ca.	  50	  kcal	  mol-­‐1,	  indicating	  that	  
H-­‐atom	   abstraction	   by	   other	   radical	   species	   is	   facile	   and,	   concurrently,	   generates	  
another	  established	  antioxidant,	  NO.43	  
HNO	  is	   isoelectronic	  with	  formaldehyde;	  hence	  one	  can	  envision	  HNO	  as	  an	  
“aldehyde	  mimetic.”	   	  Nagasawa	  and	  co-­‐workers	  were	  among	   the	   first	   to	   study	   the	  
biology	  of	  HNO	  as	  an	  effective	  inhibitor	  of	  mitochondrial	  aldehyde	  dehydrogenase,44	  
an	   enzyme	   with	   an	   active	   cite	   cysteine	   residue	   responsible	   for	   the	   oxidation	   of	  
acetaldehyde	   to	   acetic	   acid.	   	   Inhibition	   of	   aldehyde	   dehydrogenase	   results	   in	  
acetaldehydemia,	  a	  condition	  with	  general	  “hangover”-­‐like	  symptoms	  such	  as	  facial	  
flushing,	   light-­‐headedness,	   palpitations,	   and	   nausea.	   	   Cyanamide	   (H2NCN),	   an	  
alcohol	  deterrent	  used	  clinically	   in	  Europe,	  Canada,	  and	   Japan,	  has	  been	  shown	   to	  
generate	  HNO	   following	  metabolic	   activation.44-­‐46	   	   These	   reports	  were	   the	   first	   to	  
indicate	  the	  pharmacological	  utility	  of	  HNO.	  	  A	  summary	  of	  the	  biologically	  relevant	  
properties	  and	  reactivities	  of	  HNO	  is	  shown	  in	  Figure	  1-­‐1.	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Figure	  1-­‐1.	  	  The	  biologically	  relevant	  properties	  and	  reactivities	  of	  HNO.	  
§ 1.2	  	  Previously	  Reported	  Classes	  of	  HNO	  Donors	  
Given	  its	  inherent	  activity,	  HNO	  cannot	  be	  used	  directly;	  donor	  molecules	  are	  
required	  for	  the	  generation	  of	  HNO	  in	  situ.	  	  The	  most	  commonly	  used	  HNO	  donor	  is	  
Angeli’s	  salt	  (AS),	  a	  compound	  that	  has	  been	  known	  since	  1896.47	  	  That	  same	  year,	  
another	  HNO	  donor,	  Piloty’s	  acid	  (PA),	  was	  also	  reported.48	  	  In	  the	  intervening	  115	  
years,	   very	   few	   other	   classes	   of	   HNO	   donors	   suitable	   for	   use	   under	   physiological	  
conditions	   have	   been	   developed.49,50	   These	   include	   primary	   amine-­‐based	  
diazeniumdiolates	  such	  as	  IPA/NO,51-­‐52	  acyloxy	  nitroso	  compounds	  (AcON),53-­‐54	  and	  
precursors	  to	  the	  acyl	  nitroso	  compounds	  (AcN),55-­‐56	  which	  themselves	  are	  unstable.	  	  
Indeed,	  several	  recent	  reviews	  of	  HNO	  chemistry	  and	  biology	  have	  made	  pleas	   for	  
new	   donors:	   	   (1)	   “As	   this	   field	   grows,	   there	   will	   certainly	   be	   a	   call	   for	   the	  
development	   of	   new	   and	   novel	   HNO	   donors.”57	   (2)	   “Sensitive,	   specific	   detection	  
methods	   and	   a	   larger	   variety	   of	   HNO	   donors	   than	   Angeli’s	   salt	   and	   Piloty’s	   acid,	  
which	   were	   first	   synthesized	   in	   the	   late	   1800’s,	   will	   be	   required	   to	   advance	   this	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promising	  area	  of	  biomedical	  research.”58	  (3)	  “The	  design	  and	  development	  of	  novel	  
HNO	   donors	   with	   distinct	   properties	   (e.g.,	   different	   half-­‐lives	   and/or	   release	  
kinetics,	  cellular	  permeability	  and	  so	  on)	  is	  paramount	  to	  further	  our	  understanding	  
of	  the	  biological	  activity	  and	  therapeutic	  utility	  of	  HNO.”22	  	  
	  
	  	  




1.2.1	  	  Angeli’s	  Salt	  (AS)	  
	   The	   availability	   of	   NO	   donors	   such	   as	   secondary	   amine-­‐based	  
diazeniumdiolates	  (e.g.,	  DEA/NO,	  Scheme	  1-­‐4)	  was	   invaluable	  to	  the	  elucidation	  of	  
the	  biological	  properties	  and	  endogenous	  production	  of	  NO.59-­‐62	   	  Angeli’s	  salt	  (AS),	  
an	   oxygen-­‐based	   diazeniumdiolate,	   releases	   HNO	   under	   physiological	   conditions	  
and	  becomes	  an	  NO	  donor	  under	  acidic	  conditions	  (pH	  <	  4)	  as	  shown	  in	  Scheme	  1-­‐
5.63-­‐64	   	   Due	   to	   the	   relatively	   short	   half-­‐life	   of	   AS	   (t1/2	   =	   2.5	   min),	   only	   the	   acute	  
biological	  properties	  of	  HNO	  may	  be	  examined.	   	  Unfortunately,	  AS	  is	  not	  amenable	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1.2.2	  	  Piloty’s	  Acid	  (PA)	  and	  its	  Derivatives	  
	   Piloty’s	   acid	   (PA)	   is	   an	   N-­‐substituted	   hydroxylamine	   derivative	   equipped	  
with	  a	  sulfinate	  leaving	  group	  and	  releases	  HNO	  under	  alkaline	  conditions	  (Scheme	  
1-­‐6a).65	   	   However,	   at	   neutral	   pH,	   PA	   itself	   is	   quite	   stable	   (t1/2	   >	   1	   h),	   and	   under	  
physiological	  conditions	  is	  oxidized,	  presumably	  to	  the	  corresponding	  nitroxide,	  and	  
becomes	  an	  NO	  donor	  (Scheme	  1-­‐6b).66	   	   In	  order	  to	   favor	  deprotonation	  and	  HNO	  
formation,	  vs.	  oxidation,	  electron-­‐withdrawing	  groups	  were	  attached	  to	  the	  phenyl	  
















half-life dependent on (1) pH,
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DEA/NO (R = Et) is a commonly used NO donor
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with	   an	   increased	   stability	   of	   the	   sulfinate	   leaving	   group.67	   	   The	  Toscano	   Lab	   has	  
generated	  a	  wide	  variety	  of	  PA	  derivatives,	  most	  notably	  2-­‐bromo-­‐Piloty’s	  acid	  (2-­‐
BrPA),	   which	   decomposes	   with	   a	   half-­‐life	   (t1/2	   =	   2.4	   min)	   and	   quantitative	   HNO	  
production	  at	  pH	  7.4,	  37	  °C,	  comparable	  to	  AS	  making	  it	  a	  viable	  alternative	  for	  the	  
study	  of	  HNO	  (Scheme	  1-­‐6c).	  
	  






1.2.3	  	  Primary	  Amine-­‐Based	  Diazeniumdiolates	  (IPA/NO)	  
	   Primary	   amine-­‐based	   diazeniumdiolates	   may	   be	   useful	   as	   HNO	   donors	   in	  
complement	   to	   the	  existing	   series	  of	   secondary	  amine-­‐based	  derivatives,	   however	  
the	  comparison	  in	  versatility	  is	  proving	  to	  be	  no	  match.51,52	  	  So	  far,	  the	  only	  reported	  
example	   in	   its	   salt	   form	   is	   the	   isopropyl	   amine	   derivative	   IPA/NO,	   as	   these	  
compounds	  are	  prone	  to	  explosive	  degradation	  and	  must	  be	  stored	  in	  small	  batches	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IPA/NO	  efficiently	  produces	   ca.	   equimolar	   amounts	   of	  HNO	  and	  NO	  at	   neutral	   pH	  
along	  with	  a	  nitrosamine	  and	  isopropylamine,	  respectively	  (Scheme	  1-­‐7a).	  	  The	  HNO	  
formation	  pathway	  requires	  tautomerization	  of	  a	   labile	  proton,	  which	  explains	  the	  
thermal	   instability	   of	   these	   structures.	   	   Furthermore,	   the	   nitrosamine	   byproduct,	  
known	  for	  its	  toxicity	  as	  an	  alkylating	  agent,	  further	  decomposes	  into	  N2	  and	  either	  
isopropylene	  gas	  or	  an	  alkylated	  nucleophile	  (Scheme	  1-­‐7b).	  
	  
Scheme	  1-­‐7.	  	  IPA/NO	  Decomposition	  Pathways	  to	  HNO	  and	  NO	  
	  
	   The	  O2-­‐protected	  variants	  of	  IPA/NO,	  on	  the	  other	  hand,	  provide	  solid-­‐state	  
stability	   to	   this	   class	   of	   compounds.	   	   Unexpectedly,	   dual	   mechanisms	   of	   HNO	  
generation	   by	   IPA/NO-­‐AcOM	   (iPrHN-­‐N(O)=NO–CH2OAc)	   and	   IPA/NO-­‐aspirin	   can	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1.2.4	  	  Acyloxy	  Nitroso	  Compounds	  (AcON)	  
	   Acyloxy	   nitroso	   compounds	   (AcON)	   exist	   as	   blue	   monomeric	   C-­‐nitroso	  
compounds	   and	   are	   prepared	   from	   the	   oxidation	   of	   oximes	   in	   the	   presence	   of	  
carboxylic	   acids.53,54	   	   Hydrolysis	   of	   these	   compounds	   releases	   HNO	   at	   rates	  
dependent	  on	  the	  structure	  of	  the	  acyl	  group	  (Scheme	  1-­‐9a).	   	  However,	  the	  overall	  
chemistry	   of	   this	   class	   of	   HNO	   donors	   is	   more	   complicated	   than	   was	   originally	  
anticipated.	   	   For	   example,	   direct	   and	   HNO-­‐mediated	   reactions	   of	   acyloxy	   nitroso	  
compounds	   have	   been	   demonstrated	   with	   thiol-­‐containing	   proteins	   (Scheme	   1-­‐
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Scheme	  1-­‐9.	  	  Direct	  and	  HNO-­‐Mediated	  Reactions	  of	  Acyloxy	  Nitroso	  Compounds70	  
	  
	  
1.2.5	  	  Precursors	  to	  Acyl	  Nitroso	  Compounds	  (AcN)	  
	   Acyl	   nitroso	   compounds	   are	   transient	   electrophiles	   that	   react	   with	  
nucleophiles	   to	   yield	   HNO,	   and	   are	   the	   most	   common	   organic	   precursors	   to	  
HNO.49,72-­‐75	   	   These	   species	   are	   generated	   by	   a	   variety	   of	   chemical	   processes,	  
including	   the	   reaction	   of	   tertiary	   amine	   N-­‐oxide	   with	   nitrile	   oxides,76-­‐78	   the	  


































































































hydroxylamine	  derivatives,81,82	  the	  thermal	  fragmentation	  of	  Diels-­‐Alder	  adducts,73-­‐
75,79,83-­‐87	  the	  rearrangement	  of	  nitrocarbenes,88,89	  and	  the	  photo-­‐	  or	  thermal-­‐induced	  
fragmentation	   of	   1,2,4-­‐oxadiazole-­‐4-­‐oxide	   derivatives.90,91	   	   The	   Toscano	   Lab	   has	  
generated	   a	   wide	   variety	   of	   both	   thermal	   and	   photochemical	   precursors	   to	   AcN
compounds,	   applying	   time-­‐resolved	   IR	   studies	   for	   the	   direct	   spectroscopic	  
observation	  of	  these	  reactive	  intermediates	  (Scheme	  1-­‐10).56	  	  
Scheme	  1-­‐10.	  	  Generation	  of	  Acyl	  Nitroso	  Compounds	  
1.2.6	  	  Cyanamide	  
N-­‐Hydroxycyanamide	  (HOHN–CN)	  is	  an	  N-­‐substituted	  hydroxylamine	  with	  a	  
carbon-­‐based	  leaving	  group	  (cyanide)	  and	  a	  proposed	  intermediate	  in	  the	  oxidative	  
bioactivation	  of	  cyanamide	  (H2NCN),	  an	  alcohol	  deterrent	  used	  clinically	  in	  Europe,	  
Canada,	   and	   Japan.42-­‐44	   	   Cyanamide	   has	   been	   shown	   to	   generate	   HNO,	  which	   is	   a	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However,	  N-­‐hydroxycyanamide	  is	  unstable	  and	  has	  not	  yet	  been	  isolated	  to	  confirm	  
its	   reactivity.	   In	   addition,	   evidence	   exists	   that	   it	   can	   be	   further	   oxidatively	  
metabolized	  to	  a	  nitrosyl	  cyanide	  intermediate	  (O=NCN)	  that	  can	  also	  generate	  HNO	  
following	  hydrolysis	  of	  the	  nitrile	  group	  to	  form	  an	  acyl	  nitroso	  compound	  (Scheme	  
1-­‐11).44	   	   An	  N,O-­‐dibenzoyl	   derivative	   of	  N-­‐hydroxycyanamide	   has	   been	   reported,	  
but	   this	  precursor	   releases	  HNO	  not	  via	  N-­‐hydroxycyanamide,	  but	  presumably	  via	  
an	   acyl	   nitroso	   intermediate,	   and	   only	   following	   treatment	   with	   esterase	   or	   base	  
(Scheme	  1-­‐12).81	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§ 1.3	  	  Introduction	  to	  This	  Work	  
The	  two	  general	  strategies	  we	  have	  used	  to	  generate	  HNO	  at	  physiological	  pH	  
and	  temperature	  are	  the	  dissociation	  of	  N-­‐substituted	  hydroxylamines	  where	  X	  is	  a	  
good	  leaving	  group	  and	  the	  generation	  and	  hydrolysis	  of	  AcN	  compounds	  (Scheme	  
1-­‐13).	   	   Piloty’s	   acid	   and	   its	   derivatives,	   with	   sulfinate	   leaving	   groups,	   are	   classic	  
examples	  of	  the	  former	  strategy.	  	  	  
Scheme	  1-­‐13.	  	  General	  Strategies	  for	  HNO	  Release	  
	  
	   As	  organic	  chemists	  studying	  in	  this	  field,	  there	  is	  a	  desire	  to	  “add	  carbon”	  to	  
HNO	  such	  that	  we	  may	  continue	  to	  call	  ourselves	  organic	  chemists.	   	  Therefore,	  we	  
have	   synthesized	   and	   examined	   alternative	   carbon-­‐based	   leaving	   groups	   suitable	  
for	  HNO	  generation	  at	  neutral	  pH	  without	  enzymatic	  activation.	  	  Importantly,	  these	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Fortunately,	   much	   stronger	   carbon-­‐based	   acids	   exist	   that	   we	   propose	   could	   be	  
suitable	   leaving	   groups.	   	   Chapter	   2	   introduces	   three	   new	   classes	   of	   HNO	   donors	  
based	  on	  Meldrum’s	  acid,	  barbituric	  acid,	  and	  pyrazolone	  scaffolds.	  	  Chapter	  3	  deals	  
with	   the	   expansion	   of	   the	   pyrazolone	   scaffold,	   while	   Chapter	   4	   expands	   on	   the	  
barbituric	  acid	  scaffold,	  which	  includes	  overcoming	  alternative,	  non-­‐HNO	  formation	  
pathways.	   	   Lastly,	   Chapter	   5	   discusses	   the	   application	   of	   an	   assay	   developed	   to	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   I.	   J.	  Am.	  Chem.	  Soc.	  2012,	  134,	  
12016−12027.	  
	  
(20)	  Gratzel,	  M.;	   Taniguchi,	   S.;	  Henglein,	   A.	  Ber.	  Bunsen-­‐Ges.	  Phys.	  Chem.	  1970,	  74,	  
1003–1010.	  
	  
(21)	  Ellis,	  Jr.,	  H.	  B.;	  Ellison,	  G.	  B.	  J.	  Chem.	  Phys.	  1983,	  78,	  6541–6558.	  
	  
(22)	  Miranda,	  K.	  Coord.	  Chem.	  Rev.	  2005,	  249,	  433−455.	  
	  
(23)	  Fukuto,	  J.	  M.;	  Bartberger,	  M.	  D.;	  Dutton,	  A.	  S.;	  Paolocci,	  N.;	  Wink,	  D.	  A.;	  Houk,	  K.	  
N.	  Chem.	  Res.	  Toxicol.	  2005,	  18,	  790−801.	  
	  
(24)	  Irvine,	   J.	  C.;	  Ritchie,	  R.	  H.;	  Favaloro,	   J.	  L.;	  Andrews,	  K.	  L.;	  Widdop,	  R.	  E.;	  Kemp-­‐
Harper,	  B.	  K.	  Trends	  Pharmacol.	  Sci.	  2008,	  29,	  601−608.	  
	  
(25)	   Fukuto,	   J.	   M.;	   Bianco,	   C.	   L.;	   Chavez,	   T.	   A.	   Free	   Radical	   Biol.	   Med.	   2009,	   47,	  
1318−1324.	  
	  
(26)	   Flores-­‐Santana,	   W.;	   Salmon,	   D.	   J.;	   Donzelli,	   S.;	   Switzer,	   C.	   H.;	   Basudhar,	   D.;	  
Ridnour,	  L.;	  Cheng,	  R.;	  Glynn,	  S.	  A.;	  Paolocci,	  N.;	  Fukuto,	  J.	  M.;	  Miranda,	  K.	  M.;	  Wink,	  D.	  
A.	  Antioxid.	  Redox	  Signaling	  2011,	  14,	  1659−1674.	  
	  
(27)	  Kemp-­‐Harper,	  B.	  K.	  Antioxid.	  Redox	  Signaling	  2011,	  14,	  1609−1613.	  
	  
(28)	   Tocchetti,	   C.	   G.;	   Stanley,	   B.	   A.;	   Murray,	   C.	   I.;	   Sivakumaran,	   V.;	   Donzelli,	   S.;	  
Mancardi,	  D.;	  Pagliaro,	  P.;	  Gao,	  W.	  D.;	  van	  Eyk,	  J.;	  Kass,	  D.	  A.;	  Wink,	  D.	  A.;	  Paolocci,	  N.	  
Antioxid.	  Redox	  Signaling	  2011,	  14,	  1687–1698.	  
	  
	   20	  
(29)	  Doyle,	  M.	  P.;	  Mahapatro,	  S.	  N.;	  Broene,	  R.	  D.;	  Guy,	   J.	  K.	   J.	  Am.	  Chem.	  Soc.	  1988,	  
110,	  593–599.	  
	  
(30)	  Wong,	  P.	  S.	  Y.;	  Hyun,	  J.;	  Fukuto,	  J.	  M.;	  Shirota,	  F.	  N.;	  DeMaster,	  E.	  G.;	  Shoeman,	  D.	  	  	  
W.;	  Nagasawa,	  H.	  T.	  Biochemistry	  1998,	  37,	  5362–5371.	  
	  
(31)	  Bartberger,	  M.	  D.;	  Fukuto,	  J.	  M.;	  Houk,	  K.	  N.	  Proc.	  Natl.	  Acad.	  Sci.	  U.S.A.	  2001,	  98,	  
2194–2198.	  
	  
(32)	  Janaway,	  G.	  A.;	  Brauman,	  J.	  I.	  J.	  Phys.	  Chem.	  A	  2000,	  104,	  1795–1798.	  
	  
(33)	  Bartberger,	  M.	  D.;	   Liu,	  W.;	   Ford,	   E.;	  Miranda,	   K.	  M.;	   Switzer,	   C.;	   Fukuto,	   J.	  M.;	  
Farmer,	  P.	   J.;	  Wink,	  D.	  A.;	  Houk,	  K.	  N.	  Proc.	  Natl.	  Acad.	  Sci.	  U.S.A.	  2002,	  99,	   10958–
10963.	  
	  
(34)	  Shafirovich,	  V.;	  Lymar,	  S.	  V.	  J.	  Am.	  Chem.	  Soc.	  2003,	  125,	  6547–6552.	  
	  
(35)	  Bazylinski,	  D.	  A.;	  Hollocher,	  T.	  C.	  J.	  Am.	  Chem.	  Soc.	  1985,	  107,	  7982–6.	  	  
	  
(36)	  Farmer,	  P.	  J.;	  Sulc,	  F.	  J.	  Inorg.	  Biochem.	  2005,	  99,	  166–184.	  	  
	  
(37)	  Sulc,	  F.;	   Immoos,	  C.	  E.;	  Pervitsky,	  D.;	  Farmer,	  P.	   J.	   J.	  Am.	  Chem.	  Soc.	  2004,	  126,	  
1096–1101.	  
	  
(38)	  Immoos,	  C.	  E.;	  Sulc,	  F.;	  Farmer,	  P.	  J.;	  Czarnecki,	  K.;	  Bocian,	  D.	  F.;	  Levina,	  A.;	  	  
Aitken,	  J.	  B.;	  Armstrong,	  R.	  S.;	  Lay,	  P.	  A.	  J.	  Am.	  Chem.	  Soc.	  2005,	  127,	  814–815.	  
	  
(39)	  Murphy,	  M.	  E.;	  Sies,	  H.	  Proc.	  Natl.	  Acad.	  Sci.	  U.S.A.	  1991,	  88,	  10860–4.	  	  
	  
(40)	  Liochev,	  S.	  I.;	  Fridovich,	  I.	  J.	  Biol.	  Chem.	  2001,	  276,	  35253–35257.	  
	  
(41)	  Marti,	  M.	  A.;	  Bari,	  S.	  E.;	  Estrin,	  D.	  A.;	  Doctorovich,	  F.	  J.	  Am.	  Chem.	  Soc.	  2005,	  127,	  
4680–4684.	  	  
	  
(42)	  Dobmeier,	  K.	  P.;	  Riccio,	  D.	  A.;	   Schoenfisch,	  M.	  H.	  Anal.	  Chem.	  2008,	   80,	   1247–
1254.	  
	  
(43)	  Dixon,	  R.	  N.	  J.	  Chem.	  Phys.	  1996,	  104,	  6905–6906.	  
	  
(44)	   DeMaster,	   E.	   G.;	   Redfern,	   B.;	   Nagasawa,	   H.	   T.	  Biochem.	   Pharmacol.	  1998,	   55,	  
2007−2015.	  
	  
(45)	  Nagasawa,	  H.	  T.;	  DeMaster,	  E.	  G.;	  Redfern,	  B.;	  Shirota,	  F.	  N.;	  Goon,	  D.	  J.	  W.	  J.	  Med.	  
Chem.	  1990,	  33,	  3120−3122.	  
	  
	  
	   21	  
(46)	   Shirota,	   F.	   N.;	   Goon,	   D.	   J.	   W.;	   DeMaster,	   E.	   G.;	   Nagasawa,	   H.	   T.	   Biochem.	  
Pharmacol.	  1996,	  52,	  141−147.	  
	  
(47)	  Angeli,	  A.	  Gazz.	  Chim.	  Ital.	  1896,	  26,	  17–25.	  
	   	  
(48)	  Piloty,	  O.	  Ber.	  Dtsch.	  Chem.	  Ges.	  1896,	  29,	  1559–1567.	  
	   	  
(49)	  Miranda,	  K.	  M.;	  Nagasawa,	  H.	  T.;	  Toscano,	   J.	  P.	  Curr.	  Top.	  Med.	  Chem.	  2005,	  5,	  
649–664.	  
	   	  
(50)	  DuMond,	  J.	  F.;	  King,	  S.	  B.	  Antioxid.	  Redox	  Signaling	  2011,	  14,	  1637–1648.	  
	  
(51)	  Miranda,	  K.	  M.;	  Katori,	  T.;	  Torres	  de	  Holding,	  C.	  L.;	  Thomas,	  L.;	  Ridnour,	  L.	  A.;	  
McLendon,	   W.	   J.;	   Cologna,	   S.	   M.;	   Dutton,	   A.	   S.;	   Champion,	   H.	   C.;	   Mancardi,	   D.;	  
Tocchetti,	  C.	  G.;	   Saavedra,	   J.	  E.;	  Keefer,	  L.	  K.;	  Houk,	  K.	  N.;	  Fukuto,	   J.	  M.;	  Kass,	  D.	  A.;	  
Paolocci,	  N.;	  Wink,	  D.	  A.	  J.	  Med.	  Chem.	  2005,	  48,	  8220–8228.	  
	   	  
(52)	  Salmon,	  D.	  J.;	  Torres	  de	  Holding,	  C.	  L.;	  Thomas,	  L.;	  Peterson,	  K.	  V.;	  Goodman,	  G.	  
P.;	   Saavedra,	   J.	   E.;	   Srinivasan,	  A.;	  Davies,	   K.	  M.;	   Keefer,	   L.	   K.;	  Miranda,	  K.	  M.	   Inorg.	  
Chem.	  2011,	  50,	  3262–3270.	  
	   	  
(53)	  Sha,	  X.;	  Isbell,	  T.	  S.;	  Patel,	  R.	  P.;	  Day,	  C.	  S.;	  King,	  S.	  B.	  J.	  Am.	  Chem.	  Soc.	  2006,	  128,	  
9687–9692.	  
	   	  
(54)	  Shoman,	  M.	  E.;	  DuMond,	  J.	  F.;	  Isbell,	  T.	  S.;	  Crawford,	  J.	  H.;	  Brandon,	  A.;	  Honovar,	  
J.;	  Vitturi,	  D.	  A.;	  White,	   C.	  R.;	   Patel,	  R.	   P.;	  King,	   S.	  B.	   J.	  Med.	  Chem.	  2011,	  54,	   1059–
1070.	  
	   	  
(55)	  Corrie,	   J.	   E.	   T.;	  Kirby,	  G.	  W.;	  Mackinnon,	   J.	  W.	  M.	   J.	  Chem.	  Soc.,	  Perkin	  Trans.	  1	  
1985,	  883–886.	  
	   	  
(56)	  Cohen,	  A.	  D.;	  Zeng,	  B.-­‐B.;	  King,	  S.	  B.;	  Toscano,	  J.	  P.	   J.	  Am.	  Chem.	  Soc.	  2003,	  125,	  
1444–1445.	  
	   	  
(57)	  Fukuto,	  J.	  M.;	  Bartberger,	  M.	  D.;	  Dutton,	  A.	  S.;	  Paolocci,	  N.;	  Wink,	  D.	  A.;	  Houk,	  K.	  
N.	  Chem.	  Res.	  Toxicol.	  2005,	  18,	  790–801.	  
	   	  
(58)	  Miranda,	  K.	  M.	  Coord.	  Chem.	  Rev.	  2005,	  249,	  433–455.	  
	  
(59)	  Hrabie,	  J.	  A.;	  Keefer,	  L.	  K.	  Chem.	  Rev.	  2002,	  102,	  1135–1154.	  
	  
(60)	  Thomas,	  D.	  D.;	  Miranda,	  K.	  M.;	  Espey,	  M.	  G.;	  Citrin,	  D.;	  Jourd’Heuil,	  D.;	  Paolocci,	  
N.;	   Hewett,	   S.	   J.;	   Colton,	   C.	   A.;	   Grisham,	   M.	   B.;	   Feelisch,	   M.;	   Wink,	   D.	   A.	  Methods	  
Enzymol.	  2002,	  359,	  84–105.	  
	  
(61)	  Keefer,	  L.	  K.	  Annu.	  Rev.	  Pharmacol.	  Toxicol.	  2003,	  43,	  585–607.	  
	   22	  
	  
(62)	  Feelisch,	  M.;	  Stamler,	  J.	  S.	  Donors	  of	  Nitrogen	  Oxides.	  In	  Methods	  in	  Nitric	  Oxide	  
Research;	  Feelisch,	  M.,	   Stamler,	   J.	   S.,	  Eds.;	   John	  Wiley	  &	  Sons:	  New	  York,	  1996;	  pp	  
71–115.	  
	  
(63)	  Bonner,	  F.	  T.;	  Ravid,	  B.	  Inorg.	  Chem.	  1975,	  14,	  558–563.	  
	  
(64)	  Hughes,	  M.	  N.;	  Wimbledon,	  P.	  E.	  J.	  Chem.	  Soc.,	  Dalton	  Trans.	  1976,	  8,	  703–707.	  
	  
(65)	  Bonner,	  F.T.;	  Ko,	  Y.	  Inorg.	  Chem.	  1992,	  31,	  2514–2519.	  
	  
(66)	  Zamora,	  R.;	  Grzesiok,	  A.;	  Weber,	  H.;	  Feelisch,	  M.	  Biochem.	  J.	  1995,	  312,	  333–339.	  
	  
(67)	  Toscano,	  J.	  P.;	  Brookfield,	  F.	  A.;	  Cohen,	  A.	  D.;	  Courtney,	  S.	  M.;	  Frost,	  L.	  M.;	  Kalish,	  
V.	  J.	  	  “N-­‐Hydroxysulfonamide	  Derivatives	  as	  Physiologically	  Useful	  Nitroxyl	  Donors”	  
U.S.	  Patent	  8,030,356,	  2011.	  
	  
(68)	   Andrei,	   D.;	   Salmon,	   D.	   J.;	   Donzelli,	   S.;	   Wahab,	   A.;	   Klose,	   J.	   R.;	   Citro,	   M.	   L.;	  
Saavedra,	  J.	  E.;	  Wink,	  D.	  A.;	  Miranda,	  K.	  M.;	  Keefer,	  L.	  K.	  	  J.	  Am.	  Chem.	  Soc.	  2010,	  132,	  
16526–16532.	  
	  
(69)	  Basudhar,	  D.;	  Bharadwaj,	  G.;	  Cheng,	  R.	  Y.;	  Jain,	  S.;	  Shi,	  S.;	  Heinecke,	  J.	  L.;	  Holland,	  
R.	   J.;	  Ridnour,	  L.	  A.;	  Caceres,	  V.	  M.;	  Spadari-­‐Bratfisch,	  R.	  C.;	  Paolocci,	  N.;	  Vela ́zquez-­‐
Martínez,	  C.	  A.;	  Wink,	  D.	  A.;	  Miranda,	  K.	  M.	  	  J.	  Med.	  Chem.	  2013,	  56,	  7804−7820.	  
	  
(70)	  Mitroka,	  S.;	  Shoman,	  M.	  E.;	  DuMond,	  J.	  F.;	  Bellavia,	  L.;	  Aly,	  O.	  M.;	  Abdel-­‐Aziz,	  M.;	  
Kim-­‐Shapiro,	  D.	  B.;	  King,	  S.	  B.	  	  J.	  Med.	  Chem.	  2013,	  56,	  6583−6592.	  
	  
(71)	  Shoman,	  M.	  E.;	  DuMond,	  J.	  F.;	  Isbell,	  T.	  S.;	  Crawford,	  J.	  H.;	  Brandon,	  A.;	  Honovar,	  
J.;	  Vitturi,	  D.	  A.;	  White,	   C.	  R.;	   Patel,	  R.	   P.;	  King,	   S.	  B.	   J.	  Med.	  Chem.	  2011,	  54,	   1059–
1070.	  
	  
(72)	  King,	  S.	  B.;	  Nagasawa,	  H.	  T.	  Methods	  Enzymol.	  1999,	  301,	  211–220.	  
	  
(73)	  Atkinson,	  R.	  N.;	  Storey,	  B.	  M.;	  King,	  S.	  B.	  Tetrahedron	  Lett.	  1996,	  37,	  9287–9290.	  
	  
(74)	  Kirby,	  G.	  W.;	  Sweeny,	  J.	  G.	  J.	  Chem.	  Soc.	  Perkin	  Trans.	  1	  1981,	  3250–3254.	  
	  
(75)	   Corrie,	   J.	   E.	   T.;	   Kirby,	   G.	  W.;	  Mackinnon,	   J.	  W.	  M.	   J.	  Chem.	  Soc.	  Perkin	  Trans.	  1	  
1985,	  883–886.	  
	  
(76)	  Quadrelli,	  P.;	  Invernizzi,	  A.	  G.;	  Caramella,	  P.	  Tetrahedron	  Lett.	  1996,	  37,	  1909–
1912.	  
	  
(77)	  Quadrelli,	  P.;	  Mella,	  M.;	  Caramella,	  P.	  Tetrahedron	  Lett.	  1998,	  39,	  3233–3236.	  
	  
	   23	  
(78)	  Quadrelli,	   P.;	  Mella,	  M.;	   Invernizzi,	   A.	   G.;	   Caramella,	   P.	  Tetrahedron	  1999,	  55,	  
10497–10510.	  
	  
(79)	  Kirby,	  G.	  W.	  Chem.	  Soc.	  Rev.	  1977,	  6,	  1–24.	  
	  
(80)	  Kirby,	  G.	  W.;	  Sweeny,	  J.	  G.	  Chem.	  Commun.	  1973,	  704–705.	  
	  
(81)	  Nagasawa,	  H.	  T.;	  Lee,	  M.	   J.;	  Kwon,	  C.	  H.;	  Shirota,	  F.	  N.;	  DeMaster,	  E.	  G.	  Alcohol	  
1992,	  9,	  349–353.	  
	  
(82)	  Sutton,	  A.	  D.;	  Williamson,	  M.;	  Weismiller,	  H.;	  Toscano,	  J.	  P.	  Org.	  Lett.	  2012,	  14,	  
472–475.	  	  
	  
(83)	  Keck,	  G.	  E.;	  Webb,	  R.	  R.;	  Yates,	  J.	  B.	  Tetrahedron	  Lett.	  1981,	  37,	  4007–4016.	  
	  
(84)	  Ensley,	  H.	  E.;	  Mahadevan,	  S.	  Tetrahedron	  Lett.	  1989,	  30,	  3255–3258.	  
	  
(85)	  Xu,	  Y.	  P.;	  Alavanja,	  M.	  M.;	  Johnson,	  V.	  L.;	  Yasaki,	  G.;	  King,	  S.	  B.	  Tetrahedron	  Lett.	  
2000,	  41,	  4265–4269.	  
	  
(86)	  Zeng,	  B.	  B.;	  King,	  S.	  B.	  Synthesis	  2002,	  2335–2337.	  
	  
(87)	  Zeng,	  B.	  B.;	  Huang,	  J.	  M.;	  Wright,	  M.	  W.;	  King,	  S.	  B.	  Bioorg.	  Med.	  Chem.	  Lett.	  2004,	  
14,	  5565–5568.	  
	  
(88)	  O'Bannon,	  P.	  E.;	  Dailey,	  W.	  P.	  Tetrahedron	  Lett.	  1988,	  29,	  987–990.	  
	  
(89)	  O'Bannon,	  P.	  E.;	  Dailey,	  W.	  P.	  Tetrahedron	  Lett.	  1988,	  29,	  5719–5722.	  
	  
(90)	  Quadrelli,	  P.;	  Mella,	  M.;	  Caramella,	  P.	  Tetrahedron	  Lett.	  1999,	  40,	  797–800.	  
	  
(91)	  Quadrelli,	  P.;	  Campari,	  G.;	  Mella,	  M.;	  Caramella,	  P.	  Tetrahedron	  Lett.	  2000,	  41,	  
2019–2022.	  
	   24	  
Chapter	  2.	  
Development	  of	  N-­‐Substituted	  
Hydroxylamines	  as	  Efficient	  	  






§ 2.1	  	  Abstract	  
	   Due	   to	   its	   inherent	   reactivity,	   nitroxyl	   (HNO)	   must	   be	   generated	   in	   situ	  
through	   the	   use	   of	   donor	   compounds,	   but	   very	   few	   physiologically	   useful	   HNO	  
donors	   exist.	   	   Novel	   N-­‐substituted	   hydroxylamines	   with	   carbon-­‐based	   leaving	  
groups	   have	   been	   synthesized,	   and	   their	   structures	   confirmed	   by	   X-­‐ray	  
crystallography.	   	   These	   compounds	   generate	   HNO	   under	   nonenzymatic,	  
physiological	   conditions,	   with	   the	   rate	   and	   amount	   of	   HNO	   released	   being	  
dependent	   mainly	   on	   the	   nature	   of	   the	   leaving	   group.	   	   A	   barbituric	   acid	   and	   a	  
pyrazolone	  derivative	  have	  been	  developed	  as	  efficient	  HNO	  donors	  with	  half-­‐lives	  























t1/2  = 9.5 min
37 °C
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§ 2.2	  	  Introduction	  
	   Nitroxyl	  (HNO)	  has	  been	  shown	  to	  have	  biological	  activity	  distinct	  from	  that	  
of	   its	  redox	  cousin,	  nitric	  oxide	  (NO),	  and	  related	  nitrogen	  oxides.1−11	   	  Much	  of	  the	  
recent	   interest	   in	  HNO	  has	  been	  catalyzed	  by	  research	  suggesting	  that	   it	  may	  be	  a	  
novel	  therapeutic	  for	  the	  treatment	  of	  heart	  failure.1−5	  	  At	  neutral	  pH	  in	  the	  absence	  
of	  chemical	  traps,	  HNO	  efficiently	  dimerizes	  (k	  =	  8	  ×	  106	  M−1s−1)	  to	  hyponitrous	  acid	  
(HON=NOH),	  which	   subsequently	   dehydrates	   to	   nitrous	   oxide	   (N2O).12	   	   Given	   this	  
inherent	  reactivity,	  HNO	  cannot	  be	  used	  directly;	  donor	  molecules	  are	  required	  for	  
the	  generation	  of	  HNO	  in	  situ.	  	  	  
	   The	   most	   commonly	   used	   HNO	   donor	   is	   Angeli’s	   salt	   (AS)	   (Figure	   2-­‐1),	   a	  
compound	  that	  has	  been	  known	  since	  1896.13	  	  That	  same	  year,	  another	  HNO	  donor,	  
Piloty’s	  acid	  (PA),	  was	  also	  reported.14	  	  In	  the	  intervening	  115	  years,	  very	  few	  other	  
classes	   of	   HNO	   donors	   suitable	   for	   use	   under	   physiological	   conditions	   have	   been	  
developed.15,16	   	   These	   include	   primary	   amine-­‐based	   diazeniumdiolates	   such	   as	  
IPA/NO,17,18	   acyloxy	   nitroso	   compounds	   (AcON),19,20	   and	   precursors	   to	   the	   acyl	  
nitroso	   compounds	   (AcN),21−23	   which	   themselves	   are	   unstable.	   	   Indeed,	   several	  
recent	  reviews	  of	  HNO	  chemistry	  and	  biology	  have	  made	  pleas	  for	  new	  donors.6−8	  	  
	  
Figure	  2-­‐1.	  	  Previously	  reported	  classes	  of	  HNO	  donors.	  
	   Herein,	  we	   are	   pleased	   to	   report	   a	   new	   class	   of	  HNO	   donors	   based	   on	   the	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a	   good	   leaving	   group.	   	   Piloty’s	   acid	   and	   its	   derivatives,24	   with	   sulfinate	   leaving	  
groups,	  are	  classic	  examples	  of	  this	  strategy.	  	  We	  have	  employed	  good	  carbon-­‐based	  
leaving	  groups	  such	   that	  HNO	   is	   released	  along	  with	  a	  stable	  carbanion	  at	  neutral	  
pH.	  	  	  
Scheme	  2-­‐1.	  	  General	  Strategy	  for	  HNO	  Release	  
	  
	   N-­‐Hydroxycyanamide	  (HOHN–CN)	  is	  an	  N-­‐substituted	  hydroxylamine	  with	  a	  
carbon-­‐based	  leaving	  group	  (cyanide)	  and	  a	  proposed	  intermediate	  in	  the	  oxidative	  
bioactivation	  of	  cyanamide	  (H2NCN),	  an	  alcohol	  deterrent	  used	  clinically	  in	  Europe,	  
Canada,	   and	   Japan.25−27	   	   Cyanamide	   has	   been	   shown	   to	   generate	  HNO,	  which	   is	   a	  
potent	   inhibitor	   of	   aldehyde	   dehydrogenase,	   following	   metabolic	   activation.	  	  
However,	  N-­‐hydroxycyanamide	  is	  unstable	  and	  has	  not	  yet	  been	  isolated	  to	  confirm	  
its	   reactivity.	   In	   addition,	   evidence	   exists	   that	   it	   can	   be	   further	   oxidatively	  
metabolized	  to	  a	  nitrosyl	  cyanide	  intermediate	  (O=NCN)	  that	  can	  also	  generate	  HNO	  
following	   hydrolysis	   of	   the	   nitrile	   group	   to	   form	   an	   acyl	   nitroso	   compound.26	   	   An	  
N,O-­‐dibenzoyl	   derivative	   of	   N-­‐hydroxycyanamide	   has	   been	   reported,	   but	   this	  
precursor	   releases	  HNO	  not	   via	  N-­‐hydroxycyanamide,	   but	   presumably	   via	   an	   acyl	  
nitroso	  intermediate,	  and	  only	  following	  treatment	  with	  esterase	  or	  base.28	  
	   We	   have	   synthesized	   and	   examined	   alternative	   N-­‐substituted	  
hydroxylamines	  with	   carbon-­‐based	   leaving	   groups	   suitable	   for	  HNO	  generation	   at	  
neutral	  pH	  without	  enzymatic	  activation.	  In	  addition,	  these	  derivatives	  importantly	  
avoid	  the	  release	  of	  toxic	  cyanide.	  
HN OH
X
HNO    +    XpH 7.4
H+
. .
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§ 2.3	  	  Results	  and	  Discussion	  
	   We	   first	   considered	   Meldrum’s	   acid	   derivative	   1a,	   which	   was	   expected	   to	  
generate	   HNO	   as	   shown	   in	   Scheme	   2-­‐2a.	   	   This	   precursor	   was	   easily	   synthesized	  
without	   the	   need	   for	   chromatographic	   purification	   by	   formation	   of	   the	  
corresponding	   bromide	   followed	   by	   reaction	   with	   N,O-­‐bis(tert-­‐butoxycarbonyl)	  
hydroxylamine	   and	   subsequent	   acid	   deprotection,	   as	   shown	   in	   Scheme	   2-­‐3.	   	   The	  
other	   precursors	   reported	   here	   were	   synthesized	   analogously,	   and	   all	   structures	  
were	   confirmed	   by	   X-­‐ray	   crystallography.	   	   (See	   Experimental	   and	   Supporting	  
Information	  for	  experimental	  details	  concerning	  the	  synthesis	  and	  characterization	  
of	  all	  precursors.)	  	  
Scheme	  2-­‐2.	  	  Potential	  HNO	  Release	  Pathways	  from	  (a)	  Meldrum’s	  Acid	  Derivatives	  1a	  
and	  2a	  and	  (b)	  Barbituric	  Acid	  Derivatives	  3a	  and	  4a	  
	  
	  
Scheme	  2-­‐3.	  	  Synthesis	  of	  Meldrum’s	  Acid	  Derivative	  1a	  
	  
1a  R: CH3













3a  R: CH2CH3




















1b  R: CH3
2b  R: C(CH3)=NOCH3
3b  R: CH2CH3
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   Compound	   1a	   was	   examined	   for	   HNO	   generation	   by	   gas	   chromatographic	  
(GC)	   headspace	   analysis	   to	   quantify	   the	   amount	   of	   its	   dimerization	   product,	   N2O,	  
formed	  following	  decomposition	  in	  pH	  7.4	  phosphate	  buffered	  saline	  (PBS)	  at	  37	  °C.	  	  
(See	   Experimental	   for	   details.)	   	   Unfortunately,	   only	   trace	   amounts	   of	   N2O	   are	  
observed	  (Table	  2-­‐1).	  	  Meldrum’s	  acid	  (pKa	  =	  4.8)29	  is	  completely	  ionized	  at	  pH	  7.4,	  
and	   its	   5,5-­‐dimethyl	   derivative	   has	   a	   hydrolysis	   half-­‐life	   of	   about	   12	   h	   under	  
physiological	   conditions.30	   	  Nonetheless,	   the	  major	  product	  observed	   for	  1a	   by	   1H	  
NMR	   spectroscopy	   is	   acetone	   (Supporting	   Information),	   indicative	   of	   a	   dominant	  
ring-­‐opening	  reaction	  pathway.	  	  	  
Table	  2-­‐1.	  	  Decomposition	  of	  HNO	  Donors	  
donor	   %	  HNOa	   %	  carbanionb	   t1/2	  (min)c	  
1a	   2	   4d	   f	  
2a	   25	   34d	   0.9	  
3a	   2	   6e	   f	  
4a	   110	   >95	   0.7	  
6a	   110	   >95	   9.5	  
aDonor	  compounds	  (0.1	  mM)	  were	  incubated	  at	  37	  °C	  in	  PBS,	  pH	  7.4.	  	  HNO	  yields	  are	  reported	  
relative	   to	   the	   standard	   HNO	   donor,	   Angeli’s	   salt,	   as	   determined	   by	   N2O	   headspace	   analysis	  
(SEM	  ±	  5%;	  n	  ≥	  3).	  	  N2O	  production	  was	  completely	  quenched	  with	  added	  glutathione	  (0.2	  mM).	  	  
bYields	  of	  carbanions	  1b–4b,	  6b	  were	  determined	  by	  1H	  NMR	  spectroscopy.	  	  cDetermined	  from	  
UV-­‐vis	   kinetic	   experiments.	   	   dRelative	   to	   the	   major	   byproduct,	   acetone.	   	   eRelative	   to	  
rearrangement	  byproduct	  5.	  	  fNot	  determined.	  
	  
	   We	  next	  examined	  Meldrum’s	  acid	  derivative	  2a,	  equipped	  with	  an	  electron-­‐
deficient	  O-­‐methyloxime	  moiety.	  	  Relative	  to	  1a,	  an	  enhanced	  HNO	  yield	  is	  observed	  
(Table	  2-­‐1),	  attributed	  to	  2b	  being	  a	  better	  leaving	  group.	  	  However,	  acetone	  is	  still	  
the	   major	   product,	   indicating	   that	   the	   non-­‐HNO	   producing	   ring-­‐opening	   reaction	  
pathway	  remains	  competitive	  with	  the	  desired	  pathway.	   	  Evidently,	  a	  more	  robust	  
ring	  system	  that	  disfavors	  alternative	  decomposition	  pathways	  is	  necessary.	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   To	  explore	  the	  impact	  of	  a	  different	  ring	  system,	  we	  evaluated	  barbituric	  acid	  
derivatives	  3a	  and	  4a	  (Scheme	  2-­‐2b).	   	  Barbiturate	  3a	  unexpectedly	  produced	  very	  
little	   HNO	   (Table	   2-­‐1).	   	   Following	   a	   large-­‐scale	   decomposition,	   the	  major	   organic	  
byproduct	   was	   isolated	   and	   identified	   by	   X-­‐ray	   crystallography,	   revealing	   that	  
barbiturate	  3a	  primarily	  undergoes	  an	  intramolecular	  rearrangement	  to	  compound	  
5	  in	  pH	  7.4	  buffer	  solutions	  (Scheme	  2-­‐4).	  	  	  
Scheme	  2-­‐4.	  	  Major	  Reaction	  Pathway	  for	  Barbiturate	  3a	  
	  
	   Given	   the	   positive	   impact	   that	   an	   electron-­‐deficient	   O-­‐methyloxime	   group	  
had	   on	   HNO	   production	   from	   Meldrum’s	   acid	   derivatives	   above,	   we	   analyzed	   an	  
analogous	  substitution	  on	  the	  barbituric	  acid	  ring	  system.	  	  Satisfyingly,	  exchanging	  
the	  ethyl	  group	  in	  3a	  with	  an	  O-­‐methyloxime	  in	  barbiturate	  4a	  strongly	  favors	  the	  
generation	   of	   HNO,	   as	   reflected	   by	   the	   high	   yield	   of	   N2O	   observed	   following	  
decomposition	  (Table	  2-­‐1).	   	  HNO	  was	  confirmed	  as	   the	  source	  of	  N2O	   for	   this	  and	  
the	   other	   precursors	   examined	   by	   quenching	   with	   glutathione,	   a	   known	   efficient	  
trap	  for	  HNO.31,32	  	  	  
	   The	  decomposition	  of	  4a	  was	  monitored	  by	  1H	  NMR	  spectroscopy	  in	  PBS	  (pH	  
7.4,	   room	   temperature),	   and	   the	   only	   detectable	   organic	   byproduct	   was	   the	  
expected	  carbanion	  4b	  (Figure	  2-­‐2a).	  	  With	  an	  estimated	  pKa	  of	  ca.	  4	  (Figure	  2-­‐3a),	  
the	  byproduct	  is	  completely	  ionized	  at	  neutral	  pH.	  	  Influenced	  by	  the	  O-­‐methyloxime	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4.7).33	   	   Although	   the	   pharmacology	   of	   4b	   has	   not	   yet	   been	   evaluated,	   barbituric	  
acids	   and	   their	  C5-­‐substituted	  derivatives	   in	   general	  have	   an	  expansive	  history	   in	  
medicinal	   chemistry	   including	   hypnotic,	   sedative,	   antiepileptic,	   and	  
immunomodulation	  applications.34	  
	  
Figure	  2-­‐2.	  	  1H	  NMR	  analysis	  of	  the	  decomposition	  of	  (a)	  4a	  to	  4b	  and	  (b)	  6a	  to	  6b	  in	  10%	  
D2O,	  PBS,	  pH	  7.4	  at	  room	  temperature.	  	  In	  each	  case,	  the	  red	  spectrum	  was	  collected	  at	  
the	  start	  of	   the	  experiment,	  and	  the	  blue	  spectrum	  after	  complete	  decomposition.	   	   In	  
the	  insert	  of	  (a),	  the	  kinetics	  of	  decomposition	  are	  shown.	  	  The	  red	  triangles	  represent	  
the	  N-­‐CH3’s	  (6H)	  and	  the	  oxime	  C-­‐CH3	  (3H)	  of	  4a,	  and	  the	  blue	  circles	  represent	  the	  N-­‐
CH3’s	   (6H)	  and	   the	  oxime	  C-­‐CH3	   (3H)	  of	  carbanion	  4b.	   	  The	  solid	  curves	  are	  calculated	  
best	   fits	   to	   a	   single	   exponential	   function	   (k	   =	   2.4	   ×	   10-­‐3	   s-­‐1	   for	   each	   fit).	   	   In	   (b),	   the	  
asterisks	  (*)	  indicate	  signals	  due	  to	  the	  minor	  anti-­‐6b	  isomer.	  
	  
	   The	  kinetics	  of	  decomposition	  from	  4a	  to	  4b	  was	  easily	  monitored	  by	  UV-­‐vis	  
spectroscopy	  given	  the	  distinctive	  absorbance	  of	  anion	  4b	  (λmax	  =	  261	  nm)	  (Figure	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2-­‐4a).	   	   Analysis	   of	   the	   decomposition	   rate	   as	   a	   function	   of	   pH	   reveals	   a	   sharp	  
increase	  near	  pH	  8	  (Figure	  2-­‐4b).	  	  Barbiturate	  4a	  has	  a	  half-­‐life	  of	  ca.	  1	  min	  at	  pH	  7.4	  
and	  37	  °C	  (Figure	  2-­‐4a)	  but	  is	  relatively	  stable	  at	  pH	  4.0	  and	  room	  temperature,	  with	  
a	  half-­‐life	  of	  approximately	  12	  h	  under	  these	  conditions	  (Supporting	  Information).	  	  	  
	  
	  
Figure	  2-­‐3.	  	  Plot	  of	  the	  concentration	  of	  (a)	  4b,	  4b-­‐H+,	  and	  (b)	  6b,	  6b-­‐H+	  as	  a	  function	  of	  
pH.	  	  In	  (a),	  the	  green	  squares	  represent	  4b-­‐H+	  (λmax	  =	  298	  nm),	  and	  blue	  circles	  represent	  
carbanion	  4b	  (λmax	  =	  261	  nm).	  	  In	  (b),	  the	  green	  squares	  represent	  6b-­‐H+	  (λmax	  =	  270	  nm),	  
where	   the	   last	   three	   data	   points	  were	   omitted	   due	   to	   spectral	   overlap,	   and	   the	   blue	  
circles	   represent	   carbanion	   6b	   (λmax	   =	   253	   nm).	   	   See	   Supporting	   Information	   for	  
representative	  UV-­‐vis	  spectra	  of	  4b	  and	  6b	  at	  high	  and	  low	  pH.	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Figure	  2-­‐4.	  	  UV-­‐vis	  analysis	  of	  the	  decomposition	  of	  (a)	  4a	  (time	  between	  traces	  =	  30	  s)	  
and	   (b)	  6a	   (time	   between	   traces	   =	   240	   s)	   at	   37	   °C	   in	   PBS,	   pH	   7.4.	   	   (c)	   Plot	   of	   UV-­‐vis	  
determined	  decomposition	  rate	  as	  a	   function	  of	  pH	  at	  25	   °C	   for	  4a	   (monitored	  at	  261	  
nm)	  and	  6a	  (monitored	  at	  253	  nm).	  
	  
	   33	  
	   To	  demonstrate	  the	  generality	  of	  this	  approach	  for	  HNO	  generation,	  we	  have	  
also	   examined	  another	  N-­‐substituted	  hydroxylamine	  with	   a	   suitable	   carbon-­‐based	  
leaving	  group.	  	  Like	  barbiturates	  3a	  and	  4a,	  pyrazolone	  6a	  (synthesized	  analogously	  
to	   compounds	   1a−4a)	   also	   takes	   advantage	   of	   the	   formation	   of	   an	   aromatic	  
byproduct	  (6b)	  (Scheme	  2-­‐5)	  and	  efficiently	  produces	  HNO	  with	  a	  half-­‐life	  of	  ca.	  10	  
min	  at	  pH	  7.4,	  37	   °C	   (Table	  2-­‐1).	   	  Another	  potentially	  practical	  benefit	  enjoyed	  by	  
precursor	   6a	   is	   that	   byproduct	   6b,	   formed	   along	   with	   HNO,	   is	   a	   4-­‐substituted	  
derivative	   of	   edaravone	   (Scheme	  2-­‐5),	   a	   potent	   antioxidant	   already	   in	   clinical	   use	  
for	  the	  treatment	  of	  stroke	  and	  cardiovascular	  disease.35,36	  	  Moreover,	  a	  variety	  of	  4-­‐
substituted	  edaravone	  analogues	  have	  also	  shown	  strong	  antioxidant	  activity.37	  	  	  
Scheme	  2-­‐5.	  	  HNO	  Release	  from	  Pyrazolone	  Derivative	  6a	  
	  
	   The	   decomposition	   of	  6a	   was	   analyzed	   similarly	   to	   that	   of	  4a	   by	   1H	   NMR	  
spectroscopy	   in	  PBS	   (pH	  7.4,	   room	   temperature)	   (Figure	  2-­‐2b).	   	   The	  only	  organic	  
byproducts	  observed	  by	  this	  analysis	  are	  the	  syn	  (major)	  and	  anti	  (minor)	  isomers	  
of	  6b	   (Scheme	  2-­‐5),	   and	   the	   relative	   abundance	   of	   these	   isomers	   is	   unchanged	   at	  
high	  and	  low	  pH.	  	  Donors	  6a,	  2a,	  and	  4a	  are	  observed	  to	  be	  all	  syn	  by	  NMR	  analysis	  
and	  X-­‐ray	  crystallography.	  	  	  
	   The	  pKa	  of	  6b/6b-­‐H+	  is	  estimated	  to	  be	  ca.	  6	  (Figure	  2-­‐3b),	  shifted	  below	  that	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this	   byproduct	   is	   ionized	   at	   pH	   7.4.	   	   As	   was	   the	   case	   for	   precursor	   4a,	   the	  
decomposition	   rate	   of	   pyrazolone	   6a	   is	   highly	   pH	   dependent,	   here	   with	   a	   sharp	  
increase	  near	  pH	  10	  (Figure	  2-­‐4c);	  6a	  is	  much	  more	  stable	  at	  pH	  4.0,	  with	  a	  half-­‐life	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§ 2.4	  	  Conclusion	  
	   The	  data	  presented	  on	  compounds	  1a−4a	  and	  6a	  suggest	  that	  the	  ability	  of	  
these	  N-­‐substituted	  hydroxylamines	  to	  generate	  HNO	  is	  based	  mainly	  on	  the	  nature	  
of	  the	  leaving	  group.	  	  To	  produce	  HNO	  efficiently,	  the	  driving	  force	  for	  the	  formation	  
of	   a	   stabilized	   carbanion	   must	   overcome	   other	   non-­‐HNO	   producing	   reaction	  
pathways.	   	  Barbiturate	  4a	  and	  pyrazolone	  6a,	  easily	  synthesized	  without	  the	  need	  
for	   chromatographic	   purification,	   have	   been	   developed	   as	   effective	   HNO	   donors	  
with	  half-­‐lives	  at	  pH	  7.4,	  37	  °C	  of	  0.7	  and	  9.5	  min,	  respectively.	   	  These	  compounds	  
represent	   new	   examples	   of	   the	   general	   strategy	   for	   HNO	   production	   from	   N-­‐
substituted	  hydroxylamines	  with	  good	  leaving	  groups.	  	  Future	  work	  will	  involve	  the	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§ 2.5	  	  Experimental	  
2.5.1	  	  Methods	  and	  Materials	  
All	   starting	   materials	   were	   of	   reagent	   grade	   and	   used	   without	   further	  
purification.	   	   5-­‐Bromo-­‐5-­‐methyl-­‐Meldrum’s	   acid38	   was	   obtained	   through	  
bromination	  of	  5-­‐methyl-­‐Meldrum’s	  acid	  (sodium	  bicarbonate,	  bromine,	  water).	  	  5-­‐
Acetyl-­‐Meldrum’s	   acid39	  was	   obtained	   through	   acylation	   of	  Meldrum’s	   acid	   (acetic	  
acid,	   N,N-­‐dicyclohexylcarbodiimide,	   4-­‐dimethylaminopyridine,	   dichloromethane).	  	  
5-­‐Acetyl	   N,N-­‐dimethylbarbituric	   acid39,40	   was	   obtained	   through	   acylation	   of	   N,N-­‐
dimethylbarbituric	   acid	   (acetyl	   chloride,	   pyridine,	   dichloromethane).	   	   5-­‐Ethyl	  
barbituric	   acid41	   was	   obtained	   through	   reduction	   of	   5-­‐acetyl-­‐Meldrum’s	   acid	  
(sodium	  cyanoborohydride,	  acetic	  acid).	   	  4-­‐Acetyl-­‐N-­‐phenyl-­‐5-­‐methyl-­‐pyrazolone42	  
was	   obtained	   through	   acylation	  of	  N-­‐phenyl-­‐5-­‐methyl-­‐pyrazolone	   (acetyl	   chloride,	  
calcium	   oxide,	   dioxane).	   	   N,O-­‐bis(tert-­‐butoxycarbonyl)-­‐hydroxylamine43	   was	  
obtained	   through	   N,O	   diBoc	   protection	   of	   hydroxylamine	   hydrochloride	   (di-­‐tert-­‐
butyl	   dicarbonate,	   triethylamine,	   petroleum	  ether,	   tert-­‐butyl	  methyl	   ether,	  water).	  	  
NMR	   spectra	  were	   obtained	   on	   a	  Bruker	  Avance	   400	  MHz	  FT-­‐NMR	   spectrometer.	  	  
All	  chemical	  shifts	  are	  reported	  in	  parts	  per	  million	  (ppm)	  relative	  to	  residual	  CHCl3	  
(7.26	  ppm	   for	   1H,	   77.23	  ppm	   for	   13C),	   residual	  DMSO	   (2.50	  ppm	   for	   1H,	   39.52	   for	  
13C),	  or	  residual	  H2O	  (4.8	  ppm	  for	  1H).	  	  High-­‐resolution	  mass	  spectra	  were	  obtained	  
on	   a	   VG	   Analytical	   VG70SE	   magnetic	   sector	   mass	   spectrometer	   operating	   in	   fast	  
atom	  bombardment	  (FAB)	  mode.	  	  Gas	  chromatography	  (GC)	  headspace	  analysis	  was	  
performed	   on	   a	   Varian	   CP-­‐3800	   instrument	   equipped	   with	   ECD	   detection	   and	   a	  
RestekShinCarbon	   ST	   80/100	  molecular	   sieve	   packed	   column.	   	   Ultraviolet-­‐visible	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(UV-­‐vis)	   absorption	   spectra	   were	   obtained	   using	   a	   Hewlett	   Packard	   8453	   diode	  
array	   spectrometer.	   	   Phosphate-­‐buffered	   saline	   (PBS)	   solutions	   (0.1	   M)	   were	  
prepared	   with	   140	   mM	   NaCl	   and	   3	   mM	   KCl,	   with	   100	   mM	  
diethylenetriaminepentaacetic	  acid	  (DTPA),	  adjusted	  to	  pH	  7.4.	   	  Buffered	  solutions	  
(0.1	   M)	   for	   UV-­‐vis	   experiments	   were	   prepared	   from	   HCl/NaCl	   (pH	   1.7),	  
AcOH/AcONa	  (pH	  3.0,	  3.5,	  4.0,	  4.5,	  5.0,	  5.5),	  or	  NaPO3H2/Na2PO3H	  (pH	  6.0,	  6.5,	  7.0,	  
8.0,	  9.0,	  9.5,	  9.8,	  10.0,	  10.5,	  10.6).	  
	  
2.5.2	   	   Nitrous	   Oxide	   (N2O)	   Quantification	   by	   Gas	   Chromatographic	  
Headspace	  Analysis	  
	  
Gas	   chromatography	   was	   performed	   on	   a	   Varian	   CP-­‐3800	   instrument	  
equipped	   with	   a	   1041	  manual	   injector,	   electron	   capture	   detector,	   and	   a	   25m	   5Å	  
molecular	  sieve	  capillary	  column.	   	  Grade	  5.0	  nitrogen	  was	  used	  as	  both	  the	  carrier	  
(8	  mL/min)	  and	  the	  make-­‐up	  (22	  mL/min)	  gas.	  	  The	  injector	  oven	  and	  the	  detector	  
oven	  were	  kept	  at	  200	  °C	  and	  300	  °C,	  respectively.	  	  All	  nitrous	  oxide	  analyses	  were	  
performed	  with	   the	   column	  oven	  held	   constant	  at	  150	   °C.	   	  All	   gas	   injections	  were	  
made	  using	  a	  100	  μL	  gastight	  syringe	  with	  a	  sample-­‐lock.	  	  Samples	  were	  prepared	  in	  
15	  mL	   amber	   headspace	   vials	  with	   volumes	   pre-­‐measured	   for	   sample	   uniformity	  
(actual	  vial	  volume	  ranges	  from	  15.19	  –	  15.20	  mL).	  	  Vials	  were	  charged	  with	  5	  mL	  of	  
PBS	  buffer	  containing	  DTPA,	  purged	  with	  argon,	  and	  sealed	  with	  a	  rubber	  septum.	  	  
The	  vials	  were	  equilibrated	  for	  at	  least	  10	  minutes	  at	  37	  °C	  in	  a	  dry	  block	  heater.	  	  A	  
10	   mM	   stock	   solution	   of	   Angeli’s	   salt	   (AS)	   was	   prepared	   in	   10	   mM	   sodium	  
hydroxide,	  and	  HNO	  donors	  1a	  –	  4a,	  6a	   (10	  mM)	  were	  prepared	  in	  acetonitrile	  or	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methanol	  and	  used	   immediately	  after	  preparation.	   	  From	  these	  stock	  solutions,	  50	  
μL	  was	   introduced	   into	   individual	   thermally-­‐equilibrated	   headspace	   vials	   using	   a	  
gastight	  syringe,	  yielding	  final	  substrate	  concentrations	  of	  0.1	  mM.	  	  Substrates	  were	  
then	  incubated	  long	  enough	  to	  ensure	  complete	  decomposition	  and	  equilibration	  of	  
N2O	  with	  the	  headspace.	  	  The	  headspace	  (60	  μL)	  was	  then	  sampled	  and	  injected	  five	  
successive	  times	  using	  a	  gastight	  syringe	  with	  a	  sample	  lock.	  	  This	  was	  repeated	  for	  
n≥3	   vials	   per	   donor.	   	   The	   N2O	   yield	   was	   averaged	   and	   reported	   relative	   to	   the	  
standard,	  Angeli’s	  salt.	  	  For	  chemical	  trapping	  of	  HNO,	  glutathione	  (100	  μL	  of	  10	  mM	  
in	   PBS)	   was	   added	   prior	   to	   HNO	   donor	   addition	   to	   give	   a	   final	   glutathione	  
concentration	   of	   0.2	   mM,	   and	   headspace	   sampling	   for	   N2O	   was	   analogously	  
performed	  as	  stated	  above.	  
	  
2.5.3	  	  1H	  NMR	  Kinetic	  Experiment	  with	  Barbituate	  Donor	  4a	  
A	  20	  mM	  aqueous	  solution	  of	  4a	   (2.6	  mg,	  0.1	  mL	  D2O,	  0.4	  mL	  DI	  H2O)	  was	  
freshly	  prepared,	  and	  an	  initial	  1H	  NMR	  spectrum	  using	  a	  1	  s	  presaturation	  pulse	  to	  
suppress	  the	  H2O	  signal	  was	  obtained.	   	  The	  sample	  was	  removed	  from	  the	  magnet	  
and	  thin-­‐walled	  Teflon	  tubing	  (18-­‐guage)	  was	  extended	  through	  the	  NMR	  cap	   into	  
the	  NMR	  tube	  to	  just	  above	  the	  HNO	  donor	  solution.	  	  The	  Teflon	  tube	  was	  fitted	  on	  a	  
syringe	  with	   needle	   containing	   2.4	  mL	   0.5	  M	  PBS,	   pH	   7.4,	  which	   accounts	   for	   the	  
empty	  space	  in	  the	  tube	  plus	  the	  deliverable	  0.5	  mL	  of	  buffer	  solution.	  	  The	  sample	  
was	  carefully	   returned	   to	   the	  magnet	  and	  shimmed	   to	  address	  any	  changes	   in	   the	  
homogeneity	   of	   the	   field.	   	   A	   canned	   pulse	   sequence	   (Bruker	   sequence	   lc2pr)	  was	  
used	   to	   acquire	  a	   solvent	   suppressed	   spectrum	  every	  37	   s	   for	   ca.	  80	  minutes;	   the	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experiment	  was	  started	  prior	  to	  the	  initiation	  of	  the	  reaction.	  	  At	  the	  end	  of	  the	  first	  
spectral	   acquisition,	   the	   reaction	  was	   started	  by	   syringing	   the	  buffer	   solution	   into	  
the	   HNO	   donor	   solution,	   and	   the	   resultant	   solution	   was	   mixed	   three	   times	   by	  
drawing	  and	  dispensing	  ca.	  0.5	  mL.	  	  At	  the	  conclusion	  of	  mixing,	  the	  excess	  solution	  
was	  cleared	  from	  the	  tube	  leaving	  ca.	  0.5	  mL	  of	  the	  reaction	  in	  the	  NMR	  tube;	  this	  
coincided	   with	   the	   end	   of	   the	   second	   spectral	   acquisition.	   	   At	   the	   end	   of	   the	  
experiment,	  the	  ser	  file	  was	  split	  (using	  the	  au	  program	  splitser)	   in	  128	  individual	  
free	  induction	  decays	  (FID’s)	  for	  post-­‐acquisition	  processing	  and	  analysis.	  	  The	  data	  
were	   processed	   with	   the	   academic	   version	   of	   ACDLabs	   NMRprocessor	   software:	  
each	   FID	  was	   Fourier	   transformed,	   phased,	   baseline	   corrected,	   and	   integral	   areas	  
measured	  for	  each	  of	  the	  peaks	  in	  the	  spectrum.	  	  The	  most	  downfield	  reactant	  and	  
product	  peak	  were	  integrated	  as	  one	  signal	  and	  served	  as	  the	  internal	  standard	  for	  
the	  calculated	  integration	  areas	  for	  the	  other	  signals.	  	  Integral	  areas	  were	  plotted	  as	  
a	  function	  of	  time	  and	  fit	  to	  a	  single	  exponential	  function	  to	  obtain	  the	  rates.	  
	  
2.5.4	  	  Decomposition	  Kinetics	  by	  UV-­‐vis	  Spectroscopy	  
Stock	   solutions	   of	   HNO	   donor	   (1	   mM)	   were	   prepared	   in	   acetonitrile	  
immediately	  prior	  to	  use.	  	  To	  a	  quartz	  cuvette	  was	  added	  3	  mL	  of	  PBS	  buffer	  at	  the	  
appropriate	  pH.	  	  The	  cuvette	  was	  then	  placed	  in	  a	  heated	  cell	  block,	  which	  was	  held	  
at	  25	  °C	  or	  37	  °C	  by	  a	  circulating	  water	  bath.	  	  The	  buffer	  was	  allowed	  to	  thermally	  
equilibrate	  until	  a	  constant	  baseline	  was	  achieved,	  after	  which	  50	  μL	  of	  HNO	  donor	  
stock	   solution	  was	   added,	   the	   cuvette	   solution	   briefly	  mixed,	   and	   the	   kinetic	   run	  
started.	  	  Complete	  spectra	  at	  37	  °C	  in	  pH	  7.4	  buffer	  were	  obtained	  every	  30	  s	  for	  the	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conversion	   of	   4a	   to	   4b	   and	   240	   s	   for	   the	   conversion	   of	   6a	   to	   6b.	   	   In	   addition,	  
complete	  spectra	  at	  25	  °C	  in	  pH	  7.4,	  8.1,	  8.5,	  9.0,	  and	  9.5	  buffers	  were	  obtained	  every	  
0.5	  s	  for	  the	  conversion	  of	  4a	  to	  4b,	  and	  complete	  spectra	  at	  25	  °C	  in	  pH	  7.4,	  8.1,	  8.5,	  
9.0,	  9.5,	  9.8,	  10.0,	  10.5,	  and	  10.6	  buffers	  were	  obtained	  every	  0.5	  s	  for	  the	  conversion	  
of	  6a	  to	  6b.	  	  The	  stability	  at	  pH	  4,	  room	  temperature	  of	  4a	  and	  6a	  was	  obtained	  by	  
the	   intermittent	  collection	  of	  complete	  spectra	   from	  pH	  4	  solutions	  of	  each	  donor,	  
which	  were	  prepared	  as	  stated	  above.	  	  Kinetic	  traces	  were	  derived	  from	  the	  spectra	  
by	   plotting	   the	   absorbance	   at	   a	   given	   wavelength	   versus	   time	   and	   fit	   to	   a	   single	  
exponential	  function	  to	  obtain	  the	  rates.	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2.5.5	  	  Experimental	  Procedures	  
5-­‐(N-­‐(N,O-­‐bis(tert-­‐butoxycarbonyl))-­‐hydroxylamine)-­‐5-­‐methyl-­‐
Meldrum’s	   acid	   (1b-­‐diBoc).	   	   To	   a	   solution	   of	   N,O-­‐bis(tert-­‐butoxycarbonyl)-­‐
hydroxylamine	   (1.81	   g,	   7.75	   mmol)	   in	   dimethylformamide	   (25	   mL)	   at	   room	  
temperature	   was	   added	   sodium	   hydride,	   60%	   (0.340	   g,	   8.52	   mmol),	   and	   the	  
reaction	  stirred	  for	  one	  hour.	  	  To	  this	  solution	  was	  added	  1b-­‐Br	  (1.84	  g,	  7.75	  mmol),	  
and	   the	   reaction	  proceeded	  at	   room	  temperature	   for	  an	   additional	  17	  hours.	   	  The	  
reaction	  was	  diluted	  with	  ether	  (50	  mL)	  and	  washed	  with	  ammonium	  chloride	  (x2),	  
water,	  and	  brine.	  	  The	  solvent	  was	  removed	  via	  rotary	  evaporation,	  which	  gave	  the	  
title	  compound	  as	  an	  oil	  that	  aerated	  and	  solidified	  in	  vacuo.	   	  Recrystallization	  from	  
dichloromethane	   and	   hexanes	   gave	   the	   title	   compound	   as	   a	   white	   solid	   (1.79	   g,	  
59%).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  1.90	  (s,	  3H),	  1.83	  (s,	  3H),	  1.80	  (s,	  3H).	  	  13C	  NMR	  
(100	   MHz,	   CDCl3)	   δ:	   167.04,	   163.92,	   154.77,	   151.91,	   107.49,	   85.51,	   84.88,	   64.80,	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5-­‐(N-­‐hydroxylamine)-­‐5-­‐methyl-­‐Meldrum’s	   acid	   hydrochloride	  
monohydrate	   (1a).	   	   To	   a	   solution	   of	   1b-­‐diBoc	   (0.190	   g,	   0.488	   mmol)	   in	  
dichloromethane	  (10	  mL)	  and	  methanol	  (0.99	  mL)	  at	  0	  °C	  was	  added	  acetyl	  chloride	  
(1.7	   mL,	   24	   mmol)	   over	   two	  minutes.	   	   The	   reaction	   was	   allowed	   warm	   to	   room	  
temperature	  in	  the	  ice	  bath,	  and	  continued	  to	  stir	  overnight.	  	  The	  white	  precipitate	  
was	   filtered	   and	   characterized	   as	   the	   title	   compound	   (0.094	   g,	   86%).	  	  
Recrystallization	   from	  methanol	   and	   dichloromethane	   gave	   X-­‐ray	   quality	   crystals.	  	  
1H	  NMR	  (400	  MHz,	  d6-­‐DMSO)	  δ:	  10.32	  (s,	  1H),	  8.40	  (br.	  s,	  3H),	  1.73	  (s,	  3H),	  1.71	  (s,	  
3H),	   1.44	   (s,	   3H).	   	   13C	   NMR	   (100	  MHz,	  d6-­‐DMSO)	   δ:	   168.99,	   105.57,	   66.14,	   28.88,	  
28.33,	  20.96.	  	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐Meldrum’s	   acid	   (2b-­‐H+).	   	  To	  a	  solution	  of	  5-­‐	  
acetyl-­‐Meldrum’s	   acid	   (1.644	   g,	   8.831	   mmol)	   in	   methanol	   (50	   mL)	   at	   room	  
temperature	   was	   added	   O-­‐methoxyhydroxylamine	   hydrochloride	   (0.738	   g,	   8.84	  
mmol)	  and	  sodium	  bicarbonate	  (0.743	  g,	  8.84	  mmol),	  and	  the	  reaction	  continued	  at	  
room	   temperature	   for	   24	   hours.	   	   The	   reaction	   was	   concentrated	   in	   vacuo,	  
redissolved	  in	  dichloromethane,	  filtered,	  and	  concentrated	  in	  vacuo	   to	  give	  the	  title	  
compound	  as	  a	  light	  yellow	  solid	  (1.714	  g,	  90%).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  13.11	  
(s,	  1H),	  3.88	  (s,	  3H),	  2.71	  (s,	  3H),	  1.69	  (6H).	   	  13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  169.77,	  
166.95,	   162.58,	   103.12,	   80.79,	   64.68,	   26.46,	   14.86.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	  
216.08696	  (MH+);	  calc.	  for	  C9H13NO5:	  216.08720.	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐5-­‐bromo-­‐Meldrum’s	   acid	   (2b-­‐Br).	   	   To	   a	  
solution	  of	  4b-­‐H+	  (0.681	  g,	  2.87	  mmol)	  and	  triethylamine	  (0.40	  mL,	  2.87	  mmol)	   in	  
dichloromethane	   (20	  mL)	  at	  0	   °C	  was	  added	  a	  solution	  of	  bromine	   (0.15	  mL,	  2.87	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mmol)	   in	  dichloromethane	  (2	  mL).	   	  The	  reaction	  was	  stirred	  for	   five	  minutes	  then	  
extracted	  with	  water	  and	  brine,	  dried	  over	  magnesium	  sulfate,	  and	  concentrated	  in	  
vacuo	   to	  give	  the	  title	  compound	  as	  an	  orange	  solid	  (0.810	  g,	  96%).	   	  1H	  NMR	  (400	  
MHz,	  CDCl3)	  δ:	  3.94	   (s,	  3H),	  2.19	   (s,	  3H),	  1.85	   (s,	  3H),	  1.78	   (s,	  3H).	   	   13C	  NMR	  (100	  
MHz,	   CDCl3)	   δ:	   161.53,	   151.23,	   107.27,	   63.19,	   55.82,	   28.74,	   28.38,	   12.71.	   	   HR-­‐MS	  
(FAB):	  found	  m/z	  =	  295.99537	  (MH+);	  calc.	  for	  C9H12BrNO5:	  295.99566.	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐5-­‐(N-­‐(N,O-­‐bis(tert-­‐butoxycarbonyl))-­‐
hydroxylamine)-­‐Meldrum’s	   acid	   (2b-­‐diBoc).	   	   To	   a	   solution	   of	   N,O-­‐bis(tert-­‐
butoxycarbonyl)-­‐hydroxylamine	   (0.642	   g,	   2.75	   mmol)	   in	   dimethylformamide	   (20	  
mL)	   at	   room	   temperature	  was	   added	   sodium	  hydride,	   60%	   (0.121	   g,	   3.03	  mmol),	  
and	  the	  reaction	  stirred	   for	  one	  hour.	   	  To	  this	  solution	  was	  added	  2b-­‐Br	   (0.810	  g,	  
2.75	  mmol),	  and	  the	  reaction	  proceeded	  at	  room	  temperature	  for	  an	  additional	  24	  
hours.	   	  The	  reaction	  was	  diluted	  with	  ether	  (50	  mL)	  and	  washed	  with	  ammonium	  
chloride	  (x2),	  water,	  and	  brine	  then	  concentrated	   in	  vacuo	   to	  give	  crude	  2b-­‐diBoc	  
~30-­‐40%	  pure	  by	  1H	  NMR,	  which	  was	  used	  without	   further	  purification.	   	   1H	  NMR	  
(400	  MHz,	  CDCl3)	  δ:	  3.94	  (s,	  3H),	  1.99	  (br.	  s.,	  3H),	  1.82	  (br.	  s.,	  3H),	  1.73	  (s,	  3H),	  1.51	  
(s,	  9H),	  1.48	  (s,	  9H).	  
5-­‐(N-­‐hydroxylamine)-­‐5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐Meldrum’s	   acid	   (2a).	  
To	  a	  solution	  of	  2b-­‐diBoc	   from	  the	  previous	  reaction	  in	  methanol	  (20	  mL)	  at	  0	  °C	  
was	   added	   acetyl	   chloride	   (4	  mL)	   over	   three	  minutes.	   	   The	   reaction	  was	   allowed	  
warm	   to	   room	   temperature	   in	   the	   ice	   bath,	   and	   continued	   to	   stir	   overnight.	   	   The	  
reaction	  was	   concentrated	   in	   vacuo,	   redissolved	   in	   dichloromethane,	   filtered,	   and	  
the	  filtrate	  was	  concentrated	  in	  vacuo.	  	  Recrystallization	  from	  dichloromethane	  and	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hexanes	   gave	   the	   title	   compound	   as	   pale	   orange	   needles	   (0.68	   g,	   10%	   over	   two	  
steps).	  	  1H	  NMR	  (400	  MHz,	  d6-­‐DMSO)	  δ:	  8.38	  (d,	  1H,	  J	  =	  2.3	  Hz),	  6.94	  (d,	  1H,	  J	  =	  2.4	  
Hz),	   3.81	   (s,	   3H),	   1.91	   (s,	   3H),	   1.74	   (s,	   3H),	   1.71	   (s,	   3H).	   	   13C	  NMR	   (100	  MHz,	  d6-­‐
DMSO)	  δ:	  163.88,	  150.39,	  107.08,	  74.46,	  62.97,	  29.78,	  27.97,	  11.32.	   	  HR-­‐MS	  (FAB):	  
found	  m/z	  =	  247.09360	  (MH+);	  calc.	  for	  C9H14N2O6:	  247.09301.	  
5-­‐bromo-­‐5-­‐ethyl-­‐N,N-­‐dimethylbarbituric	   acid	   (3b-­‐Br).	   	   To	   a	   solution	   of	  
3b-­‐H+	   (1.06	   g,	   5.74	   mmol)	   and	   triethylamine	   (0.81	   mL,	   5.74	   mmol)	   in	  
dichloromethane	  (50	  mL) at	  0	   °C	  was	  added	  a	  solution	  of	  bromine	  (0.30	  mL,	  5.74	  
mmol)	   in	  dichloromethane	  (2	  mL).	   	  The	  reaction	  was	  stirred	  for	   five	  minutes	  then	  
extracted	  with	  water	  and	  brine,	  dried	  over	  magnesium	  sulfate,	  and	  concentrated	  in	  
vacuo	  to	  give	  the	  title	  compound	  as	  a	  white	  solid	  (1.42	  g,	  94%).	  	  1H	  NMR	  (400	  MHz,	  
CDCl3)	   δ:	   3.38	   (s,	   6H),	   2.61	   (q,	   2H),	   0.85	   (t,	   3H).	   	   13C	   NMR	   (100	   MHz,	   CDCl3)	   δ:	  
166.07,	  150.09,	  49.93,	  30.30,	  29.66,	  10.70.	   	  HR-­‐MS	  (FAB):	   found	  m/z	  =	  265.00118	  
(MH+);	  calc.	  for	  C8H11BrN2O3:	  265.00108.	  
5-­‐(N-­‐(N,O-­‐bis(tert-­‐butoxycarbonyl))-­‐hydroxylamine)-­‐5-­‐ethyl-­‐N,N-­‐
dimethylbarbituric	   acid	   (3b-­‐diBoc).	   	   To	   a	   solution	   of	   N,O-­‐bis(tert-­‐
butoxycarbonyl)-­‐hydroxylamine	  (1.26	  g,	  5.41	  mmol)	  in	  dimethylformamide	  (50	  mL)	  
at	  room	  temperature	  was	  added	  sodium	  hydride,	  60%	  (0.238	  g,	  5.95	  mmol),	  and	  the	  
reaction	  stirred	  for	  one	  hour.	  	  To	  this	  solution	  was	  added	  3b-­‐Br	  (1.42	  g,	  5.41	  mmol),	  
and	   the	   reaction	  proceeded	  at	   room	   temperature	   for	  an	  additional	  20	  hours.	   	  The	  
reaction	  was	  diluted	  with	  ether	  (50	  mL)	  and	  washed	  with	  ammonium	  chloride	  (x2),	  
water,	  and	  brine.	  	  The	  solvent	  was	  removed	  via	  rotary	  evaporation,	  which	  gave	  the	  
title	  compound	  as	  an	  oil	  that	  aerated	  and	  solidified	  in	  vacuo.	  	  Recrystallization	  from	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dichloromethane	   and	   hexanes	   gave	   the	   title	   compound	   as	   a	   white	   solid	   (1.67	   g,	  
74%).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  3.35	  (s,	  3H),	  3.33	  (s,	  3H),	  2.17	  (m,	  2H),	  1.54	  (s,	  
9H),	   1.41	   (br.s.,	   9H),	   0.89	   (t,	   3H).	   	   13C	   NMR	   (100	  MHz,	   CDCl3)	   δ:	   169.60,	   166.47,	  
151.81,	  150.74,	  85.20,	  84.40,	  70.70,	  29.41,	  29.03,	  28.82,	  27.99,	  27.94,	  27.61,	  27.57,	  
7.88.	  	  HR-­‐MS	  (FAB):	  found	  m/z	  =	  416.20253	  (MH+);	  calc.	  for	  C18H29N3O8:	  416.20329.	  
5-­‐(N-­‐hydroxylamine)-­‐5-­‐ethyl-­‐N,N-­‐dimethylbarbituric	   acid	  
hydrochloride	   (3a).	   	   To	   a	   solution	   of	   3b-­‐diBoc	   (0.415	   g,	   1	   mmol)	   in	  
dichloromethane	  (20	  mL)	  and	  methanol	  (2.0	  mL)	  at	  0	  °C	  was	  added	  acetyl	  chloride	  
(3.5	  mL,	   50	  mmol)	   over	   three	  minutes.	   	   The	   reaction	  was	   allowed	  warm	   to	   room	  
temperature	  in	  the	  ice	  bath,	  and	  continued	  to	  stir	  overnight.	  	  The	  white	  precipitate	  
was	   filtered	   and	   characterized	   as	   the	   title	   compound	   (0.109	   g,	   43%).	  	  
Recrystallization	   from	  methanol	   and	   dichloromethane	   gave	   X-­‐ray	   quality	   crystals.	  
1H	  NMR	  (400	  MHz,	  d6-­‐DMSO)	  δ:	  10.	  27	  (s,	  1H),	  7.24	  (t,	  1H,	  J	  =	  50.8	  Hz),	  3.21	  (s,	  6H),	  
1.78	  (q,	  2H,	  J	  =	  7.4	  Hz),	  0.72	  (t,	  3H,	  J	  =	  7.7	  Hz).	   	  Rearrangement	  to	  5	  precluded	  the	  
collection	   of	   13C	   NMR.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	   216.09879	   (MH+);	   calc.	   for	  
C8H13N3O4:	  216.09843.	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐N,N-­‐dimethylbarbituric	   acid	   (4b-­‐H+).	   	   To	   a	  
suspension	   of	   5-­‐acetyl-­‐N,N-­‐dimethylbarbituric	   acid	   (15.43	   g,	   77.8	   mmol)	   in	  
methanol	   (125	   mL)	   was	   added	   O-­‐methoxyhydroxylamine	   hydrochloride	   (6.50	   g,	  
77.8	  mmol)	  and	  sodium	  bicarbonate	  (6.54	  g,	  77.8	  mmol).	  	  The	  reaction	  was	  heated	  
to	  reflux	  for	  one	  hour	  then	  allowed	  to	  cool	  on	  ice.	  	  The	  precipitate	  was	  filtered,	  re-­‐
dissolved	   in	  dichloromethane,	   filtered,	  and	  the	  solution	  was	  concentrated	   in	  vacuo	  
to	   give	   the	   title	   compound	   as	   a	   white	   solid	   (15.36	   g,	   87%).	   	   1H	   NMR	   (400	  MHz,	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CDCl3)	  δ:	  14.54	  (s,	  1H),	  3.88	  (s,	  3H),	  3.32	  (s,	  3H),	  3.30	  (s,	  3H),	  2.76	  (s,	  3H).	  	  13C	  NMR	  
(100	  MHz,	  CDCl3)	  δ:	  169.63,	  166.11,	  162.55,	  151.42,	  86.97,	  64.55,	  27.87,	  14.75.	  	  HR-­‐
MS	  (FAB):	  found	  m/z	  =	  228.09857	  (MH+);	  calc.	  for	  C9H13N3O4:	  228.09843.	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐5-­‐bromo-­‐N,N-­‐dimethylbarbituric	   acid	   (4b-­‐
Br).	  	  To	  a	  solution	  of	  4b-­‐H+	  (7.27	  g,	  32	  mmol)	  and	  triethylamine	  (4.5	  mL,	  32	  mmol)	  
in	  dichloromethane	  (50	  mL)	  at	  0	  °C	  was	  added	  a	  solution	  of	  bromine	  (1.65	  mL,	  32	  
mmol)	  in	  dichloromethane	  (10	  mL).	  	  The	  reaction	  was	  stirred	  for	  five	  minutes	  then	  
extracted	  with	  water	  and	  brine,	  dried	  over	  magnesium	  sulfate,	  and	  concentrated	  in	  
vacuo	  to	  give	  the	  title	  compound	  as	  a	  white	  solid	  (9.51	  g,	  97%).	  	  1H	  NMR	  (400	  MHz,	  
CDCl3)	   δ:	   3.87	   (s,	   3H),	   3.35	   (s,	   6H),	   2.06	   (s,	   3H).	   	   13C	   NMR	   (100	   MHz,	   CDCl3)	   δ:	  
163.77,	   151.70,	   150.02,	   62.87,	   60.13,	   30.00,	   12.69.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	  
308.00717	  (MH+);	  calc.	  for	  C9H12BrN3O4:	  308.00690.	  
5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐5-­‐(N-­‐(N,O-­‐bis(tert-­‐butoxycarbonyl))-­‐
hydroxylamine-­‐N,N-­‐dimethylbarbituric	   acid	   (4b-­‐diBoc).	   	   To	   a	   solution	   of	  N,O-­‐
bis(tert-­‐butoxycarbonyl)-­‐hydroxylamine	   (5.83	   g,	   25	   mmol)	   in	   dimethylformamide	  
(100	  mL)	  at	  room	  temperature	  was	  added	  sodium	  hydride,	  60%	  (1.1	  g,	  27.5	  mmol),	  
and	  the	  reaction	  stirred	  for	  one	  hour.	  	  To	  this	  solution	  was	  added	  4b-­‐Br	  (7.65	  g,	  25	  
mmol),	  and	  the	  reaction	  proceeded	  at	  room	  temperature	  for	  an	  additional	  20	  hours.	  	  
The	  reaction	  was	  diluted	  with	  ether	  (150	  mL)	  and	  washed	  with	  ammonium	  chloride	  
(x2),	  water,	  and	  brine.	  	  The	  solvent	  was	  removed	  via	  rotary	  evaporation,	  which	  gave	  
the	  title	  compound	  as	  an	  oil	  that	  aerated	  and	  solidified	  in	  vacuo.	  	  This	  material	  was	  
used	  without	  further	  purification.	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  3.84	  (s,	  3H),	  3.32	  (s,	  
6H),	   1.94	   (br.	  m.,	   3H),	   1.52	   (s,	   9H),	   1.46	   (br.	  m.,	   9H).	   	  HR-­‐MS	   (FAB):	   found	  m/z	   =	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459.20898	  (MH+);	  calc.	  for	  C19H30N3O9:	  459.20910.	  
5-­‐(N-­‐hydroxylamine)-­‐5-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐N,N-­‐
dimethylbarbituric	  acid	  (4a).	  	  Methanol	  (100	  mL)	  at	  0	  °C	  was	  charged	  with	  acetyl	  
chloride	   (25	  mL)	  over	  10	  minutes	   then	   stirred	   for	   an	   additional	   five	  minutes.	   	   To	  
this	  acidic	  solution	  was	  added	  a	  solution	  of	  4b-­‐diBoc	  in	  methanol	  (70	  mL),	  and	  the	  
cloudy	   reaction	   was	   allowed	   to	   warm	   to	   room	   temperature	   in	   the	   ice	   bath	   over	  
night.	   	   The	   reaction	   was	   concentrated	   in	   vacuo,	   re-­‐dissolved	   in	   dichloromethane,	  
filtered,	  and	  the	   filtrate	  was	  concentrated	   in	  vacuo	   to	  give	   the	  title	  compound	  as	  a	  
sticky	   solid.	   	   Recrystallization	   from	   dichloromethane	   and	   hexanes	   gave	   white	  
needles	  (3.98	  g,	  62%	  over	  two	  steps).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  6.38	  (d,	  1H,	  J	  =	  
4.0	  Hz),	  5.32	  (d,	  1H,	  J	  =	  4.0	  Hz),	  3.82	  (s,	  3H),	  3.36	  (s,	  6H),	  1.89	  (s,	  3H).	  	  13C	  NMR	  (100	  
MHz,	   CDCl3)	   δ:	   167.10,	   152.47,	   150.86,	   74.93,	   62.80,	   29.38,	   10.93.	   	   HR-­‐MS	   (FAB):	  
found	  m/z	  =	  259.10454	  (MH+);	  calc.	  for	  C9H14N4O5:	  259.10424.	  
4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐N-­‐phenyl-­‐3-­‐methyl-­‐pyrazolone	   (6b-­‐H+).	   	  To	  
a	   suspension	   of	   4-­‐acetyl-­‐N-­‐phenyl-­‐3-­‐methyl-­‐pyrazolone	   (3.69	   g,	   17.1	   mmol)	   in	  
methanol	  (50	  mL)	  was	  added	  O-­‐methoxyhydroxylamine	  hydrochloride	  (1.43	  g,	  17.1	  
mmol)	   and	   sodium	  bicarbonate	   (1.44	   g,	   17.1	  mmol).	   	   The	   reaction	  was	   heated	   to	  
reflux	   for	   one	   hour	   then	   allowed	   to	   cool	   to	   room	   temperature.	   	   The	   reaction	  was	  
concentrated	  in	  vacuo,	  re-­‐dissolved	  in	  dichloromethane,	  filtered,	  and	  the	  filtrate	  was	  
concentrated	   in	  vacuo	   to	  give	  the	  title	  compound	  as	  a	  red	  brown	  oil	   that	  solidified	  
upon	  standing	  (4.15	  g,	  99%).	   	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.85	  (m,	  2H),	  7.44	  (m,	  
2H),	  7.26	  (m,	  1H),	  3.92	  (s,	  3H),	  2.43	  (s,	  3H),	  2.29	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  CDCl3)	  
δ:	   170.58,	  156.30,	  155.54,	  154.44,	  146.17,	  138.22,	  128.93,	  125.89,	  120.67,	  120.62,	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118.75,	   96.46,	   62.15,	   43.06,	   16.94,	   15.75,	   12.95.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	  
246.12350	  (MH+);	  calc.	  for	  C13H15N3O2:	  246.12425.	  
4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐4-­‐bromo-­‐N-­‐phenyl-­‐3-­‐methyl-­‐pyrazolone	  
(6b-­‐Br).	   	   To	   a	   biphasic	   mixture	   of	   6b-­‐H+	   (1.078	   g,	   4.4	   mmol)	   and	   sodium	  
bicarbonate	  (0.369	  g,	  4.4	  mmol)	  in	  dichloromethane	  (20	  mL)	  and	  water	  (20	  mL)	  at	  
room	  temperature	  was	  added	  bromine	  (0.23	  mL,	  4.4	  mmol)	  at	  once.	   	  The	  reaction	  
was	   vigorously	   stirred	   for	   five	   minutes,	   transferred	   to	   a	   separatory	   funnel	   and	  
shaken	   until	   a	   clear,	   colorless	   aqueous	   layer	   resulted.	   	   The	   organic	   layer	   was	  
separated,	  dried	  over	  magnesium	  sulfate,	  filtered,	  and	  concentrated	  in	  vacuo	  to	  give	  
the	  title	  compound	  as	  a	  brown	  oil	  (1.38	  g,	  97%).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.88	  
(m,	  2H),	  7.40	  (m,	  2H),	  7.22	  (m,	  1H),	  3.90	  (s,	  3H),	  2.44	  (s,	  3H),	  2.22	  (s,	  3H).	  	  13C	  NMR	  
(100	  MHz,	  CDCl3)	  δ:	  167.06,	  157.83,	  151.27,	  137.69,	  129.11,	  125.78,	  119.08,	  62.73,	  
56.61,	   15.71,	   11.70.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	   326.03272	   (MH+);	   calc.	   for	  
C13H14BrN3O2:	  326.03219.	  
4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐4-­‐(N-­‐(N,O-­‐bis(tert-­‐butoxycarbonyl))-­‐
hydroxylamine-­‐N-­‐phenyl-­‐3-­‐methyl-­‐pyrazolone	  (6b-­‐diboc).	  	  To	  a	  solution	  of	  N,O-­‐
bis(tert-­‐butoxycarbonyl)-­‐hydroxylamine	   (0.992	   g,	   4.25	   mmol)	   in	  
dimethylformamide	  (20	  mL)	  at	  room	  temperature	  was	  added	  sodium	  hydride,	  60%	  
(0.187	  g,	   4.68	  mmol),	   and	   the	   reaction	   stirred	   for	  one	  hour.	   	  To	   this	   solution	  was	  
added	  6b-­‐Br	  (1.38	  g,	  4.25	  mmol),	  and	  the	  reaction	  proceeded	  at	  room	  temperature	  
for	   30	   minutes.	   	   The	   reaction	   was	   diluted	   with	   ether	   (50	   mL)	   and	   washed	   with	  
ammonium	   chloride	   (x2),	   water,	   and	   brine.	   	   The	   solvent	  was	   removed	   via	   rotary	  
evaporation,	  which	  gave	  the	  title	  compound	  as	  an	  oil	  that	  aerated	  and	  solidified	   in	  
	   50	  
vacuo.	   	   This	   material	   was	   used	   without	   further	   purification.	   	   1H	   NMR	   (400	  MHz,	  
CDCl3)	  δ:	  7.89	  (m,	  2H),	  7.37	  (m,	  2H),	  7.16	  (m,	  1H),	  3.85	  (s,	  3H),	  2.24	  (br.	  s.,	  3H),	  2.05	  
(br.	  m.,	  3H),	  1.52	  (s,	  9H),	  1.40	  (br.	  m.,	  9H).	  
4-­‐(N-­‐hydroxylamine)-­‐4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐N-­‐phenyl-­‐3-­‐
methylpyrazolone	   (6a).	   	  To	  a	  solution	  of	  6b-­‐diBoc	   from	  the	  previous	  reaction	  in	  
methanol	  (50	  mL)	  at	  0	  °C	  was	  added	  acetyl	  chloride	  (3	  mL)	  over	  three	  minutes.	  	  The	  
reaction	  was	  allowed	  warm	  to	  room	  temperature	  in	  the	  ice	  bath,	  and	  continued	  to	  
stir	   overnight.	   	   The	   reaction	   was	   concentrated	   in	   vacuo,	   re-­‐dissolved	   in	  
dichloromethane,	  filtered,	  and	  the	  filtrate	  was	  concentrated	  in	  vacuo	  to	  give	  the	  title	  
compound	   as	   a	   sticky	   solid.	   	   Recrystallization	   from	  dichloromethane	   and	  hexanes	  
gave	  the	  title	  compound	  as	  white	  needles	  (0.412	  g,	  35%	  over	  two	  steps).	   	  1H	  NMR	  
(400	  MHz,	  CDCl3)	  δ:	  7.92	  (m,	  2H),	  7.41	  (m,	  2H),	  7.20	  (m,	  1H),	  6.25	  (d,	  1H,	  J	  =	  2.5	  Hz),	  
4.68	  (d,	  1H,	  J	  =	  2.5	  Hz),	  3.92	  (s,	  3H),	  2.23	  (s,	  3H),	  1.79	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  
CDCl3)	   δ:	   170.23,	   159.62,	   148.66,	   137.85,	   129.07,	   125.59,	   119.03,	   78.10,	   62.59,	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§ 2.7	  	  Supporting	  Information	  
Figure	  2-­‐5.	   	   1H	  NMR	  spectra	  of	  the	  decomposition	  of	  Meldrum’s	  acid	  donor	  1a	   in	  PBS,	  
pH	  7.4.	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Figure	  2-­‐6.	   	   1H	  NMR	  spectra	  of	  the	  decomposition	  of	  Meldrum’s	  acid	  donor	  2a	   in	  PBS,	  
pH	  7.4.	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Figure	  2-­‐7.	   	   1H	  NMR	  spectra	  of	  the	  decomposition	  of	  Meldrum’s	  acid	  donor	  3a	   in	  PBS,	  
pH	  7.4.	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Figure	   2-­‐8.	   	  UV-­‐vis	   spectral	   and	   kinetic	   data	   for	   the	   decomposition	   of	   barbituric	   acid	  
donor	  4a	  and	  pyrazolone	  donor	  6a	  in	  pH	  4	  buffer	  at	  room	  temperature.	  
Figure	   2-­‐9.	   	  UV-­‐vis	   spectra	  at	   low	  and	  high	  pH	   for	  byproducts	  of	  decomposition	   from	  
barbituric	  acid	  donor	  4a	  and	  pyrazolone	  donor	  6a.	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2.7.1	  	  X-­‐Ray	  Crystallography	  Data	  
All	   reflection	   intensities	  were	  measured	   at	   110(2)	  K	   using	   a	  KM4/Xcalibur	  
(detector:	  Sapphire3)	  with	  enhance	  graphite-­‐monochromated	  Mo	  Kα	  radiation	  (λ	  =	  
0.71073	  Å)	  under	  the	  program	  CrysAlisPro	  (Version	  1.171.35.11	  Oxford	  Diffraction	  
Ltd.,	  2011).	  	  The	  program	  CrysAlisPro	  (Version	  1.171.35.11,	  Oxford	  Diffraction	  Ltd.,	  
2011)	  was	  used	   to	   refine	   the	  cell	  dimensions.	   	  Data	   reduction	  was	  done	  using	   the	  
program	   CrysAlisPro	   (Version	   1.171.35.11,	   Oxford	   Diffraction	   Ltd.,	   2011).	   	   The	  
structure	   was	   solved	   with	   the	   program	   SHELXS-­‐97	   (Sheldrick,	   2008)	   and	   was	  
refined	   on	   F2	   with	   SHELXL-­‐97	   (Sheldrick,	   2008).	   	   Analytical	   numeric	   absorption	  
corrections	  based	  on	  a	  multifaceted	   crystal	  model	  were	  applied	  using	  CrysAlisPro	  
(Version	  1.171.35.11,	  Oxford	  Diffraction	  Ltd.,	   2011).	   	  The	   temperature	  of	   the	  data	  
collection	   was	   controlled	   using	   the	   system	   Cryojet	   (manufactured	   by	   Oxford	  
Instruments).	   	   The	   H	   atoms	   (except	   when	   specified)	   were	   placed	   at	   calculated	  
positions	  using	  the	  instructions	  AFIX	  23	  (only	  for	  3a	  and	  5),	  AFIX	  43	  (only	  for	  6a)	  or	  
AFIX	  137	  with	  isotropic	  displacement	  parameters	  having	  values	  1.2	  or	  1.5	  times	  Ueq	  
of	  the	  attached	  C	  atoms.	  	  The	  positions	  of	  the	  H	  atoms	  attached	  to	  all	  N	  (i.e.,	  NH	  for	  
2a,	  4a,	  6a	   and	  5;	  NH2	   for	  1a	   and	  3a)	  or	  O	   (i.e.,	  OH;	  H2O	  only	   for	  1a)	   atoms	  were	  
found	   from	   difference	   Fourier	   maps.	   	   The	   N–H,	   O–H	   and	   HH	   (only	   for	   1a)	  
distances	  were	  restrained	  to	  0.88	  (NH)	  /	  0.99(3)	  (NH2),	  0.84(3)	  and	  1.33(3)	  Å	  (so	  





1a, Fw	  =	  243.64,	   colorless	   block,	   0.34	  × 0.22	  × 0.10	  
mm3,	   triclinic,	   P-­‐1	   (no.	   2),	   a	   =	   6.04443(18),	   b	   =	  
7.6997(2),	   c	   =	   12.3317(4)	   Å,	   α	   =	   74.488(3),	   β	   =	  
85.322(3),	  γ	  =	  86.211(3)°,	  V	  =	  550.59(3)	  Å3,	  Z	  =	  2,	  Dx	  
=	   1.470	   g	   cm−3,	   µ	   =	   0.357	   mm−1,	   abs.	   corr.	   range:	  
0.922−0.969.	  	  4798	  Reflections	  were	  measured	  up	  to	  
a	  resolution	  of	  (sin	  θ/λ)max	  =	  0.59	  Å−1.	  1936	  Reflections	  were	  unique	  (Rint	  =	  0.0180),	  
of	   which	   1680	   were	   observed	   [I	   >	   2σ(I)].	   154	   Parameters	   were	   refined	   using	   6	  
restraints.	  R1/wR2	  [I	  >	  2σ(I)]:	  0.0278/0.0709.	  R1/wR2	  [all	  refl.]:	  0.0334/0.0731.	  S	  =	  
1.100.	  Residual	  electron	  density	  found	  between	  −0.26	  and	  0.32	  e	  Å−3.	  
2a,	   Fw	   =	   246.22,	   colorless	   plate,	   0.47	  ×	   0.35	   ×	   0.04	  
mm3,	  monoclinic,	  P21/c	   (no.	   14),	  a	  =	  11.4024(3),	  b	   =	  
12.4341(3),	   c	   =	   8.0005(3)	   Å,	   β	   =	   99.510(3)°,	   V	   =	  
1118.71(6)	   Å3,	   Z	   =	   4,	   Dx	   =	   1.462	   g	   cm−3,	   µ	   =	   0.124	  
mm−1,	   abs.	   corr.	   range:	   0.956−0.996.	   10603	  
Reflections	   were	   measured	   up	   to	   a	   resolution	   of	   (sin	   θ/λ)max	   =	   0.65	   Å−1.	   2575	  
Reflections	  were	  unique	   (Rint	   =	   0.0317),	   of	  which	  2062	  were	  observed	   [I	  >	  2σ(I)].	  
164	  Parameters	  were	  refined	  with	  2	  restraints.	  R1/wR2	  [I	  >	  2σ(I)]:	  0.0337/0.0795.	  
R1/wR2	   [all	   refl.]:	   0.0471/0.0849.	   S	   =	   1.028.	   Residual	   electron	   density	   found	  
between	  −0.23	  and	  0.38	  e	  Å−3.	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3a, Fw	   =	   251.67,	   colorless	   lath,	   0.38	   × 0.11	   × 0.07	  
mm3,	   triclinic,	   P-­‐1	   (no.	   2),	   a	   =	   7.5765(3),	   b	   =	  
7.6395(4),	   c	   =	   11.1394(3)	   Å,	   α	   =	   81.909(3),	   β	   =	  
81.289(3),	  γ	  =	  63.606(4)°,	  V	  =	  568.92(4)	  Å3,	  Z	  =	  2,	  Dx	  =	  
1.469	  g	  cm−3,	  µ	  =	  0.340	  mm−1,	  abs.	  corr.	  range:	  0.926−0.980.	  	  8665	  Reflections	  were	  
measured	  up	  to	  a	  resolution	  of	  (sin	  θ/λ)max	  =	  0.62	  Å−1.	  2291	  Reflections	  were	  unique	  
(Rint	   =	   0.0273),	   of	   which	   1970	   were	   observed	   [I	   >	   2σ(I)].	   160	   Parameters	   were	  
refined	   with	   3	   restraints.	   R1/wR2	   [I	   >	   2σ(I)]:	   0.0295/0.0781.	   R1/wR2	   [all	   refl.]:	  
0.0367/0.0814.	  S	  =	  1.064.	  Residual	  electron	  density	  found	  between	  −0.25	  and	  0.31	  e	  
Å−3.	  
4a,	   Fw	   =	   258.24,	   colorless	   lath,	   0.44	   ×	   0.15	   ×	   0.03	  
mm3,	   triclinic,	   P 1 	  (no.	   2),	   a	   =	   7.7437(3),	   b	   =	  
10.5514(4),	   c	   =	   15.0891(6)	   Å,	   α	   =	   107.325(3),	   β	   =	  
97.908(3),	  γ	  =	  90.257(3)°,	  V	  =	  1164.41(8)	  Å3,	  Z	  =	  4,	  Dx	  
=	  1.473	  g	   cm−3,	  µ	  =	  0.121	  mm−1,	   abs.	   corr.	   range:	  0.957−0.996.	   	  16907	  Reflections	  
were	  measured	  up	  to	  a	  resolution	  of	  (sin	  θ/λ)max	  =	  0.63	  Å−1.	  4706	  Reflections	  were
unique	   (Rint	   =	   0.0310),	   of	  which	   3609	  were	   observed	   [I	  >	  2σ(I)].	   345	   Parameters	  
were	   refined	   with	   4	   restraints.	   R1/wR2	   [I	   >	   2σ(I)]:	   0.0369/0.0832.	   R1/wR2	   [all	  
refl.]:	  0.0559/0.0895.	  S	  =	  1.035.	  Residual	  electron	  density	  found	  between	  −0.23	  and	  
0.29	  e	  Å−3.	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5,	   Fw	   =	   215.21,	   colorless	   small	   block,	   0.21	   × 0.13	   ×
0.10	  mm3,	  monoclinic,	  P21/c	  (no.	  14),	  a	  =	  11.1127(4),	  
b	  =	  9.1165(2),	  c	  =	  10.0702(3)	  Å,	  β	  =	  104.117(3)°,	  V	  =	  
989.39(5)	  Å3,	  Z	  =	  4,	  Dx	  =	  1.445	  g	  cm−3,	  µ	  =	  0.117	  mm−1,	  
abs.	  corr.	  range:	  0.982−0.991.	  	  5394	  Reflections	  were	  measured	  up	  to	  a	  resolution	  of	  
(sin	  θ/λ)max	  =	  0.59	  Å−1.	  1734	  Reflections	  were	  unique	  (Rint	  =	  0.0305),	  of	  which	  1390	  
were	  observed	  [I	  >	  2σ(I)].	  145	  Parameters	  were	  refined	  using	  2	  restraints.	  R1/wR2	  
[I	   >	  2σ(I)]:	   0.0399/0.1056.	  R1/wR2	   [all	   refl.]:	   0.0518/0.1123.	   S	   =	   1.058.	   Residual	  
electron	  density	  found	  between	  −0.26and	  0.25	  e	  Å−3.	  
6a,	   Fw	   =	   276.30,	   colorless	   lath,	   0.43	   ×	   0.22	   ×	   0.08	  
mm3,	   monoclinic,	   P21/c	   (no.	   14),	   a	  =	   5.8807(2),	   b	   =	  
26.2720(8),	   c	   =	   9.1340(3)	   Å,	   β =	   101.419(4)°,	   V	   =	  
1383.25(8)	   Å3,	   Z	   =	   4,	   Dx	   =	   1.327	   g	   cm−3,	   µ	   =	   0.097	   mm−1,	   abs.	   corr.	   range:	  
0.969−0.993.	  	  11490	  Reflections	  were	  measured	  up	  to	  a	  resolution	  of	  (sin	  θ/λ)max	  =	  
0.63	  Å−1.	  2803	  Reflections	  were	  unique	  (Rint	  =0.0283),	  of	  which	  2300	  were	  observed	  
[I	   >	   2σ(I)].	   190	   Parameters	   were	   refined	   with	   2	   restraints.	   R1/wR2	   [I	   >	   2σ(I)]:	  
0.0376/0.0922.	   R1/wR2	   [all	   refl.]:	   0.0484/0.0966.	   S	   =	   1.038.	   Residual	   electron	  
density	  found	  between	  −0.29	  and	  0.31	  e	  Å−3.	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2.7.2	  	  1H	  and	  13C	  NMR	  Spectra	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Chapter	  3.	  
The	  “Catch-­‐and-­‐Release”	  of	  	  
Nitroxyl	  (HNO)	  with	  Pyrazolones	  
	   	   	   	  
	  
	  
§ 3.1	  	  Abstract	  	  
	   A	   first-­‐pass	  extension	  of	   the	  hydroxylamino-­‐pyrazolone	   (HAPY)	   class	  of	  nitroxyl	  
(HNO)	   donors	   utilizing	   pyrazolone	   (PY)	   leaving	   groups	   is	   described.	   	   HNO,	   a	   highly	  
reactive	   “aldehyde	   mimetic”	   of	   significant	   biological	   relevance,	   was	   used	   as	   a	   reagent	  
along	  with	  a	  variety	  of	  PY	  compounds	  to	  synthesize	  the	  corresponding	  HAPY	  donors	  in	  
what	  can	  be	  considered	  an	  N-­‐selective	  HNO-­‐aldol	  reaction	  in	  up	  to	  quantitative	  yields.	  	  
The	  bimolecular	  rate	  constant	  of	  HNO	  with	  PY	  in	  pH	  7.4	  phosphate	  buffer	  at	  37	  °C	  can	  
reach	  8	  ×	  105	  M–1s–1.	  	  The	  HAPY	  compounds	  generate	  HNO	  quantitatively	  (trapped	  as	  a	  
phosphine	   aza-­‐ylide)	   with	   half-­‐lives	   spanning	   three	   orders	   of	   magnitude	   under	  
physiologically	  relevant	  conditions.	  	  DFT	  calculations	  confirm	  the	  energetically	  favorable	  
reactions	  between	  HNO	  and	  the	  PY	  enol	  and	  enolate,	  whereas	  HNO	  release	  is	  expected	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§ 3.2	  	  Introduction	  
Heart	   failure,	  defined	  as	   the	   inability	  of	   the	  heart	   to	  pump	  enough	  blood	  to	  
supply	   the	   metabolic	   demands	   of	   the	   body,	   affects	   more	   than	   23	   million	   people	  
worldwide	  with	  total	  annual	  costs	  in	  2013	  of	  $32	  billion	  in	  the	  US	  alone.1-­‐3	  Nitroxyl	  
(HNO),	  the	  one-­‐electron	  reduced	  and	  protonated	  form	  of	  nitric	  oxide	  (NO),	  has	  been	  
shown	   to	   improve	   both	   vasorelaxation	   and	   myocardial	   contractility,	   making	   it	   a	  
promising	  alternative	  therapeutic	  in	  the	  fight	  against	  congestive	  heart	  failure.4-­‐8	  	  	  
The	   practical	   use	   of	   HNO	   as	   a	   therapeutic	   agent	   is	   complicated	   due	   to	   its	  
propensity	   to	   spontaneously	   dimerize	   (k	   =	   8	   ×	   106	   M–1s–1)	   to	   hyponitrous	   acid	  
(HON=NOH),	  which	   dehydrates	   to	   give	   nitrous	   oxide	   (N2O).9	   	   Thus,	   HNO	   donors,	  
such	  as	  Angeli’s	  salt	  (Na2N2O3),	  have	  been	  utilized	  to	  discern	  the	  biological	  activity	  
of	   HNO.4-­‐8	   	   Angeli’s	   salt	   has	   a	   relatively	   short	   half-­‐life	   of	   ca.	   2-­‐3	   min	   at	   pH	   7.4,	  	  	  	  	  	  	  	  	  	  	  
37	   °C,10	   and	   produces	   HNO	   along	   with	   an	   equimolar	   amount	   of	   nitrite,	   which	  
possesses	   its	   own	   biological	   activity.11-­‐12	   	   Unfortunately,	   Angeli’s	   salt	   is	   not	   ideal	  
from	  a	  drug	  development	  perspective	  since	  derivatives	  have	  yet	  to	  be	  successfully	  
realized.	  
Identifying	   physiologically	   useful	   donor	   molecules	   that	   evolve	   HNO	   in	   a	  
controlled	   and	   tunable	   fashion	   is	   an	   important	   and	   ongoing	   challenge	   for	  
fundamental	  research	  and	  biomedical	  applications.	  	  Furthermore,	  sustained	  release	  
of	   low	   concentrations	   of	  HNO	  might	   be	   an	   important	   step	   to	  mimic	   hypothesized	  
endogenous	  HNO	  production.13	   	   In	   comparison,	   the	   availability	   of	  NO	  donors	  was	  
invaluable	   to	   the	   elucidation	   of	   the	   biological	   properties	   and	   endogenous	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production	  of	  NO.	   	  Thus,	  new	   robust	  HNO	  donor	  platforms	  amenable	   to	   structure	  
activity	   relationship	   (SAR)	   studies	   designed	   to	   optimize	   both	   physiochemical	   and	  
physiological	  properties	  are	  desired.	  	  	  
The	  most	  commonly	  used	  strategy	  for	  prolonging	  HNO	  release	  is	  through	  the	  
use	   of	   ester	   prodrugs	   of	   otherwise	   efficient	   HNO	   donors.	   	   These	   include	   acyloxy	  
nitroso	   compounds,14-­‐15	   esters	   of	   primary	   amine-­‐based	   diazeniumdiolates	   such	   as	  
IPA/NO,16-­‐19	  and	  precursors	  to	  acyl	  nitroso	  compounds20-­‐22	  such	  as	  N,O-­‐bis-­‐acylated	  
hydroxylamine	   derivatives.23	   	   The	   tunability	   of	   this	   strategy	   is	   reliant	   on	   the	  
precursor	  ester	  hydrolysis	  rates,	  which	  can	  vary	  from	  seconds	  to	  hours.	   	  However,	  
the	   overall	   chemistry	   of	   these	   long-­‐acting	   HNO	   donors	   can	   be	   more	   complicated	  
than	   is	  originally	  anticipated.	   	  For	  example,	  direct	  and	  HNO-­‐mediated	  reactions	  of	  
acyloxy	   nitroso	   compounds	   have	   been	   demonstrated	   with	   thiol-­‐containing	  
proteins,24-­‐25	   dual	   mechanisms	   of	   HNO	   generation	   by	   IPA/NO-­‐AcOM	   (iPrHN-­‐
N(O)=NO–CH2OAc)	   and	   IPA/NO-­‐aspirin	   can	   occur	   in	   the	   absence	   of	   esterase,18-­‐19	  
and	   optimization	   of	   HNO	   production	   from	   N,O-­‐bis-­‐acylated	   hydroxylamine	  
derivatives	   requires	   the	   use	   of	   urea-­‐based	   precursors	   with	   arenesulfonyl	   leaving	  
groups	   in	   order	   to	   avoid	   both	   amide	   hydrolysis	   and	   acyl	   migration	   pathways.23	  	  
Additionally,	   these	   precursors	   are	   all	   susceptible	   to	   esterase-­‐mediated	   hydrolysis,	  
which	   complicates	   drug	   development	   since	   esterase	   activity	   not	   only	   depends	   on	  
the	   substrate,	   but	   also	   shows	   strong	   interspecies,	   interorgan,	   and	   interindividual	  
variability.26	  	  
Previously,	   we	   have	   reported	   the	   development	   of	   N-­‐substituted	  
hydroxylamines	   as	   efficient	  HNO	  donors	   based	   on	   the	   general	   formula	   (HOHN–X)	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where	   X	   is	   a	   good	   carbon-­‐based	   leaving	   group.27	   	   The	   rate	   and	   amount	   of	   HNO	  
released	   from	   these	   compounds	   is	   dependent	  mainly	   on	   the	  nature	  of	   the	   leaving	  
group	   X.	   	   We	   identified	   examples	   from	   three	   independent	   hydroxylamine-­‐
substituted	   classes	   shown	   in	   Figure	   3-­‐1:	   	   (1)	   the	   hydroxylamino-­‐Meldrum’s	   acid	  
(HAMA)	   class,	   (2)	   the	   hydroxylamino-­‐barbituric	   acid	   (HABA)	   class,	   and	   (3)	   the	  
hydroxylamino-­‐pyrazolone	  (HAPY)	  class.	  	  	  
	  
Figure	  3-­‐1.	  	  Previous	  examples	  from	  the	  HAMA,	  HABA,	  and	  HAPY	  classes	  of	  HNO	  donors.	  
	  
Each	   example	   shares	   in	   common	  an	  O-­‐methyloxime	  moiety	   attached	   to	   the	  
carbon	   bearing	   the	   hydroxylamine	   group.	   	   Simple	   alkyl	   group	   exchanges	   on	   the	  
HAMA	   and	   HABA	   scaffolds	   resulted	   in	   negligible	   HNO	   production	   following	  
incubation	  at	  pH	  7.4,	  37	  °C	  due	  to	  either	  competitive	  hydrolysis	  or	  rearrangement	  
mechanisms	   of	   their	   ring	   core	   systems,	   respectively.27	   The	   hydrolysis	   pathway	  
remains	  dominant	  in	  HAMA-­‐1	  even	  with	  O-­‐methyloxime	  substitution.	  	  At	  this	  point,	  
strategies	   to	   curtail	   these	  non-­‐HNO	  producing	  pathways,	   such	   that	   the	  HAMA	  and	  
HABA	  classes	  can	  be	  expanded,	  are	  not	  obvious,	  but	  will	  be	  addressed	  in	  Chapter	  4.	  	  	  
On	  the	  other	  hand,	  the	  HAPY	  class	  of	  HNO	  donors	  (Scheme	  3-­‐1)	  offers	  several	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and	  rearrangement,	  (2)	  multiple	  synthetic	  handles	  are	  available	  to	  investigate	  SAR,	  
and	  (3)	  the	  byproducts	  are	  related	  to	  edaravone	  (Radicut),28-­‐30	  	  a	  potent	  antioxidant	  
marketed	   in	   Japan	   to	   treat	   acute	   ischemic	   stroke,	   which	   has	   been	   reported	   to	   be	  
effective	  for	  myocardial	  ischemia	  as	  well.	  	  	  
	  
Scheme	  3-­‐1.	  	  General	  HNO	  Release	  from	  HAPY	  Class	  	  
	  
	  
	   Herein,	  we	  are	  pleased	  to	  report	  a	   first-­‐pass	  extension	  of	   the	  HAPY	  class	  of	  
HNO	  donors	  by	  varying	  the	  groups	  at	  the	  R1,	  R2,	  and	  R3	  positions	  on	  the	  pyrazolone	  
ring.	   	   In	   doing	   so,	   we	   have	   uncovered	   an	   unexpected	   reactivity	   of	   HNO	   with	  
pyrazolones,	   and	  have	   also	  developed	  a	   1H	  NMR	  assay	   for	   evaluating	   half-­‐life	   and	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§ 3.3	  	  Results	  and	  Discussion	  
3.3.1	  	  Early	  Studies	  	  	  
Due	  to	  the	  deleterious	  effect	  simple	  alkyl	  groups	  had	  on	  HNO	  production	  in	  
the	  HAMA	  and	  HABA	  classes,	  we	  first	  considered	  HAPY-­‐2	  (R1	  =	  phenyl,	  R2	  and	  R3	  =	  
methyl),	   which	   was	   expected	   to	   generate	   HNO	   as	   shown	   in	   Scheme	   3-­‐1.	   	   This	  
precursor	  was	  synthesized	  from	  the	  expected	  organic	  byproduct	  of	  HNO	  release,	  PY-­‐
2,	   which	   was	   readily	   prepared	   through	   the	   condensation	   of	   ethyl	   2-­‐
methylacetoacetate	  and	  phenylhydrazine.	   	   Installation	  of	   the	  hydroxylamine	  group	  
was	   accomplished	   analogously	   to	   the	   previously	   reported	   synthesis	   of	  HAPY-­‐1	  by	  
formation	   of	   the	   corresponding	   bromide	   followed	   by	   reaction	   with	   N,O-­‐bis(tert-­‐
butoxycarbonyl)	   hydroxylamine	   and	   subsequent	   acid	   deprotection	   (Scheme	   3-­‐2,	  
Path	  A).27	  
Previously,	  we	   examined	  HAPY-­‐1	   for	  HNO	  production	   in	   pH	  7.4	   phosphate	  
buffered	  saline	  at	  37	  °C	  by	  gas	  chromatographic	  headspace	  analysis	  to	  quantify	  the	  
amount	  of	  its	  dimerization	  product,	  N2O,	  as	  well	  as	  1H	  NMR	  spectroscopy	  to	  quantify	  
the	   amount	   of	   the	   expected	   organic	   byproduct	   PY-­‐1.	   	   HNO	  was	   confirmed	   as	   the	  
source	  of	  N2O	   for	  HAPY-­‐1	  by	  quenching	  with	  glutathione	   (GSH),	  a	  known	  efficient	  
trap	  for	  HNO.31-­‐32	  	  	  	  	  
Upon	   examination	   of	   HAPY-­‐2,	   however,	   only	   trace	   amounts	   of	   N2O	   were	  
observed	  following	  24	  h	  incubation,	  and	  1H	  NMR	  analysis	  revealed	  that	  HAPY-­‐2	  was	  
essentially	   stable.	   	   Interestingly,	   upon	   24	   h	   incubation	   with	   excess	   GSH	   (ca.	   5	  
equivalents),	   enhanced	  conversion	  of	  HAPY-­‐2	   to	  byproduct	  PY-­‐2	  was	  observed	  by	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1H	  NMR	   spectroscopy;	   the	   relative	   yield	   of	   PY-­‐2	  was	   36%.	   	   Importantly,	   no	   other	  
products	  arising	  from	  HAPY-­‐2	  were	  observed.	  	  Four	  conclusions	  can	  be	  drawn	  from	  
these	   results:	   	   (1)	   the	   pyrazolone	   ring	   is	   stable	   against	   hydrolysis	   and	  
rearrangement,	   (2)	   the	   decomposition	   rates	   of	   HAPY-­‐1	   and	   HAPY-­‐2	   differ	  
dramatically,	   (3)	   byproduct	   PY-­‐2	   may	   be	   an	   efficient	   trap	   for	   HNO,	   and	   (4)	   an	  
alternative	   means	   of	   monitoring	   HNO	   release	   in	   an	   expanded	   HAPY	   class	   is	  
necessary.	  
	  
3.3.2	  	  Synthesis	  	  	  
Clearly,	   a	   large	   variation	   in	   effective	   half-­‐life	   is	   observed	   when	   the	   R3	  
position	  of	  the	  pyrazolone	  ring	  is	  interconverted	  between	  an	  O-­‐methyloxime	  group	  
and	   a	   methyl	   group.	   	   Moving	   forward,	   we	   probed	   the	   R1	   and	   R2	   positions	   with	  
simple	   hydrogen,	   methyl,	   and	   substituted	   phenyl	   variations.	   	   Accordingly,	   PY-­‐3	   –	  	  
PY-­‐12	  (Table	  3-­‐1)	  were	  prepared	  (see	  Experimental).	  
	   Next,	  we	  wanted	  to	  test	  the	  possibility	  that	  PY-­‐2	  may	  be	  an	  efficient	  trap	  for	  
HNO.	   	  Therefore,	  we	  monitored	  the	  reaction	  of	  PY-­‐2	  and	  Angeli’s	  salt	   in	  10%	  D2O,	  
pH	  7.4	  phosphate	  buffer	  with	  the	  metal	  chelator,	  diethylenetriaminepentaacetic	  acid	  
(DTPA),	   at	   room	   temperature	   by	   1H	   NMR	   spectroscopy	   (Figure	   3-­‐2).	   	   Consistent	  
with	  our	  hypothesis,	  we	  observe	  the	  complete	  conversion	  of	  PY-­‐2	  to	  HAPY-­‐2,	  which	  
is	   the	   first	   example	   of	  what	   can	   be	   considered	   an	  N-­‐selective	   HNO-­‐aldol	   reaction	  
utilizing	  the	  smallest	  nitroso	  compound,	  HNO,	  as	  the	  reagent.	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Figure	   3-­‐2.	   	   (a)	   The	   N-­‐selective	   HNO-­‐aldol	   reaction	   between	   PY-­‐2	   and	   Angeli’s	   salt-­‐
derived	  HNO.	   	   (b)	   1H	  NMR	  spectra	  of	   the	   formation	  of	  HAPY-­‐2	   from	  PY-­‐2	  and	  Angeli’s	  
salt-­‐derived	  HNO	  in	  10%	  D2O,	  pH	  7.4	  phosphate	  buffer	  (0.25	  M)	  with	  DTPA	  (0.2	  mM)	  at	  
room	   temperature.	   	   (c)	   The	   kinetics	   of	   the	   reaction	   using	   the	   integrated	   area	   of	   the	  
upfield	  methyl	  group	  of	  PY-­‐2	  relative	  to	  the	  upfield	  methyl	  group	  of	  HAPY-­‐2.	  	  The	  solid	  
curves	  are	  calculated	  best	  fits	  to	  a	  single	  exponential	  function	  (k	  =	  4.0	  ×	  10–4	  s–1	  for	  each	  
fit).	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This	   new	   reactivity	   of	   HNO	   is	   not	   so	   unexpected	   given	   what	   has	   been	  
reported	  in	  the	  literature.	  	  The	  chemical	  similarity	  between	  HNO	  and	  an	  aldehyde	  is	  
greater	  than	  between	  HNO	  and	  an	  oxyacid.9	  	  In	  addition,	  HNO	  is	  a	  potent	  inhibitor	  of	  
aldehyde	  dehydrogenase,33-­‐34	  demonstrating	  its	  chemical	  similarity	  to	  acetaldehyde,	  
though	   HNO	   is	   isoelectronic	   with	   formaldehyde.	   	   Pyrazolones,	   as	   well	   as	   other	  
reactive	   enols	   and	   enolates,	   readily	   form	   aldol	   condensation	   products	   with	  
aldehydes	   in	   aqueous	   media.35	   	   Moreover,	   the	   nitroso-­‐aldol	   reaction	   between	  
carbonyl	   compounds	   and	   nitrosoarene	   and	   acyl	   nitroso	   compounds	   to	   produce	  
enantioselective	  amines	  and	  alcohols	   following	  N–O	  bond	  reduction	  has	  been	  well	  
documented.36-­‐38	  
	   The	  reaction	  of	  HNO	  with	  PY	  to	  give	  HAPY	  is	  synthetically	  attractive,	  as	  it	  is	  
the	   one-­‐step	   umpolung	   strategy	   (Scheme	   3-­‐2,	   Path	   B)	   to	   the	   traditional	  
bromination-­‐displacement-­‐deprotection	  strategy	  (Scheme	  3-­‐2,	  Path	  A).	  	  As	  such,	  we	  
endeavored	  to	  find	  a	  preparatory	  procedure	  for	  this	  HNO-­‐aldol	  reaction	  and	  apply	  it	  
to	  an	  expanded	  HAPY	  class.	  
	  




We	   have	   been	   able	   to	   develop	   a	   general	   synthetic	   protocol	   at	   room	  
temperature	   that	   features	   the	   use	   of	   Angeli’s	   salt,	   which	   has	   a	   suitable	   HNO	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from	  the	  HAPY	  product.	   	  To	  initiate	  decomposition	  of	  Angeli’s	  salt,	  DTPA	  was	  used	  
as	   a	   proton	   source	   as	   well	   as	   to	  maintain	   a	   buffered	   solution	   and	   preclude	   HNO	  
reactivity	  with	  trace	  metals.	  	  A	  50%	  v/v	  aqueous	  ethanol	  solution	  allowed	  both	  the	  
organic	  and	  salt	  reagents	  to	  be	  readily	  soluble	  at	  typical	  reaction	  concentrations	  (0.1	  
–	  0.4	  M)	  (See	  Experimental).	  	  The	  use	  of	  ethanol	  also	  aided	  in	  the	  preliminary	  drying	  
steps	   by	   allowing	   the	   mild	   azeotropic	   removal	   of	   the	   water.	   	   This	   procedure	   is	  
applicable	  for	  each	  HAPY	  example;	  the	  isolated	  synthetic	  yields	  are	  shown	  in	  Table	  
3-­‐1.	  	  	  




HAPY	   R1	   R2	   R3	   %	  yield	  
1	   Ph	   Me	   C(=NOMe)Me	   74	  
2	   Ph	   Me	   Me	   89	  
3	   Me	   Me	   C(=NOMe)Me	   44	  
4	   Me	   Me	   Me	   76	  
5	   H	   Me	   C(=NOMe)Me	   35	  
6	   H	   Me	   Me	   75	  
7	   4-­‐ClPh	   Me	   Me	   94	  
8	   2-­‐ClPh	   Me	   Me	   96	  
9	   Me	   Ph	   Me	   89	  
10	   Ph	   Ph	   Me	   99	  
11	   Me	   4-­‐ClPh	   Me	   99	  
12	   Me	   2-­‐ClPh	   Me	   87	  
	  
	   Surprisingly,	  even	  the	  relatively	  efficient	  HNO	  donor,	  HAPY-­‐1,	  can	  be	  isolated	  
starting	   from	   PY-­‐1	   in	   better	   yield	   and	   in	   fewer	   steps	   when	   compared	   to	   the	  
traditional	   bromination-­‐displacement-­‐deprotection	   strategy	   (1	   step,	   74%	   vs.	   3	  
Angeli's salt (2 eq.)
DTPA (0.5 eq.)
50% v/v aq. ethanol
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steps,	  34%	  overall).	   	  The	  caveat	  here	  is	  that	  conversion	  to	  HAPY-­‐1,	  or	  the	  other	  O-­‐
methyloxime	  derivatives	  HAPY-­‐3	  and	  HAPY-­‐5,	  is	  not	  complete,	  and	  requires	  the	  use	  
of	   chromatographic	   separation	   to	   isolate.	   	   Fortunately,	   their	   respective	   isolated	  
yields	   correspond	   well	   with	   the	   conversion	   yields,	   and	   under	   these	   reaction	  
conditions,	   the	   HAPY	   products	   are	   relatively	   stable	   several	   hours	   after	   HNO	  
generation	  from	  Angeli’s	  salt	  has	  completed.	  	  Therefore,	  we	  believe	  the	  lower	  yields	  
for	  these	  compounds	  are	  primarily	  due	  to	  less	  efficient	  trapping	  of	  HNO	  rather	  than	  
the	  reactivity	  of	  the	  HAPY	  product.	   	  Otherwise,	  complete	  conversion	  was	  observed	  
in	  the	  other	  HAPY	  examples,	  each	  equipped	  with	  a	  methyl	  group	  in	  the	  R3	  position,	  
resulting	  in	  excellent	  isolated	  yields.	  
	  
3.3.3	  	  Kinetic	  Evaluation	  	  	  
Given	  the	  high	  conversion	  yields,	  particularly	  for	  the	  R3	  =	  methyl	  examples,	  
we	   have	   quantified	   this	   reactivity	   of	   HNO	   with	   pyrazolones	   utilizing	   PY-­‐2	   as	   an	  
example.	   	  We	   employed	   a	   competitive	   trapping	   experiment	   using	   the	  HNO	  donor,	  
HABA-­‐1,	   and	   tris(4,6-­‐dimethyl-­‐3-­‐sulfanatophenyl)phosphine	   trisodium	   salt	  
(TXPTS),	  another	  efficient	  and	  selective	  trap	  for	  HNO	  at	  pH	  7.4,	  37	  °C	  (kTXPTS	  =	  9	  ×	  
105	  M–1s–1)	  following	  Scheme	  3-­‐3.39-­‐40	  	  HNO	  reacts	  with	  two	  equivalents	  of	  TXPTS	  to	  
give	  the	  diagnostic	  aza-­‐ylide	  product	  as	  well	  as	  the	  corresponding	  phosphine	  oxide,	  
where	  the	  rate-­‐limiting	  step	  is	  assumed	  to	  be	  the	  initial	  reaction	  between	  HNO	  and	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Scheme	  3-­‐3.	  	  Competitive	  HNO	  Trapping	  Experiment	  at	  pH	  7.4,	  37	  °C	  
	  
To	  determine	  the	  rate	  constant	  for	  the	  reaction	  of	  PY-­‐2	  with	  HNO	  (Equation	  
1),	   we	   evaluated	   the	   concentration	   of	   TXPTS	   required	   to	   achieve	   equal	   product	  
distributions	   of	   HAPY-­‐2	   compared	   to	   the	   aza-­‐ylide	   product	   of	   TXPTS.40-­‐41	  
Importantly,	   all	   the	  HNO	  produced	   under	   these	   conditions	  must	   react	  with	   either	  
PY-­‐2	  or	  TXPTS	  in	  order	  for	  Equation	  1	  to	  be	  valid;	  HNO	  dimerization	  cannot	  occur.	  	  	  
𝑘𝑘 -­‐2 =   
[ ]
[ -­‐2]
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  	  	  
	   Accordingly,	  due	  to	   its	  diagnostic	  1H	  NMR	  signals,	  byproduct	  BA-­‐1	  (Scheme	  
3-­‐3)	   served	   as	   an	   internal	   reference	   such	   that	   all	   species	   involved	   could	   be	  
quantified,	   including	   the	   aza-­‐ylide	   product	   of	   TXPTS,	   which	   had	   only	   been	  
characterized	  by	   31P	  NMR	  and	  HPLC	  previously.	   	   The	   results	   shown	   in	  Figure	  3-­‐3	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of	  TXPTS	  required	  to	  affect	  equal	  product	  distributions	  is	  ca.	  8.5	  mM,	  which	  gives	  an	  
HNO	   trapping	   rate	   constant	   for	   PY-­‐2	   of	   ca.	   8	   ×	   105	   M–1s–1	   at	   pH	   7.4,	   37	   °C,	  
comparable	  to	  that	  of	  TXPTS.	  	  	  
	  
Figure	  3-­‐3.	   	  Competition	  for	  HABA-­‐1-­‐derived	  HNO	  at	  pH	  7.4,	  37	  °C:	  	  PY-­‐2	  vs.	  TXPTS.	  	  (a)	  
All	  competition	  reactions	  contained	  HABA-­‐1	  (5	  mM)	  and	  PY-­‐2	  (5	  mM)	  in	  2.0	  mL	  of	  10%	  
D2O,	   pH	   7.4	   phosphate	   buffer	   (0.25	   M)	   with	   DTPA	   (0.2	   mM).	   	   Each	   reaction	   was	  
incubated	   under	   argon	   for	   30	   minutes	   at	   37	   °C	   to	   ensure	   complete	   decomposition	   of	  
HABA-­‐1	   before	   1H	   NMR	   analysis	   of	   the	   reaction	   mixture.	   	   (b)	   Representative	   1H	   NMR	  




	   These	  results	  indicate	  that	  PY-­‐2	  to	  HAPY-­‐2	  formation	  is	  efficient	  and	  can	  be	  
used	  diagnostically	  as	  an	  alternative	  means	  of	  HNO	  quantification.	   	  Also,	   the	  “HNO	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transfer	   reaction”	   between	   HABA-­‐1	   and	   PY-­‐2	   demonstrates	   that	   HNO	   donors	  
beyond	  Angeli’s	  salt	  can	  be	  used	  in	  the	  HNO-­‐aldol	  reaction.	  
	  
3.3.4	  	  DFT	  Calculations	  
We	  modeled	   the	   thermodynamic	  driving	   forces	   for	   three	  possible	   reactions	  
involving	   HNO	   with	   the	   synthesized	   pyrazolone	   examples	   (Scheme	   3-­‐4).	   	   All	  
calculations	  were	   performed	  with	   Spartan	   ’14	   at	   the	   B3LYP/6-­‐31G*	   level	  with	   an	  
SM8	  solvation	  model	  for	  aqueous	  solvation	  (Supporting	  Information).42	   	  Optimized	  
geometries	   and	   vibrational	   frequencies	   were	   calculated	   for	   each	   reactant	   and	  
product	   independently.	   	  Reaction	   II	  was	  balanced	  using	  a	  hydronium	  cation	  and	  a	  
water	  molecule	   on	   the	   left	   and	   right	   side	   of	   the	   reaction,	   respectively.	   	   Table	   3-­‐2	  
shows	  the	  Gibbs	  free	  energy	  differences	  for	  reaction	  I,	  II,	  and	  III.	  
	  
Scheme	  3-­‐4.	  	  Possible	  Reactions	  Involving	  HNO	  with	  Pyrazolones	  
	  
Reaction	   (I)	  HNO	  with	   neutral	   PY	   in	   the	   enol	   tautomer	   to	   give	   neutral	  HAPY,	   (II)	  
HNO	  with	  the	  enolate	  of	  PY	  to	  give	  neutral	  HAPY,	  and	  (III)	  HNO	  with	  the	  enolate	  of	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Table	  4-­‐2.	  	  Gibbs	  Free	  Energy	  Differences	  in	  Reactions	  I,	  II,	  and	  III	  	  






1	   Ph	   Me	   C(=NOMe)Me	   -­‐0.7	   -­‐27.5	   a	  
2	   Ph	   Me	   Me	   -­‐13.0	   -­‐34.4	   13.7	  
3	   Me	   Me	   C(=NOMe)Me	   -­‐0.6	   -­‐30.6	   a	  
4	   Me	   Me	   Me	   -­‐13.1	   -­‐38.7	   10.2	  
5	   H	   Me	   C(=NOMe)Me	   	  	  -­‐0.6	   -­‐30.8	   a	  
6	   H	   Me	   Me	   -­‐12.5	   -­‐38.1	   10.9	  
7	   4-­‐ClPh	   Me	   Me	   -­‐13.0	   -­‐33.5	   14.0	  
8	   2-­‐ClPh	   Me	   Me	   -­‐12.2	   -­‐36.3	   12.0	  
9	   Me	   Ph	   Me	   -­‐10.8	   -­‐34.7	   13.2	  
10	   Ph	   Ph	   Me	   -­‐11.0	   -­‐31.5	   a	  
11	   Me	   4-­‐ClPh	   Me	   -­‐10.6	   -­‐34.3	   14.6	  
12	   Me	   2-­‐ClPh	   Me	   	  	  	  -­‐8.0	   -­‐32.8	   15.8	  
aGround	   state	   structures	   were	   not	   found	   for	   these	   oxyanions	   since	   the	   calculated	   structures	  
resemble	   dissociated	   HNO	   and	   the	   corresponding	   organic	   byproduct.	   	   Free	   energies	   are	   given	  
for	  298.15	  K.	  	  
	  
Consistent	  with	   the	   experimental	   results	   above,	   these	   calculations	   indicate	  
that	   both	   reaction	   I,	   and	  particularly,	   reaction	   II	   are	   thermodynamically	   favorable	  
for	  the	  forward	  PY	  to	  HAPY	  reaction	  for	  all	  examples.	  	  On	  the	  other	  hand,	  reaction	  III	  
is	   thermodynamically	   unfavorable.	   	   In	   addition,	   ground	   state	   structures	  were	   not	  
found	   for	   the	   oxyanions	   of	   HAPY-­‐1,	   HAPY-­‐3,	   HAPY-­‐5,	   and	   HAPY-­‐10	   since	   the	  
calculated	   structures	   resemble	   dissociated	   HNO	   and	   the	   corresponding	   PY	  
byproduct.	  	  Thus,	  HNO	  generation	  from	  the	  expanded	  HAPY	  class	  is	  expected	  to	  be	  
dependent	  on	  the	  pKa	  of	  the	  HAPY	  donor,	  which	  in	  turn	  is	   likely	  dependent	  on	  the	  
pKa	  of	  the	  PY	  bydroduct.	  
	  
3.3.5	  	  HNO	  Release	  from	  the	  Expanded	  HAPY	  Class	  	  	  
As	   described	   above,	   the	   reaction	   of	   HNO	   with	   pyrazolones	   can	   be	   taken	  
advantage	   of	   synthetically	   and	   potentially	   used	   as	   an	   alternative	   means	   of	  
quantifying	  HNO	  production.	   	  Yet,	   the	  original	  purpose	  of	  this	   investigation	  was	  to	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study	  the	  HNO	  production	  from	  these	  newly	  prepared	  HAPY	  compounds.	  	  With	  this	  
reversible	   reactivity	   in	  mind,	   an	   additional	   trap	   for	   HNO	   is	   required	   to	   drive	   the	  
HAPY	   to	   PY	   reaction	   forward.	   	  We	  had	   demonstrated	   this	   earlier	   by	   using	  GSH,	   a	  
biologically	  relevant	  trap	  for	  HNO	   in	  vivo.	   	  However,	  TXPTS	  is	  best	  suited	  for	  these	  
mechanistic	  studies	  since	  it	  has	  selective	  and	  irreversible	  reactivity	  with	  HNO,	  and	  
the	  diagnostic	  aza-­‐ylide	  singlet	   in	   the	  1H	  NMR	  spectrum	  is	  distinct	   from	  the	  HAPY	  
and	  PY	  compounds.	  	  
We	   first	   examined	   the	   effect	   that	   increasing	   [TXPTS]	  has	  on	   the	  half-­‐life	   of	  
HAPY-­‐2,	   as	   an	   example.	   	   Following	   a	   48	   h	   incubation	   of	   HAPY-­‐2	   with	   0	   –	   20	  
equivalents	  of	  TXPTS	  in	  pH	  7.4	  phosphate	  buffer	  at	  37	  °C,	  1H	  NMR	  analysis	  indicates	  
the	   incremental	   consumption	   of	   HAPY-­‐2	   with	   TXPTS	   increasing	   from	   0	   to	   ca.	   4	  
equivalents,	   whereas	   the	   relative	   percentage	   of	   HAPY-­‐2	   remains	   effectively	  
unchanged	  when	  TXPTS	  exceeded	  ca.	  4	  equivalents	  (Figure	  3-­‐4).	  	  Importantly,	  these	  
results	   indicate	   no	  bimolecular,	   direct	   reaction	   between	  TXPTS	   and	  HAPY-­‐2	   since	  
HAPY-­‐2	  consumption	  is	  not	  linear	  with	  the	  change	  in	  initial	  [TXPTS].	  	  Therefore,	  we	  
believe	  that	  the	  HAPY-­‐2	  to	  PY-­‐2	  conversion	  is	  the	  result	  of	  the	  irreversible	  reaction	  
of	   the	   released	   HNO	   with	   TXPTS,	   thereby	   minimizing	   the	   PY-­‐2	   to	   HAPY-­‐2	   back-­‐
reaction.	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Figure	  3-­‐4.	  	  	  Incubation	  of	  HAPY-­‐2	  at	  pH	  7.4,	  37	  °C	  after	  48	  h	  as	  a	  function	  of	  [TXPTS]0.	  	  
Conditions:	  	  HAPY	  (1	  mM)	  in	  10%	  D2O,	  pH	  7.4	  phosphate	  buffer	  (0.25	  M)	  with	  DTPA	  (0.2	  
mM)	  at	  37	  °C	  under	  argon.	  	  	  
	  
	   The	  timecourse	  for	  the	  disappearance	  of	  HAPY-­‐2	  and	  appearance	  of	  PY-­‐2	  and	  
HNO	   (trapped	   as	   the	   TXPTS	   aza-­‐ylide)	  with	   ca.	   6	   equivalents	   of	   TXPTS	   as	  well	   as	  
representative	  1H	  NMR	  spectra	  at	  t	  =	  0	  h,	  240	  h,	  and	  480	  h	  are	  shown	  in	  Figure	  3-­‐5.	  	  
With	  a	  half-­‐life	  of	  47	  h	  and	  a	  quantitative	  TXPTS	  aza-­‐ylide	  yield,	  HAPY-­‐2	   is	  a	  very	  
long-­‐lived,	  yet	  pure	  HNO	  donor.	  	  	  
Fortunately,	   under	   these	   anaerobic	   assay	   conditions,	   the	   TXPTS	   aza-­‐ylide	  
product	   is	  stable.	   	  The	  TXPTS	  oxide	  product	  slowly	   increases	  beyond	  the	  expected	  
stoichiometric	   amount	   due	   to	   oxidation	   of	   the	   excess	   TXPTS,	   as	   maintaining	   a	  
rigorously	  anaerobic	  assay	  condition	  for	  this	  extended	  time	  period	  is	  experimentally	  
challenging.	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Figure	  3-­‐5.	  	  (a)	  Timecourse	  for	  the	  disappearance	  of	  HAPY-­‐2	  and	  appearance	  of	  PY-­‐2	  and	  
TXPTS	  aza-­‐ylide	  with	  added	  TXPTS	  (6	  equivalents).	  The	  solid	  curves	  are	  calculated	  best	  
fits	  to	  a	  single	  exponential	  function	  (k	  =	  4.1	  ×	  10–6	  s–1	  for	  each	  fit).	  	  (b)	  1H	  NMR	  spectra	  at	  
t	  =	  0	  h,	  240	  h,	  and	  480	  h;	  see	  Experimental	  for	  details.	  
	  
	   Likewise,	   an	   unknown	   oxidation	   product	   forms	   slowly	   from	   the	   organic	  
byproduct	  PY-­‐2	  (Figure	  3-­‐5).	  	  Following	  overnight	  aerobic	  incubation	  of	  PY-­‐2	  in	  pH	  
7.4	  phosphate	  buffer	  at	  37	  °C	  in	  the	  absence	  of	  metal	  chelator,	  the	  oxidized	  product	  
precipitated	   from	   solution,	   which	   was	   briefly	   reheated	   in	   order	   to	   affect	  
recrystallization.	   	   X-­‐ray	   crystallography	   confirmed	   the	   identity	   of	   the	   oxidized	  
product	   as	   PY-­‐2OH,	   the	   corresponding	   alcohol	   of	   PY-­‐2	   (Supporting	   Information).	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Recall	  that	  PY-­‐2	  is	  a	  derivative	  of	  edaravone,	  which	  has	  beneficial	  effects	  attributed	  
to	   its	   free	   radical	   scavenging	  ability	   through	  a	   single	  electron	   transfer	  mechanism	  
with	   reactive	   oxygen	   species	   such	   as	   hydroxyl	   and	   peroxyl	   radicals.43	   	   Therefore,	  
this	   1H	  NMR	  assay	   for	  evaluating	  half-­‐life	  and	  HNO	  production	  requires	   the	  use	  of	  
excess	   TXPTS	   (>	   5	   equivalents)	   under	   anaerobic	   conditions	   in	   order	   to	   reduce	  
complications	   from	   the	   PY	   to	   HAPY	   back-­‐reaction	   as	  well	   as	   from	   TXPTS	   and	   PY	  
oxidation.	  
	   The	  half-­‐life	  of	  HAPY-­‐1	  was	  previously	  reported	  to	  be	  9.5	  minutes	  in	  pH	  7.4	  
phosphate	  buffer	  at	  37	  °C,	  which	  was	  determined	  by	  UV-­‐vis	  analysis	  in	  the	  absence	  
of	   an	   additional	   trap	   for	   HNO	   (such	   as	   TXPTS).27	   Following	   the	   1H	   NMR	   assay	  
described	   above,	   the	   observed	   half-­‐life	   of	   HAPY-­‐1	   was	   reduced	   in	   half	   to	   four	  
minutes	   (Supporting	   Information),	   presumably	   due	   to	   minimization	   of	   the	   back-­‐
reaction,	  PY-­‐1	  to	  HAPY-­‐1	  (Table	  3-­‐3).	  	  	  
	   Given	   the	   large	   difference	   in	   half-­‐lives	   between	   HAPY-­‐1	   and	   HAPY-­‐2,	   we	  
examined	  additional	  examples,	  specifically	  HAPY-­‐3	  –	  HAPY-­‐12.	   	  Since	  changing	  the	  
R3	  position	  clearly	  has	  a	  large	  effect	  on	  half-­‐life,	  we	  next	  explored	  the	  perhaps	  more	  
subtle	  effects	  at	  the	  R1	  and	  R2	  positions.	   	  With	  a	  variety	  of	  derivatives	   in	  hand,	  we	  
followed	  their	  decomposition	  according	  to	  the	  1H	  NMR	  protocol	  used	  with	  HAPY-­‐1	  
and	  HAPY-­‐2	  described	  above.	  	  We	  also	  measured	  the	  pKa	  values	  of	  their	  respective	  
PY	  byproducts.	   	   For	   solubility	   reasons,	   all	   pKa	  measurements	  were	   determined	   in	  
50%	  v/v	  aqueous	  ethanol	  by	  titration.	  	  The	  results	  are	  shown	  in	  Table	  3-­‐3.	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Table	  3-­‐3.	  	  Incubation	  of	  HAPY-­‐1	  –	  HAPY-­‐12	  in	  pH	  7.4	  Phosphate	  Buffer	  at	  37	  °C	  Under	  
Argon	  with	  Added	  TXPTS	  	  	  
	  
HAPYa	   R1	   R2	   R3	   t1/2	  (min)	   k	  (s-­‐1)b	   pKa	  of	  PYc	  
1	   Ph	   Me	   C(=NOMe)Me	   4	   3.0	  ×	  10-­‐3	   6.8d	  	  
2	   Ph	   Me	   Me	   2793	   4.1	  ×	  10-­‐6	   8.8	  
3	   Me	   Me	   C(=NOMe)Me	   11	   1.0	  ×	  10-­‐3	   7.4	  
4	   Me	   Me	   Me	   5674	   2.0	  ×	  10-­‐6	   9.5	  
5	   H	   Me	   C(=NOMe)Me	   14	   8.2	  ×	  10-­‐4	   8.2	  
6	   H	   Me	   Me	   4585	   2.5	  ×	  10-­‐6	   	  10.0	  
7	   4-­‐ClPh	   Me	   Me	   1473	   7.8	  ×	  10-­‐6	   8.4	  
8	   2-­‐ClPh	   Me	   Me	   1887	   6.1	  ×	  10-­‐6	   8.7	  
9	   Me	   Ph	   Me	   753	   1.5	  ×	  10-­‐5	   8.5	  
10	   Ph	   Ph	   Me	   460	   2.5	  ×	  10-­‐5	   8.1	  
11	   Me	   4-­‐ClPh	   Me	   799	   1.4	  ×	  10-­‐5	   8.0	  
12	   Me	   2-­‐ClPh	   Me	   71	   1.6	  ×	  10-­‐4	   8.0	  
aIncubation	  conditions:	   	  HAPY	  (1	  mM)	  and	  TXPTS	  (5	  mM)	  in	  10%	  D2O,	  pH	  7.4	  phosphate	  buffer	  
(0.25	   M)	   with	   DTPA	   (0.2	   mM)	   at	   37	   °C	   under	   argon.	   	   HNO	   yields	   are	   quantitative	   for	   all	  
examples.	   	  bThe	  rates	  are	  calculated	  best	  fits	  to	  a	  single	  exponential	  function	  of	  the	  integrated	  
1H	   NMR	   data	   for	   HAPY	   disappearance/PY	   appearance.	   	   cDetermined	   by	   titration	   in	   50%	   v/v	  
aqueous	  ethanol.	  	  dThe	  pKa	  of	  PY-­‐1	  was	  previously	  determined	  in	  water	  (pKa	  of	  PY-­‐1	  =	  6.0).27	  
	  
	  
	   First,	   we	   changed	   the	   R1	   position	   from	   phenyl	   in	   HAPY-­‐1	   and	   HAPY-­‐2	   to	  
methyl	   (HAPY-­‐3	   and	   HAPY-­‐4,	   respectively)	   and	   hydrogen	   (HAPY-­‐5	   and	   HAPY-­‐6,	  
respectively).	  	  As	  the	  R1	  substituent	  is	  changed	  from	  phenyl	  to	  methyl	  or	  hydrogen,	  
we	  observe	  a	  decrease	  in	  rate,	  which	  seems	  to	  correlate	  well	  with	  the	  pKa	  values	  of	  
the	  respective	  PY	  byproducts.	  	  Although	  the	  R3	  =	  O-­‐methyloxime	  derivatives,	  HAPY-­‐
3	  and	  HAPY-­‐5,	  have	  half-­‐lives	  between	  those	  of	  HAPY-­‐1	  and	  HAPY-­‐2,	  the	  R3	  =	  methyl	  
derivatives,	  HAPY-­‐4	  and	  HAPY-­‐6,	  have	  even	  slower	  dissociation	  rates	  than	  HAPY-­‐2.	  	  
Importantly,	  the	  HNO	  yield	  for	  all	  of	  these	  precursors	  remains	  quantitative,	  and	  as	  
R3P=NH   +   R3P=O
HNO    +
TXPTS (> 5 eq.)
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such,	  HAPY-­‐4	  and	  HAPY-­‐6	  are	  the	  longest-­‐lived	  reported	  pure	  HNO	  donors	  to	  date	  
with	  half-­‐lives	  measuring	  95	  h	  and	  76	  h,	  respectively.	  
	   Next,	  we	  explored	  substitution	  on	   the	  phenyl	   ring	  of	  HAPY-­‐2	  with	  4-­‐chloro	  
(HAPY-­‐7)	   and	   2-­‐chloro	   (HAPY-­‐8)	   groups.	   	   These	   derivatives	   have	   slightly	   faster	  
rates	  when	  compared	  to	  HAPY-­‐2,	  but	  are	  still	  over	  two	  orders	  of	  magnitude	  slower	  
than	  HAPY-­‐1.	  	  	  
	   We	   then	  made	  changes	   to	   the	  R2	  position	  by	   first	   synthesizing	  HAPY-­‐9,	   the	  
isomer	   of	  HAPY-­‐2.	   	   Interestingly,	   the	   decomposition	   rate	   of	  HAPY-­‐9	   is	   over	   three	  
times	  faster	  than	  that	  of	  HAPY-­‐2.	  	  The	  impact	  of	  R2	  substitution	  is	  best	  illustrated	  by	  
comparing	  HAPY-­‐4	  with	  HAPY-­‐9,	  HAPY-­‐11,	  and	  HAPY-­‐12,	  where	  the	  observed	  rate	  
changes	  span	  two	  orders	  of	  magnitude.	  	  
	   All	  told,	  by	  varying	  groups	  at	  the	  R1,	  R2,	  and	  R3	  positions	  on	  the	  pyrazolone	  
ring,	   the	   observed	   rate	   changes	   span	   one,	   two,	   and	   three	   orders	   of	   magnitude,	  
respectively.	   	   The	   distance	   removed	   from	   the	   carbon	   bearing	   the	   hydroxylamine	  
group	  is	  greatest	  for	  the	  R1	  position	  and	  shortest	  for	  the	  R3	  position,	  and	  inductive	  
effects	   are	   expected	   to	   follow	   likewise.	   	   However,	   only	   the	   R3	   position	   allows	   for	  
additional	   resonance	   stabilization	   in	   the	   dissociated	   PY	   byproduct,	  which	   has	   the	  
largest	  impact	  on	  the	  PY	  byproduct	  pKa	  (e.g.,	  the	  pKa	  difference	  of	  PY-­‐1	  and	  PY-­‐2	  is	  
two	  pH	  units).	  	  	  
As	   suggested	   from	  our	   calculations,	  HNO	   release	   is	   governed	  by	   the	  pKa	   of	  
the	   donor,	   which	   likely	   correlates	   with	   the	   pKa	   of	   the	   byproduct.	   	   This	   trend	   is	  
reinforced	  by	  UV-­‐vis	  analysis	  of	  the	  decomposition	  rates	  of	  the	  representative	  HAPY	  
compounds	  as	  a	  function	  of	  pH,	  where	  the	  observed	  sharp	  increases	  reflect	  rapid	  PY	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formation	   as	   a	   result	   of	   HAPY	   deprotonation	   (Figure	   3-­‐6).	   	   Decomposition	   rates	  
reach	  the	  time	  resolution	  limit	  (ca.	  0.15	  s-­‐1),	  precluding	  a	  complete	  pKa	  analysis	  for	  
each	  donor;	  however,	  these	  results	  indicate	  that	  the	  barrier	  to	  dissociation	  must	  be	  
very	   low	   once	   deprotonation	   of	   the	   donor	   occurs.	   	   Moreover,	   with	   such	   large	  
approximate	   pKa	   values,	   HNO	   evolution	   at	   neutral	   pH	   suggests	   a	   near	   barrierless	  
dissociation	  from	  the	  deprotonated	  donor.	  	  	  
	  
Figure	  3-­‐6.	  	  Plot	  of	  UV-­‐vis	  determined	  decomposition	  rates	  as	  a	  function	  of	  pH	  at	  25	  °C	  
for	   HAPY-­‐5	   (red),	   HAPY-­‐10	   (purple),	   HAPY-­‐11	   (blue),	   and	   HAPY-­‐12	   (green).	   	   The	   solid	  
curves	  are	  calculated	  best	  fits	  to	  a	  sigmoid	  function	  (SEM	  ±	  10	  %;	  n	  ≥	  3).	  
	  
However,	  byproduct	  pKa	  alone	  does	  not	  always	  correlate	  with	  donor	  pKa.	  	  For	  
example,	   the	   pKa	   values	   of	   PY-­‐5,	   PY-­‐10	   –	   PY-­‐12	   are	   all	   ca.	   8,	   yet	  HAPY-­‐5	   is	  more	  
acidic	   than	   HAPY-­‐12,	   which	   in	   turn	   is	   more	   acidic	   than	   HAPY-­‐10	   and	   HAPY-­‐11	  
(Figure	  3-­‐6).	   	  This	  trend	  is	  mirrored	  in	  the	  half-­‐lives	  of	  these	  donors	  at	  neutral	  pH	  
(Table	  3-­‐3).	  	  The	  half-­‐lives	  of	  HAPY-­‐5,	  HAPY-­‐10,	  HAPY-­‐11,	  and	  HAPY-­‐12	  are	  14,	  460,	  
799,	   and	   71	   minutes,	   respectively.	   	   The	   fact	   that	   decomposition	   of	   HAPY-­‐5	   as	   a	  
function	   of	   pH	   is	   approaching	   a	   limiting	   rate	   constant	   at	   a	   pH	   apparently	   much	  
lower	   than	   that	   for	   HAPY-­‐10	   –	   HAPY-­‐12	   in	   this	   analysis	   (Figure	   3-­‐6)	   suggests	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contribution	  from	  deprotonation	  at	  the	  R1	  position	  proton	  (N–H)	  of	  the	  pyrazolone	  
ring.	  	  This	  may	  explain	  the	  greater	  acidity	  of	  HAPY-­‐5.	  	  In	  comparison,	  a	  pKa	  value	  of	  
11.5	   is	   estimated	   for	   the	  R1	  position	  proton	  of	  HAPY-­‐6,	   the	  R3	  =	  methyl	   analog	  of	  
HAPY-­‐5	   (Supporting	   Information).	   	   For	   the	   HAPY	   class	   as	   a	   whole,	   HNO	   release	  
following	  HOHN–PY	  deprotonation	  remains	  the	  most	  plausible	  mechanism	  in	  water	  
(Scheme	  3-­‐5).	  
	  
Scheme	  3-­‐5.	  	  Proposed	  Mechanism	  of	  HNO	  Release	  
	  
	  
The	  pKa	  values	  of	  the	  PY	  byproducts	  are	  a	  reflection	  of	  the	  weighted	  average	  
of	   the	   various	   tautomers	   that	   are	   known	   to	   exist	   in	   pyrazolones,	   such	   as	  
edaravone.44-­‐46	   	   Presumably,	   the	   pKa	   value	   of	   the	   carbon	   formerly	   bearing	   the	  
hydroxylamine	  is	  the	  most	  relevant	  to	  predicting	  SAR	  for	  HNO	  release;	  however,	  we	  
can	  assume	  from	  this	  first-­‐pass	  study	  that	  PY	  byproducts	  with	  pKa	  values	  ≤	  ca.	  8	  in	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§ 3.4	  	  Conclusion	  
The	  HAPY	  class	  represents	  a	  new	  and	  robust	  HNO	  donor	  platform	  capable	  of	  
producing	   HNO	   quantitatively	   over	   extended	   periods	   of	   time	   along	   with	   a	   PY	  
byproduct	  that	   is	  related	  to	  edaravone,	  a	  potent	  antioxidant	  already	  in	  clinical	  use	  
for	   the	   treatment	   of	   stroke	   and	   cardiovascular	   disease.	   	   The	   HNO	   release	   rate	   is	  
highly	   tunable	   by	   varying	   the	   groups	   at	   the	   R1,	   R2,	   and	   R3	   positions	   on	   the	  
pyrazolone	   ring,	   and	   experimental	   and	   computational	   investigations	   suggest	   that	  
the	  HNO	  release	  rate	  correlates	  with	  HAPY	  and	  PY	  pKa.	  	  The	  catch	  is	  a	  strong	  affinity	  
that	   is	   shared	  between	  HNO	  and	   the	   released	  PY	  byproduct	   since	   the	  bimolecular	  
rate	  constant	   in	  pH	  7.4	  phosphate	  buffer	  at	  37	  °C	  can	  reach	  8	  ×	  105	  M–1s–1.	   	  Given	  
that	   biological	   targets	   for	   HNO	   are	   in	   excess	   of	   HNO	   in	   vivo,	   the	   back-­‐reaction	   of	  
HNO	  and	  PY	  to	  give	  HAPY	  is	  expected	  to	  be	  negligible	  under	  these	  conditions,	  as	  is	  
the	   case	   in	   the	   1H	   NMR	   assay	   we	   developed	   for	   evaluating	   half-­‐life	   and	   HNO	  
production	  utilizing	  the	  selective,	  distinctive,	  and	  irreversible	  trap	  for	  HNO,	  TXPTS.	  	  
Yet,	  this	  back-­‐reaction,	  described	  herein	  for	  the	  first	  time	  as	  the	  HNO-­‐aldol	  reaction	  
with	  pyrazolones,	   is	  an	  efficient,	  alternative	  synthetic	  strategy	  to	  the	  cumbersome,	  
three-­‐step	   bromination-­‐displacement-­‐deprotection	   strategy,	   thus	   illustrating	   a	  
synthetically	   useful	   route	   to	   HAPY	   donors.	   	   We	   anticipate	   utilizing	   these	  
methodologies	   for	   the	   development	   of	   new	   N-­‐substituted	   hydroxylamines	   with	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§ 3.5	  	  Experimental	  
	  
3.5.1	  	  Materials	  and	  Methods	  
	  
All	   starting	   materials	   were	   of	   reagent	   grade	   and	   used	   without	   further	  
purification.	  	  Compounds	  PY-­‐1	  and	  HAPY-­‐1;27	  PY-­‐2,	  PY-­‐4,	  PY-­‐9,	  and	  PY-­‐10;47	  PY-­‐6;48	  
PY-­‐11	   and	   N-­‐methyl-­‐3-­‐(2-­‐chlorophenyl)-­‐pyrazolone;49	   and	   4-­‐acetyl-­‐3-­‐methyl-­‐
pyrazolone50	  are	  all	  known	  compounds,	  and	  were	  prepared	  according	  to	  literature	  
procedures.	   	   Angeli’s	   salt	   (Na2N2O3)	   was	   prepared	   according	   to	   King	   and	  
Nagasawa.51	  Tris(4,6-­‐dimethyl-­‐3-­‐sulfanatophenyl)phosphine	  trisodium	  salt	  (TXPTS)	  
was	  of	  reagent	  grade	  and	  used	  without	   further	  purification.	   	  Synthetic	  TXPTS	  aza-­‐
ylide	  was	  obtained	  through	  the	  amidation	  of	  TXPTS	  using	  hydroxylamine	  O-­‐sulfonic	  
acid	  in	  water.52	  	  NMR	  spectra	  were	  obtained	  on	  a	  Bruker	  Avance	  400	  MHz	  FT-­‐NMR	  
spectrometer.	  	  All	  chemical	  shifts	  are	  reported	  in	  parts	  per	  million	  (ppm)	  relative	  to	  
residual	  CHCl3	  (7.26	  ppm	  for	  1H,	  77.23	  ppm	  for	  13C),	  residual	  DMSO	  (2.50	  ppm	  for	  
1H,	   39.52	   for	   13C),	   or	   residual	  MeOH	   (3.31	  ppm	   for	   1H,	   49.15	  ppm	   for	   13C).	   	  High-­‐
resolution	  mass	  spectra	  were	  obtained	  on	  a	  VG	  Analytical	  VG70SE	  magnetic	  sector	  
mass	  spectrometer	  operating	   in	  fast	  atom	  bombardment	  (FAB)	  mode.	   	  Ultraviolet-­‐
visible	   (UV-­‐vis)	   absorption	   spectra	   were	   obtained	   using	   a	   Hewlett	   Packard	   8453	  
diode	  array	  spectrometer.	   	  Buffered	  solutions	  (0.1	  M)	  for	  UV-­‐vis	  experiments	  were	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3.5.2	  	  Incubation	  Procedure	  of	  HAPY	  Donors	  at	  pH	  7.4,	  37	  °C	  with	  TXPTS	  	  
General	  
All	   1H	   NMR	   spectra	   were	   obtained	   in	   pH	   7.4	   solution	   containing	   0.25	   M	  
phosphate	  buffer,	  0.2	  mM	  of	  the	  metal	  chelator	  diethylenetriaminepentaacetic	  acid	  
(DTPA),	  and	  10	  %	  D2O	  on	  a	  Bruker	  Avance	  400	  MHz	  FT-­‐NMR	  spectrometer	  using	  a	  1	  
second	  presaturation	  pulse	  to	  suppress	  the	  water	  signal.	  	  The	  data	  were	  processed	  
with	  the	  academic	  version	  of	  ACDLabs	  NMR	  processor	  software:	  each	  free	  induction	  
decay	   was	   Fourier	   transformed,	   phased,	   baseline	   corrected,	   and	   integral	   areas	  
measured	  for	  the	  methyl	  groups	  of	  compounds	  HAPY-­‐1	  –	  HAPY-­‐12	  and	  PY-­‐1	  –	  PY-­‐2	  
and	  the	  downfield	  methyl	  group	  of	  TXPTS	  aza-­‐ylide.	   	  The	  1H	  NMR	  spectrum	  of	  the	  
HNO	  derived	  TXPTS	   aza-­‐ylide	   product	  matched	   that	   of	   synthetic	   TXPTS	   aza-­‐ylide.	  	  
The	  HNO	  yield	  from	  compounds	  HAPY-­‐1	  –	  HAPY-­‐12	  was	  determined	  from	  the	  final	  
TXPTS	  aza-­‐ylide	  yield.	  	  	  
NMR	  Procedure	  
The	  NMR	  procedure	   used	  was	   based	   on	   an	  HPLC	  protocol	   developed	   by	   S.	  
Bruce	   King	   and	   co-­‐workers.39-­‐40	   	   To	   an	   argon-­‐purged	   NMR	   solution	   (1.00	   mL)	  
containing	  TXPTS	  (3.3	  mg,	  5	  mM)	  was	  added	  HAPY-­‐1	  –	  HAPY-­‐12	  (10	  µL	  of	  100	  mM	  
in	  methanol-­‐d4)	  to	  give	  1	  mM	  as	  the	  initial	  concentration	  of	  HAPY-­‐1	  –	  HAPY-­‐12.	  	  The	  
solution	   was	   briefly	   mixed,	   ca.	   0.5	   mL	   was	   transferred	   to	   an	   argon-­‐purged	   NMR	  
tube,	  and	  an	  initial	  1H	  NMR	  spectrum	  was	  obtained.	  	  The	  sample	  was	  then	  either	  (1)	  
externally	   incubated	   at	   37	   °C	   and	   1H	  NMR	   spectra	  were	   collected	   at	   regular	   time	  
intervals,	   or	   (2)	   internally	   incubated	   at	   37	   °C	   and	   1H	  NMR	   spectra	  were	   collected	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using	   a	   canned	   Bruker	   pulse	   sequence,	   zg2d,	   modified	   to	   include	   a	   1	   second	  
presaturation	  pulse	  during	  the	  relaxation	  delay.	  
	  	  
3.5.3	  	  Experimental	  Procedures	  	  
	  
Scheme	  3-­‐6.	  	  Synthesis	  of	  4-­‐Acetyl-­‐1,3-­‐dimethyl-­‐pyrazolone	  (1)	  
	  
	  
4-­‐Acetyl-­‐1,3-­‐dimethyl-­‐pyrazolone	   (1).	   	  To	  methylacetoacetate	  (2.32	  g,	  20	  
mmol)	   on	   ice	  was	   added	  methylhydrazine	   (1.05	  mL,	   20	  mmol)	   over	   two	   to	   three	  
minutes	  with	   stirring.	   	  The	   reaction	  was	   then	  stirred	   for	   five	  minutes,	  whereupon	  
1,3-­‐dimethyl	  pyrazolone	  precipitated	  from	  solution.	  	  The	  reaction	  was	  diluted	  with	  
ethanol	  (20	  mL)	  and	  concentrated	   in	  vacuo	   to	  give	  dry	  1,3-­‐dimethyl	  pyrazolone	  as	  
an	   off-­‐white	   solid.	   	   This	   was	   then	   taken	   up	   with	   trimethylorthoacetate	   (10	   mL)	  
under	  nitrogen	  and	  heated	   to	  65	  °C	   for	   two	  hours.	   	  The	  clear,	   red-­‐orange	  solution	  
was	   concentrated	   in	   vacuo,	   the	   solid	   was	   dissolved	   in	   water	   (10	   mL),	   and	   the	  
solution	   was	   allowed	   to	   stand	   at	   4	   °C	   overnight.	   	   Filtration	   of	   the	   resulting	  
precipitate	  gave	  the	  title	  compound	  as	  an	  orange	  solid	  (1.36	  g,	  44%).	  	  	  1H	  NMR	  (400	  
MHz,	  CDCl3)	  δ:	  3.55	  (s,	  3H),	  2.38	  (s,	  3H),	  2.36	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  
195.31,	   159.59,	   146.84,	   103.20,	   32.50,	   27.45,	   15.53.	   	   HR-­‐MS	   (FAB):	   found	  m/z	  =	  




1.  NH2NHCH3 (1 eq.)
     neat, 0 °C, 5 min
2.  TMOA, 65 °C, 2 h, N2
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Scheme	  3-­‐7.	  	  Synthesis	  of	  3-­‐(2-­‐Chlorophenyl)-­‐4-­‐formyl-­‐1-­‐methyl-­‐pyrazolone	  (2)	  
	  
	   3-­‐(2-­‐Chlorophenyl)-­‐4-­‐formyl-­‐1-­‐methyl-­‐pyrazolone	   (2).	   	   To	   ethyl	   (2-­‐
chlorobenzoyl)acetate	   (0.937	   g,	   4.13	   mmol)	   at	   room	   temperature	   was	   added	  
methylhydrazine	  (0.22	  mL,	  4.1	  mmol)	  over	  two	  to	  three	  minutes	  with	  stirring.	  	  The	  
reaction	   was	   then	   heated	   to	   90	   °C	   for	   15	   min	   and	   allowed	   to	   cool	   to	   room	  
temperature	   where	   white	   solids	   formed	   upon	   standing.	   	   This	   material	   was	  
recrystallized	   from	   hot	   ethanol	   and	   water	   to	   give	   pure	   N-­‐methyl-­‐3-­‐(2-­‐
chlorophenyl)-­‐pyrazolone	   (0.410	   g,	   48%).	   	   To	   this	   product	   dissolved	   in	  
dimethylformamide	   (1	  mL)	  was	   added	   phosphoryl	   chloride	   (0.13	  mL,	   1.4	  mmol),	  
and	   the	  reaction	  was	  heated	   to	  65	  °C	  with	  stirring	   for	  2	  h	   followed	  by	  addition	  of	  
water	  (5	  mL).	  	  This	  solution	  was	  allowed	  to	  stand	  at	  room	  temperature	  for	  1	  d,	  and	  
the	  resultant	  yellow	  precipitate	  was	  collected	  by	  vacuum	  filtration	  to	  give	  the	  title	  
compound	  (0.370	  g,	  79%).	   	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  9.51	   (s,	  1H),	  7.44	   (m,	  
4H),	  3.60	  (s,	  3H).	   	  13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  δ:	  181.98,	  155.60,	  132.93,	  132.23,	  
131.72,	   130.20,	   129.29,	   126.88,	   104.44,	   33.14.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	  
237.04354	   (MH+,35Cl),	   239.04114	   (MH+,37Cl);	   calc.	   for	   C11H10ClN2O2:	   237.04308	  












1.  NH2NHCH3 (1 eq.)
     neat, 90 °C, 15 min
2.  POCl3 (0.7 eq.)
     DMF, 65 °C, 2 h
3.  H2O, r.t., 1 d
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Scheme	  3-­‐8.	  	  Synthesis	  of	  4-­‐(Acetyl-­‐O-­‐methoxyoxime)-­‐1,3-­‐dimethyl-­‐pyrazolone	  (PY-­‐3)	  
	  
4-­‐(Acetyl-­‐O-­‐methoxyoxime)-­‐1,3-­‐methyl-­‐pyrazolone	  (PY-­‐3).	  	  Compound	  1	  
(0.771	  g,	  5	  mmol),	  O-­‐methylhydroxylamine	  hydrochloride	  (0.459	  g,	  5.5	  mmol),	  and	  
sodium	  bicarbonate	  (0.462	  g,	  5.5	  mmol)	  was	  taken	  up	  in	  methanol	  (50	  mL),	  and	  the	  
reaction	  was	  refluxed	  with	  stirring	  for	  2	  h	  followed	  by	  concentration	  in	  vacuo.	  	  The	  
resultant	  material	   was	   taken	   up	   in	   dichloromethane,	   filtered	   through	   cotton,	   and	  
concentrated	   in	   vacuo	   to	   give	   the	   title	   compound	   as	   an	   off-­‐white	   solid	   (0.731	   g,	  
80%).	   	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  3.85	  (s,	  3H),	  3.56	  (s,	  3H),	  2.29	  (s,	  3H),	  2.19	  (s,	  
3H).	   	   13C	   NMR	   (100	   MHz,	   CDCl3)	   δ:	   155.18,	   153.81,	   144.67,	   95.21,	   62.01,	   32.84,	  
15.63,	   13.06.	   	   HR-­‐MS	   (FAB):	   found	  m/z	  =	   184.10819	   (MH+);	   calc.	   for	   C8H14N3O2:	  
184.10860	  (MH+).	  
	  
Scheme	  3-­‐9.	  	  Synthesis	  of	  4-­‐(Acetyl-­‐O-­‐methoxyoxime)-­‐3-­‐methyl-­‐pyrazolone	  (PY-­‐5)	  
	  
	   4-­‐(Acetyl-­‐O-­‐methoxyoxime)-­‐3-­‐methyl-­‐pyrazolone	   (PY-­‐5).	   	   4-­‐Acetyl-­‐3-­‐
methyl-­‐pyrazolone	   (2.935	   g,	   20.9	   mmol),	   O-­‐methylhydroxylamine	   hydrochloride	  



























MeOH, reflux, 2 h
. .
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methanol	  (125	  mL),	  and	  the	  reaction	  was	  refluxed	  with	  stirring	  for	  21	  h	  followed	  by	  
concentration	  in	  vacuo.	   	  The	  resultant	  material	  was	  taken	  up	  in	  ethyl	  acetated	  (2	  ×	  
125	   mL),	   filtered	   through	   cotton,	   and	   concentrated	   in	   vacuo	   to	   give	   the	   title	  
compound	  as	  a	  pale	  yellow	  solid	  (2.487	  g,	  70%).	   	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  
3.78	   (s,	   3H),	   2.23	   (s,	   3H),	   2.08	   (s,	   3H).	   	   13C	   NMR	   (100	  MHz,	   DMSO-­‐d6)	   δ:	   159.86,	  
151.50,	  138.18,	  98.49,	  60.97,	  13.48,	  12.24.	   	  HR-­‐MS	  (FAB):	   found	  m/z	  =	  170.09335	  
(MH+);	  calc.	  for	  C7H12N3O2:	  170.09295	  (MH+).	  
	  
Scheme	  3-­‐10.	  	  Synthesis	  of	  4-­‐Methyl-­‐N-­‐(4-­‐chlorophenyl)-­‐3-­‐methyl-­‐pyrazolone	  (PY-­‐7)	  
	  
	   4-­‐Methyl-­‐N-­‐(4-­‐chlorophenyl)-­‐3-­‐methyl-­‐pyrazolone	   (PY-­‐7).	   	   Ethyl	   2-­‐
methylacetoacetate	   (0.71	   mL,	   5	   mmol),	   4-­‐chlorophenylhydrazine	   hydrochloride	  
(0.895	  g,	  5	  mmol),	  and	  sodium	  acetate	  (0.410	  g,	  5	  mmol)	  was	   taken	  up	   in	  ethanol	  
(50	  mL),	   and	   the	   reaction	  was	   refluxed	  with	   stirring	   for	   1	  d	   followed	  by	   filtration	  
through	   cotton	   and	   concentration	   in	   vacuo.	   	   The	   resultant	   material	   was	  
recrystallized	   from	  hot	   ethanol	   and	  1N	  HCl	   to	   give	   the	   title	   compound	   as	   a	  white	  
solid	  (0.867	  g,	  78%).	  	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  7.75	  (d,	  2H,	  J	  =	  8.9	  Hz),	  7.50	  
(d,	  2H,	  J	  =	  8.9	  Hz),	  2.13	  (s,	  3H),	  1.80	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  δ:	  157.00,	  
147.74,	  135.68,	  129.73,	  129.02,	  121.95,	  99.34,	  11.27,	  6.58.	  	  HR-­‐MS	  (FAB):	  found	  m/z	  
=	   223.06396	   (MH+,35Cl),	   225.06151	   (MH+,37Cl);	   calc.	   for	   C11H12ClN2O:	   223.06382	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Scheme	  3-­‐11.	  	  Synthesis	  of	  4-­‐Methyl-­‐N-­‐(2-­‐chlorophenyl)-­‐3-­‐methyl-­‐pyrazolone	  (PY-­‐8)	  
	  
4-­‐Methyl-­‐N-­‐(2-­‐chlorophenyl)-­‐3-­‐methyl-­‐pyrazolone	   (PY-­‐8).	   	   Ethyl	   2-­‐
methylacetoacetate	   (0.71	   mL,	   5	   mmol),	   2-­‐chlorophenylhydrazine	   hydrochloride	  
(0.895	  g,	  5	  mmol),	  and	  sodium	  acetate	  (0.410	  g,	  5	  mmol)	  was	  taken	  up	  in	  acetic	  acid	  
(50	  mL),	  and	  the	  reaction	  was	  refluxed	  with	  stirring	  for	  18	  h	  followed	  by	  filtration	  
through	   cotton	  and	   concentration	   in	  vacuo.	   	   The	   resultant	  material	  was	   triturated	  
with	  diethylether	  to	  remove	  the	  colored	  impurities	  and	  filtered,	  then	  extracted	  into	  
ethylacetate	   (2	   ×	   100	  mL),	   washed	  with	   water	   and	   brine,	   dried	   over	  magnesium	  
sulfate,	  filtered,	  and	  concentrated	  in	  vacuo	  to	  give	  the	  title	  compound	  as	  an	  off-­‐white	  
solid	   (0.696	  g,	  63%).	   	   1H	  NMR	  (400	  MHz,	  MeOD-­‐d4)	  δ:	  7.58	  (m,	  1H),	  7.45	  (m,	  3H),	  
2.17	  (s,	  3H),	  1.85	  (s,	  3H).	   	  13C	  NMR	  (100	  MHz,	  MeOD-­‐d4)	  δ:	  164.84,	  148.59,	  135.09,	  
134.26,	   132.08,	   131.66,	   131.51,	   129.09.	   	   HR-­‐MS	   (FAB):	   found	  m/z	   =	   223.06348	  
(MH+,35Cl),	   225.06092	   (MH+,37Cl);	   calc.	   for	   C11H12ClN2O:	   223.06382	   (MH+,35Cl),	  
225.06087	  (MH+,37Cl).	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4-­‐Methyl-­‐N-­‐methyl-­‐3-­‐(2-­‐chlorophenyl)-­‐pyrazolone	   (PY-­‐12).	   	   To	   a	  
solution	   of	   compound	   2	   (0.370	   g,	   1.56	   mmol)	   in	   acetic	   acid	   (20	   mL)	   was	   added	  
sodium	  cyanoborohydride	  (0.211	  g,	  3.2	  mmol),	  and	  the	  reaction	  was	  heated	  to	  65	  °C	  
and	  stirred	  for	  2	  hours.	   	  The	  reaction	  was	  then	  concentrated	   in	  vacuo,	   taken	  up	   in	  
1N	   HCl,	   extracted	   into	   ethylacetate	   (2	   ×	   50	   mL),	   washed	   with	   brine,	   dried	   over	  
magnesium	   sulfate,	   filtered,	   and	   concentrated	   in	   vacuo.	   	   The	   resultant	   viscous	   oil	  
was	   triturated	   with	   dichloromethane	   and	   hexanes	   and	   filtered	   to	   give	   the	   title	  
compound	  as	  a	  white	  solid	  (0.070	  g,	  20%).	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  7.51	  (d,	  
1H,	  J	  =	  6.8	  Hz),	  7.38	  (m,	  3H),	  3.57	  (s,	  3H),	  1.76	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  
δ:	  150.47,	  145.54,	  132.95,	  132.69,	  132.07,	  129.78,	  129.44,	  126.99,	  95.74,	  33.23,	  7.74.	  	  
HR-­‐MS	  (FAB):	  found	  m/z	  =	  225.06188	  (MH+,37Cl);	  calc.	  for	  C11H12ClN2O:	  225.06087	  
(MH+,37Cl).	   	  
	  
Scheme	  3-­‐13.	  	  Synthesis	  of	  HAPY	  Donors	  via	  the	  HNO-­‐Aldol	  Procedure	  	  	  
	  
General	  HNO-­‐aldol	  procedure:	  
To	   the	   PY	   substrate	   (0.20	   mmol),	   Angeli’s	   salt	   (49	   mg,	   0.40	   mmol),	   and	  
powdered	  DTPA	  (39	  mg,	  0.10	  mmol)	  under	  argon	  at	  room	  temperature	  was	  added	  a	  
degassed	  mixture	  of	  50%	  v/v	  aqueous	  ethanol	  (1	  mL)	  via	  syringe.	  	  The	  reaction	  was	  
allowed	   to	   stir	   for	   1.5	   hours,	   diluted	   with	   ethanol	   (>5	   mL),	   and	   concentrated	   to	  
dryness	   in	  vacuo	  with	  minimum	  heat	  (<30	  °C).	   	  The	  material	  was	  then	  taken	  up	  in	  
Angeli's salt (2 eq.)
DTPA (0.5 eq.)
50% v/v aq. ethanol
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minimum	  ethanol,	  eluted	   through	  a	  short	  silica	  plug,	  and	  concentrated	   in	  vacuo	   to	  
give	   the	   desired	   HAPY	   product	   or	   to	   allow	   for	   further	   purification	   if	   complete	  
conversion	  was	  not	  observed	  (i.e.,	  the	  O-­‐methyloxime	  derivatives	  HAPY-­‐1,	  HAPY-­‐3,	  
and	   HAPY-­‐5).	   	   The	   crude	   reaction	   mixture	   was	   loaded	   with	   methanol	   onto	   an	  
analytical	   TLC	   plate	   (250	   µm	   thickness)	   and	   developed	   in	   either	   50%	   v/v	   ethyl	  
acetate/dichloromethane	   (HAPY-­‐1)	   or	   ethyl	   acetate	   (HAPY-­‐3	   and	   HAPY-­‐5).	   	   The	  
product	  band	  (Rf	  >	  0.5)	  was	  scraped	  off	  the	  plate	  into	  a	  flask	  using	  a	  metal	  spatula.	  	  
The	   product	   is	   eluted	   with	   methanol	   (10	   mL),	   filtered	   through	   cotton,	   and	  
concentrated	   in	   vacuo	   to	   yield	   the	   desired	   product	   typically	   as	   off-­‐white/white	  




2).	   	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.93	  (d,	  2H,	  J	  =	  8.8	  Hz),	  7.40	  (dd,	  2H,	  J	  =	  7.4	  Hz),	  
7.18	  (t,	  1H,	  J	  =	  7.4	  Hz),	  5.70	  (b.s.,	  1H),	  4.77	  (s,	  1H),	  2.21	  (s,	  3H),	  1.28	  (s,	  3H).	  	  13C	  NMR	  
(100	  MHz,	   CDCl3)	  δ:	   174.06,	   162.07,	   138.12,	   129.05,	   125.31,	   118.86,	   71.23,	   16.97,	  
13.33.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	   220.10932	   (MH+);	   calc.	   for	   C11H14N3O2:	  
220.10860	  (MH+).	  
4-­‐(N-­‐Hydroxylamine)-­‐4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐N-­‐methyl-­‐3-­‐methyl-­‐
pyrazolone	  (HAPY-­‐3).	   	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  6.12	  (s,	  1H),	  4.67	  (s,	  1H),	  3.90	  
(s,	  3H),	  3.33	  (s,	  3H),	  2.12	  (s,	  3H),	  1.74	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  171.68,	  
158.97,	   76.62,	   62.53,	   31.77,	   14.39,	   10.96.	   	   HR-­‐MS	   (FAB):	   found	  m/z	  =	   215.11454	  
(MH+);	  calc.	  for	  C8H15N4O3:	  215.11442	  (MH+).	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   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐methyl-­‐3-­‐methyl-­‐pyrazolone	   (HAPY-­‐
4).	   	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  7.52	  (d,	  1H,	  J	  =	  2.8	  Hz),	  6.25	  (d,	  1H,	  J	  =	  2.8	  Hz),	  
3.12	   (s,	   3H),	   1.96	   (s,	   3H),	   1.00	   (s,	   3H).	   13C	   NMR	   (100	   MHz,	   DMSO-­‐d6)	   δ:	   175.34,	  
161.94,	   68.96,	   30.73,	   15.98,	   12.70.	   	  HR-­‐MS	   (FAB):	   found	  m/z	  =	  158.09320	   (MH+);	  
calc.	  for	  C6H12N3O2:	  158.09295	  (MH+).	  
4-­‐(N-­‐Hydroxylamine)-­‐4-­‐(acetyl-­‐O-­‐methoxyoxime)-­‐3-­‐methyl-­‐pyrazolone	  
(HAPY-­‐5).	   	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  10.96	  (s,	  1H),	  7.76,	  (d,	  1H,	  J	  =	  2.7	  Hz),	  
6.60	  (d,	  1H,	  J	  =	  2.7	  Hz),	  3.76	  (s,	  3H),	  1.98	  (s,	  3H),	  1.79	  (s,	  3H).	   	  13C	  NMR	  (100	  MHz,	  
DMSO-­‐d6)	  δ:	  173.93,	  159.50,	  151.82,	  74.23,	  61.60,	  14.85,	  10.57.	  	  HR-­‐MS	  (FAB):	  found	  
m/z	  =	  201.09920	  (MH+);	  calc.	  for	  C7H13N4O3:	  201.09817	  (MH+).	  	  
4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐3-­‐methyl-­‐pyrazolone	  (HAPY-­‐6).	  	  1H	  NMR	  
(400	  MHz,	  DMSO-­‐d6)	  δ:	  10.77	  (s,	  1H),	  7.50	  (d,	  1H,	  J	  =	  2.9	  Hz),	  6.16	  (d,	  1H,	  J	  =	  2.9	  Hz),	  
1.93	   (s,	  3H),	  0.97	   (s,	  3H).	   	   13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  δ:	  178.26,	  161.86,	  67.98,	  
15.96,	   13.03.	   	   HR-­‐MS	   (FAB):	   found	  m/z	  =	   144.07683	   (MH+);	   calc.	   for	   C5H10N3O2:	  
144.07730	  (MH+).	   	  
4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐(4-­‐chlorophenyl)-­‐3-­‐methyl-­‐
pyrazolone	  (HAPY-­‐7).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.90	  (d,	  2H,	  J	  =	  9.0	  Hz),	  7.35	  (d,	  
2H,	  J	  =	  9.0	  Hz),	  5.66	  (d,	  1H,	  J	  =	  2.8	  Hz),	  4.45	  (d,	  1H,	  J	  =	  2.8	  Hz),	  2.20	  (s,	  3H),	  1.28	  (s,	  
3H).	   13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  173.96,	  162.18,	  136.77,	  130.36,	  129.09,	  119.92,	  
71.19,	  16.92,	  13.31.	   	  HR-­‐MS	   (FAB):	   found	  m/z	  =	  254.06968	   (MH+,35Cl),	  256.06703	  
(MH+,37Cl);	  	  calc.	  for	  C11H13ClN3O2:	  254.06963	  (MH+,35Cl),	  256.06668	  (MH+,37Cl).	  
	   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐(2-­‐chlorophenyl)-­‐3-­‐methyl-­‐
pyrazolone	  (HAPY-­‐8).	  	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  7.73	  (d,	  1H,	  J	  =	  2.8	  Hz),	  7.60	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(m,	  1H),	  7.43	  (m,	  3H),	  6.50	  (d,	  1H,	   J	  =	  2.8	  Hz),	  2.07	  (s,	  3H),	  1.17	  (s,	  3H).	   	   13C	  NMR	  
(100	   MHz,	   DMSO-­‐d6)	   δ:	   174.77,	   163.32,	   134.75,	   130.81,	   130.12,	   129.94,	   129.06,	  
127.96,	   69.42,	   16.24,	   12.90.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	   254.06967	   (MH+,35Cl),	  
256.06718	   (MH+,37Cl);	   	   calc.	   for	   C11H13ClN3O2:	   254.06963	   (MH+,35Cl),	   256.06668	  
(MH+,37Cl).	  
	   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐methyl-­‐3-­‐phenyl-­‐pyrazolone	   (HAPY-­‐
9).	   	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  8.06	  (m,	  2H),	  7.64	  (d,	  2H,	  J	  =	  2.5	  Hz),	  7.45	  (m,	  
3H),	  6.48	  (d,	  2H,	  J	  =	  2.5	  Hz),	  3.29	  (s,	  3H),	  1.21	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  
δ:	   176.13,	   157.36,	   130.44,	   129.88,	   128.60,	   126.21,	   69.33,	   31.20,	   17.88.	   	   HR-­‐MS	  
(FAB):	  found	  m/z	  =	  220.10897	  (MH+);	  calc.	  for	  C11H14N3O2:	  220.10860	  (MH+).	  
	   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐phenyl-­‐3-­‐phenyl-­‐pyrazolone	   (HAPY-­‐
10).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  8.21	  (m,	  2H),	  8.05	  (m,	  2H),	  7.45	  (m,	  5H),	  7.24	  (m,	  
1H),	  5.95	  (d,	  1H,	  J	  =	  3.2	  Hz),	  4.50	  (d,	  1H,	  J	  =	  3.3	  Hz),	  1.48	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  
CDCl3)	   δ:	   174.98,	   157.74,	   138.21,	   130.97,	   130.26,	   129.10,	   129.09,	   126.79,	   125.51,	  
119.01,	   71.51,	   18.92.	   	   HR-­‐MS	   (FAB):	   found	   m/z	   =	   282.12461	   (MH+);	   calc.	   for	  
C16H16N3O2:	  282.12425	  (MH+).	  
	   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐methyl-­‐3-­‐(4-­‐chlorophenyl)-­‐
pyrazolone	   (HAPY-­‐11).	   	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ:	  8.06	  (d,	  2H,	   J	  =	  8.7	  Hz),	  
7.66	  (d,	  1H,	  J	  =	  2.6	  Hz),	  7.53	  (d,	  2H,	  J	  =	  8.7	  Hz),	  6.54	  (d,	  1H,	  J	  =	  2.6	  Hz),	  3.29	  (s,	  3H),	  
1.19	   (s,	   3H).	   	   13C	   NMR	   (100	   MHz,	   DMSO-­‐d6)	   δ:	   176.10,	   156.36,	   134.48,	   129.21,	  
128.72,	   127.96,	   62.27,	   31.24,	   17.70.	   	  HR-­‐MS	   (FAB):	   found	  m/z	  =	  254.06941	   (MH+,	  
35Cl),	   256.06193	   (MH+,	   37Cl);	   calc.	   for	   C11H13ClN3O2:	   254.06963	   (MH+,	   35Cl),	  
256.06668	  (MH+,	  37Cl).	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   4-­‐(N-­‐Hydroxylamine)-­‐4-­‐methyl-­‐N-­‐methyl-­‐3-­‐(2-­‐chlorophenyl)-­‐
pyrazolone	   (HAPY-­‐12).	   	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.71	  (m,	  1H),	  7.50	  (m,	  1H),	  
7.38	  (m,	  2H),	  5.90	  (br,	  2H),	  3.45	  (s,	  3H),	  1.26	  (s,	  3H).	  	  13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  
174.87,	  158.59,	  133.52,	  131.13,	  131.05,	  130.69,	  129.29,	  127.11,	  71.59,	  32.00,	  16.91.	  	  
HR-­‐MS	   (FAB):	   found	  m/z	  =	  254.06981(MH+,	   35Cl),	   256.06755	   (MH+,	   37Cl);	   calc.	   for	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Figure	  3-­‐7.	  	  (a)	  Plot	  of	  the	  concentration	  of	  HAPY-­‐6anion	  (λmax	  =	  266	  nm)	  as	  a	  function	  of	  
pH.	   	   The	   solid	   curve	   is	   a	   calculated	   best	   fit	   to	   a	   sigmoid	   function.	   	   (b)	   Initial	   UV-­‐vis	  
spectra	  of	  HAPY-­‐6	  in	  pH	  9.0	  and	  pH	  12.0	  compared	  with	  the	  expected	  byproduct	  of	  HNO	  
release,	  PY-­‐6anion,	  at	  pH	  12.0.	  
3.7.1	  	  X-­‐Ray	  Crystallography	  Data	  
All	   reflection	   intensities	  were	  measured	   at	   110(2)	  K	   using	   a	  KM4/Xcalibur	  
(detector:	  Sapphire3)	  with	  enhance	  graphite-­‐monochromated	  Mo	  Kα	  radiation	  (λ	  =	  
0.71073	   Å)	   under	   the	   program	   CrysAlisPro	   (Version	   1.171.36.20,	   Agilent	  
Technologies,	   2012).	   	   The	   program	   CrysAlisPro	   (Version	   1.171.36.20,	   Agilent	  
Technologies,	   2012)	  was	   used	   to	   refine	   the	   cell	   dimensions.	   	   Data	   reduction	  was	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done	   using	   the	   program	   CrysAlisPro	   (Version	   1.171.36.20,	   Agilent	   Technologies,	  
2012).	   	   The	   structure	  was	   solved	  with	   the	   program	   SHELXS-­‐97	   (Sheldrick,	   2008)	  
and	   was	   refined	   on	   F2	   with	   SHELXL-­‐97	   (Sheldrick,	   2008).	   	   Analytical	   numeric	  
absorption	   corrections	   based	   on	   a	  multifaceted	   crystal	  model	  were	   applied	   using	  
CrysAlisPro	  (Version	  1.171.36.20,	  Agilent	  Technologies,	  2012).	  	  The	  temperature	  of	  
the	   data	   collection	   was	   controlled	   using	   the	   system	   Cryojet	   (manufactured	   by	  
Oxford	   Instruments).	   	   The	   H	   atoms	  were	   placed	   at	   calculated	   positions	   using	   the	  
instructions	  AFIX	  43,	  AFIX	  137	  or	  AFIX	  147	  with	  isotropic	  displacement	  parameters	  
having	  values	  1.2	  or	  1.5	  times	  Ueq	  of	  the	  attached	  C	  or	  O	  atoms.	  
The	  structure	  is	  ordered.	  
PY-­‐2OH:	  Fw	  =	  204.23,	  colorless	  irregular	  block,	  0.55	  ×	  
0.38	   ×	   0.19	   mm3,	   monoclinic,	   P-­‐1	   (no.	   2),	   a	   =	  
6.9967(3),	   b	   =	   8.5345(5),	   c	   =	   9.7334(6)	   Å,	   α	   =	  
110.752(5),	  β	   =	   94.833(4),	   γ	  =	   106.902(5)°,	  V	  =	  508.51(5)	   Å3,	  Z	  =	   2,	  Dx	   =	   1.334	   g	  
cm−3,	   µ	   =	   0.094	   mm−1,	   abs.	   corr.	   range:	   0.966−0.987.	   6277	   Reflections	   were	  
measured	  up	  to	  a	  resolution	  of	  (sin	  θ/λ)max	  =	  0.65	  Å−1.	  2332	  Reflections	  were	  unique	  
(Rint	   =	   0.0210),	   of	   which	   2063	   were	   observed	   [I	   >	   2σ(I)].	   139	   Parameters	   were	  
refined.	  R1/wR2	   [I	  >	  2σ(I)]:	  0.0350/0.0976.	  R1/wR2	   [all	   refl.]:	  0.0399/0.1011.	  S	  =	  
1.059.	  Residual	  electron	  density	  found	  between	  –0.23	  and	  0.35	  e	  Å−3.	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3.7.2	  	  Density	  Functional	  Theory	  (DFT)	  Calculations	  
	  
All	   calculations	   were	   performed	   at	   the	   B3LYP/6-­‐31G*	   level	   with	   an	   SM8	  
solvation	   model	   for	   aqueous	   solvation	   using	   Spartan	   ’14	   modeling	   software.42	  	  
Optimized	  geometries	  and	  vibrational	  frequencies	  were	  calculated	  for	  each	  reactant	  
and	  product	  independently,	  and	  free	  energies	  are	  given	  for	  298.15	  K.	  	  	  
	  
Table	   3-­‐4.	   	   B3LYP/6-­‐31G*	   Optimized	   Geometries,	   Energies,	   and	   Entropy	   Corrections	  
for	  Nitroxyl	  (HNO)	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  -­‐130.470851	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	   	  	  	  	  	  	  	  	  -­‐19.0649	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   	  -­‐81876.18923	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
N	   7	   0.5680553	  	   0.1586597	  	   0.0000000	  
O	   8	   -­‐0.6301148	  	   -­‐0.0406719	  	   0.0000000	  
H	   1	   1.0645314	  	   -­‐0.7852429	  	   0.0000000	  
	  
	  
Table	  3-­‐5.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  Nitroxyl	  (HNO)	  
 
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   1565	  	   20.87	   	  	  	  2	  	   1652	  	   93.41	   	  3	  	   2940	   62.00 
	  
	  
Table	   3-­‐6.	   	   B3LYP/6-­‐31G*	   Optimized	   Geometries,	   Energies,	   and	   Entropy	   Corrections	  
for	  Water	  (H2O)	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	   	   	  	  	  	  	  	  	  	  -­‐76.423559	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  	  	  	  6.5320	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐47954.9099	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
H	   1	   0.0000000	  	   -­‐0.2976214	  	   -­‐0.7243625	  
O	   8	   0.0000000	  	   -­‐0.3250377	  	   0.2494010	  
H	   1	   0.0000000	  	   0.6226591	  	   0.4749616	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Table	  3-­‐7.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  Water	  (H2O)	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  




Table	  3-­‐8.	  	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  Hydronium	  (H3O+)	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐76.853354	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  41.0536	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐48216.35927	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
H	   1	   0.2212214	  	   0.0000000	  	   -­‐0.8952325	  
O	   8	   0.2542327	  	   0.0000000	  	   0.0897557	  
H	   1	   -­‐0.2377271	  	   -­‐0.7945454	  	   0.4027384	  
H	   1	   -­‐0.2377271	  	   0.7945454	  	   0.4027384	  
	  
	  
Table	  3-­‐9.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  Hydronium	  (H3O+)	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   1082	   495.92	   3	   1694	   132.51	   5	   3621	   519.14	  
2	   1683	   131.89	   4	   3555	   83.48	   6	   3622	   519.02	  
	  
	  
Table	  3-­‐10.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐1	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐819.063789	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  593.6595	  kJ/mol	  








	   136	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.0871638	   -­‐0.4580564	   0.2122397	  
C	   6	   -­‐0.0636156	  	   0.2755546	  	   -­‐0.0876464	  
N	   7	   -­‐1.1482101	  	   -­‐0.4837613	  	   0.2241276	  
N	   7	   -­‐0.7475821	  	   -­‐1.7157646	  	   0.7148325	  
C	   6	   0.5806836	  	   -­‐1.6993132	  	   0.7099278	  
C	   6	   1.3126104	  	   -­‐2.9080556	  	   1.2006235	  
H	   1	   1.9323130	  	   -­‐2.6797126	  	   2.0741340	  
H	   1	   1.9717968	  	   -­‐3.3227835	  	   0.4309135	  
H	   1	   0.5890499	  	   -­‐3.6760667	  	   1.4846787	  
C	   6	   2.4410749	  	   0.0480357	  	   0.0104945	  
N	   7	   2.5039287	  	   1.2348280	  	   -­‐0.5146796	  
O	   8	   3.8104584	  	   1.7210969	  	   -­‐0.6941023	  
C	   6	   3.6374492	  	   -­‐0.7727021	  	   0.3990201	  
H	   1	   4.5650719	  	   -­‐0.2400914	  	   0.1964479	  
H	   1	   3.6434253	  	   -­‐1.7177815	  	   -­‐0.1531426	  
H	   1	   3.5956342	  	   -­‐1.0217433	  	   1.4641223	  
C	   6	   3.7449648	  	   3.0130085	  	   -­‐1.3045828	  
H	   1	   3.2688472	  	   2.9607942	  	   -­‐2.2896587	  
H	   1	   4.7830032	  	   3.3328302	  	   -­‐1.4136398	  
H	   1	   3.2046990	  	   3.7234865	  	   -­‐0.6695527	  
O	   8	   -­‐0.1628993	  	   1.5078744	  	   -­‐0.6098399	  
H	   1	   0.7865376	  	   1.7928542	  	   -­‐0.7450680	  
C	   6	   -­‐2.5354003	  	   -­‐0.1957249	  	   0.0850639	  
C	   6	   -­‐5.2742824	  	   0.3115746	  	   -­‐0.1690959	  
C	   6	   -­‐2.9980489	  	   1.1246046	  	   0.0307135	  
C	   6	   -­‐3.4414918	  	   -­‐1.2614098	  	   0.0208271	  
C	   6	   -­‐4.8042339	  	   -­‐1.0012895	  	   -­‐0.1022510	  
C	   6	   -­‐4.3651147	  	   1.3669795	  	   -­‐0.1027382	  
H	   1	   -­‐2.2996952	  	   1.9484376	  	   0.0892735	  
H	   1	   -­‐3.0668937	  	   -­‐2.2758815	  	   0.0749875	  
H	   1	   -­‐5.4989478	  	   -­‐1.8341673	  	   -­‐0.1505906	  
H	   1	   -­‐4.7155919	  	   2.3935833	  	   -­‐0.1456589	  
H	   1	   -­‐6.3367040	  	   0.5087628	  	   -­‐0.2701802	  
	  
	  
Table	   3-­‐11.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐1	  
	   	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   30	  	   0.23	   32	   715	  	   99.26	   63	   1459	  	   334.71	  
2	   33	  	   0.78	   33	   766	  	   83.34	   64	   1482	  	   57.86	  
3	   50	  	   3.92	   34	   775	  	   54.26	   65	   1492	  	   78.87	  
4	   69	  	   1.14	   35	   845	  	   0.25	   66	   1496	  	   1.72	  
	   137	  
5	   82	  	   2.22	   36	   854	  	   0.32	   67	   1505	  	   14.90	  
6	   85	  	   2.01	   37	   914	  	   233.21	   68	   1508	  	   8.52	  
7	   126	  	   1.83	   38	   927	  	   5.11	   69	   1509	  	   12.68	  
8	   158	  	   1.36	   39	   972	  	   0.83	   70	   1523	  	   59.98	  
9	   173	  	   2.92	   40	   995	  	   0.48	   71	   1529	  	   76.94	  
10	   212	  	   0.23	   41	   1006	  	   2.40	   72	   1534	  	   45.07	  
11	   237	  	   0.70	   42	   1019	  	   1.70	   73	   1540	  	   12.52	  
12	   248	  	   2.69	   43	   1037	  	   43.44	   74	   1549	  	   93.18	  
13	   274	  	   1.78	   44	   1054	  	   87.82	   75	   1607	  	   876.46	  
14	   286	  	   2.45	   45	   1063	  	   0.28	   76	   1648	  	   17.62	  
15	   302	  	   14.68	   46	   1066	  	   344.97	   77	   1655	  	   171.60	  
16	   335	  	   13.68	   47	   1071	  	   2.23	   78	   1661	  	   38.61	  
17	   352	  	   0.43	   48	   1088	  	   54.45	   79	   3056	  	   111.82	  
18	   362	  	   0.55	   49	   1099	  	   24.04	   80	   3072	  	   20.93	  
19	   404	  	   1.41	   50	   1118	  	   19.85	   81	   3084	  	   13.14	  
20	   419	  	   0.32	   51	   1148	  	   12.09	   82	   3125	  	   49.49	  
21	   449	  	   28.26	   52	   1180	  	   2.37	   83	   3131	  	   6.70	  
22	   463	  	   26.41	   53	   1190	  	   0.50	   84	   3142	  	   8.76	  
23	   520	  	   6.32	   54	   1212	  	   1.90	   85	   3156	  	   22.11	  
24	   542	  	   0.48	   55	   1219	  	   25.21	   86	   3174	  	   106.77	  
25	   600	  	   28.71	   56	   1256	  	   68.74	   87	   3181	  	   875.98	  
26	   629	  	   0.26	   57	   1349	  	   26.91	   88	   3199	  	   2.69	  
27	   649	  	   10.92	   58	   1369	  	   2.81	   89	   3209	  	   0.52	  
28	   654	  	   5.85	   59	   1373	  	   61.52	   90	   3218	  	   26.42	  
29	   691	  	   21.40	   60	   1383	  	   94.09	   91	   3231	  	   32.17	  
30	   706	  	   2.31	   61	   1421	  	   51.21	   92	   3252	  	   2.80	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  	  -­‐818.591456	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  559.3385	  kJ/mol	  











	   138	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.0413380	  	   -­‐0.2404651	  	   0.1380892	  
C	   6	   -­‐0.1393269	  	   0.5512025	  	   -­‐0.0433794	  
N	   7	   -­‐1.2031753	  	   -­‐0.3616604	  	   0.1555978	  
N	   7	   -­‐0.7423973	  	   -­‐1.6493189	  	   0.4107325	  
C	   6	   0.5804145	  	   -­‐1.5633352	  	   0.4110811	  
C	   6	   1.3533720	  	   -­‐2.8284664	  	   0.6314983	  
H	   1	   1.8279155	  	   -­‐2.8606546	  	   1.6192000	  
H	   1	   2.1450933	  	   -­‐2.9530380	  	   -­‐0.1149146	  
H	   1	   0.6680419	  	   -­‐3.6782628	  	   0.5627761	  
C	   6	   2.4109696	  	   0.2377362	  	   0.0342045	  
N	   7	   2.6442558	  	   1.2715884	  	   -­‐0.7230983	  
O	   8	   4.0326232	  	   1.6367288	  	   -­‐0.6574269	  
C	   6	   3.5140608	  	   -­‐0.4387426	  	   0.8151040	  
H	   1	   4.1293426	  	   0.3161667	  	   1.3138306	  
H	   1	   4.1845123	  	   -­‐0.9989005	  	   0.1525964	  
H	   1	   3.1111067	  	   -­‐1.1172289	  	   1.5650840	  
C	   6	   4.2251706	  	   2.8049231	  	   -­‐1.4488498	  
H	   1	   3.9592333	  	   2.6273889	  	   -­‐2.4980535	  
H	   1	   5.2903696	  	   3.0381429	  	   -­‐1.3733572	  
H	   1	   3.6333255	  	   3.6482203	  	   -­‐1.0724254	  
O	   8	   -­‐0.2985039	  	   1.7791404	  	   -­‐0.2879009	  
C	   6	   -­‐2.5956807	  	   -­‐0.1415550	  	   0.0980185	  
C	   6	   -­‐5.3919047	  	   0.2245714	  	   -­‐0.0080896	  
C	   6	   -­‐3.1396548	  	   1.1328132	  	   -­‐0.1469884	  
C	   6	   -­‐3.4710198	  	   -­‐1.2265906	  	   0.2913158	  
C	   6	   -­‐4.8496350	  	   -­‐1.0384031	  	   0.2375801	  
C	   6	   -­‐4.5237357	  	   1.3000102	  	   -­‐0.1978091	  
H	   1	   -­‐2.4646084	  	   1.9642392	  	   -­‐0.2941583	  
H	   1	   -­‐3.0460758	  	   -­‐2.2042262	  	   0.4795761	  
H	   1	   -­‐5.5007576	  	   -­‐1.8945240	  	   0.3899734	  
H	   1	   -­‐4.9178014	  	   2.2943697	   -­‐0.3894650	  
H	   1	   -­‐6.4668676	  	   0.3681305	  	   -­‐0.0503423	  
	  
	  
Table	   3-­‐13.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐1anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   16	  	   0.41	   31	   747	  	   49.39	   61	   1435	  	   45.87	  
2	   42	  	   1.25	   32	   762	  	   52.34	   62	   1479	  	   88.57	  
3	   44	  	   8.71	   33	   763	  	   84.99	   63	   1487	  	   347.36	  
4	   81	  	   2.24	   34	   846	  	   220.92	   64	   1494	  	   49.81	  
5	   89	  	   7.82	   35	   854	  	   140.00	   65	   1498	  	   21.13	  
	   139	  
6	   111	  	   0.16	   36	   855	  	   45.51	   66	   1499	  	   5.44	  
7	   150	  	   2.17	   37	   907	  	   5.49	   67	   1506	  	   49.78	  
8	   156	  	   0.78	   38	   964	  	   0.10	   68	   1515	  	   134.02	  
9	   169	  	   4.19	   39	   978	  	   0.88	   69	   1523	  	   21.26	  
10	   206	  	   1.55	   40	   1006	  	   25.59	   70	   1537	  	   21.00	  
11	   228	  	   3.13	   41	   1014	  	   6.61	   71	   1537	  	   278.51	  
12	   249	  	   0.84	   42	   1036	  	   50.25	   72	   1559	  	   269.75	  
13	   270	  	   5.26	   43	   1049	  	   112.26	   73	   1571	  	   551.34	  
14	   291	  	   2.57	   44	   1055	  	   15.23	   74	   1623	  	   240.69	  
15	   298	  	   2.09	   45	   1061	  	   84.22	   75	   1637	  	   122.45	  
16	   346	  	   12.59	   46	   1067	  	   0.73	   76	   1658	  	   230.26	  
17	   353	  	   1.76	   47	   1081	  	   238.40	   77	   3040	  	   156.75	  
18	   370	  	   6.93	   48	   1092	  	   21.54	   78	   3063	  	   50.34	  
19	   396	  	   4.24	   49	   1100	  	   43.28	   79	   3075	  	   22.64	  
20	   419	  	   0.01	   50	   1158	  	   1.49	   80	   3098	  	   76.41	  
21	   451	  	   68.25	   51	   1179	  	   0.93	   81	   3120	  	   16.40	  
22	   464	  	   13.16	   52	   1180	  	   2.02	   82	   3129	  	   18.28	  
23	   522	  	   5.69	   53	   1191	  	   0.41	   83	   3147	  	   32.85	  
24	   558	  	   0.62	   54	   1201	  	   0.84	   84	   3159	  	   27.77	  
25	   609	  	   36.70	   55	   1223	  	   12.04	   85	   3199	  	   19.26	  
26	   632	  	   1.05	   56	   1335	  	   423.32	   86	   202	  	   16.66	  
27	   647	  	   7.53	   57	   1352	  	   71.90	   87	   3209	  	   29.67	  
28	   667	  	   32.08	   58	   1365	  	   59.44	   88	   3235	  	   30.56	  
29	   703	  	   4.24	   59	   1391	  	   138.73	   89	   3251	  	   5.06	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   -­‐949.560389	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  639.1283	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐595704.9348	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.0639329	  	   -­‐0.0863496	  	   0.4900204	  
C	   6	   -­‐0.2392076	  	   0.7109256	  	   0.2736413	  
N
N
O HN N O
OH
HAPY-1
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N	   7	   -­‐1.2404253	  	   -­‐0.2293610	  	   0.1490905	  
N	   7	   -­‐0.7506639	  	   -­‐1.5483685	  	   0.2299369	  
C	   6	   0.5209355	  	   -­‐1.5114092	  	   0.4200677	  
O	   8	   -­‐0.3589544	  	   1.9333473	  	   0.2324030	  
C	   6	   1.3359479	  	   -­‐2.7451277	  	   0.5770011	  
H	   1	   1.7683876	  	   -­‐2.7917979	  	   1.5840137	  
H	   1	   2.1685015	  	   -­‐2.7567514	  	   -­‐0.1336008	  
H	   1	   0.7108883	  	   -­‐3.6271654	  	   0.4251715	  
C	   6	   2.0958626	  	   0.1818373	  	   -­‐0.6093115	  
N	   7	   3.3141312	  	   0.1232105	  	   -­‐0.2156869	  
O	   8	   4.2371190	  	   0.3445380	  	   -­‐1.2472646	  
C	   6	   1.6242359	  	   0.4283042	  	   -­‐2.0123874	  
H	   1	   1.2858321	  	   1.4653858	  	   -­‐2.1222327	  
H	   1	   0.7735617	  	   -­‐0.2173345	  	   -­‐2.2551072	  
H	   1	   2.4243849	  	   0.2463049	  	   -­‐2.7301620	  
C	   6	   5.5643100	  	   0.2263813	  	   -­‐0.7175134	  
H	   1	   5.7389419	  	   0.9668077	  	   0.0692271	  
H	   1	   6.2277979	  	   0.4173109	  	   -­‐1.5629176	  
H	   1	   5.7437491	  	   -­‐0.7793896	  	   -­‐0.3247562	  
N	   7	   1.5187321	  	   0.1270728	  	   1.8763323	  
H	   1	   2.3929038	  	   -­‐0.3973713	  	   1.9719817	  
O	   8	   1.9613500	  	   1.4968668	  	   2.0340057	  
H	   1	   1.2989067	  	   1.8555898	  	   2.6498427	  
C	   6	   -­‐2.6365865	  	   -­‐0.0439986	  	   -­‐0.0478155	  
C	   6	   -­‐5.3947609	  	   0.2622861	  	   -­‐0.4422363	  
C	   6	   -­‐3.4713716	  	   -­‐1.1700753	  	   -­‐0.0934802	  
C	   6	   -­‐3.1848728	  	   1.2387020	  	   -­‐0.1990033	  
C	   6	   -­‐4.5585847	  	   1.3773801	  	   -­‐0.3947854	  
C	   6	   -­‐4.8407360	  	   -­‐1.0092505	  	   -­‐0.2902648	  
H	   1	   -­‐3.0403236	  	   -­‐2.1554003	  	   0.0223837	  
H	   1	   -­‐2.5422649	  	   2.1065112	  	   -­‐0.1623943	  
H	   1	   -­‐4.9715993	  	   2.3748902	  	   -­‐0.5109604	  
H	   1	   -­‐5.4749934	  	   -­‐1.8896793	  	   -­‐0.3241846	  
H	   1	   -­‐6.4623387	  	   0.3830062	  	   -­‐0.5957517	  
	  
	  
Table	   3-­‐15.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐1	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   27	  	   0.23	   35	  	   709	  	   15.43	   69	  	   1393	  	   275.98	  
2	  	   29	  	   0.37	   36	   749	  	   25.63	   70	  	   1429	  	   20.77	  
3	  	   34	  	   0.40	   37	  	   766	  	   13.64	   71	  	   1442	  	   15.30	  
4	  	   83	  	   4.24	   38	  	   775	  	   59.53	   72	  	   1488	  	   3.66	  
5	  	   88	  	   4.16	   39	  	   834	  	   80.46	   73	  	   1490	  	   11.15	  
	   141	  
6	  	   95	  	   2.98	   40	  	   860	  	   0.02	   74	  	   1495	  	   18.68	  
7	  	   109	  	   2.42	   41	  	   891	  	   91.08	   75	  	   1504	  	   7.09	  
8	  	   123	  	   0.37	   42	  	   908	  	   113.44	   76	  	   1505	  	   2.57	  
9	  	   126	  	   7.16	   43	  	   931	  	   5.83	   77	  	   1509	  	   7.76	  
10	  	   137	  	   1.17	   44	  	   951	  	   79.45	   78	  	   1516	  	   11.63	  
11	  	   158	  	   4.16	   45	  	   978	  	   0.00	   79	  	   1517	  	   14.42	  
12	  	   169	  	   7.50	   46	  	   1001	  	   1.01	   80	  	   1534	  	   38.13	  
13	  	   186	  	   4.20	   47	  	   1009	  	   4.86	   81	  	   1541	  	   198.09	  
14	  	   197	  	   3.72	   48	  	   1017	  	   0.20	   82	  	   1642	  	   0.81	  
15	  	   231	  	   8.91	   49	  	   1020	  	   6.12	   83	  	   1659	  	   104.74	  
16	  	   253	  	   31.42	   50	  	   1034	  	   12.07	   84	  	   1691	  	   124.21	  
17	  	   279	  	   3.44	   51	  	   1045	  	   41.44	   85	  	   1702	  	   457.96	  
18	  	   289	  	   41.99	   52	  	   1056	   361.95	   86	  	   1779	  	   18.21	  
19	  	   307	  	   48.89	   53	  	   1061	  	   46.18	   87	  	   3064	  	   101.91	  
20	  	   326	  	   25.70	   54	  	   1080	  	   12.44	   88	  	   3070	  	   6.45	  
21	  	   339	  	   19.59	   55	  	   1081	  	   20.59	   89	  	   3075	  	   3.88	  
22	  	   366	  	   9.12	   56	  	   1097	  	   13.18	   90	  	   3129	  	   5.09	  
23	  	   385	  	   9.64	   57	  	   1130	  	   4.00	   91	  	   3138	  	   47.03	  
24	  	   420	  	   0.60	   58	  	   1163	  	   98.37	   92	  	   3143	  	   8.77	  
25	  	   425	  	   20.81	   59	  	   1189	  	   2.09	   93	  	   3175	  	   6.88	  
26	  	   452	  	   3.79	   60	  	   1190	  	   0.09	   94	  	   3179	  	   20.46	  
27	  	   494	  	   19.92	   61	  	   1212	  	   5.43	   95	  	   3185	  	   6.93	  
28	  	   516	  	   2.46	   62	  	   1215	  	   16.49	   96	  	   3207	  	   2.75	  
29	  	   530	  	   5.16	   63	  	   1243	  	   18.56	   97	  	   3215	  	   28.22	  
30	  	   593	  	   27.90	   64	  	   1283	  	   28.14	   98	  	   3230	  	   33.61	  
31	  	   621	  	   8.78	   65	  	   1299	  	   236.05	   99	  	   3263	  	   0.46	  
32	  	   631	  	   0.54	   66	  	   1353	  	   28.85	   100	  	   3270	  	   3.48	  
33	  	   660	  	   50.43	   67	  	   1366	  	   36.55	   101	  	   3442	  	   39.54	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   -­‐949.073224	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  595.3271	  kJ/mol	  




O HN N O
O–
HAPY-1anion
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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.0214091	   -­‐0.1571378	   -­‐0.2418336	  
C	   6	   -­‐0.2097519	   0.5647410	   -­‐0.4462345	  
N	   7	   -­‐1.2183146	   -­‐0.3865459	   -­‐0.1867631	  
N	   7	   -­‐0.6879684	   -­‐1.6253974	   0.1469285	  
C	   6	   0.6238100	   -­‐1.4894948	   0.1117294	  
O	   8	   -­‐0.4362384	   1.7591017	   -­‐0.7750128	  
C	   6	   1.4758425	   -­‐2.6769185	   0.4213738	  
H	   1	   2.1330056	   -­‐2.4844335	   1.2761106	  
H	   1	   2.1332761	   -­‐2.9251359	   -­‐0.4184093	  
H	   1	   0.8314792	   -­‐3.5318636	   0.6460040	  
C	   6	   2.3647372	   0.3459400	   -­‐0.4758830	  
N	   7	   3.3632689	   -­‐0.4588540	   -­‐0.2535859	  
O	   8	   4.6030172	   0.1877153	   -­‐0.5318817	  
C	   6	   2.5837684	   1.7607122	   -­‐0.9593730	  
H	   1	   3.1822046	   2.3181304	   -­‐0.2300227	  
H	   1	   1.6352280	   2.2700151	   -­‐1.1163234	  
H	   1	   3.1668447	   1.7475798	   -­‐1.8865645	  
C	   6	   5.6609478	   -­‐0.7353628	   -­‐0.2727489	  
H	   1	   5.6645765	   -­‐1.0541235	   0.7760335	  
H	   1	   6.5820887	   -­‐0.1917828	   -­‐0.4961351	  
H	   1	   5.5870078	   -­‐1.6189226	   -­‐0.9173902	  
N	   7	   0.7492864	   1.0344728	   2.2311922	  
H	   1	   1.7762160	   0.7853203	   2.1133852	  
O	   8	   0.6256630	   2.2511769	   2.1080485	  
C	   6	   -­‐2.6226410	   -­‐0.2321559	   -­‐0.2014021	  
C	   6	   -­‐5.4320806	   0.0015406	   -­‐0.2150673	  
C	   6	   -­‐3.2344019	   0.9737642	   -­‐0.5864039	  
C	   6	   -­‐3.4341817	   -­‐1.3171117	   0.1757170	  
C	   6	   -­‐4.8212249	   -­‐1.1945907	   0.1659633	  
C	   6	   -­‐4.6257346	   1.0766866	   -­‐0.5881506	  
H	   1	   -­‐2.6097311	   1.8082664	   -­‐0.8715913	  
H	   1	   -­‐2.9561548	   -­‐2.2418577	   0.4721800	  
H	   1	   -­‐5.4242128	   -­‐2.0478765	   0.4628041	  
H	   1	   -­‐5.0748328	   2.0190565	   -­‐0.8893220	  
H	   1	   -­‐6.5134279	   0.0942735	   -­‐0.2205125	  
	  
	  
Table	   3-­‐17.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐1anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   2	   0.28	   34	   665	   110.32	   67	   1441	   77.83	  
2	   18	   0.14	   35	   692	   4.94	   68	   1471	   500.43	  
	   143	  
3	   34	   3.08	   36	   704	   11.11	   69	   1480	   27.72	  
4	   46	   7.93	   37	   737	   37.43	   70	   1489	   12.46	  
5	   62	   2.92	   38	   764	   53.30	   71	   1498	   52.46	  
6	   79	   10.99	   39	   770	   42.84	   72	   1501	   2.64	  
7	   88	   1.27	   40	   851	   225.74	   73	   1505	   503.18	  
8	   91	   8.15	   41	   854	   1.58	   74	   1511	   29.70	  
9	   106	   2.31	   42	   890	   186.90	   75	   1520	   255.51	  
10	   130	   3.80	   43	   910	   5.25	   76	   1534	   18.80	  
11	   144	   1.71	   44	   965	   0.13	   77	   1537	   55.56	  
12	   162	   4.62	   45	   978	   0.78	   78	   1540	   149.85	  
13	   170	   2.28	   46	   1014	   7.64	   79	   1561	   52.05	  
14	   212	   3.66	   47	   1019	   22.97	   80	   1572	   116.86	  
15	   218	   2.64	   48	   1038	   96.23	   81	   1602	   670.36	  
16	   241	   4.12	   49	   1053	   252.10	   82	   1621	   262.52	  
17	   254	   23.24	   50	   1058	   75.10	   83	   1638	   79.99	  
18	   262	   5.54	   51	   1073	   2.85	   84	   1659	   231.84	  
19	   294	   17.73	   52	   1075	   9.68	   85	   2933	   43.62	  
20	   319	   4.22	   53	   1088	   55.89	   86	   3048	   158.56	  
21	   340	   17.66	   54	   1096	   28.48	   87	   3067	   44.30	  
22	   350	   1.87	   55	   1102	   118.89	   88	   3068	   29.35	  
23	   380	   13.09	   56	   1158	   7.64	   89	   3112	   68.62	  
24	   393	   0.62	   57	   1178	   3.03	   90	   3117	   16.26	  
25	   419	   0.06	   58	   1180	   0.54	   91	   3124	   16.04	  
26	   434	   7.78	   59	   1200	   10.02	   92	   3149	   36.44	  
27	   476	   74.97	   60	   1203	   1.42	   93	   3165	   28.99	  
28	   496	   61.84	   61	   1232	   24.38	   94	   3195	   5.78	  
29	   523	   5.61	   62	   1338	   453.64	   95	   3202	   10.07	  
30	   564	   2.33	   63	   1349	   7.93	   96	   3210	   31.36	  
31	   611	   32.08	   64	   1364	   18.14	   97	   3229	   35.15	  
32	   633	   0.48	   65	   1378	   261.74	   98	   3252	   3.86	  




Table	  3-­‐18.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐2	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  	  -­‐611.117576	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  457.2947	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.1225504	  	   0.1528301	  	   0.3568273	  
C	   6	   0.9272259	  	   0.8410004	  	   0.2653613	  
N	   7	   -­‐0.0788429	  	   -­‐0.0606165	  	   0.0263349	  
N	   7	   0.4364668	  	   -­‐1.3386332	  	   -­‐0.0555839	  
C	   6	   1.7466909	  	   -­‐1.1991077	  	   0.1424989	  
C	   6	   3.4884350	  	   0.7182159	  	   0.6082297	  
H	   1	   3.4500363	  	   1.6063280	  	   1.2504923	  
H	   1	   4.0050531	  	   1.0023207	  	   -­‐0.3174947	  
H	   1	   4.1226819	  	   -­‐0.0110011	  	   1.1225173	  
C	   6	   2.6425378	  	   -­‐2.3959032	  	   0.1351472	  
H	   1	   3.1765132	  	   -­‐2.5027597	  	   1.0870542	  
H	   1	   3.4016929	  	   -­‐2.3230346	  	   -­‐0.6525512	  
H	   1	   2.0582706	  	   -­‐3.3042645	  	   -­‐0.0333340	  
C	   6	   -­‐1.4674844	  	   0.1566178	  	   -­‐0.1843021	  
C	   6	   -­‐4.2109983	  	   0.5168441	  	   -­‐0.6164062	  
C	   6	   -­‐2.1929693	  	   -­‐0.7877473	  	   -­‐0.9227621	  
C	   6	   -­‐2.1188945	  	   1.2770635	  	   0.3470062	  
C	   6	   -­‐3.4838143	  	   1.4522461	  	   0.1190631	  
C	   6	   -­‐3.5578803	  	   -­‐0.6054159	  	   -­‐1.1298831	  
H	   1	   -­‐1.6763431	  	   -­‐1.6545416	  	   -­‐1.3157656	  
H	   1	   -­‐1.5668890	  	   2.0010319	  	   0.9305245	  
H	   1	   -­‐3.9788428	  	   2.3253991	  	   0.5329286	  
H	   1	   -­‐4.1093133	  	   -­‐1.3449140	  	   -­‐1.7024438	  
H	   1	   -­‐5.2736902	  	   0.6581987	  	   -­‐0.7859690	  
O	   8	   0.6465056	  	   2.1668639	  	   0.3607940	  
H	   1	   1.4913022	  	   2.6529789	  	   0.4317162	  
	  
	  
Table	   3-­‐19.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐2	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   31	  	   2.99	   25	  	   774	  	   48.41	   49	  	   1448	  	   7.62	  
2	  	   57	  	   1.17	   26	  	   822	  	   2.26	   50	  	   1484	  	   138.98	  
3	  	   66	  	   4.86	   27	  	   850	  	   0.42	   51	  	   1492	  	   43.05	  
4	  	   106	  	   0.15	   28	  	   923	  	   5.48	   52	  	   1508	  	   9.26	  
5	  	   125	  	   1.89	   29	  	   969	  	   0.61	   53	  	   1509	  	   27.00	  
6	  	   164	  	   6.73	   30	  	   977	  	   50.59	   54	  	   1519	  	   12.54	  
7	  	   222	  	   54.07	   31	  	   992	  	   0.63	   55	  	   1525	  	   14.09	  
8	  	   227	  	   6.17	   32	  	   1017	  	   7.02	   56	  	   1537	  	   108.07	  
9	  	   235	  	   55.78	   33	  	   1026	  	   81.51	   57	  	   1551	  	   217.77	  
10	  	   279	  	   2.51	   34	  	   1057	  	   5.24	   58	  	   1633	  	   212.09	  
11	  	   294	  	   27.52	   35	  	   1064	  	   3.91	   59	  	   1649	  	   66.34	  
	   145	  
12	  	   339	  	   3.13	   36	  	   1080	  	   2.04	   60	  	   1661	  	   69.69	  
13	  	   350	  	   10.32	   37	  	   1099	  	   54.28	   61	  	   3047	  	   61.73	  
14	  	   399	  	   2.51	   38	  	   1112	  	   1.56	   62	  	   3059	  	   40.58	  
15	  	   420	  	   1.40	   39	  	   1121	  	   127.06	   63	  	   3099	  	   29.99	  
16	  	   516	  	   5.34	   40	  	   1187	  	   18.57	   64	  	   3110	  	   16.14	  
17	  	   566	  	   21.78	   41	  	   1190	  	   1.09	   65	  	   3125	  	   24.91	  
18	  	   608	  	   7.51	   42	  	   1211	  	   0.28	   66	  	   3150	  	   20.63	  
19	  	   630	  	   0.35	   43	  	   1243	  	   110.23	   67	  	   3206	  	   0.24	  
20	  	   654	  	   2.15	   44	  	   1328	  	   64.54	   68	  	   3216	  	   25.58	  
21	  	   666	  	   14.36	   45	  	   1357	  	   41.53	   69	  	   3227	  	   35.93	  
22	  	   688	  	   5.30	   46	  	   1369	  	   4.24	   70	  	   3247	  	   5.10	  
23	  	   706	  	   20.88	   47	  	   1416	  	   272.46	   71	  	   3267	  	   1.21	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐610.654618	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  425.1610	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐383089.6528	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.1728663	  	   0.2358654	  	   0.4538906	  
C	   6	   0.9766007	  	   0.9853925	  	   0.4540959	  
N	   7	   -­‐0.0160307	  	   0.0653284	  	   0.0160514	  
N	   7	   0.5257457	  	   -­‐1.1924461	  	   -­‐0.2442987	  
C	   6	   1.8262128	  	   -­‐1.0607008	  	   0.0253448	  
C	   6	   3.5141416	  	   0.7728354	  	   0.8451327	  
H	   1	   3.4086559	  	   1.8176222	  	   1.1592336	  
H	   1	   4.2437135	  	   0.7506808	  	   0.0225115	  
H	   1	   3.9680800	  	   0.2218178	  	   1.6811854	  
C	   6	   2.7375860	  	   -­‐2.2346342	  	   -­‐0.1434214	  
H	   1	   3.2487202	  	   -­‐2.4834294	  	   0.7952988	  
H	   1	   3.5189254	  	   -­‐2.0318774	  	   -­‐0.8868652	  
H	   1	   2.1684599	  	   -­‐3.1100880	  	   -­‐0.4703671	  
C	   6	   -­‐1.3964928	  	   0.2640981	  	   -­‐0.1755972	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C	   6	   -­‐2.1866133	  	   -­‐0.7896022	  	   -­‐0.6738015	  
C	   6	   -­‐2.0179069	  	   1.4921154	  	   0.1209485	  
C	   6	   -­‐3.3896071	  	   1.6466861	  	   -­‐0.0800147	  
C	   6	   -­‐3.5547742	  	   -­‐0.6153203	  	   -­‐0.8668224	  
H	   1	   -­‐1.7033019	  	   -­‐1.7320225	  	   -­‐0.8986633	  
H	   1	   -­‐1.4052122	  	   2.2981611	  	   0.5014999	  
H	   1	   -­‐3.8426442	  	   2.6053594	  	   0.1579587	  
H	   1	   -­‐4.1384651	  	   -­‐1.4462559	  	   -­‐1.2532664	  
H	   1	   -­‐5.2391649	  	   0.7340099	  	   -­‐0.7258435	  
O	   8	   0.7531433	  	   2.2042270	  	   0.7588514	  
	  
	  
Table	   3-­‐21.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐2anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   42	  	   0.04	   24	  	   762	  	   69.07	   47	  	   1424	  	   33.45	  
2	  	   48	  	   0.47	   25	  	   828	  	   1.38	   48	  	   1476	  	   137.25	  
3	  	   61	  	   6.87	   26	  	   856	  	   0.04	   49	  	   1495	  	   88.25	  
4	  	   141	  	   5.39	   27	  	   905	  	   5.85	   50	  	   1505	  	   4.79	  
5	  	   145	  	   3.99	   28	  	   963	  	   0.14	   51	  	   1509	  	   106.04	  
6	  	   163	  	   1.30	   29	  	   968	  	   72.37	   52	  	   1521	  	   8.56	  
7	  	   212	  	   9.57	   30	  	   976	  	   1.07	   53	  	   1525	  	   39.49	  
8	  	   216	  	   1.35	   31	  	   1013	  	   10.61	   54	  	   1535	  	   340.57	  
9	  	   269	  	   0.06	   32	  	   1020	  	   98.48	   55	  	   1543	  	   393.07	  
10	  	   297	  	   20.60	   33	  	   1056	  	   1.27	   56	  	   1607	  	   333.43	  
11	  	   336	  	   4.18	   34	  	   1056	  	   2.17	   57	  	   1635	  	   83.29	  
12	  	   362	  	   3.07	   35	  	   1076	  	   1.12	   58	  	   1657	  	   267.98	  
13	  	   388	  	   2.93	   36	  	   1091	  	   5.44	   59	  	   3021	  	   156.26	  
14	  	   422	  	   0.05	   37	  	   1105	  	   64.24	   60	  	   3050	  	   71.70	  
15	  	   524	  	   5.75	   38	  	   1139	  	   110.61	   61	  	   3057	  	   60.54	  
16	  	   573	  	   37.07	   39	  	   1150	  	   43.25	   62	  	   3099	  	   24.45	  
17	  	   629	  	   6.69	   40	  	   1176	  	   0.86	   63	  	   3106	  	   35.50	  
18	  	   632	  	   7.94	   41	  	   1200	  	   1.07	   64	  	   3140	  	   30.38	  
19	  	   647	  	   3.24	   42	  	   1315	  	   75.29	   65	  	   3192	  	   21.49	  
20	  	   662	  	   20.67	   43	  	   1341	  	   378.03	   66	  	   3205	  	   24.77	  
21	  	   706	  	   10.18	   44	  	   1355	  	   122.44	   67	  	   3227	  	   27.64	  
22	  	   730	  	   11.63	   45	  	   1365	  	   64.77	   68	  	   3248	  	   7.99	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  	  -­‐741.635611	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  507.8082	  kJ/mol	  




Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.0161767	  	   0.0452028	  	   0.1943700	  
C	   6	   0.6729899	  	   0.7849498	  	   0.1911063	  
N	   7	   -­‐0.2972683	  	   -­‐0.1858562	  	   0.0513906	  
N	   7	   0.2601273	  	   -­‐1.4768462	  	   -­‐0.0789356	  
C	   6	   1.5434213	  	   -­‐1.3790149	  	   -­‐0.0262766	  
O	   8	   0.4988254	   	  2.0000667	  	   0.2987924	  
C	   6	   2.7343876	  	   0.2189836	  	   1.5410064	  
H	   1	   2.9570282	  	   1.2751040	  	   1.7036802	  
H	   1	   3.6724088	  	   -­‐0.3444284	  	   1.5401906	  
H	   1	   2.1150097	  	   -­‐0.1438793	  	   2.3674034	  
N	   7	   2.7905458	  	   0.4681273	  	   -­‐0.9952550	  
H	   1	   3.6122847	  	   -­‐0.1423931	  	   -­‐1.0423555	  
O	   8	   3.3883890	  	   1.7651380	  	   -­‐0.7487484	  
H	   1	   2.8534671	  	   2.3531064	  	   -­‐1.3080297	  
C	   6	   2.4244736	  	   -­‐2.5709806	  	   -­‐0.1539292	  
H	   1	   3.0900016	  	   -­‐2.6605798	  	   0.7117954	  
H	   1	   3.0579115	  	   -­‐2.4923223	  	   -­‐1.0461661	  
H	   1	   1.8207289	  	   -­‐3.4769776	  	   -­‐0.2369940	  
C	   6	   -­‐1.7113854	  	   -­‐0.0595583	  	   0.0042242	  
C	   6	   -­‐4.5080376	  	   0.1334114	  	   -­‐0.0871999	  
C	   6	   -­‐2.4943611	  	   -­‐1.2146547	  	   -­‐0.1376554	  
C	   6	   -­‐2.3323787	  	   1.1953480	  	   0.1009018	  
C	   6	   -­‐3.7236885	  	   1.2778737	  	   0.0542909	  
C	   6	   -­‐3.8824875	  	   -­‐1.1101880	  	   -­‐0.1826809	  
H	   1	   -­‐2.0089846	  	   -­‐2.1784822	  	   -­‐0.2111539	  
H	   1	   -­‐1.7302199	  	   2.0859052	  	   0.2106387	  
H	   1	   -­‐4.1915778	  	   2.2548293	  	   0.1302724	  
H	   1	   -­‐4.4751223	  	   -­‐2.0131073	  	   -­‐0.2936607	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Table	   3-­‐23.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐2	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   18	  	   0.17	   28	  	   758	  	   25.04	   55	  	   1398	  	   268.05	  
2	  	   39	  	   2.57	   29	  	   775	  	   60.34	   56	  	   1419	  	   8.51	  
3	  	   89	  	   0.38	   30	  	   824	  	   32.55	   57	  	   1441	  	   26.00	  
4	  	   95	  	   9.50	   31	  	   860	  	   0.02	   58	  	   1491	  	   17.41	  
5	  	   143	  	   10.46	   32	  	   892	  	   34.42	   59	  	   1495	  	   11.49	  
6	  	   152	  	   3.46	   33	  	   898	  	   15.39	   60	  	   1502	  	   10.55	  
7	  	   169	  	   1.41	   34	  	   928	  	   6.00	   61	  	   1504	  	   0.80	  
8	  	   202	  	   21.89	   35	  	   956	  	   47.06	   62	  	   1517	  	   7.66	  
9	  	   233	  	   25.21	   36	  	   977	  	   0.00	   63	  	   1524	  	   5.68	  
10	  	   238	  	   15.14	   37	  	   998	  	   0.89	   64	  	   1540	  	   215.38	  
11	  	   248	  	   43.33	   38	  	   1016	  	   0.21	   65	  	   1641	  	   0.33	  
12	  	   265	  	   4.85	   39	  	   1020	  	   27.06	   66	  	   1658	  	   121.68	  
13	  	   286	  	   35.88	   40	  	   1028	  	   28.75	   67	  	   1686	  	   174.60	  
14	  	   306	  	   24.70	   41	  	   1050	  	   10.16	   68	  	   1695	  	   424.49	  
15	  	   337	  	   13.63	   42	  	   1060	  	   4.50	   69	  	   3063	  	   8.25	  
16	  	   368	  	   3.77	   43	  	   1090	  	   30.76	   70	  	   3075	  	   16.09	  
17	  	   385	  	   3.69	   44	  	   1116	  	   19.44	   71	  	   3121	  	   5.21	  
18	  	   418	  	   0.01	   45	  	   1138	  	   25.14	   72	  	   3145	  	   20.17	  
19	  	   459	  	   1.94	   46	  	   1156	  	   65.38	   73	  	   3169	  	   19.09	  
20	  	   527	  	   5.97	   47	  	   1169	  	   66.32	   74	  	   3169	  	   1.40	  
21	  	   578	  	   35.11	   48	  	   1189	  	   0.04	   75	  	   3207	  	   2.87	  
22	  	   614	  	   19.29	   49	  	   1210	  	   5.24	   76	  	   3216	  	   27.71	  
23	  	   621	  	   9.02	   50	  	   1263	  	   93.76	   77	  	   3229	  	   33.64	  
24	  	   631	  	   0.62	   51	  	   1325	  	   228.24	   78	  	   3263	  	   0.65	  
25	  	   666	  	   20.84	   52	  	   1352	  	   15.19	   79	  	   3270	  	   3.28	  
26	  	   708	  	   16.91	   53	  	   1364	  	   23.42	   80	  	   3431	  	   18.00	  
27	  	   739	  	   14.60	   54	  	   1369	  	   33.68	   81	  	   3727	  	   110.14	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐741.128834	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  472.3790	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.5851225	  	   -­‐1.8410150	  	   -­‐0.6197223	  
C	   6	   -­‐0.8742383	  	   -­‐0.3633975	  	   -­‐0.7956171	  
N	   7	   -­‐0.0355121	  	   0.2992146	  	   0.0807645	  
N	   7	   0.8736889	  	   -­‐0.5848576	  	   0.6978832	  
C	   6	   0.6139977	  	   -­‐1.7798839	  	   0.2827816	  
C	   6	   1.4055153	  	   -­‐2.9445603	  	   0.7616526	  
H	   1	   0.7606522	  	   -­‐3.6549387	  	   1.2943702	  
H	   1	   2.1977787	  	   -­‐2.6084607	  	   1.4347797	  
H	   1	   1.8546016	  	   -­‐3.4835739	  	   -­‐0.0800410	  
O	   8	   -­‐1.6892290	  	   0.1603122	  	   -­‐1.5601201	  
C	   6	   -­‐0.4185344	  	   -­‐2.5795818	  	   -­‐1.9387354	  
H	   1	   -­‐1.4179523	  	   -­‐2.6942216	  	   -­‐2.3698320	  
H	   1	   0.0044723	  	   -­‐3.5747330	  	   -­‐1.7660285	  
H	   1	   0.2303553	  	   -­‐2.0469064	  	   -­‐2.6421870	  
N	   7	   -­‐1.7607184	  	   -­‐2.4126529	  	   0.2493755	  
H	   1	   -­‐1.3790081	  	   -­‐3.3699158	  	   0.4147602	  
O	   8	   -­‐2.9309768	  	   -­‐2.5559829	  	   -­‐0.5124102	  
C	   6	   0.1052156	  	   1.6892137	  	   0.3313896	  
C	   6	   0.4211168	  	   4.4293966	  	   0.8661404	  
C	   6	   1.2038182	  	   2.1439144	  	   1.0774891	  
C	   6	   -­‐0.8398397	  	   2.6136198	  	   -­‐0.1418705	  
C	   6	   -­‐0.6703675	  	   3.9716346	  	   0.1278788	  
C	   6	   1.3532210	  	   3.5043547	  	   1.3385028	  
H	   1	   1.9226777	  	   1.4233990	  	   1.4454247	  
H	   1	   -­‐1.6856117	  	   2.2636904	  	   -­‐0.7167978	  
H	   1	   -­‐1.4113673	  	   4.6712110	  	   -­‐0.2479444	  
H	   1	   2.2098924	  	   3.8363245	  	   1.9172339	  
H	   1	   0.5414747	  	   5.4883966	  	   1.0708794	  
	  
	  
Table	   3-­‐25.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐2anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   34	  	   4.68	   27	  	   752	  	   34.30	   53	  	   1388	  	   205.26	  
2	  	   45	  	   8.86	   28	  	   768	  	   49.72	   54	  	   1408	  	   6.93	  
3	  	   95	  	   11.20	   29	  	   794	  	   25.81	   55	  	   1432	  	   18.95	  
4	  	   118	  	   11.21	   30	  	   846	  	   22.36	   56	  	   1456	  	   24.31	  
5	  	   144	  	   5.80	   31	  	   855	  	   0.08	   57	  	   1492	  	   12.67	  
6	  	   157	  	   11.89	   32	  	   915	  	   47.36	   58	  	   1497	  	   26.33	  
7	  	   180	  	   23.17	   33	  	   921	  	   5.15	   59	  	   1502	  	   1.47	  
8	  	   191	  	   1.97	   34	  	   968	  	   100.47	   60	  	   1507	  	   4.60	  
9	  	   219	  	   1.17	   35	  	   970	  	   0.27	   61	  	   1532	  	   7.26	  
	   150	  
10	  	   261	  	   8.70	   36	  	   985	  	   1.32	   62	  	   1540	  	   225.31	  
11	  	   265	  	   3.52	   37	  	   1017	  	   1.00	   63	  	   1639	  	   10.47	  
12	  	   273	  	   9.77	   38	  	   1025	  	   27.45	   64	  	   1656	  	   128.86	  
13	  	   311	  	   11.84	   39	  	   1039	  	   11.73	   65	  	   1672	  	   142.86	  
14	  	   324	  	   12.54	   40	  	   1049	  	   3.48	   66	  	   1690	  	   466.97	  
15	  	   367	  	   2.25	   41	  	   1060	  	   4.30	   67	  	   3058	  	   47.77	  
16	  	   385	  	   1.95	   42	  	   1090	  	   22.56	   68	  	   3062	  	   12.81	  
17	  	   417	  	   46.28	   43	  	   1109	  	   5.04	   69	  	   3089	  	   129.42	  
18	  	   421	  	   4.82	   44	  	   1133	  	   18.48	   70	  	   3121	  	   8.91	  
19	  	   522	  	   26.70	   45	  	   1160	  	   147.86	   71	  	   3130	  	   9.18	  
20	  	   540	  	   102.86	   46	  	   1174	  	   11.14	   72	  	   3139	  	   33.78	  
21	  	   579	  	   33.33	   47	  	   1184	  	   0.08	   73	  	   3167	  	   11.43	  
22	  	   615	  	   18.89	   48	  	   1210	  	   3.48	   74	  	   3208	  	   4.48	  
23	  	   632	  	   0.35	   49	  	   1284	  	   110.65	   75	  	   3216	  	   26.52	  
24	  	   662	  	   74.89	   50	  	   1338	  	   353.54	   76	  	   3232	  	   30.45	  
25	  	   670	  	   26.11	   51	  	   1353	  	   1.71	   77	  	   3260	  	   1.00	  
26	  	   705	  	   15.59	   52	  	   1366	  	   4.99	   78	  	   3260	  	   4.41	  
	  
	  
Table	  3-­‐26.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐3	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  	  -­‐627.325837	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  461.1102	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐393542.4007	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.2117165	  	   -­‐0.3782990	  	   0.2462173	  
C	   6	   -­‐1.3804963	  	   0.2784643	  	   -­‐0.1632792	  
N	   7	   -­‐2.4375791	  	   -­‐0.4139166	  	   0.2985989	  
N	   7	   -­‐2.0337805	  	   -­‐1.5237325	  	   1.0072797	  
C	   6	   -­‐0.7012002	  	   -­‐1.5037328	  	   0.9784114	  
C	   6	   0.0466954	  	   -­‐2.5962676	  	   1.6767293	  
H	   1	   0.7457341	  	   -­‐2.2019945	  	   2.4212847	  
H	   1	   0.6253607	  	   -­‐3.2080483	  	   0.9755823	  
H	   1	   -­‐0.6661328	  	   -­‐3.2496960	  	   2.1865172	  
C	   6	   1.1294478	  	   0.0974972	  	   -­‐0.0699223	  







	   151	  
O	   8	   2.4705308	  	   1.6458672	  	   -­‐1.0568078	  
C	   6	   2.3462076	  	   -­‐0.6450003	  	   0.4049565	  
H	   1	   3.2526653	  	   -­‐0.2477427	  	   -­‐0.0491260	  
H	   1	   2.2610682	  	   -­‐1.7085304	  	   0.1669553	  
H	   1	   2.4375174	  	   -­‐0.5628602	  	   1.4939823	  
C	   6	   2.3821808	  	   2.8257731	  	   -­‐1.8589235	  
H	   1	   1.8818318	  	   2.6209890	  	   -­‐2.8118639	  
H	   1	   3.4150725	  	   3.1273586	  	   -­‐2.0432778	  
H	   1	   1.8534343	  	   3.6256731	  	   -­‐1.3289804	  
O	   8	   -­‐1.5297495	  	   1.4058440	  	   -­‐0.8864367	  
H	   1	   -­‐0.5966072	  	   1.6984320	  	   -­‐1.0758074	  
C	   6	   -­‐3.8491973	  	   -­‐0.1271563	  	   0.1019346	  
H	   1	   -­‐4.3561877	  	   -­‐0.0896454	  	   1.0681966	  
H	   1	   -­‐4.3132448	  	   -­‐0.8993898	  	   -­‐0.5165407	  
H	   1	   -­‐3.9399353	  	   0.8383663	  	   -­‐0.3950294	  
	  
Table	   3-­‐27.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐3	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   22	  	   0.10	   25	  	   717	  	   8.59	   49	  	   1503	  	   63.32	  
2	  	   34	  	   1.49	   26	  	   761	  	   61.57	   50	  	   1506	  	   7.25	  
3	  	   75	  	   5.05	   27	  	   893	  	   9.55	   51	  	   1509	  	   3.93	  
4	  	   89	  	   1.13	   28	  	   912	  	   227.67	   52	  	   1511	  	   15.30	  
5	  	   115	  	   2.52	   29	  	   1015	  	   13.69	   53	  	   1515	  	   29.04	  
6	  	   122	  	   0.22	   30	  	   1017	  	   25.68	   54	  	   1523	  	   20.72	  
7	  	   156	  	   5.66	   31	  	   1061	  	   84.39	   55	  	   1529	  	   26.72	  
8	  	   170	  	   3.88	   32	  	   1068	  	   145.82	   56	  	   1533	  	   32.97	  
9	  	   214	  	   0.26	   33	  	   1072	  	   37.34	   57	  	   1554	  	   172.19	  
10	  	   225	  	   3.12	   34	  	   1075	  	   165.19	   58	  	   1632	  	   461.76	  
11	  	   245	  	   0.97	   35	  	   1117	  	   29.60	   59	  	   1649	  	   152.86	  
12	  	   265	  	   12.90	   36	  	   1168	  	   80.26	   60	  	   3054	  	   113.30	  
13	  	   311	  	   18.64	   37	  	   1174	  	   11.28	   61	  	   3068	  	   26.96	  
14	  	   331	  	   4.08	   38	  	   1177	  	   3.10	   62	  	   3081	  	   9.36	  
15	  	   351	  	   0.30	   39	  	   1220	  	   12.35	   63	  	   3094	  	   68.74	  
16	  	   376	  	   2.06	   40	  	   1267	   30.10	   64	  	   3122	  	   52.39	  
17	  	   391	  	   1.78	   41	  	   1363	  	   12.40	   65	  	   3126	  	   13.34	  
18	  	   452	  	   40.97	   42	  	   1391	  	   52.96	   66	  	   3144	  	   7.21	  
19	  	   543	  	   1.05	   43	  	   1423	  	   47.18	   67	  	   3151	  	   25.58	  
20	  	   593	  	   32.78	   44	  	   1433	  	   58.16	   68	  	   3165	  	   15.66	  
21	  	   598	  	   0.28	   45	  	   1447	  	   257.45	   69	  	   3173	  	   25.43	  
22	  	   642	  	   21.72	   46	  	   1472	  	   66.74	   70	  	   3195	  	   12.92	  
23	  	   665	  	   12.34	   47	  	   1481	  	   17.45	   71	  	   3203	  	   3.38	  
24	  	   679	  	   74.44	   48	  	   1491	  	   54.63	   72	  	   3264	  	   754.22	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐626.848205	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  426.5004	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐393250.9542	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.3346942	  	   -­‐0.2609653	  	   0.0973249	  
C	   6	   -­‐1.5699444	  	   0.1997584	  	   -­‐0.4797535	  
N	   7	   -­‐2.5424000	  	   -­‐0.5428637	  	   0.1781073	  
N	   7	   -­‐2.0303789	  	   -­‐1.3968058	  	   1.1365803	  
C	   6	   -­‐0.7117221	  	   -­‐1.2344043	  	   1.0734404	  
C	   6	   0.1376431	  	   -­‐2.0141835	  	   2.0315224	  
H	   1	   0.8874638	  	   -­‐1.3801724	  	   2.5172620	  
H	   1	   0.6761595	  	   -­‐2.8363911	  	   1.5443308	  
H	   1	   -­‐0.5049207	  	   -­‐2.4499974	  	   2.8026253	  
C	   6	   0.9983652	  	   0.2001395	  	   -­‐0.2479022	  
N	   7	   1.1321513	  	   1.4161998	  	   -­‐0.6979328	  
O	   8	   2.5035344	  	   1.6685108	  	   -­‐1.0551299	  
C	   6	   2.1841575	  	   -­‐0.7288520	  	   -­‐0.1209954	  
H	   1	   2.7803008	  	   -­‐0.6888713	  	   -­‐1.0378414	  
H	   1	   1.8672733	  	   -­‐1.7566830	  	   0.0508188	  
H	   1	   2.8492221	  	   -­‐0.4202722	  	   0.6944233	  
C	   6	   2.5906919	  	   2.9872791	  	   -­‐1.5840300	  
H	   1	   1.9744194	  	   3.1015521	  	   -­‐2.4843166	  
H	   1	   3.6442279	  	   3.1332571	  	   -­‐1.8364705	  
H	   1	   2.2808203	  	   3.7375897	  	   -­‐0.8463813	  
O	   8	   -­‐1.8386159	  	   1.0385592	  	   -­‐1.3949349	  
C	   6	   -­‐3.9689709	  	   -­‐0.4637713	  	   -­‐0.0374820	  
H	   1	   -­‐4.1381616	  	   0.2646574	  	   -­‐0.8321890	  
H	   1	   -­‐4.4902361	  	   -­‐0.1389822	  	   0.8701586	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Table	   3-­‐29.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐3anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   38	  	   2.89	   24	  	   755	  	   74.88	   47	  	   1494	  	   21.72	  
2	  	   70	  	   9.18	   25	  	   765	  	   29.76	   48	  	   1497	  	   6.24	  
3	  	   83	  	   4.77	   26	  	   842	  	   326.98	   49	  	   1508	  	   3.22	  
4	  	   96	  	   1.68	   27	  	   910	  	   4.07	   50	  	   1510	  	   108.99	  
5	  	   96	  	   2.43	   28	  	   1001	  	   20.77	   51	  	   1518	  	   7.97	  
6	  	   129	  	   0.43	   29	  	   1018	  	   33.93	   52	  	   1519	  	   19.51	  
7	  	   135	  	   3.21	   30	  	   1051	  	   20.32	   53	  	   1532	  	   279.28	  
8	  	   157	  	   0.17	   31	  	   1053	  	   12.51	   54	  	   1537	  	   44.50	  
9	  	   205	  	   1.34	   32	  	   1065	  	   263.30	   55	  	   1547	  	   348.01	  
10	  	   209	  	   2.43	   33	  	   1072	  	   7.02	   56	  	   1556	  	   285.76	  
11	  	   260	  	   15.34	   34	  	   1089	  	   91.99	   57	  	   1617	  	   309.46	  
12	  	   275	  	   2.81	   35	   1166	  	   15.03	   58	  	   3039	  	   159.48	  
13	  	   300	  	   9.96	   36	  	   1175	  	   1.76	   59	  	   3056	  	   101.19	  
14	  	   329	  	   4.23	   37	  	   1176	  	   2.12	   60	  	   3060	  	   111.76	  
15	  	   343	  	   5.81	   38	  	   1214	  	   4.04	   61	  	   3073	  	   18.82	  
16	  	   375	  	   8.10	   39	  	   1266	  	   50.70	   62	  	   3098	  	   78.98	  
17	  	   395	  	   4.97	   40	  	   1378	  	   76.21	   63	  	   3110	  	   23.50	  
18	  	   450	  	   59.72	   41	  	   1399	  	   78.77	   64	  	   3115	  	   44.53	  
19	  	   555	  	   2.46	   42	  	   1414	  	   11.11	   65	  	   3125	  	   18.00	  
20	  	   597	  	   43.61	   43	  	   1433	  	   12.25	   66	  	   3141	  	   36.08	  
21	  	   611	  	   13.11	   44	  	   1453	  	   40.44	   67	  	   3158	  	   28.58	  
22	  	   650	  	   7.22	   45	  	   1474	  	   65.64	   68	  	   3174	  	   7.86	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐757.822294	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	  	  	   	  	  	  	  	  	  	  	  	  506.6847	  kJ/mol	  






O HN N O
OH
HAPY-3
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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.4111603	  	   0.1041208	  	   0.4470887	  
C	   6	   -­‐1.5883892	  	   0.9838121	  	   -­‐0.0358315	  
N	   7	   -­‐2.5584909	  	   0.1104262	  	   -­‐0.4213701	  
N	   7	   -­‐2.1847825	  	   -­‐1.2360739	  	   -­‐0.3080871	  
C	   6	   -­‐0.9897666	  	   -­‐1.2873857	  	   0.1708483	  
O	   8	   -­‐1.6580260	  	   2.2153714	  	   -­‐0.0611850	  
C	   6	   -­‐0.2925146	  	   -­‐2.5708186	  	   0.4495690	  
H	   1	   -­‐0.1118135	  	   -­‐2.6856895	  	   1.5256516	  
H	   1	   0.6829038	  	   -­‐2.6071418	  	   -­‐0.0469285	  
H	   1	   -­‐0.9049513	  	   -­‐3.4088517	  	   0.1105242	  
C	   6	   0.8685781	  	   0.3549938	  	   -­‐0.3493739	  
N	   7	   1.9506335	  	   0.2648761	  	   0.3321381	  
O	   8	   3.1025254	  	   0.4809399	  	   -­‐0.4401179	  
C	   6	   0.7683663	  	   0.6308088	  	   -­‐1.8213250	  
H	   1	   0.5529442	  	   1.6921151	  	   -­‐1.9932739	  
H	   1	   	  -­‐0.0489088	  	   0.0559450	  	   -­‐2.2683874	  
H	   1	   1.7005015	  	   0.3804069	  	   -­‐2.3289710	  
C	   6	   4.2587311	  	   0.3077303	  	   0.3892907	  
H	   1	   4.2579340	  	   1.0236861	  	   1.2171601	  
H	   1	   5.1114274	  	   0.4964859	  	   -­‐0.2655344	  
H	   1	   4.3116646	  	   -­‐0.7120693	  	   0.7833482	  
N	   7	   -­‐0.3059603	  	   0.2309312	  	   1.9120659	  
H	   1	   0.4950551	  	   -­‐0.3408744	  	   2.1928522	  
O	   8	   0.1331940	  	   1.5685075	  	   2.2559190	  
H	   1	   -­‐0.6539719	  	   1.9339646	  	   2.6961316	  
C	   6	   -­‐3.8753482	  	   0.4365458	  	   -­‐0.9385315	  
H	   1	   -­‐3.9564017	  	   1.5227103	  	   -­‐0.9778217	  
H	   1	   -­‐4.6524413	  	   0.0331807	  	   -­‐0.2843899	  
H	   1	   -­‐4.0015319	  	   0.0213463	  	   -­‐1.9414587	  
	  
	  
Table	   3-­‐31.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐3	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   32	  	   0.43	   28	  	   690	  	   3.91	   55	  	   1484	  	   5.55	  
2	  	   55	  	   1.01	   29	  	   755	  	   35.08	   56	  	   1493	  	   10.18	  
3	  	   75	  	   2.16	   30	  	   763	  	   8.43	   57	  	   1497	  	   21.20	  
4	  	   89	  	   4.99	   31	  	   860	  	   87.93	   58	  	   1501	  	   2.85	  
5	  	   94	  	   1.66	   32	  	   896	  	   147.81	   59	  	   1505	  	   7.99	  
6	  	   96	  	   2.61	   33	  	   930	  	   68.32	   60	  	   1514	  	   18.18	  
7	  	   109	  	   0.98	   34	  	   961	  	   27.47	   61	  	   1514	  	   16.64	  
8	  	   131	  	   3.03	   35	  	   1006	  	   7.31	   62	  	   1516	  	   1.66	  
	   155	  
9	  	   147	  	   7.03	   36	  	   1025	  	   17.00	   63	  	   1532	  	   28.44	  
10	  	   162	  	   4.20	   37	  	   1031	  	   62.72	   64	  	   1541	  	   14.90	  
11	  	   165	  	   4.78	   38	  	   1045	  	   24.87	   65	  	   1676	  	   140.74	  
12	  	   171	  	   2.10	   39	  	   1056	  	   324.32	   66	  	   1687	  	   492.57	  
13	  	   207	  	   7.90	   40	  	   1067	  	   59.43	   67	  	   1771	  	   20.29	  
14	  	   246	  	   10.64	   41	  	   1082	  	   14.25	   68	  	   3064	  	   3.51	  
15	  	   267	  	   35.38	   42	  	   1094	  	   14.86	   69	  	   3064	  	   108.06	  
16	  	   299	  	   10.54	   43	  	   1177	  	   2.90	   70	  	   3072	  	   5.21	  
17	  	   311	  	   5.07	   44	  	   1181	  	   2.21	   71	  	   3089	  	   60.87	  
18	  	   325	  	   2.02	   45	  	   1211	  	   15.68	   72	  	   3122	  	   6.79	  
19	  	   345	  	   106.84	   46	  	   1227	  	   33.61	   73	  	   3131	  	   8.66	  
20	  	   361	  	   8.81	   47	  	   1253	  	   101.70	   74	  	   3137	  	   48.09	  
21	  	   394	  	   6.47	   48	  	   1286	  	   8.41	   75	  	   3159	  	   16.07	  
22	  	   421	  	   26.24	   49	  	   1306	  	   78.29	   76	  	   3169	  	   8.34	  
23	  	   496	  	   28.87	   50	  	   1381	  	   65.60	   77	  	   3178	  	   23.83	  
24	  	   510	  	   5.90	   51	  	   1424	  	   86.86	   78	  	   3179	  	   2.32	  
25	  	   576	  	   20.50	   52	  	   1427	  	   54.09	   79	  	   3198	  	   2.37	  
26	  	   598	  	   36.28	   53	  	   1444	  	   37.42	   80	  	   3444	  	   39.50	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   -­‐757.331535	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  464.0413	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   Not	  a	  ground	  state	  structure;	  HNO	  is	  dissociated	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.0872656	   0.0684498	   0.3658208	  
C	   6	   1.2979246	   0.8315112	   0.6024001	  
N	   7	   2.2709033	   -­‐0.1340585	   0.8091683	  
N	   7	   1.7938754	   -­‐1.4257887	   0.6464609	  
C	   6	   0.4940703	   -­‐1.3033009	   0.4319634	  
O	   8	   1.5440824	   2.0742055	   0.6299941	  
C	   6	   -­‐0.3294275	   -­‐2.5357479	   0.2448249	  
H	   1	   -­‐0.8626694	   -­‐2.5103062	   -­‐0.7120475	  
N
N
O HN N O
O–
HAPY-3anion
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H	   1	   -­‐1.0951830	   -­‐2.6341128	   1.0212262	  
H	   1	   0.3249818	   -­‐3.4125133	   0.2697758	  
C	   6	   -­‐1.2538124	   0.6009183	   0.2050941	  
N	   7	   -­‐2.2474037	   -­‐0.2369475	   0.2378647	  
O	   8	   -­‐3.4847387	   0.4384561	   0.0169207	  
C	   6	   -­‐1.4615905	   2.0784945	   -­‐0.0155002	  
H	   1	   -­‐1.8421149	   2.2501671	   -­‐1.0297131	  
H	   1	   -­‐0.5288079	   2.6242506	   0.1236331	  
H	   1	   -­‐2.2265246	   2.4587568	   0.6691172	  
C	   6	   -­‐4.5355779	   -­‐0.5268662	   0.0480426	  
H	   1	   -­‐4.4116873	   -­‐1.2760519	   -­‐0.7425309	  
H	   1	   -­‐5.4553654	   0.0384819	   -­‐0.1200850	  
H	   1	   -­‐4.5839222	   -­‐1.0334565	   1.0190078	  
N	   7	   0.9485974	   0.2827475	   -­‐2.1685213	  
H	   1	   1.2896092	   1.2103046	   -­‐1.7895147	  
O	   8	   1.9250200	   -­‐0.4569775	   -­‐2.3279562	  
C	   6	   3.6978831	   0.1061294	   0.7552683	  
H	   1	   3.8761549	   1.1392343	   1.0567862	  
H	   1	   4.0857019	   -­‐0.0473567	   -­‐0.2594004	  
H	   1	   4.2126989	   -­‐0.5720706	   1.4397845	  
	  
	  
Table	   3-­‐33.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐3anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   29	   0.25	   27	   616	   73.08	   53	   1490	   576.63	  
2	   38	   0.42	   28	   665	   36.57	   54	   1492	   24.13	  
3	   52	   0.35	   29	   682	   15.63	   55	   1499	   3.12	  
4	   70	   3.26	   30	   755	   20.87	   56	   1502	   22.45	  
5	   86	   7.65	   31	   766	   15.27	   57	   1516	   37.33	  
6	   93	   12.20	   32	   870	   353.72	   58	   1525	   107.40	  
7	   111	   14.29	   33	   945	   30.05	   59	   1534	   36.54	  
8	   121	   4.40	   34	   1007	   15.24	   60	   1535	   21.37	  
9	   126	   14.51	   35	   1023	   16.04	   61	   1539	   14.14	  
10	   152	   7.67	   36	   1053	   238.06	   62	   1560	   92.75	  
11	   155	   1.58	   37	   1055	   137.41	   63	   1571	   528.20	  
12	   164	   1.70	   38	   1069	   4.81	   64	   1581	   98.10	  
13	   207	   0.17	   39	   1074	   3.10	   65	   1627	   185.42	  
14	   227	   1.71	   40	   1101	   102.31	   66	   2976	   35.41	  
15	   246	   38.60	   41	   1153	   6.63	   67	   3046	   159.94	  
16	   251	   15.09	   42	   1172	   3.49	   68	   3057	   117.23	  
17	   269	   16.85	   43	   1185	   53.54	   69	   3063	   38.81	  
18	   310	   6.36	   44	   1219	   4.99	   70	   3065	   22.68	  
19	   331	   30.82	   45	   1267	   29.93	   71	   3109	   69.76	  
	   157	  
20	   357	   6.31	   46	   1351	   74.95	   72	   3120	   18.55	  
21	   383	   1.90	   47	   1397	   89.78	   73	   3121	   22.07	  
22	   396	   0.51	   48	   1424	   26.41	   74	   3137	   39.41	  
23	   450	   27.37	   49	   1438	   28.86	   75	   3143	   37.69	  
24	   561	   2.89	   50	   1452	   62.57	   76	   3165	   28.54	  
25	   581	   79.57	   51	   1461	   603.10	   77	   3181	   3.45	  




Table	  3-­‐34.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐4	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐419.379039	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  326.8122	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐263086.0114	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.7239106	  	   0.3076125	  	   0.1668687	  
C	   6	   -­‐0.4797297	  	   0.9893448	  	   0.0611517	  
N	   7	   -­‐1.4518539	  	   0.1006997	  	   -­‐0.2659170	  
N	   7	   -­‐0.9444521	  	   -­‐1.1698650	  	   -­‐0.3642765	  
C	   6	   0.3630098	  	   -­‐1.0341897	  	   -­‐0.1147889	  
C	   6	   2.0774420	  	   0.8678795	  	   0.4864347	  
H	   1	   2.0064582	  	   1.7868117	  	   1.0807486	  
H	   1	   2.6628199	  	   1.1043045	  	   -­‐0.4117460	  
H	   1	   2.6669962	  	   0.1594699	  	   1.0786204	  
C	   6	   1.2681189	  	   -­‐2.2242216	  	   -­‐0.1518605	  
H	   1	   1.7798839	  	   -­‐2.3719851	  	   0.8071372	  
H	   1	   2.0468256	  	   -­‐2.1164824	  	   -­‐0.9165081	  
H	   1	   0.6943423	  	   -­‐3.1281054	  	   -­‐0.3739173	  
O	   8	   -­‐0.8208944	  	   2.2996057	  	   0.2353313	  
N	   7	   -­‐0.0007461	  	   2.8220369	  	   0.3208369	  
C	   6	   -­‐2.8777055	  	   0.3539588	  	   -­‐0.3810899	  
H	   1	   -­‐3.0322903	  	   1.3816949	  	   -­‐0.7114779	  
H	   1	   -­‐3.3901363	  	   0.2037703	  	   0.5747163	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Table	   3-­‐35.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐4	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   30	  	   0.12	   18	  	   857	  	   10.77	   35	  	   1510	  	   32.30	  
2	  	   66	  	   0.39	   19	  	   1004	  	   62.18	   36	  	   1516	  	   8.48	  
3	  	   115	  	   0.75	   20	  	   1015	  	   5.22	   37	  	   1524	  	   1.77	  
4	  	   119	  	   15.42	   21	  	   1063	  	   4.76	   38	  	   1529	  	   15.73	  
5	  	   168	  	   13.50	   22	  	   1076	  	   6.54	   39	  	   1535	  	   23.22	  
6	  	   203	  	   105.04	   23	  	   1087	  	   10.50	   40	  	   1567	  	   122.04	  
7	  	   229	  	   4.67	   24	  	   1121	  	   195.15	   41	  	   1632	  	   156.41	  
8	  	   272	  	   10.59	   25	  	   1193	  	   14.57	   42	  	   3044	  	   62.38	  
9	  	   284	  	   20.48	   26	  	   1225	  	   62.64	   43	  	   3052	  	   44.96	  
10	  	   291	  	   10.71	   27	  	   1285	  	   28.68	   44	  	   3082	  	   74.81	  
11	  	   371	  	   0.39	   28	  	   1311	  	   75.92	   45	  	   3096	  	   36.96	  
12	  	   556	  	   12.39	   29	  	   1415	  	   98.14	   46	  	   3104	  	   17.12	  
13	  	   569	  	   12.08	   30	  	   1429	  	   121.29	   47	  	   3116	  	   32.00	  
14	  	   603	  	   5.57	   31	  	   1449	  	   4.10	   48	  	   3145	  	   24.36	  
15	  	   650	  	   1.56	   32	  	   1472	  	   36.42	   49	  	   3162	  	   15.88	  
16	  	   693	  	   4.09	   33	  	   1500	  	   33.51	   50	  	   3198	  	   5.90	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐418.909769	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  295.4126	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐262799.0449	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6948843	  	   0.4201498	  	   0.3085493	  
C	   6	   -­‐0.5340356	  	   1.1247330	  	   0.3729937	  
N	   7	   -­‐1.4609388	  	   0.2467705	  	   -­‐0.1885770	  
N	   7	   -­‐0.9021361	  	   -­‐0.9531029	  	   -­‐0.5911495	  
C	   6	   0.3964831	  	   -­‐0.8238997	  	   -­‐0.2842223	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H	   1	   2.7450431	  	   1.0826949	  	   -­‐0.0254231	  
H	   1	   2.4948658	  	   0.2822624	  	   1.5236082	  
H	   1	   1.8706660	  	   1.9177436	  	   1.2637127	  
C	   6	   1.3446436	  	   -­‐1.9423536	  	   -­‐0.5820399	  
H	   1	   1.8475834	  	   -­‐2.3007844	  	   0.3257564	  
H	   1	   2.1345081	  	   -­‐1.6316254	  	   -­‐1.2786021	  
H	   1	   0.8043331	  	   -­‐2.7826340	  	   -­‐1.0294037	  
O	   8	   -­‐0.8380649	  	   2.2909054	  	   0.8184417	  
C	   6	   -­‐2.8782399	  	   0.4783549	  	   -­‐0.3305169	  
H	   1	   -­‐3.1917360	  	   0.3955491	  	   -­‐1.3775224	  
H	   1	   -­‐3.0777956	  	   1.4898056	  	   0.0286376	  
H	   1	   -­‐3.4647051	  	   -­‐0.2358636	  	   0.2599628	  
	  
	  
Table	   3-­‐37.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐4anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   58	  	   2.80	   17	  	   884	  	   7.23	   33	  	   1509	  	   185.01	  
2	  	   74	  	   0.12	   18	  	   994	  	   39.45	   34	  	   1521	  	   20.79	  
3	  	   119	  	   0.48	   19	  	   1016	  	   12.97	   35	  	   1521	  	   5.53	  
4	  	   129	  	   10.05	   20	  	   1055	  	   29.31	   36	  	   1523	  	   24.16	  
5	  	   165	  	   0.91	   21	  	   1060	  	   3.22	   37	  	   1538	  	   141.29	  
6	  	   203	  	   10.83	   22	  	   1080	  	   1.17	   38	  	   1556	  	   131.94	  
7	  	   257	  	   0.42	   23	  	   1155	  	   86.10	   39	  	   1585	  	   315.63	  
8	  	   260	  	   16.92	   24	  	   1191	  	   1.87	   40	  	   3013	  	   158.50	  
9	  	   296	  	   9.46	   25	  	   1259	  	   72.87	   41	  	   3044	  	   97.53	  
10	  	   367	  	   4.57	   26	  	   1308	  	   79.07	   42	  	   3047	  	   72.14	  
11	  	   569	  	   39.99	   27	  	   1388	  	   96.05	   43	  	   3053	  	   130.48	  
12	  	   592	  	   12.01	   28	  	   1419	  	   2.92	   44	  	   3089	  	   31.87	  
13	  	   612	  	   5.33	   29	  	   1429	  	   24.21	   45	  	   3098	  	   42.31	  
14	  	   650	  	   0.93	   30	  	   1458	  	   77.28	   46	  	   3104	  	   53.41	  
15	  	   738	  	   10.41	   31	  	   1480	  	   209.44	   47	  	   3134	  	   34.36	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐549.89706	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  376.6585	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐344975.3307	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6674974	  	   -­‐0.0312016	  	   0.2081174	  
C	   6	   -­‐0.5732141	  	   0.8736346	  	   0.1660289	  
N	   7	   -­‐1.6275977	  	   0.0417863	  	   -­‐0.0540181	  
N	   7	   -­‐1.2521411	  	   -­‐1.3016038	  	   -­‐0.2243723	  
C	   6	   0.0305132	  	   -­‐1.3773154	  	   -­‐0.1035355	  
O	   8	   -­‐0.6244446	  	   2.1023471	  	   0.3060451	  
C	   6	   1.3235318	  	   -­‐0.0041299	  	   1.5958698	  
H	   1	   1.6603111	  	   1.0093295	  	   1.8223900	  
H	   1	   2.1868379	  	   -­‐0.6764463	  	   1.6180184	  
H	   1	   0.6187408	  	   -­‐0.3236712	  	   2.3701152	  
N	   7	   1.5557045	  	   0.3364823	  	   -­‐0.9185137	  
H	   1	   2.3018885	  	   -­‐0.3652952	  	   -­‐0.9494583	  
O	   8	   2.2909875	  	   1.5422003	  	   -­‐0.5842923	  
H	   1	   1.8345244	  	   2.2194901	  	   -­‐1.1112639	  
C	   6	   0.7597784	  	   -­‐2.6674931	  	   -­‐0.2355038	  
H	   1	   1.3401742	  	   -­‐2.8860519	  	   0.6681470	  
H	   1	   1.4646004	  	   -­‐2.6380902	  	   -­‐1.0757288	  
H	   1	   0.0514905	  	   -­‐3.4807230	  	   -­‐0.4081954	  
C	   6	   -­‐3.0238089	  	   0.4081661	  	   -­‐0.1969990	  
H	   1	   -­‐3.6343621	  	   -­‐0.1292852	  	   0.5327235	  
H	   1	   -­‐3.3819217	  	   0.1733043	  	   -­‐1.2030979	  
H	   1	   -­‐3.1037844	  	   1.4811849	  	   -­‐0.0224786	  
	  
	  
Table	   3-­‐39.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐4	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   62	  	   5.71	   21	  	   760	  	   22.89	   41	  	   1492	  	   18.15	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3	  	   97	  	   15.63	   23	  	   891	  	   19.29	   43	  	   1509	  	   9.81	  
4	  	   130	  	   5.37	   24	  	   939	  	   25.60	   44	  	   1513	  	   11.24	  
5	  	   139	  	   12.94	   25	  	   965	  	   31.05	   45	  	   1521	  	   1.88	  
6	  	   168	  	   0.28	   26	  	   1024	  	   47.74	   46	  	   1532	  	   8.00	  
7	  	   206	  	   69.21	   27	  	   1033	  	   3.95	   47	  	   1543	  	   18.21	  
8	  	   214	  	   24.00	   28	  	   1052	  	   29.65	   48	  	   1669	  	   210.81	  
9	  	   248	  	   4.68	   29	  	   1067	  	   70.06	   49	  	   1677	  	   448.01	  
10	  	   256	  	   6.15	   30	  	   1138	  	   3.80	   50	  	   3062	  	   10.19	  
11	  	   270	  	   26.74	   31	  	   1158	  	   29.01	   51	  	   3075	  	   17.46	  
12	  	   311	  	   14.92	   32	  	   1179	  	   2.57	   52	  	   3087	  	   61.46	  
13	  	   328	  	   13.61	   33	  	   1248	  	   113.47	   53	  	   3119	  	   7.11	  
14	  	   357	  	   4.13	   34	  	   1259	  	   24.02	   54	  	   3144	  	   21.22	  
15	  	   409	  	   11.21	   35	  	   1335	  	   51.97	   55	  	   3156	  	   18.41	  
16	  	   575	  	   20.86	   36	  	   1372	  	   51.17	   56	  	   3165	  	   13.26	  
17	  	   585	  	   40.67	   37	  	   1423	  	   31.30	   57	  	   3166	  	   10.87	  
18	  	   610	  	   6.67	   38	  	   1427	  	   80.26	   58	  	   3196	  	   3.16	  
19	  	   622	  	   3.76	   39	  	   1447	  	   60.59	   59	  	   3433	  	   19.99	  
20	  	   742	  	   14.36	   40	  	   1473	  	   18.53	   60	  	   3722	  	   104.49	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐549.389029	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  341.0871	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐344665.0384	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.5432454	  	   -­‐0.5334428	  	   -­‐0.1322298	  
C	   6	   -­‐0.9702601	  	   0.9245379	  	   -­‐0.0008716	  
N	   7	   0.1330444	  	   1.5965676	  	   0.4273200	  
N	   7	   1.2815950	  	   0.7911809	  	   0.4877507	  
C	   6	   0.9364003	  	   -­‐0.4052621	  	   0.1425796	  
C	   6	   1.9247615	  	   -­‐1.5166368	  	   0.1202060	  
H	   1	   1.6515057	  	   -­‐2.2897245	  	   0.8499816	  
H	   1	   2.9192178	  	   -­‐1.1352786	  	   0.3647358	  
H	   1	   1.9565019	  	   -­‐1.9975274	  	   -­‐0.8639804	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C	   6	   -­‐0.9161180	  	   -­‐1.1262694	  	   -­‐1.4855654	  
H	   1	   -­‐1.9989014	  	   -­‐1.2813192	  	   -­‐1.4884047	  
H	   1	   -­‐0.4254366	  	   -­‐2.0958613	  	   -­‐1.6238354	  
H	   1	   -­‐0.6334576	  	   -­‐0.4761163	  	   -­‐2.3209763	  
N	   7	   -­‐1.1508515	  	   -­‐1.3030395	  	   1.0646519	  
H	   1	   -­‐0.6697767	  	   -­‐2.2196969	  	   0.9409594	  
O	   8	   -­‐2.5348735	  	   -­‐1.5291215	  	   0.8861759	  
C	   6	   0.2612520	  	   3.0212057	  	   0.6709507	  
H	   1	   0.6104355	  	   3.2039516	  	   1.6910040	  
H	   1	   -­‐0.7237901	  	   3.4685721	  	   0.5351626	  
H	   1	   0.9684468	  	   3.4690483	  	   -­‐0.0330666	  
	  
	  
Table	   3-­‐41.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐4anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   64	  	   11.66	   20	  	   752	  	   18.12	   39	  	   1471	  	   44.92	  
2	  	   79	  	   0.35	   21	  	   803	  	   29.37	   40	  	   1493	  	   10.98	  
3	  	   113	  	   14.69	   22	  	   862	  	   11.13	   41	  	   1496	  	   22.44	  
4	  	   123	  	   8.82	   23	  	   943	  	   87.51	   42	  	   1500	  	   3.16	  
5	  	   144	  	   7.52	   24	  	   968	  	   36.52	   43	  	   1512	  	   9.09	  
6	  	   169	  	   17.18	   25	  	   1022	  	   13.81	   44	  	   1529	  	   4.51	  
7	  	   177	  	   1.22	   26	  	   1036	  	   18.10	   45	  	   1540	  	   15.22	  
8	  	   247	  	   10.61	   27	  	   1049	  	   7.19	   46	  	   1661	  	   308.37	  
9	  	   253	  	   5.87	   28	  	   1066	  	   36.65	   47	  	   1674	  	   385.58	  
10	  	   268	  	   18.82	   29	  	   1117	  	   22.19	   48	  	   3057	  	   13.43	  
11	  	   296	  	   5.49	   30	  	   1164	  	   24.59	   49	  	   3059	  	   46.02	  
12	  	   312	  	   10.33	   31	  	   1169	  	   8.31	   50	  	   3082	  	   81.05	  
13	  	   357	  	   2.93	   32	  	   1248	  	   87.60	   51	  	   3103	  	   106.21	  
14	  	   403	  	   14.07	   33	  	   1270	  	   17.28	   52	  	   3115	  	   12.91	  
15	  	   559	  	   80.55	   34	  	   1344	  	   73.82	   53	  	   3130	  	   23.45	  
16	  	   580	  	   23.97	   35	  	   1405	  	   14.88	   54	  	   3136	  	   29.82	  
17	  	   587	  	   25.07	   36	  	   1419	  	   116.74	   55	  	   3150	  	   21.38	  
18	  	   608	  	   2.36	   37	  	   1432	  	   7.13	   56	  	   3164	  	   12.21	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Table	  3-­‐42.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐5	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐588.01246	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  391.2127	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐368889.6087	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.7796140	  	   -­‐0.3777535	  	   0.2542232	  
C	   6	   -­‐1.9453394	  	   0.2748677	  	   -­‐0.1660934	  
N	   7	   -­‐2.9923681	  	   -­‐0.4228846	  	   0.3037214	  
N	   7	   -­‐2.6007109	  	   -­‐1.5228842	  	   1.0285410	  
C	   6	   -­‐1.2689904	  	   -­‐1.4983019	  	   0.9991359	  
C	   6	   -­‐0.5179078	  	   -­‐2.5821689	  	   1.7071310	  
H	   1	   0.1771001	  	   -­‐2.1794777	  	   2.4508123	  
H	   1	   0.0651319	  	   -­‐3.1963464	  	   1.0118701	  
H	   1	   -­‐1.2293269	  	   -­‐3.2349895	  	   2.2194956	  
C	   6	   0.5625838	  	   0.0947998	  	   -­‐0.0654699	  
N	   7	   0.6005916	  	   1.1785570	  	   -­‐0.7819402	  
O	   8	   1.9024583	  	   1.6315985	  	   -­‐1.0718533	  
C	   6	   1.7789790	  	   -­‐0.6378384	  	   0.4248813	  
H	   1	   2.6880788	  	   -­‐0.2318612	  	   -­‐0.0157719	  
H	   1	   1.7070153	  	   -­‐1.7017436	  	   0.1834914	  
H	   1	   1.8532190	  	   -­‐0.5578960	  	   1.5152806	  
C	   6	   1.8123587	  	   2.8012924	  	   -­‐1.8889049	  
H	   1	   1.3134307	  	   2.5834523	  	   -­‐2.8397091	  
H	   1	   2.8447020	  	   3.1032234	  	   -­‐2.0761727	  
H	   1	   1.2811750	  	   3.6065311	  	   -­‐1.3696061	  
H	   1	   -­‐3.9754845	  	   -­‐0.2111343	  	   0.1749576	  
O	   8	   -­‐2.1036530	  	   1.3941550	  	   -­‐0.8999366	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Table	   3-­‐43.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐5	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   33	  	   1.51	   22	  	   725	  	   5.67	   43	  	   1492	  	   35.93	  
2	  	   73	  	   3.95	   23	  	   755	  	   36.43	   44	  	   1500	  	   21.15	  
3	  	   107	  	   0.52	   24	  	   785	  	   16.05	   45	  	   1507	  	   7.11	  
4	  	   123	  	   2.06	   25	  	   909	  	   216.01	   46	  	   1508	  	   1.77	  
5	  	   131	  	   0.92	   26	  	   1002	  	   24.90	   47	  	   1523	  	   50.13	  
6	  	   171	  	   3.39	   27	  	   1005	  	   63.80	   48	  	   1525	  	   54.39	  
7	  	   215	  	   0.07	   28	  	   1060	  	   163.27	   49	  	   1533	  	   37.65	  
8	  	   223	  	   0.04	   29	  	   1066	  	   223.66	   50	  	   1550	  	   131.23	  
9	  	   249	  	   0.79	   30	  	   1073	  	   1.80	   51	  	   1615	  	   435.28	  
10	   	  296	  	   21.67	   31	  	   1086	  	   19.87	   52	  	   1651	  	   167.08	  
11	  	   328	  	   7.62	   32	  	   1108	  	   23.57	   53	  	   3054	  	   113.57	  
12	  	   349	  	   0.89	   33	  	   1143	  	   17.99	   54	  	   3068	  	   23.25	  
13	  	   359	  	   4.65	   34	  	   1179	  	   2.41	   55	  	   3080	  	   9.26	  
14	  	   408	  	   3.20	   35	  	   1220	  	   9.79	   56	  	   3122	  	   52.40	  
15	  	   446	  	   41.41	   36	  	   1255	  	   97.67	   57	  	   3126	  	   13.45	  
16	  	   469	  	   116.89	   37	  	   1332	  	   8.36	   58	  	   3143	  	   7.08	  
17	  	   543	  	   0.05	   38	  	   1408	  	   16.76	   59	  	   3151	  	   25.27	  
18	  	   562	  	   6.51	   39	  	   1422	  	   69.35	   60	  	   3173	  	   24.30	  
19	  	   598	  	   29.48	   40	  	   1443	  	   303.53	   61	  	   3196	  	   12.22	  
20	  	   651	  	   87.10	   41	  	   1444	  	   38.59	   62	  	   3283	  	   690.65	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐587.534096	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  355.5968	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.9483545	  	   -­‐0.3252580	  	   0.0668253	  
C	   6	   -­‐2.1846271	  	   0.1432293	  	   -­‐0.5021595	  
N	   7	   -­‐3.1384302	  	   -­‐0.6311003	  	   0.1334290	  
N	   7	   -­‐2.6370704	  	   -­‐1.4981195	  	   1.0830477	  
C	   6	   -­‐1.3204277	  	   -­‐1.3236420	  	   1.0236699	  
C	   6	   -­‐0.4654010	  	   -­‐2.1160239	  	   1.9658167	  
H	   1	   0.2809817	  	   -­‐1.4861849	  	   2.4619818	  
H	   1	   0.0770980	  	   -­‐2.9264504	  	   1.4635803	  
H	   1	   -­‐1.1049322	  	   -­‐2.5689024	  	   2.7294542	  
C	   6	   0.3836614	  	   0.1477886	  	   -­‐0.2655238	  
N	   7	   0.5156371	  	   1.3758495	  	   -­‐0.6825143	  
O	   8	   1.8876679	  	   1.6383713	  	   -­‐1.0335552	  
C	   6	   1.5703995	  	   -­‐0.7831263	  	   -­‐0.1645514	  
H	   1	   2.1621629	  	   -­‐0.7238259	  	   -­‐1.0832846	  
H	   1	   1.2539988	  	   -­‐1.8141342	  	   -­‐0.0125523	  
H	   1	   2.2395566	  	   -­‐0.4913326	  	   0.6536921	  
C	   6	   1.9763834	  	   2.9738319	  	   -­‐1.5184447	  
H	   1	   1.3645221	  	   3.1178585	  	   -­‐2.4176107	  
H	   1	   3.0310281	  	   3.1285861	  	   -­‐1.7611115	  
H	   1	   1.6628257	  	   3.6998679	  	   -­‐0.7582788	  
H	   1	   -­‐4.1403707	  	   -­‐0.5409830	  	   0.0115610	  
O	   8	   -­‐2.4663093	  	   1.0037002	  	   -­‐1.3934711	  
	  
	  
Table	   3-­‐45.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐5anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   41	  	   3.17	   21	  	   737	  	   21.79	   41	  	   1483	  	   257.20	  
2	  	   86	  	   7.80	   22	  	   773	  	   25.41	   42	  	   1492	  	   5.80	  
3	  	   99	  	   0.09	   23	  	   806	  	   32.93	   43	  	   1498	  	   6.04	  
4	  	   103	  	   4.21	   24	  	   847	  	   323.79	   44	  	   1509	  	   28.56	  
5	  	   133	  	   0.56	   25	  	   993	  	   110.63	   45	  	   1510	  	   61.13	  
6	  	   148	  	   8.07	   26	  	   1005	  	   3.48	   46	  	   1519	  	   20.35	  
7	  	   182	  	   3.67	   27	  	   1052	  	   38.09	   47	  	   1539	  	   36.47	  
8	  	   203	  	   0.51	   28	  	   1055	  	   157.99	   48	  	   1547	  	   504.23	  
9	  	   239	  	   25.51	   29	  	   1071	  	   0.92	   49	  	   1552	  	   392.07	  
10	  	   274	  	   3.42	   30	  	   1082	  	   60.04	   50	  	   1618	  	   333.90	  
11	  	   287	  	   2.61	   31	  	   1100	  	   114.19	   51	  	   3039	  	   159.00	  
12	  	   329	  	   7.24	   32	  	   1117	  	   0.90	   52	  	   3056	  	   49.27	  
13	  	   363	  	   13.12	   33	  	   1186	  	   2.00	   53	  	   3073	  	   19.85	  
14	  	   406	  	   12.73	   34	  	   1209	  	   7.52	   54	  	   3098	  	   79.21	  
15	  	   433	  	   63.34	   35	  	   1246	  	   4.95	   55	  	   3109	  	   22.57	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16	  	   455	  	   74.50	   36	  	   1353	  	   24.10	   56	  	   3125	  	   18.20	  
17	  	   552	  	   2.95	   37	  	   1396	  	   97.12	   57	  	   3141	  	   35.87	  
18	  	   590	  	   24.77	   38	  	   1416	  	   5.53	   58	  	   3157	  	   28.06	  
19	  	   622	  	   13.95	   39	  	   1437	  	   42.64	   59	  	   3194	  	   20.16	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐718.508674	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  436.148	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐450766.4176	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.5488549	  	   -­‐0.0087294	  	   0.2966453	  
C	   6	   -­‐1.7267288	  	   0.8757830	  	   -­‐0.1846993	  
N	   7	   -­‐2.6779534	  	   -­‐0.0082044	  	   -­‐0.5827926	  
N	   7	   -­‐2.3182464	  	   -­‐1.3525688	  	   -­‐0.4735570	  
C	   6	   -­‐1.1275857	  	   -­‐1.4021806	  	   0.0163923	  
O	   8	   -­‐1.8059484	  	   2.1045011	  	   -­‐0.2029808	  
C	   6	   -­‐0.4319475	  	   -­‐2.6849130	  	   0.3024980	  
H	   1	   -­‐0.2620499	  	   -­‐2.7999768	  	   1.3802743	  
H	   1	   0.5480581	  	   -­‐2.7214621	  	   -­‐0.1847925	  
H	   1	   -­‐1.0404730	  	   -­‐3.5235534	  	   -­‐0.0422009	  
C	   6	   0.7253335	  	   0.2418650	  	   -­‐0.5083225	  
N	   7	   1.8124673	  	   0.1579845	  	   0.1660064	  
O	   8	   2.9570116	  	   0.3746046	  	   -­‐0.6178078	  
C	   6	   0.6149579	  	   0.5107946	  	   -­‐1.9809948	  
H	   1	   0.4563406	  	   1.5811067	  	   -­‐2.1591741	  
H	   1	   -­‐0.2388798	  	   -­‐0.0218305	  	   -­‐2.4111505	  
H	   1	   1.5247947	  	   0.2074508	  	   -­‐2.5007872	  
C	   6	   4.1211686	  	   0.2044737	  	   0.2004180	  
H	   1	   4.1264605	  	   0.9203995	  	   1.0283668	  
H	   1	   4.9672743	  	   0.3954420	  	   -­‐0.4623339	  
H	   1	   4.1810197	  	   -­‐0.8151659	  	   0.5942052	  
N	   7	   -­‐0.4365070	  	   0.1165113	  	   1.7602777	  
N
HN
O HN N O
OH
HAPY-5
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H	   1	   0.3653749	  	   -­‐0.4557015	  	   2.0371990	  
O	   8	   0.0025082	  	   1.4545650	  	   2.1033947	  
H	   1	   -­‐0.7771808	  	   1.8117802	  	   2.5632944	  
H	   1	   -­‐3.5892628	  	   0.2264404	  	   -­‐0.9620430	  
	  
	  
Table	   3-­‐47.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐5	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   22	  	   0.40	   25	  	   644	  	   10.62	   49	  	   1440	  	   3.70	  
2	  	   69	  	   0.50	   26	  	   751	  	   16.51	   50	  	   1482	  	   7.26	  
3	  	   84	  	   6.70	   27	  	   763	  	   29.93	   51	  	   1494	  	   10.68	  
4	  	   94	  	   2.24	   28	  	   771	  	   28.47	   52	  	   1498	  	   17.91	  
5	  	   107	  	   1.65	   29	  	   875	  	   73.80	   53	  	   1503	  	   1.40	  
6	  	   117	  	   1.96	   30	  	   898	  	   127.44	   54	  	   1504	  	   9.41	  
7	  	   146	  	   5.84	   31	  	   929	  	   99.14	   55	  	   1514	  	   8.33	  
8	  	   156	  	   1.31	   32	  	   997	  	   15.51	   56	  	   1515	  	   17.12	  
9	  	   161	  	   1.45	   33	  	   1012	  	   4.43	   57	  	   1532	  	   28.05	  
10	  	   169	  	   2.81	   34	  	   1029	  	   20.34	   58	  	   1683	  	   40.40	  
11	  	   195	  	   0.05	   35	  	   1047	  	   32.07	   59	  	   1699	  	   661.42	  
12	  	   251	  	   15.62	   36	  	   1056	  	   367.58	   60	  	   1768	  	   19.84	  
13	  	   277	  	   10.47	   37	  	   1079	  	   17.17	   61	  	   3063	  	   82.20	  
14	  	   309	  	   6.08	   38	  	   1082	  	   28.89	   62	  	   3064	  	   26.50	  
15	  	   319	  	   16.94	   39	  	   1103	  	   30.23	   63	  	   3069	  	   2.86	  
16	  	   342	  	   62.99	   40	  	   1178	  	   2.53	   64	  	   3121	  	   7.41	  
17	  	   353	  	   63.09	   41	  	   1195	  	   72.07	   65	  	   3130	  	   8.65	  
18	  	   407	  	   6.58	   42	  	   1210	  	   11.83	   66	  	   3136	  	   48.34	  
19	  	   415	  	   7.01	   43	  	   1284	  	   18.18	   67	  	   3168	  	   8.49	  
20	  	   468	  	   83.46	   44	  	   1297	  	   70.56	   68	  	   3175	  	   9.05	  
21	  	   512	  	   12.01	   45	  	   1306	  	   46.84	   69	  	   3177	  	   17.27	  
22	  	   518	  	   95.25	   46	  	   1380	  	   50.74	   70	  	   3445	  	   38.86	  
23	  	   584	  	   23.42	   47	  	   1401	  	   82.80	   71	  	   3596	  	   211.53	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   -­‐718.017094	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  390.2085	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   Not	  a	  ground	  state	  structure;	  HNO	  is	  dissociated	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.8897996	   -­‐0.0602097	   -­‐0.3755040	  
C	   6	   -­‐2.1403720	   0.4651086	   -­‐0.8926977	  
N	   7	   -­‐3.0637703	   -­‐0.4846269	   -­‐0.5049160	  
N	   7	   -­‐2.5341821	   -­‐1.5414715	   0.2082488	  
C	   6	   -­‐1.2334508	   -­‐1.2994091	   0.2584175	  
O	   8	   -­‐2.4449829	   1.5052057	   -­‐1.5492058	  
C	   6	   -­‐0.3454993	   -­‐2.2635734	   0.9760941	  
H	   1	   0.2079265	   -­‐1.7668265	   1.7814772	  
H	   1	   0.4048671	   -­‐2.6974744	   0.3078198	  
H	   1	   -­‐0.9566355	   -­‐3.0641779	   1.4038529	  
C	   6	   0.4293010	   0.5143274	   -­‐0.5686257	  
N	   7	   1.4619714	   -­‐0.2287839	   -­‐0.3027021	  
O	   8	   2.6739920	   0.5051555	   -­‐0.4851190	  
C	   6	   0.5677570	   1.9433334	   -­‐1.0322508	  
H	   1	   0.9590270	   2.5572568	   -­‐0.2119993	  
H	   1	   -­‐0.3948145	   2.3366768	   -­‐1.3580932	  
H	   1	   1.2964940	   2.0101347	   -­‐1.8460412	  
C	   6	   3.7715652	   -­‐0.3612935	   -­‐0.2023398	  
H	   1	   3.7404422	   -­‐0.7198888	   0.8332440	  
H	   1	   4.6678317	   0.2444917	   -­‐0.3563794	  
H	   1	   3.7865801	   -­‐1.2227483	   -­‐0.8803739	  
N	   7	   -­‐1.5177289	   1.3686555	   1.8136065	  
H	   1	   -­‐2.0739699	   1.9453067	   1.1192516	  
O	   8	   -­‐2.3087944	   0.7394192	   2.5201555	  







O HN N O
O–
HAPY-5anion
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Table	   3-­‐49.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐5anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   -­‐43	   9.32	   24	   592	   60.63	   47	   1477	   44.06	  
2	   -­‐23	   5.04	   25	   612	   46.13	   48	   1492	   422.03	  
3	   37	   0.02	   26	   673	   43.84	   49	   1494	   326.15	  
4	   69	   7.21	   27	   751	   4.92	   50	   1499	   9.72	  
5	   82	   6.97	   28	   758	   26.54	   51	   1505	   9.83	  
6	   85	   9.82	   29	   798	   48.47	   52	   1521	   122.49	  
7	   102	   5.76	   30	   873	   321.76	   53	   1532	   26.68	  
8	   116	   2.85	   31	   994	   75.95	   54	   1534	   28.44	  
9	   140	   13.05	   32	   1020	   7.15	   55	   1559	   137.63	  
10	   147	   6.69	   33	   1055	   315.63	   56	   1570	   66.82	  
11	   191	   13.72	   34	   1070	   5.24	   57	   1579	   581.46	  
12	   221	   26.61	   35	   1077	   3.01	   58	   1630	   193.38	  
13	   226	   33.74	   36	   1092	   85.53	   59	   2955	   46.71	  
14	   251	   14.40	   37	   1115	   3.85	   60	   3046	   154.17	  
15	   271	   24.63	   38	   1117	   51.06	   61	   3063	   41.50	  
16	   301	   2.37	   39	   1174	   2.32	   62	   3066	   24.39	  
17	   319	   7.10	   40	   1206	   4.41	   63	   3108	   70.93	  
18	   358	   23.17	   41	   1256	   28.29	   64	   3121	   23.51	  
19	   400	   4.16	   42	   1340	   54.49	   65	   3123	   21.35	  
20	   443	   57.34	   43	   1391	   78.61	   66	   3144	   35.69	  
21	   457	   38.81	   44	   1422	   34.21	   67	   3163	   28.67	  
22	   499	   46.78	   45	   1442	   65.03	   68	   3179	   2.18	  
23	   561	   6.17	   46	   1468	   506.54	   69	   3604	   125.20	  
	  
	  
Table	  3-­‐50.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐6	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐380.066128	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  257.5155	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐238433.3682	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	  	   6	   -­‐0.0012941	  	   -­‐0.6332998	  	   0.0008509	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N	   7	   -­‐0.7232614	  	   1.4601851	  	   -­‐0.0007344	  
N	   7	   0.6407509	  	   1.5700133	  	   -­‐0.0000300	  
C	   6	   1.0674297	  	   0.3027823	  	   -­‐0.0021440	  
H	   1	   -­‐1.3124565	  	   2.2840479	  	   -­‐0.0019890	  
C	   6	   2.5304030	  	   -­‐0.0053629	  	   -­‐0.0012923	  
H	   1	   2.8175404	  	   -­‐0.5974393	  	   0.8763593	  
H	   1	   3.1115569	  	   0.9207396	  	   0.0081250	  
H	   1	   2.8216184	  	   -­‐0.5834513	  	   -­‐0.8865503	  
C	   6	   0.0730538	  	   -­‐2.1305192	  	   0.0015701	  
H	   1	   -­‐0.8785170	  	   -­‐2.5844753	  	   0.3018988	  
H	   1	   0.8270675	  	   -­‐2.4916253	  	   0.7101548	  
H	   1	   0.3309510	   -­‐2.5403349	  	   -­‐0.9833823	  
O	   8	   -­‐2.4716296	  	   -­‐0.0968927	  	   0.0107040	  
H	   1	   -­‐2.5928740	  	   -­‐1.0596865	  	   -­‐0.0935414	  
	  
	  
Table	   3-­‐51.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐6	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   107	  	   0.54	   15	  	   770	  	   5.10	   29	  	   1508	  	   7.09	  
2	  	   149	  	   3.63	   16	  	   961	  	   28.59	   30	  	   1514	  	   17.49	  
3	  	   172	  	   20.86	   17	  	   1006	  	   63.24	   31	  	   1525	  	   4.11	  
4	  	   195	  	   120.92	   18	  	   1065	  	   1.53	   32	  	   1530	  	   3.01	  
5	  	   233	  	   2.14	   19	  	   1085	  	   2.57	   33	  	   1554	  	   192.56	  
6	  	   276	  	   23.17	   20	  	   1109	  	   147.03	   34	  	   1633	  	   158.23	  
7	  	   289	  	   6.36	   21	  	   1145	  	   18.46	   35	  	   3046	  	   55.26	  
8	  	   332	  	   28.88	   22	  	   1156	  	   98.10	   36	  	   3055	  	   38.10	  
9	  	   429	  	   66.66	   23	  	   1222	  	   40.20	   37	  	   3099	  	   39.21	  
10	  	   506	  	   25.80	   24	  	   1363	  	   93.42	   38	  	   3105	  	   14.06	  
11	  	   568	  	   15.16	   25	  	   1415	  	   117.86	   39	  	   3115	  	   37.48	  
12	  	   672	  	   9.45	   26	  	   1440	  	   34.55	   40	  	   3145	  	   24.02	  
13	  	   697	  	   5.55	   27	  	   1453	  	   3.72	   41	  	   3610	  	   244.42	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐379.595625	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  223.0236	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐238146.3671	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.5055753	  	   -­‐0.2929715	  	   0.0094368	  
C	   6	   -­‐1.6958443	  	   0.4786730	  	   0.0310258	  
N	   7	   -­‐1.2333856	  	   1.7879491	  	   0.0146000	  
N	   7	   0.1432923	  	   1.9066690	  	   -­‐0.0096111	  
C	   6	   0.5606684	  	   0.6332797	  	   -­‐0.0140311	  
H	   1	   -­‐1.8115821	  	   2.6192789	  	   0.0377488	  
C	   6	   2.0259655	  	   0.3327436	  	   -­‐0.0418937	  
H	   1	   2.3369844	  	   -­‐0.2536002	  	   0.8327180	  
H	   1	   2.5998043	  	   1.2649098	  	   -­‐0.0509318	  
H	   1	   2.3047904	  	   -­‐0.2504693	  	   -­‐0.9293832	  
C	   6	   -­‐0.4480373	  	   -­‐1.7892726	  	   0.0139251	  
H	   1	   -­‐1.4671978	  	   -­‐2.1918933	  	   0.0546738	  
H	   1	   0.0993244	  	   -­‐2.1976523	  	   0.8763337	  
H	   1	   0.0316277	  	   -­‐2.2078543	  	   -­‐0.8834214	  
O	   8	   -­‐2.9408349	  	   0.1602103	  	   0.0588103	  
	  
	  
Table	   3-­‐53.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐6anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   22	  	   1.49	   14	  	   792	  	   9.27	   27	  	   1506	  	   4.77	  
2	  	   98	  	   14.75	   15	  	   930	  	   27.34	   28	  	   1510	  	   158.45	  
3	  	   116	  	   19.85	   16	  	   988	  	   99.94	   29	  	   1521	  	   5.87	  
4	  	   154	  	   0.59	   17	  	   1059	  	   0.02	   30	  	   1522	  	   34.16	  
5	  	   213	  	   29.17	   18	  	   1079	  	   1.07	   31	  	   1538	  	   344.05	  
6	  	   256	  	   5.18	   19	  	   1100	  	   39.91	   32	  	   1589	  	   342.40	  
7	  	   282	  	   0.88	   20	  	   1151	  	   22.90	   33	  	   3016	  	   138.65	  
8	  	   431	  	   63.46	   21	  	   1182	  	   59.35	   34	  	   3044	  	   67.14	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10	  	   584	  	   39.29	   23	  	   1382	  	   52.25	   36	  	   3090	  	   31.54	  
11	  	   670	  	   15.41	   24	  	   1414	  	   41.68	   37	  	   3099	  	   42.34	  
12	  	   712	  	   4.09	   25	  	   1424	  	   13.72	   38	  	   3134	  	   33.88	  
13	  	   750	  	   4.88	   26	  	   1483	  	   201.85	   39	  	   3598	  	   78.35	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐510.583141	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  307.2283	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐320322.0869	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.1231117	  	   -­‐0.2841939	  	   -­‐0.2004076	  
C	   6	   -­‐0.5695334	  	   1.1804075	  	   -­‐0.0493404	  
N	   7	   0.5740192	  	   1.8688917	  	   0.2043141	  
N	   7	   1.7211724	  	   1.0733400	  	   0.3064389	  
C	   6	   1.3639491	  	   -­‐0.1497289	  	   0.1014574	  
H	   1	   0.6520336	  	   2.8642383	  	   0.3828779	  
C	   6	   2.3389161	  	   -­‐1.2732784	  	   0.1361728	  
H	   1	   2.0866292	  	   -­‐1.9919373	  	   0.9259469	  
H	   1	   3.3438520	  	   -­‐0.8908740	  	   0.3276289	  
H	   1	   2.3410928	  	   -­‐1.8205552	  	   -­‐0.8132553	  
O	   8	   -­‐1.7099599	  	   1.6472889	  	   -­‐0.1405069	  
C	   6	   -­‐0.3857942	  	   -­‐0.7933624	  	   -­‐1.6248209	  
H	   1	   -­‐1.4567545	  	   -­‐0.7631111	  	   -­‐1.8342776	  
H	   1	   -­‐0.0357026	  	   -­‐1.8250926	  	   -­‐1.7289102	  
H	   1	   0.1360561	  	   -­‐0.1775020	  	   -­‐2.3641289	  
N	   7	   -­‐0.7478580	  	   -­‐1.0779252	  	   0.8818552	  
H	   1	   -­‐0.3211791	  	   -­‐2.0090747	  	   0.8535154	  
O	   8	   -­‐2.1281272	  	   -­‐1.3655358	  	   0.5397668	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Table	   3-­‐55.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐6	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   72	  	   1.11	   18	  	   762	  	   20.41	   35	  	   1445	  	   3.26	  
2	  	   107	  	   11.46	   19	  	   772	  	   25.94	   36	  	   1494	  	   15.81	  
3	  	   146	  	   4.39	   20	  	   848	  	   43.93	   37	  	   1496	  	   12.60	  
4	  	   167	  	   0.16	   21	  	   889	  	   27.51	   38	  	   1505	  	   8.08	  
5	  	   211	  	   11.25	   22	  	   951	  	   45.77	   39	  	   1517	  	   6.96	  
6	  	   222	  	   3.03	   23	  	   995	  	   11.99	   40	  	   1528	  	   6.63	  
7	  	   248	  	   10.05	   24	  	   1033	  	   46.22	   41	  	   1678	  	   33.73	  
8	  	   259	  	   69.69	   25	  	   1055	  	   14.43	   42	  	   1687	  	   694.59	  
9	  	   297	  	   16.35	   26	  	   1092	  	   48.60	   43	  	   3062	  	   9.32	  
10	  	   328	  	   46.33	   27	  	   1130	  	   9.10	   44	  	   3075	  	   15.38	  
11	  	   345	  	   8.86	   28	  	   1160	  	   39.22	   45	  	   3117	  	   7.78	  
12	  	   425	  	   5.85	   29	  	   1216	  	   114.02	   46	  	   3145	  	   20.50	  
13	  	   496	  	   146.70	   30	  	   1308	  	   10.75	   47	  	   3164	  	   22.65	  
14	  	   561	  	   31.22	   31	  	   1333	  	   52.49	   48	  	   3164	  	   2.31	  
15	  	   582	  	   27.74	   32	  	   1371	  	   47.68	   49	  	   3432	  	   19.67	  
16	  	   629	  	   12.17	   33	  	   1402	  	   74.86	   50	  	   3596	  	   180.30	  
17	  	   719	  	   2.54	   34	  	   1433	  	   11.92	   51	  	   3723	  	   106.80	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐510.074697	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  271.0122	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐320011.6896	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.4927162	  	   0.0571893	  	   -­‐0.0258868	  
C	   6	   -­‐0.9209071	  	   1.5173689	  	   0.0957674	  
N	   7	   0.1644597	  	   2.1619140	  	   0.5993900	  
N	   7	   1.3110047	  	   1.3644929	  	   0.6975040	  
C	   6	   0.9744477	  	   0.1744040	  	   0.3220017	  
H	   1	   0.2596872	  	   3.1648622	  	   0.7270012	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H	   1	   1.6436007	  	   -­‐1.7258667	  	   1.0337293	  
H	   1	   2.9395489	  	   -­‐0.5716188	  	   0.6304642	  
H	   1	   2.0349519	  	   -­‐1.4081767	  	   -­‐0.6580721	  
O	   8	   -­‐2.0035828	  	   2.0417263	  	   -­‐0.1941132	  
C	   6	   -­‐0.8021749	  	   -­‐0.5218591	  	   -­‐1.4011459	  
H	   1	   -­‐1.8841000	  	   -­‐0.6740782	  	   -­‐1.4558142	  
H	   1	   -­‐0.3070144	  	   -­‐1.4910060	  	   -­‐1.5266485	  
H	   1	   -­‐0.4799470	  	   0.1354452	  	   -­‐2.2163044	  
N	   7	   -­‐1.1669328	  	   -­‐0.7167229	  	   1.1328865	  
H	   1	   -­‐0.6860714	  	   -­‐1.6357450	  	   1.0274271	  
O	   8	   -­‐2.5406521	  	   -­‐0.9295239	  	   0.8808598	  
	  
Table	   3-­‐57.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐6anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   76	  	   8.82	   17	  	   719	  	   7.34	   33	  	   1431	  	   19.99	  
2	  	   125	  	   12.45	   18	  	   780	  	   27.70	   34	  	   1455	  	   5.73	  
3	  	   145	  	   6.77	   19	  	   809	  	   53.11	   35	  	   1495	  	   14.89	  
4	  	   172	  	   4.57	   20	  	   865	  	   13.04	   36	  	   1496	  	   17.26	  
5	  	   185	  	   25.56	   21	  	   952	  	   87.88	   37	  	   1505	  	   3.94	  
6	  	   221	  	   7.30	   22	  	   994	  	   23.53	   38	  	   1531	  	   6.69	  
7	  	   262	  	   4.31	   23	  	   1038	  	   16.96	   39	  	   1670	  	   88.81	  
8	  	   292	  	   9.81	   24	  	   1051	  	   2.60	   40	  	   1682	  	   667.30	  
9	  	   297	  	   13.96	   25	  	   1089	  	   39.43	   41	  	   3058	  	   18.37	  
10	  	   327	  	   11.68	   26	  	   1112	  	   4.41	   42	  	   3059	  	   36.26	  
11	  	   411	  	   4.12	   27	  	   1166	  	   39.26	   43	  	   3101	  	   108.12	  
12	  	   466	  	   141.37	   28	  	   1218	  	   98.16	   44	  	   3115	  	   13.73	  
13	  	   552	  	   40.23	   29	  	   1316	  	   21.79	   45	  	   3130	  	   24.43	  
14	  	   572	  	   63.13	   30	  	   1342	  	   60.57	   46	  	   3135	  	   27.95	  
15	  	   584	  	   17.67	   31	  	   1391	  	   35.34	   47	  	   3164	  	   12.86	  
16	  	   686	  	   62.14	   32	  	   1408	  	   9.04	   48	  	   3582	  	   164.09	  
	  
	  
Table	  3-­‐58.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐7	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1070.713457	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  428.275	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.1469309	  	   0.1991542	  	   0.3509865	  
C	   6	   0.9368068	  	   0.8625249	  	   0.2877277	  
N	   7	   -­‐0.0503943	  	   -­‐0.0546695	  	   0.0203817	  
N	   7	   0.4953009	  	   -­‐1.3172743	  	   -­‐0.1063928	  
C	   6	   1.8016649	  	   -­‐1.1536564	  	   0.0909005	  
C	   6	   3.5008279	  	   0.7844591	  	   0.6203555	  
H	   1	   4.0244202	  	   1.0753723	  	   -­‐0.2990946	  
H	   1	   4.1407686	  	   0.0675226	  	   1.1452472	  
H	   1	   3.4403161	  	   1.6738718	  	   1.2589193	  
C	   6	   2.7273231	  	   -­‐2.3259204	  	   0.0367473	  
H	   1	   3.2532179	  	   -­‐2.4651693	  	   0.9890382	  
H	   1	   3.4927047	  	   -­‐2.1930456	  	   -­‐0.7366409	  
H	   1	   2.1694585	  	   -­‐3.2398206	  	   -­‐0.1827363	  
C	   6	   -­‐1.4435647	  	   0.1275925	  	   -­‐0.1706938	  
C	   6	   -­‐4.1867605	  	   0.4048679	  	   -­‐0.5628041	  
C	   6	   -­‐2.1664704	  	   -­‐0.8699977	  	   -­‐0.8394864	  
C	   6	   -­‐2.1117259	  	   1.2622779	  	   0.3084588	  
C	   6	   -­‐3.4836204	  	   1.4032004	  	   0.1042086	  
C	   6	   -­‐3.5375350	  	   -­‐0.7349192	  	   -­‐1.0326464	  
H	   1	   -­‐1.6449124	  	   -­‐1.7487209	  	   -­‐1.1959934	  
H	   1	   -­‐1.5713562	  	   2.0334560	  	   0.8389297	  
H	   1	   -­‐3.9991341	  	   2.2823034	  	   0.4738905	  
H	   1	   -­‐4.0937156	  	   -­‐1.5083043	  	   -­‐1.5501446	  
Cl	   17	   -­‐5.9270524	  	   0.5801524	  	   -­‐0.8146434	  
O	   8	   0.6272398	  	   2.1765554	  	   0.4300985	  
H	   1	   1.4592615	  	   2.6781875	  	   0.5353866	  
	  
Table	   3-­‐59.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐7	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   31	  	   2.54	   25	  	   708	  	   6.82	   49	  	   1440	  	   85.08	  
2	  	   44	  	   0.95	   26	  	   712	  	   24.19	   50	  	   1449	  	   19.47	  
3	  	   58	  	   0.91	   27	  	   747	  	   29.68	   51	  	   1454	  	   81.98	  
4	  	   98	  	   1.17	   28	  	   827	  	   5.20	   52	  	   1498	  	   82.49	  
5	  	   128	  	   0.86	   29	  	   833	  	   5.96	   53	  	   1500	  	   28.60	  
6	  	   137	  	   1.59	   30	  	   845	  	   52.12	   54	  	   1509	  	   13.56	  
7	  	   171	  	   8.02	   31	  	   960	  	   2.21	   55	  	   1518	  	   42.80	  
8	  	   224	  	   18.57	   32	  	   971	  	   0.90	   56	  	   1528	  	   65.32	  
9	  	   233	  	   66.59	   33	  	   977	  	   85.97	   57	  	   1536	  	   124.34	  
10	  	   254	  	   7.88	   34	  	   1025	  	   35.37	   58	  	   1546	  	   360.14	  
11	  	   260	  	   12.47	   35	  	   1029	  	   85.17	   59	  	   1630	  	   98.68	  
12	  	   286	  	   40.50	   36	  	   1063	  	   3.70	   60	  	   1643	  	   191.78	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13	  	   318	  	   3.92	   37	  	   1081	  	   2.01	   61	  	   1651	  	   14.55	  
14	  	   332	  	   5.01	   38	  	   1095	  	   85.71	   62	  	   3049	  	   60.60	  
15	  	   371	  	   1.71	   39	  	   1104	  	   45.85	   63	  	   3060	  	   38.99	  
16	  	   409	  	   0.82	   40	  	   1121	  	   107.44	   64	  	   3101	  	   29.35	  
17	  	   423	  	   0.73	   41	  	   1140	  	   7.31	   65	  	   3111	  	   14.96	  
18	  	   489	  	   72.68	   42	  	   1188	  	   30.69	   66	  	   3123	  	   25.41	  
19	  	   518	  	   10.88	   43	  	   1211	  	   0.17	   67	  	   3151	  	   19.93	  
20	  	   568	  	   26.19	   44	  	   1246	  	   108.70	   68	  	   3237	  	   3.78	  
21	  	   609	  	   3.66	   45	  	   1328	  	   39.76	   69	  	   3238	  	   2.91	  
22	  	   642	  	   0.23	   46	  	   1337	  	   23.93	   70	  	   3258	  	   0.51	  
23	  	   654	  	   1.34	   47	  	   1355	  	   50.24	   71	  	   3277	  	   1.90	  
24	  	   688	  	   4.67	   48	  	   1416	  	   314.96	   72	  	   3678	  	   254.39	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1070.252293	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  396.8443	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐671498.0981	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.1946860	   0.2838020	  	   0.4359125	  
C	   6	   0.9825510	  	   1.0062959	  	   0.4480322	  
N	   7	   0.0078511	  	   0.0632125	  	   0.0148065	  
N	   7	   0.5754042	  	   -­‐1.1816594	  	   -­‐0.2547642	  
C	   6	   1.8742019	  	   -­‐1.0192859	  	   0.0053024	  
C	   6	   3.5277727	  	   0.8483567	  	   0.8167531	  
H	   1	   4.2564484	  	   0.8221205	  	   -­‐0.0063419	  
H	   1	   3.9915539	  	   0.3201282	  	   1.6622015	  
H	   1	   3.4063037	  	   1.8967990	  	   1.1122662	  
C	   6	   2.8130204	  	   -­‐2.1694426	  	   -­‐0.1750890	  
H	   1	   3.3358874	  	   -­‐2.4094906	  	   0.7593047	  
H	   1	   3.5842002	  	   -­‐1.9424254	  	   -­‐0.9219920	  
H	   1	   2.2645479	  	   -­‐3.0574721	  	   -­‐0.5031799	  
C	   6	   -­‐1.3744179	  	   0.2299787	  	   -­‐0.1593881	  
C	   6	   -­‐4.1424053	  	   0.4993190	  	   -­‐0.5187974	  
C	   6	   -­‐2.1464147	  	   -­‐0.8418914	  	   -­‐0.6470979	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C	   6	   -­‐3.3980138	  	   1.5727298	  	   -­‐0.0368584	  
C	   6	   -­‐3.5197750	  	   -­‐0.7087685	  	   -­‐0.8255335	  
H	   1	   -­‐1.6473002	  	   -­‐1.7738842	  	   -­‐0.8790494	  
H	   1	   -­‐1.4270581	  	   2.2658989	  	   0.5154843	  
H	   1	   -­‐3.8838491	  	   2.5130149	  	   0.2016573	  
H	   1	   -­‐4.0999910	  	   -­‐1.5441342	  	   -­‐1.2022381	  
Cl	   17	   -­‐5.8818819	  	   0.6661331	  	   -­‐0.7405949	  
O	   8	   0.7286919	  	   2.2176179	  	   0.7561712	  
	  
	  
Table	   3-­‐61.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐7anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   41	  	   0.54	   24	  	   710	  	   23.03	   47	  	   1422	  	   11.69	  
2	  	   49	  	   1.63	   25	  	   730	  	   10.57	   48	  	   1431	  	   40.20	  
3	  	   66	  	   0.11	   26	  	   763	  	   57.25	   49	  	   1455	  	   47.97	  
4	  	   111	  	   3.71	   27	  	   835	  	   8.70	   50	  	   1486	  	   184.58	  
5	  	   119	  	   6.79	   28	  	   840	  	   18.12	   51	  	   1505	  	   5.52	  
6	  	   144	  	   0.17	   29	  	   842	  	   45.76	   52	  	   1514	  	   120.43	  
7	  	   174	  	   0.03	   30	  	   956	  	   0.24	   53	  	   1522	  	   7.56	  
8	  	   220	  	   1.68	   31	  	   968	  	   0.14	   54	  	   1530	  	   431.26	  
9	  	   254	  	   0.81	   32	  	   975	  	   99.84	   55	  	   1531	  	   171.27	  
10	  	   257	  	   8.06	   33	  	   1020	  	   3.33	   56	  	   1544	  	   365.46	  
11	  	   266	  	   15.14	   34	  	   1023	  	   104.94	   57	  	   1606	  	   282.14	  
12	  	   319	  	   2.69	   35	  	   1057	  	   0.42	   58	  	   1626	  	   149.89	  
13	  	   348	  	   8.36	   36	  	   1079	  	   1.14	   59	  	   1647	  	   183.01	  
14	  	   378	  	   2.59	   37	  	   1098	  	   87.53	   60	  	   3022	  	   156.52	  
15	  	   396	  	   1.07	   38	  	   1104	  	   17.32	   61	  	   3052	  	   69.31	  
16	  	   425	  	   0.03	   39	  	   1114	  	   12.82	   62	  	   3057	  	   59.30	  
17	  	   491	  	   78.12	   40	  	   1148	  	   47.73	   63	  	   3101	  	   23.41	  
18	  	   519	  	   9.45	   41	  	   1156	  	   103.79	   64	  	   3106	  	   35.12	  
19	  	   578	  	   44.08	   42	  	   1197	  	   2.27	   65	  	   3141	  	   29.75	  
20	  	   634	  	   9.78	   43	  	   1313	  	   41.86	   66	  	   3228	  	   6.16	  
21	  	   647	  	   2.77	   44	  	   1328	  	   0.84	   67	  	   3233	  	   5.06	  
22	  	   649	  	   9.64	   45	  	   1350	  	   153.51	   68	  	   3252	  	   12.51	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1201.231562	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  478.7001	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753669.2042	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.7769855	   0.0734007	   0.1852081	  
C	   6	   1.4174387	   0.7828539	   0.1953124	  
N	   7	   0.4689417	   -­‐0.2113990	   0.0624142	  
N	   7	   1.0536506	   -­‐1.4896300	   -­‐0.0742113	  
C	   6	   2.3346470	   -­‐1.3616343	   -­‐0.0324991	  
O	   8	   1.2121547	   1.9921314	   0.3057915	  
C	   6	   3.5044012	   0.2621569	   1.5248401	  
H	   1	   3.7092888	   1.3223552	   1.6840992	  
H	   1	   4.4524696	   -­‐0.2841381	   1.5162414	  
H	   1	   2.8995808	   -­‐0.1108878	   2.3574634	  
N	   7	   3.5282170	   0.5148003	   -­‐1.0122642	  
H	   1	   4.3631615	   -­‐0.0765175	   -­‐1.0707819	  
O	   8	   4.0963516	   1.8254844	   -­‐0.7707427	  
H	   1	   3.5520284	   2.3983802	   -­‐1.3368225	  
C	   6	   3.2418540	   -­‐2.5326761	   -­‐0.1684802	  
H	   1	   3.9102694	   -­‐2.6124444	   0.6960293	  
H	   1	   3.8723010	   -­‐2.4337670	   -­‐1.0607405	  
H	   1	   2.6587625	   -­‐3.4515686	   -­‐0.2561509	  
C	   6	   -­‐0.9442866	   -­‐0.1175298	   0.0281684	  
C	   6	   -­‐3.7270813	   0.0081553	   -­‐0.0380896	  
C	   6	   -­‐1.7025138	   -­‐1.2892183	   -­‐0.1103153	  
C	   6	   -­‐1.5958534	   1.1209709	   0.1336159	  
C	   6	   -­‐2.9877866	   1.1794142	   0.1002418	  
C	   6	   -­‐3.0923446	   -­‐1.2266853	   -­‐0.1439568	  
H	   1	   -­‐1.1994714	   -­‐2.2431280	   -­‐0.1915062	  
H	   1	   -­‐1.0184684	   2.0279878	   0.2410289	  
H	   1	   -­‐3.4897170	   2.1370264	   0.1818724	  
H	   1	   -­‐3.6744346	   -­‐2.1346503	   -­‐0.2522999	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Table	   3-­‐63.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐7	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	  	   24	  	   0.06	   28	  	   712	  	   0.47	   55	   1370	   51.55	  
2	  	   33	  	   1.22	   29	  	   713	  	   10.33	   56	   1397	   305.58	  
3	  	   70	  	   0.64	   30	  	   741	  	   12.63	   57	   1421	   8.23	  
4	  	   88	  	   4.50	   31	  	   758	  	   31.31	   58	   1442	   18.42	  
5	  	   128	  	   8.58	   32	  	   826	  	   52.25	   59	   1460	   7.11	  
6	  	   140	  	   0.91	   33	  	   839	  	   0.67	   60	   1491	   16.29	  
7	  	   145	  	   6.68	   34	  	   848	  	   58.45	   61	   1495	   14.48	  
8	  	   183	  	   0.43	   35	  	   892	  	   31.86	   62	   1507	   9.18	  
9	  	   224	  	   48.43	   36	   898	   30.75	   63	   1519	   8.42	  
10	  	   228	  	   1.64	   37	   956	   53.65	   64	   1526	   4.34	  
11	  	   240	  	   1.80	   38	   970	   0.39	   65	   1535	   402.65	  
12	  	   252	  	   3.31	   39	   976	   0.41	   66	   1629	   2.18	  
13	  	   259	  	   20.78	   40	   1020	   29.03	   67	   1648	   49.64	  
14	  	   268	  	   64.38	   41	  	   1023	  	   24.15	   68	   1687	   138.66	  
15	  	   317	  	   7.66	   42	   1031	   37.95	   69	   1697	   448.28	  
16	  	   319	  	   6.15	   43	   1052	   11.19	   70	   3065	   7.36	  
17	  	   334	  	   30.59	   44	   1098	   68.25	   71	   3075	   15.78	  
18	  	   386	  	   16.19	   45	   1102	   33.11	   72	   3122	   4.77	  
19	  	   399	  	   1.59	   46	   1126	   24.48	   73	   3146	   19.61	  
20	  	   421	  	   0.16	   47	   1150	   8.45	   74	   3169	   17.51	  
21	   432	  	   14.95	   48	   1157	   75.82	   75	   3170	   2.61	  
22	  	   508	  	   50.15	   49	   1170	   64.03	   76	   3236	   3.56	  
23	  	   524	  	   10.99	   50	   1209	   6.92	   77	   3242	   2.95	  
24	   	  580	  	   31.40	   51	   1267	   84.17	   78	   3269	   0.46	  
25	   	  615	  	   18.67	   52	   1324	   226.29	   79	   3274	   4.62	  
26	  	   622	  	   7.06	   53	   1334	   5.44	   80	   3432	   18.60	  
27	  	   645	  	   0.64	   54	   1349	   7.92	   81	   3726	   108.20	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1200.725219	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  441.7324	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.0163014	  	   0.3394052	  	   0.1477668	  
C	   6	   0.6710296	  	   1.0231604	  	   0.2777659	  
N	   7	   -­‐0.2755822	  	   0.0687389	  	   -­‐0.0484915	  
N	   7	   0.3082644	  	   -­‐1.2030962	  	   -­‐0.2302067	  
C	   6	   1.5843375	  	   -­‐1.0811307	  	   -­‐0.0725480	  
O	   8	   0.4435130	   2.1920972	   0.6009742	  
C	   6	   2.9477287	  	   0.6039421	  	   1.3194044	  
H	   1	   3.3166921	  	   1.6289950	  	   1.2145568	  
H	   1	   3.8014922	  	   -­‐0.0807744	  	   1.2859500	  
H	   1	   2.4511379	  	   0.4869038	  	   2.2887888	  
N	   7	   2.6154928	  	   0.8316134	  	   -­‐1.2263691	  
H	   1	   3.4409156	  	   0.1926845	  	   -­‐1.2678103	  
O	   8	   3.1067641	  	   2.1390282	  	   -­‐1.1240479	  
C	   6	   2.4846453	  	   -­‐2.2579280	  	   -­‐0.2037196	  
H	   1	   3.0726231	  	   -­‐2.4040749	  	   0.7094484	  
H	   1	   3.1949953	  	   -­‐2.1076477	  	   -­‐1.0262410	  
H	   1	   1.8975772	  	   -­‐3.1581045	  	   -­‐0.3997391	  
C	   6	   -­‐1.6860478	  	   0.1696036	  	   -­‐0.1135305	  
C	   6	   -­‐4.4703474	  	   0.3065651	  	   -­‐0.2621748	  
C	   6	   -­‐2.4438544	   -­‐0.9883174	   -­‐0.3493711	  
C	   6	   -­‐2.3427577	   1.4009380	   0.0444668	  
C	   6	   -­‐3.7332190	   1.4643111	   -­‐0.0293988	  
C	   6	   -­‐3.8319092	   -­‐0.9204205	   -­‐0.4238685	  
H	   1	   -­‐1.9348690	   -­‐1.9345875	   -­‐0.4746130	  
H	   1	   -­‐1.7650800	   2.2954191	   0.2293589	  
H	   1	   -­‐4.2338987	   2.4182615	   0.0949025	  
H	   1	   -­‐4.4087715	   -­‐1.8199666	   -­‐0.6067134	  
Cl	   17	   -­‐6.2271733	   0.3943814	   -­‐0.3545402	  
	  
	  
Table	   3-­‐65.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐7anion	  
	  	  	  	  	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   20	   2.70	   27	   660	   64.97	   53	   1349	   1.12	  
2	   36	   7.77	   28	   707	   0.26	   54	   1387	   221.71	  
3	   72	   12.90	   29	   713	   12.31	   55	   1413	   6.64	  
4	   103	   7.14	   30	   754	   22.15	   56	   1427	   21.76	  
5	   124	   1.95	   31	   793	   18.23	   57	   1449	   14.48	  
6	   131	   11.12	   32	   836	   1.12	   58	   1461	   15.25	  
7	   149	   10.19	   33	   845	   64.70	   59	   1491	   13.27	  
8	   174	   0.88	   34	   847	   33.94	   60	   1494	   24.01	  
9	   176	   25.32	   35	   914	   73.55	   61	   1507	   5.55	  
	   181	  
10	   228	   2.32	   36	   964	   0.31	   62	   1532	   54.46	  
11	   238	   12.24	   37	   972	   39.78	   63	   1533	   384.50	  
12	   255	   1.34	   38	   973	   70.51	   64	   1626	   7.69	  
13	   263	   14.14	   39	   1023	   5.02	   65	   1646	   66.18	  
14	   306	   6.26	   40	   1027	   53.14	   66	   1671	   141.39	  
15	   318	   1.89	   41	   1041	   11.55	   67	   1690	   463.20	  
16	   325	   17.49	   42	   1049	   2.09	   68	   3058	   45.74	  
17	   375	   16.01	   43	   1098	   43.31	   69	   3062	   11.02	  
18	   396	   4.03	   44	   1104	   46.34	   70	   3081	   136.99	  
19	   400	   26.96	   45	   1114	   2.42	   71	   3120	   8.90	  
20	   422	   0.30	   46	   1145	   12.63	   72	   3128	   9.51	  
21	   486	   183.93	   47	   1159	   144.32	   73	   3139	   31.79	  
22	   520	   18.23	   48	   1174	   13.14	   74	   3168	   11.42	  
23	   537	   51.60	   49	   1206	   5.90	   75	   3236	   4.08	  
24	   579	   34.57	   50	   1284	   96.96	   76	   3244	   2.51	  
25	   618	   14.70	   51	   1329	   70.85	   77	   3267	   0.65	  
26	   645	   0.71	   52	   1341	   316.91	   78	   3268	   3.03	  
	  
	  
Table	  3-­‐66.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐8	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  -­‐1070.706172	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  427.4027	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐671775.6076	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.0102059	   -­‐0.4648007	   0.5621577	  
C	   6	   0.8635377	   0.2502545	   0.8563888	  
N	   7	   -­‐0.1056050	   -­‐0.1063171	   -­‐0.0393297	  
N	   7	   0.3793226	   -­‐1.0244047	   -­‐0.9509619	  
C	   6	   1.6409416	   -­‐1.2352406	   -­‐0.5732994	  
C	   6	   3.3339922	   -­‐0.4244936	   1.2646933	  
H	   1	   4.1199995	   0.0222200	   0.6435480	  
H	   1	   3.6713936	   -­‐1.4286113	   1.5469951	  
H	   1	   3.2847875	   0.1613801	   2.1895681	  
C	   6	   2.5036537	   -­‐2.1992028	   -­‐1.3219940	  
H	   1	   2.8642192	   -­‐3.0042009	   -­‐0.6702461	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H	   1	   1.9430103	   -­‐2.6501610	   -­‐2.1450038	  
C	   6	   -­‐1.4109972	   0.4355684	   -­‐0.1823846	  
C	   6	   -­‐3.9687940	   1.5256670	   -­‐0.5372636	  
C	   6	   -­‐2.3996267	   0.2732937	   0.7990635	  
C	   6	   -­‐1.7338488	   1.1308744	   -­‐1.3531600	  
C	   6	   -­‐3.0043379	   1.6684441	   -­‐1.5357814	  
C	   6	   -­‐3.6685348	   0.8271255	   0.6305761	  
H	   1	   -­‐0.9667111	   1.2356262	   -­‐2.1123342	  
H	   1	   -­‐3.2346011	   2.2052625	   -­‐2.4498877	  
H	   1	   -­‐4.4128526	   0.6935593	   1.4073530	  
H	   1	   -­‐4.9590208	   1.9504075	   -­‐0.6647259	  
Cl	   17	   -­‐2.0854466	   -­‐0.6722956	   2.2503228	  
O	   8	   0.5754934	   1.1934759	   1.7887655	  
H	   1	   1.3710803	   1.3402708	   2.3357458	  
	  
	  
Table	   3-­‐67.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐8	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   33	   1.56	   25	   702	   28.48	   49	   1435	   58.60	  
2	   53	   10.05	   26	   727	   15.42	   50	   1458	   3.26	  
3	   62	   0.43	   27	   748	   48.96	   51	   1479	   50.69	  
4	   81	   2.65	   28	   776	   45.14	   52	   1500	   21.68	  
5	   143	   2.66	   29	   831	   3.91	   53	   1503	   2.91	  
6	   158	   1.75	   30	   878	   1.11	   54	   1511	   14.49	  
7	   160	   1.75	   31	   955	   2.38	   55	   1515	   50.77	  
8	   195	   77.30	   32	   980	   33.42	   56	   1522	   42.11	  
9	   203	   44.37	   33	   989	   0.02	   57	   1533	   87.81	  
10	   230	   5.37	   34	   1025	   67.61	   58	   1543	   178.45	  
11	   253	   2.27	   35	   1050	   91.76	   59	   1630	   9.50	  
12	   280	   5.61	   36	   1062	   1.53	   60	   1638	   231.04	  
13	   299	   11.39	   37	   1067	   10.90	   61	   1648	   4.59	  
14	   322	   5.88	   38	   1085	   0.50	   62	   3050	   58.68	  
15	   376	   2.72	   39	   1105	   88.77	   63	   3057	   41.89	  
16	   425	   17.39	   40	   1128	   31.28	   64	   3103	   38.19	  
17	   457	   1.77	   41	   1155	   10.96	   65	   3108	   9.74	  
18	   479	   11.22	   42	   1192	   2.07	   66	   3116	   39.14	  
19	   525	   2.43	   43	   1194	   21.12	   67	   3148	   21.28	  
20	   570	   19.59	   44	   1244	   118.32	   68	   3222	   0.23	  
21	   607	   6.05	   45	   1291	   23.08	   69	   3230	   8.15	  
22	   651	   10.33	   46	   1326	   18.02	   70	   3239	   8.46	  
23	   660	   9.53	   47	   1348	   17.11	   71	   3245	   8.15	  
24	   692	   2.66	   48	   1416	   181.44	   72	   3690	   218.80	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1070.23931	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  396.2348	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐671490.0968	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.0488394	   -­‐0.4547807	   0.6732204	  
C	   6	   0.8850112	   0.2325763	   1.0919322	  
N	   7	   -­‐0.1051665	   -­‐0.1773655	   0.1626278	  
N	   7	   0.4155817	   -­‐0.9969108	   -­‐0.8432390	  
C	   6	   1.6949486	   -­‐1.1614089	   -­‐0.4941640	  
C	   6	   3.3789927	   -­‐0.3759652	   1.3555536	  
H	   1	   4.1609339	   0.0787658	   0.7290756	  
H	   1	   3.7604503	   -­‐1.3598536	   1.6650657	  
H	   1	   3.2878349	   0.2398132	   2.2582559	  
C	   6	   2.5777630	   -­‐2.0380294	   -­‐1.3259581	  
H	   1	   2.9783519	   -­‐2.8769486	   -­‐0.7425796	  
H	   1	   3.4400100	   -­‐1.4833596	   -­‐1.7176142	  
H	   1	   2.0150523	   -­‐2.4448066	   -­‐2.1716801	  
C	   6	   -­‐1.3729743	   0.4104668	   -­‐0.0279127	  
C	   6	   -­‐3.8806924	   1.6273616	   -­‐0.4793853	  
C	   6	   -­‐2.3800156	   0.3869379	   0.9508520	  
C	   6	   -­‐1.6760306	   1.0259198	   -­‐1.2538388	  
C	   6	   -­‐2.9114976	   1.6212338	   -­‐1.4846631	  
C	   6	   -­‐3.6132640	   1.0059542	   0.7379666	  
H	   1	   -­‐0.9044936	   1.0166202	   -­‐2.0159943	  
H	   1	   -­‐3.1082025	   2.0901976	   -­‐2.4434522	  
H	   1	   -­‐4.3594092	   0.9720800	   1.5241633	  
H	   1	   -­‐4.8439575	   2.1000091	   -­‐0.6407624	  
Cl	   17	   -­‐2.1629646	   -­‐0.5002093	   2.4600389	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Table	   3-­‐69.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐8anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   42	   5.88	   24	   725	   28.55	   47	   1418	   4.51	  
2	   52	   1.53	   25	   738	   6.64	   48	   1435	   32.61	  
3	   84	   6.30	   26	   757	   49.08	   49	   1475	   21.02	  
4	   84	   1.72	   27	   777	   63.54	   50	   1485	   181.03	  
5	   148	   0.62	   28	   845	   4.83	   51	   1506	   34.36	  
6	   156	   4.15	   29	   867	   1.99	   52	   1508	   185.60	  
7	   164	   3.46	   30	   938	   2.44	   53	   1522	   20.69	  
8	   193	   1.66	   31	   962	   0.14	   54	   1524	   125.77	  
9	   225	   3.93	   32	   977	   49.40	   55	   1532	   23.99	  
10	   249	   9.04	   33	   1019	   60.89	   56	   1547	   287.80	  
11	   276	   10.69	   34	   1048	   104.71	   57	   1605	   385.20	  
12	   292	   2.54	   35	   1057	   1.00	   58	   1624	   44.59	  
13	   328	   0.79	   36	   1069	   3.17	   59	   1646	   91.07	  
14	   378	   15.86	   37	   1079	   1.38	   60	   3016	   160.71	  
15	   424	   17.04	   38	   1115	   22.08	   61	   3049	   72.08	  
16	   456	   4.16	   39	   1128	   31.23	   62	   3050	   67.77	  
17	   477	   6.66	   40	   1158	   30.16	   63	   3097	   27.67	  
18	   537	   1.32	   41	   1160	   57.61	   64	   3102	   38.30	  
19	   583	   34.24	   42	   1183	   0.22	   65	   3139	   30.81	  
20	   626	   10.27	   43	   1284	   27.21	   66	   3219	   5.10	  
21	   651	   7.88	   44	   1319	   5.77	   67	   3232	   5.07	  
22	   653	   22.24	   45	   1338	   28.59	   68	   3236	   13.96	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  -­‐1201.222966	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  477.8088	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   2.2817321	   -­‐0.0177457	   0.2688175	  
C	   6	   1.0272969	   0.8396164	   0.4837288	  
N	   7	   -­‐0.0175173	   0.0889766	   0.0003750	  
N	   7	   0.3972948	   -­‐1.1364559	   -­‐0.5714507	  
C	   6	   1.6791582	   -­‐1.2113101	   -­‐0.4553921	  
O	   8	   0.9481848	   1.9609140	   0.9870888	  
C	   6	   2.9099090	   -­‐0.4133844	   1.6133213	  
H	   1	   3.2373575	   0.4831657	   2.1428553	  
H	   1	   3.7757557	   -­‐1.0620810	   1.4486435	  
H	   1	   2.1905218	   -­‐0.9516564	   2.2386700	  
N	   7	   3.1771564	   0.7022694	   -­‐0.6645613	  
H	   1	   3.9335794	   0.0583216	   -­‐0.9165962	  
O	   8	   3.8893644	   1.7413134	   0.0532837	  
H	   1	   3.4344628	   2.5490270	   -­‐0.2392482	  
C	   6	   2.4424833	   -­‐2.3813923	   -­‐0.9682229	  
H	   1	   3.0255412	   -­‐2.8490391	   -­‐0.1671004	  
H	   1	   3.1482463	   -­‐2.0796454	   -­‐1.7517812	  
H	   1	   1.7567019	   -­‐3.1206404	   -­‐1.3875296	  
C	   6	   -­‐1.3846274	   0.4664273	   -­‐0.0590371	  
C	   6	   -­‐4.0718109	   1.2421372	   -­‐0.2090304	  
C	   6	   -­‐2.3756730	   -­‐0.2535516	   0.6237485	  
C	   6	   -­‐1.7604804	   1.5871168	   -­‐0.8065502	  
C	   6	   -­‐3.0942273	   1.9800705	   -­‐0.8767881	  
C	   6	   -­‐3.7148700	   0.1227208	   0.5415044	  
H	   1	   -­‐0.9896113	   2.1404116	   -­‐1.3314190	  
H	   1	   -­‐3.3670089	   2.8525395	   -­‐1.4606602	  
H	   1	   -­‐4.4629190	   -­‐0.4546876	   1.0725257	  
H	   1	   -­‐5.1149983	   1.5348998	   -­‐0.2661351	  
Cl	   17	   -­‐1.9472110	   -­‐1.6342617	   1.6261022	  
	  
	  
Table	   3-­‐71.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐8	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   24	   1.40	   28	   708	   31.62	   55	   1372	   38.87	  
2	   39	   4.70	   29	   724	   7.40	   56	   1408	   169.47	  
3	   63	   0.06	   30	   745	   29.75	   57	   1421	   8.41	  
4	   73	   2.94	   31	   759	   12.81	   58	   1443	   8.99	  
5	   113	   9.93	   32	   776	   55.50	   59	   1483	   20.65	  
6	   126	   0.41	   33	   831	   39.27	   60	   1488	   22.04	  
7	   154	   6.40	   34	   874	   3.43	   61	   1495	   8.18	  
8	   161	   3.77	   35	   892	   21.56	   62	   1511	   9.25	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9	   198	   0.74	   36	   904	   27.12	   63	   1517	   12.44	  
10	   223	   4.58	   37	   952	   14.33	   64	   1527	   42.97	  
11	   229	   26.30	   38	   956	   39.48	   65	   1530	   90.28	  
12	   245	   16.24	   39	   990	   0.20	   66	   1631	   8.34	  
13	   256	   52.21	   40	   1024	   36.95	   67	   1646	   25.04	  
14	   283	   2.93	   41	   1030	   19.93	   68	   1675	   68.78	  
15	   287	   11.26	   42	   1052	   57.78	   69	   1697	   440.03	  
16	   318	   37.46	   43	   1055	   43.89	   70	   3065	   9.35	  
17	   344	   27.38	   44	   1070	   11.31	   71	   3075	   16.52	  
18	   351	   8.64	   45	   1106	   41.17	   72	   3121	   6.60	  
19	   405	   14.31	   46	   1132	   26.33	   73	   3144	   19.96	  
20	   460	   2.85	   47	   1153	   33.09	   74	   3166	   12.90	  
21	   463	   5.31	   48	   1157	   28.06	   75	   3168	   8.29	  
22	   491	   12.20	   49	   1187	   59.09	   76	   3222	   0.30	  
23	   539	   8.66	   50	   1194	   5.22	   77	   3230	   8.64	  
24	   579	   32.79	   51	   1266	   37.45	   78	   3239	   9.21	  
25	   613	   14.87	   52	   1299	   2.17	   79	   3245	   6.28	  
26	   624	   6.84	   53	   1326	   114.70	   80	   3433	   18.29	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1200.71576	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  441.9393	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753354.3198	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.9840536	   -­‐0.0650869	   0.2881352	  
C	   6	   0.7259482	   0.7356831	   0.5833366	  
N	   7	   -­‐0.2968389	   0.0623918	   -­‐0.0418269	  
N	   7	   0.1214935	   -­‐1.1533489	   -­‐0.6245823	  
C	   6	   1.3906675	   -­‐1.2627719	   -­‐0.4109039	  
O	   8	   0.5976840	   1.7712501	   1.2421687	  
C	   6	   2.8105354	   -­‐0.3559995	   1.5333240	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H	   1	   3.5631840	   -­‐1.1209815	   1.3161559	  
H	   1	   2.2000641	   -­‐0.7036349	   2.3738781	  
N	   7	   2.7687141	   0.7423455	   -­‐0.7893335	  
H	   1	   3.4987068	   0.0378942	   -­‐1.0307676	  
O	   8	   3.4280650	   1.8479496	   -­‐0.2182222	  
C	   6	   2.1454816	   -­‐2.4460290	   -­‐0.9052102	  
H	   1	   2.6399054	   -­‐2.9693711	   -­‐0.0790047	  
H	   1	   2.9281333	   -­‐2.1422900	   -­‐1.6114255	  
H	   1	   1.4642719	   -­‐3.1380090	   -­‐1.4064551	  
C	   6	   -­‐1.6611018	   0.4493766	   -­‐0.1131967	  
C	   6	   -­‐4.3398360	   1.2587538	   -­‐0.3043321	  
C	   6	   -­‐2.6841014	   -­‐0.3150891	   0.4674749	  
C	   6	   -­‐2.0037113	   1.6336447	   -­‐0.7764955	  
C	   6	   -­‐3.3313368	   2.0427185	   -­‐0.8661520	  
C	   6	   -­‐4.0179606	   0.0779681	   0.3624964	  
H	   1	   -­‐1.2045136	   2.2184096	   -­‐1.2190578	  
H	   1	   -­‐3.5725907	   2.9644478	   -­‐1.3848655	  
H	   1	   -­‐4.7879755	   -­‐0.5370791	   0.8138943	  
H	   1	   -­‐5.3782075	   1.5643815	   -­‐0.3793295	  
Cl	   17	   -­‐2.3101503	   -­‐1.7709206	   1.3770394	  
	  
	  
Table	   3-­‐73.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐8anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   12	   7.91	   27	   673	   60.24	   53	   1341	   71.96	  
2	   41	   7.61	   28	   706	   31.19	   54	   1398	   137.72	  
3	   70	   10.73	   29	   723	   1.59	   55	   1405	   6.93	  
4	   77	   0.38	   30	   752	   45.95	   56	   1428	   14.34	  
5	   130	   16.54	   31	   769	   51.50	   57	   1454	   12.49	  
6	   151	   5.98	   32	   798	   23.06	   58	   1477	   19.15	  
7	   162	   6.04	   33	   851	   29.97	   59	   1491	   11.04	  
8	   172	   10.19	   34	   870	   1.47	   60	   1495	   23.05	  
9	   192	   13.06	   35	   914	   56.87	   61	   1506	   4.25	  
10	   198	   6.77	   36	   949	   3.05	   62	   1527	   139.31	  
11	   239	   4.20	   37	   961	   78.64	   63	   1533	   5.86	  
12	   260	   1.85	   38	   978	   0.12	   64	   1628	   9.56	  
13	   269	   2.89	   39	   1024	   18.65	   65	   1643	   31.55	  
14	   285	   7.60	   40	   1040	   22.92	   66	   1664	   119.52	  
15	   306	   6.00	   41	   1051	   4.97	   67	   1688	   408.66	  
16	   333	   12.67	   42	   1055	   78.58	   68	   3058	   39.31	  
17	   349	   11.50	   43	   1069	   15.42	   69	   3060	   22.44	  
18	   402	   7.51	   44	   1109	   19.52	   70	   3100	   120.02	  
19	   442	   24.33	   45	   1118	   26.98	   71	   3117	   13.39	  
	   188	  
20	   460	   4.71	   46	   1149	   32.06	   72	   3130	   12.27	  
21	   486	   7.53	   47	   1164	   57.36	   73	   3139	   34.33	  
22	   534	   17.23	   48	   1187	   14.04	   74	   3163	   11.16	  
23	   554	   78.09	   49	   1191	   28.01	   75	   3216	   7.50	  
24	   581	   39.70	   50	   1277	   26.70	   76	   3228	   6.54	  
25	   614	   12.72	   51	   1301	   3.26	   77	   3239	   11.18	  




Table	  3-­‐74.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐9	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  	  -­‐611.119386	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  460.2285	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐383372.9175	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2279980	   -­‐0.5972430	   0.4991380	  
C	   6	   2.4013577	   0.1075204	   0.2694476	  
N	   7	   2.1039122	   1.2267176	   -­‐0.4360540	  
N	   7	   0.7658943	   1.3160387	   -­‐0.6797098	  
C	   6	   0.2371656	   0.2116743	   -­‐0.1255479	  
C	   6	   3.0174180	   2.2813104	   -­‐0.8472432	  
H	   1	   2.6416284	   2.7180891	   -­‐1.7726173	  
H	   1	   4.0051926	   1.8525931	   -­‐1.0188724	  
H	   1	   3.0916560	   3.0615029	   -­‐0.0835099	  
C	   6	   1.1030536	   -­‐1.8674621	   1.2876683	  
H	   1	   1.1123806	   -­‐2.7673902	   0.6595223	  
H	   1	   0.1767964	   -­‐1.8845898	   1.8704190	  
H	   1	   1.9266650	   -­‐1.9656083	   2.0053586	  
C	   6	   -­‐1.2186751	   -­‐0.0085336	   -­‐0.2003982	  
C	   6	   -­‐4.0079908	   -­‐0.3934044	   -­‐0.3544722	  
C	   6	   -­‐1.7694665	   -­‐1.3008983	   -­‐0.2096477	  
C	   6	   -­‐2.0956528	   1.0882743	   -­‐0.2786995	  
C	   6	   -­‐3.4724796	   0.8973322	   -­‐0.3570598	  
C	   6	   -­‐3.1498683	   -­‐1.4904623	   -­‐0.2825808	  
H	   1	   -­‐4.1299724	   1.7600045	   -­‐0.4136283	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H	   1	   -­‐5.0823659	   -­‐0.5399752	   -­‐0.4100304	  
H	   1	   -­‐1.1151326	   -­‐2.1651687	   -­‐0.1852482	  
H	   1	   -­‐1.6785141	   2.0898479	   -­‐0.2747765	  
O	   8	   3.6960940	   -­‐0.1133755	   0.6334065	  
H	   1	   3.7647008	   -­‐1.0174995	   0.9957315	  
	  
	  
Table	   3-­‐75.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐9	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   47	   0.88	   25	   791	   21.17	   49	   1471	   20.84	  
2	   79	   2.01	   26	   822	   19.14	   50	   1480	   38.19	  
3	   81	   3.96	   27	   861	   0.65	   51	   1493	   54.14	  
4	   110	   1.86	   28	   930	   5.04	   52	   1511	   36.13	  
5	   133	   12.86	   29	   969	   0.76	   53	   1518	   2.64	  
6	   171	   0.03	   30	   994	   0.41	   54	   1528	   24.11	  
7	   197	   95.33	   31	   1016	   17.31	   55	   1530	   9.66	  
8	   224	   36.49	   32	   1017	   1.38	   56	   1557	   11.27	  
9	   254	   1.91	   33	   1039	   125.37	   57	   1566	   156.26	  
10	   271	   10.77	   34	   1065	   22.36	   58	   1611	   122.58	  
11	   295	   5.48	   35	   1072	   5.55	   59	   1640	   13.01	  
12	   327	   8.54	   36	   1080	   6.02	   60	   1665	   10.27	  
13	   331	   4.50	   37	   1112	   3.05	   61	   3046	   57.58	  
14	   391	   0.88	   38	   1151	   150.03	   62	   3088	   77.89	  
15	   419	   0.08	   39	   1186	   32.76	   63	   3097	   35.82	  
16	   513	   4.33	   40	   1189	   0.02	   64	   3124	   24.91	  
17	   576	   12.15	   41	   1212	   0.15	   65	   3168	   13.03	  
18	   614	   6.99	   42	   1263	   37.10	   66	   3201	   3.39	  
19	   633	   0.17	   43	   1281	   20.68	   67	   3202	   4.58	  
20	   660	   0.54	   44	   1308	   59.11	   68	   3209	   11.43	  
21	   672	   19.80	   45	   1338	   30.54	   69	   3221	   38.19	  
22	   712	   19.17	   46	   1366	   3.17	   70	   3227	   41.21	  
23	   719	   33.13	   47	   1409	   242.41	   71	   3234	   13.79	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  	  -­‐610.65229	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  427.8126	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐383087.5582	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.3873872	   -­‐0.6600497	   0.4897516	  
C	   6	   2.6076012	   0.0428783	   0.3189587	  
N	   7	   2.2356149	   1.2318268	   -­‐0.3061037	  
N	   7	   0.8880471	   1.3234881	   -­‐0.5463574	  
C	   6	   0.3798171	   0.1753032	   -­‐0.0567854	  
C	   6	   3.1283292	   2.2806060	   -­‐0.7441372	  
H	   1	   3.1363312	   2.3695207	   -­‐1.8367973	  
H	   1	   4.1297505	   2.0210210	   -­‐0.3964293	  
H	   1	   2.8324021	   3.2463104	   -­‐0.3212992	  
C	   6	   1.3116520	   -­‐1.9830485	   1.1889925	  
H	   1	   1.1618477	   -­‐2.8371274	   0.5105789	  
H	   1	   0.5066699	   -­‐2.0259792	   1.9339693	  
H	   1	   2.2604707	   -­‐2.1597804	   1.7102829	  
C	   6	   -­‐1.0762991	   -­‐0.0387740	   -­‐0.1342891	  
C	   6	   -­‐3.8784665	   -­‐0.4051650	   -­‐0.3002595	  
C	   6	   -­‐1.6504389	   -­‐1.3191218	   -­‐0.0362381	  
C	   6	   -­‐1.9455505	   1.0541851	   -­‐0.3237955	  
C	   6	   -­‐3.3230140	   0.8732176	   -­‐0.4083032	  
C	   6	   -­‐3.0324851	   -­‐1.4983433	   -­‐0.1151773	  
H	   1	   -­‐3.9646119	   1.7380241	   -­‐0.5528181	  
H	   1	   -­‐3.4423410	   -­‐2.5012523	   -­‐0.0365185	  
H	   1	   -­‐4.9535061	   -­‐0.5446702	   -­‐0.3605654	  
H	   1	   -­‐1.0055811	   -­‐2.1815766	   0.0867416	  
H	   1	   -­‐1.5096619	   2.0447466	   -­‐0.4012644	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Table	   3-­‐77.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐9anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   1	   1.15	   24	   786	   19.28	   47	   1450	   183.48	  
2	   76	   0.82	   25	   846	   9.80	   48	   1462	   7.39	  
3	   92	   3.36	   26	   858	   0.38	   49	   1480	   1.45	  
4	   110	   0.58	   27	   922	   4.26	   50	   1500	   92.30	  
5	   126	   1.88	   28	   961	   0.77	   51	   1511	   351.61	  
6	   142	   7.47	   29	   981	   0.42	   52	   1522	   5.39	  
7	   200	   0.46	   30	   1003	   16.69	   53	   1530	   26.04	  
8	   254	   0.57	   31	   1015	   3.27	   54	   1544	   1.76	  
9	   274	   10.12	   32	   1032	   29.67	   55	   1558	   34.52	  
10	   284	   10.15	   33	   1045	   38.75	   56	   1570	   609.40	  
11	   330	   21.56	   34	   1062	   6.26	   57	   1633	   1.82	  
12	   343	   2.74	   35	   1063	   9.58	   58	   1660	   28.89	  
13	   379	   6.84	   36	   1107	   8.28	   59	   3008	   142.59	  
14	   419	   0.11	   37	   1181	   0.15	   60	   3048	   49.14	  
15	   514	   1.44	   38	   1188	   2.26	   61	   3059	   167.43	  
16	   575	   29.13	   39	   1206	   8.54	   62	   3095	   49.50	  
17	   632	   0.25	   40	   1220	   59.81	   63	   3117	   44.87	  
18	   641	   5.76	   41	   1279	   79.65	   64	   3176	   8.26	  
19	   673	   26.18	   42	   1293	   67.68	   65	   3200	   6.32	  
20	   684	   6.66	   43	   1334	   12.97	   66	   3208	   11.91	  
21	   708	   28.16	   44	   1364	   0.31	   67	   3220	   32.72	  
22	   741	   30.66	   45	   1388	   74.48	   68	   3227	   47.41	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  	  -­‐741.63449	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  512.2117	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.0125600	   -­‐0.6692558	   0.2153561	  
C	   6	   2.2888911	   0.1852619	   0.1244898	  
N	   7	   1.8650175	   1.4731938	   -­‐0.0042953	  
N	   7	   0.4813263	   1.5965305	   -­‐0.0566489	  
C	   6	   -­‐0.0506499	   0.4161510	   0.0453318	  
O	   8	   3.4623994	   -­‐0.2001839	   0.1589396	  
C	   6	   2.6909867	   2.6592805	   -­‐0.1446975	  
H	   1	   2.5273393	   3.1264055	   -­‐1.1192492	  
H	   1	   3.7319206	   2.3478749	   -­‐0.0583799	  
H	   1	   2.4552136	   3.3790341	   0.6425725	  
C	   6	   0.9685895	   -­‐1.3720509	   1.5822995	  
H	   1	   1.8616314	   -­‐1.9893731	   1.6969529	  
H	   1	   0.0870029	   -­‐2.0093915	   1.6773197	  
H	   1	   0.9429793	   -­‐0.6355219	   2.3916157	  
N	   7	   1.0024272	   -­‐1.5491405	   -­‐0.9795268	  
H	   1	   0.0837359	   -­‐1.9931988	   -­‐1.0413619	  
O	   8	   1.8786507	   -­‐2.6809718	   -­‐0.7545329	  
H	   1	   2.6695788	   -­‐2.4413727	   -­‐1.2667492	  
C	   6	   -­‐1.5097912	   0.2501149	   0.0075625	  
C	   6	   -­‐4.3131036	   -­‐0.0041323	   -­‐0.0819019	  
C	   6	   -­‐2.1250484	   -­‐1.0059323	   0.1494981	  
C	   6	   -­‐2.3317816	   1.3800373	   -­‐0.1813970	  
C	   6	   -­‐3.7137825	   1.2521718	   -­‐0.2237262	  
C	   6	   -­‐3.5137396	   -­‐1.1300527	   0.1029770	  
H	   1	   -­‐4.3281243	   2.1353549	   -­‐0.3693306	  
H	   1	   -­‐3.9660717	   -­‐2.1102211	   0.2153978	  
H	   1	   -­‐5.3937440	   -­‐0.1003443	   -­‐0.1163385	  
H	   1	   -­‐1.5285805	   -­‐1.8968204	   0.3074828	  
H	   1	   -­‐1.8661609	   2.3525189	   -­‐0.2936337	  
	  
	  
Table	   3-­‐79.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐9	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   29	   0.39	   28	   760	   20.04	   55	   1430	   20.23	  
2	   62	   3.14	   29	   789	   18.32	   56	   1438	   140.57	  
3	   79	   1.65	   30	   815	   31.56	   57	   1472	   11.39	  
4	   100	   0.67	   31	   861	   0.64	   58	   1490	   7.37	  
5	   105	   0.20	   32	   884	   34.06	   59	   1511	   8.02	  
6	   143	   0.81	   33	   940	   36.34	   60	   1515	   12.53	  
7	   157	   2.20	   34	   942	   5.86	   61	   1517	   8.48	  
8	   183	   0.44	   35	   968	   37.31	   62	   1526	   10.90	  
	   193	  
9	   223	   1.18	   36	   980	   0.71	   63	   1539	   43.71	  
10	   255	   2.56	   37	   1006	   0.88	   64	   1545	   1.46	  
11	   266	   6.62	   38	   1017	   5.32	   65	   1603	   48.55	  
12	   279	   3.37	   39	   1025	   65.12	   66	   1640	   3.62	  
13	   310	   11.46	   40	   1033	   11.63	   67	   1662	   1.22	  
14	   320	   3.11	   41	   1062	   4.10	   68	   1681	   795.96	  
15	   340	   9.81	   42	   1064	   135.20	   69	   3085	   16.47	  
16	   354	   7.95	   43	   1119	   5.91	   70	   3090	   70.78	  
17	   416	   0.28	   44	   1130	   10.54	   71	   3157	   18.45	  
18	   422	   23.86	   45	   1176	   2.86	   72	   3161	   15.35	  
19	   448	   147.96	   46	   1194	   4.76	   73	   3178	   19.31	  
20	   498	   3.47	   47	   1195	   20.31	   74	   3198	   2.19	  
21	   614	   54.69	   48	   1218	   4.14	   75	   3208	   1.03	  
22	   629	   2.34	   49	   1247	   59.82	   76	   3216	   13.54	  
23	   653	   18.67	   50	   1263	   116.76	   77	   3227	   38.36	  
24	   665	   49.07	   51	   1336	   71.94	   78	   3237	   30.74	  
25	   674	   16.46	   52	   1357	   77.75	   79	   3240	   9.05	  
26	   707	   40.21	   53	   1371	   7.72	   80	   3467	   32.15	  
27	   745	   27.03	   54	   1383	   90.70	   81	   3722	   110.52	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  	  -­‐741.126974	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  474.0132	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐464950.5545	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2764962	   -­‐0.7474886	   0.1782950	  
C	   6	   2.5265486	   0.1224540	   0.1656210	  
N	   7	   2.1171916	   1.3534442	   -­‐0.2534907	  
N	   7	   0.7397602	   1.4532432	   -­‐0.3931339	  
C	   6	   0.2169947	   0.2958418	   -­‐0.1071504	  
O	   8	   3.6894455	   -­‐0.1837435	   0.4594785	  
C	   6	   2.9359409	   2.5369040	   -­‐0.4460429	  
H	   1	   2.8715108	   2.8824925	   -­‐1.4814572	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H	   1	   2.6069866	   3.3381188	   0.2207626	  
C	   6	   1.1497547	   -­‐1.5371552	   1.4763380	  
H	   1	   1.8133722	   -­‐2.4036164	   1.3724180	  
H	   1	   0.1265930	   -­‐1.8819308	   1.6430550	  
H	   1	   1.4525048	   -­‐0.9490498	   2.3494737	  
N	   7	   1.4101965	   -­‐1.6521582	   -­‐1.0980736	  
H	   1	   0.4570413	   -­‐2.0649519	   -­‐1.1307571	  
O	   8	   2.3126587	   -­‐2.7060934	   -­‐0.8801456	  
C	   6	   -­‐1.2432139	   0.1325789	   -­‐0.1335099	  
C	   6	   -­‐4.0521725	   -­‐0.1135134	   -­‐0.1959353	  
C	   6	   -­‐1.8589997	   -­‐1.1309869	   -­‐0.0905173	  
C	   6	   -­‐2.0694527	   1.2729757	   -­‐0.2037348	  
C	   6	   -­‐3.4533379	   1.1496905	   -­‐0.2367667	  
C	   6	   -­‐3.2485835	   -­‐1.2504401	   -­‐0.1242023	  
H	   1	   -­‐4.0672163	   2.0436126	   -­‐0.2894513	  
H	   1	   -­‐3.6955463	   -­‐2.2394061	   -­‐0.0941441	  
H	   1	   -­‐5.1332434	   -­‐0.2088874	   -­‐0.2178957	  
H	   1	   -­‐1.2474177	   -­‐2.0258434	   -­‐0.0452331	  
H	   1	   -­‐1.5996532	   2.2497380	   -­‐0.2289403	  
	  
	  
Table	   3-­‐81.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐9anion	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   47	   4.15	   27	   755	   30.53	   53	   1406	   38.11	  
2	   74	   7.31	   28	   779	   41.54	   54	   1421	   35.94	  
3	   81	   4.74	   29	   802	   26.73	   55	   1450	   60.70	  
4	   95	   5.86	   30	   839	   17.72	   56	   1470	   29.72	  
5	   107	   6.44	   31	   860	   0.01	   57	   1486	   5.84	  
6	   130	   8.06	   32	   938	   3.62	   58	   1508	   2.33	  
7	   152	   7.60	   33	   955	   108.59	   59	   1514	   9.40	  
8	   179	   15.28	   34	   974	   87.76	   60	   1535	   2.40	  
9	   214	   4.73	   35	   975	   27.71	   61	   1539	   38.46	  
10	   252	   6.49	   36	   989	   1.56	   62	   1544	   7.73	  
11	   263	   6.51	   37	   1016	   1.41	   63	   1592	   67.38	  
12	   277	   4.43	   38	   1030	   54.48	   64	   1637	   3.13	  
13	   303	   11.82	   39	   1035	   7.56	   65	   1660	   7.84	  
14	   320	   21.60	   40	   1061	   49.67	   66	   1674	   755.80	  
15	   350	   1.39	   41	   1063	   9.44	   67	   3051	   56.49	  
16	   354	   13.33	   42	   1111	   30.58	   68	   3086	   94.21	  
17	   407	   22.28	   43	   1116	   4.88	   69	   3119	   9.41	  
18	   418	   0.14	   44	   1170	   2.05	   70	   3152	   79.69	  
19	   495	   31.91	   45	   1187	   0.09	   71	   3156	   18.29	  
20	   551	   169.96	   46	   1204	   19.59	   72	   3158	   44.21	  
	   195	  
21	   606	   53.37	   47	   1216	   0.40	   73	   3195	   3.30	  
22	   630	   2.32	   48	   1257	   90.64	   74	   3203	   8.21	  
23	   649	   15.82	   49	   1268	   72.49	   75	   3212	   0.20	  
24	   663	   33.94	   50	   1336	   41.51	   76	   3219	   36.89	  
25	   706	   25.65	   51	   1362	   105.34	   77	   3231	   33.54	  
26	   710	   54.56	   52	   1370	   37.73	   78	   3239	   15.47	  
	  
	  
Table	  3-­‐82.	  	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐10	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐802.857405	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  591.8378	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐503658.7947	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6190253	   -­‐1.5419797	   -­‐0.4078239	  
C	   6	   -­‐0.7627205	   -­‐1.5676442	   -­‐0.3403067	  
N	   7	   -­‐1.2101896	   -­‐0.3088748	   -­‐0.0367705	  
N	   7	   -­‐0.1536048	   0.5523998	   0.1129437	  
C	   6	   0.9405550	   -­‐0.1864878	   -­‐0.1083434	  
C	   6	   1.5006064	   -­‐2.6963825	   -­‐0.7842054	  
H	   1	   0.9598387	   -­‐3.4141770	   -­‐1.4124238	  
H	   1	   1.8810409	   -­‐3.2458470	   0.0859163	  
H	   1	   2.3647230	   -­‐2.3610609	   -­‐1.3655826	  
C	   6	   2.2664195	   0.4566920	   -­‐0.0613719	  
C	   6	   4.7831802	   1.7181873	   0.0323677	  
C	   6	   3.4134765	   -­‐0.2538861	   0.3290590	  
C	   6	   2.4035742	   1.8152623	   -­‐0.3970127	  
C	   6	   3.6478726	   2.4379771	   -­‐0.3494189	  
C	   6	   4.6598900	   0.3714472	   0.3733615	  
H	   1	   3.7322454	   3.4871297	   -­‐0.6172362	  
H	   1	   5.5328870	   -­‐0.1954986	   0.6823726	  
H	   1	   3.3283444	   -­‐1.2938586	   0.6241404	  
H	   1	   1.5213391	   2.3701210	   -­‐0.6986160	  
H	   1	   5.7530943	   2.2050815	   0.0642763	  
C	   6	   -­‐2.5372962	   0.1459544	   0.2047603	  
C	   6	   -­‐5.1230323	   1.0886885	   0.7023162	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C	   6	   -­‐3.6313975	   -­‐0.4472634	   -­‐0.4355218	  
C	   6	   -­‐4.9182968	   0.0237368	   -­‐0.1744576	  
C	   6	   -­‐4.0244075	   1.6852435	   1.3241675	  
H	   1	   -­‐1.8744415	   1.6717303	   1.5608996	  
H	   1	   -­‐3.4790075	   -­‐1.2640530	   -­‐1.1284014	  
H	   1	   -­‐5.7619109	   -­‐0.4436996	   -­‐0.6728570	  
H	   1	   -­‐4.1673822	   2.5163474	   2.0078957	  
H	   1	   -­‐6.1265651	   1.4526225	   0.8979332	  
O	   8	   -­‐1.6503479	   -­‐2.5780193	   -­‐0.5216694	  
H	   1	   -­‐1.1530541	   -­‐3.4176595	   -­‐0.5741992	  
	  
Table	   3-­‐83.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐10	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   33	   0.21	   32	   775	   46.75	   63	   1366	   6.51	  
2	   37	   1.16	   33	   785	   2.99	   64	   1370	   5.28	  
3	   64	   7.57	   34	   794	   30.19	   65	   1413	   405.59	  
4	   71	   0.70	   35	   853	   0.55	   66	   1450	   1.55	  
5	   91	   0.44	   36	   861	   0.82	   67	   1482	   41.49	  
6	   145	   2.02	   37	   927	   5.59	   68	   1486	   76.62	  
7	   156	   0.37	   38	   933	   4.54	   69	   1495	   64.93	  
8	   186	   2.61	   39	   969	   1.18	   70	   1512	   18.32	  
9	   241	   89.46	   40	   971	   0.54	   71	   1520	   3.40	  
10	   249	   34.21	   41	   981	   83.63	   72	   1532	   101.95	  
11	   261	   1.79	   42	   994	   0.32	   73	   1551	   213.65	  
12	   272	   4.47	   43	   996	   0.29	   74	   1560	   7.10	  
13	   304	   21.66	   44	   1017	   1.11	   75	   1611	   224.36	  
14	   311	   1.79	   45	   1019	   0.06	   76	   1641	   18.21	  
15	   343	   4.61	   46	   1032	   49.91	   77	   1651	   32.05	  
16	   397	   11.68	   47	   1057	   11.15	   78	   1660	   80.33	  
17	   418	   0.03	   48	   1066	   9.39	   79	   1665	   2.02	  
18	   420	   1.18	   49	   1073	   0.86	   80	   3048	   55.86	  
19	   431	   1.74	   50	   1102	   94.39	   81	   3099	   31.57	  
20	   500	   5.30	   51	   1112	   3.01	   82	   3129	   20.36	  
21	   530	   5.37	   52	   1115	   20.28	   83	   3202	   3.89	  
22	   627	   24.00	   53	   1146	   67.51	   84	   3209	   1.06	  
23	   629	   3.79	   54	   1190	   0.98	   85	   3209	   9.29	  
24	   633	   1.09	   55	   1192	   0.08	   86	   3218	   22.75	  
25	   648	   6.75	   56	   1211	   13.44	   87	   3220	   31.39	  
26	   664	   2.78	   57	   1212	   1.78	   88	   3227	   44.42	  
27	   684	   10.88	   58	   1224	   95.98	   89	   3230	   36.73	  
28	   706	   23.97	   59	   1266	   36.12	   90	   3235	   14.81	  
29	   712	   36.75	   60	   1322	   42.29	   91	   3246	   4.83	  
30	   721	   13.62	   61	   1338	   40.01	   92	   3263	   1.62	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31	   749	   54.81	   62	   1358	   42.80	   93	   3678	   247.95	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐802.396021	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  559.9689	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐503376.889	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.5877823	   -­‐1.6487395	   -­‐0.5006172	  
C	   6	   -­‐0.8220144	   -­‐1.7396280	   -­‐0.4572379	  
N	   7	   -­‐1.2498622	   -­‐0.4490629	   -­‐0.0484478	  
N	   7	   -­‐0.1831551	   0.4068535	   0.1546939	  
C	   6	   0.9086299	   -­‐0.3221948	   -­‐0.1225465	  
C	   6	   1.4466011	   -­‐2.7899562	   -­‐0.9539548	  
H	   1	   0.8112985	   -­‐3.5315763	   -­‐1.4526901	  
H	   1	   1.9573597	   -­‐3.3145024	   -­‐0.1321617	  
H	   1	   2.2231495	   -­‐2.4776978	   -­‐1.6633283	  
C	   6	   2.2291824	   0.3272171	   -­‐0.0217897	  
C	   6	   4.7393409	   1.6118817	   0.1782162	  
C	   6	   3.4130714	   -­‐0.4144293	   0.1366930	  
C	   6	   2.3341554	   1.7307083	   -­‐0.0720907	  
C	   6	   3.5701037	   2.3630683	   0.0288553	  
C	   6	   4.6521531	   0.2210286	   0.2327917	  
H	   1	   3.6185338	   3.4474429	   -­‐0.0162790	  
H	   1	   5.5484665	   -­‐0.3797918	   0.3568734	  
H	   1	   3.3588974	   -­‐1.4950530	   0.2021845	  
H	   1	   1.4237230	   2.3078141	   -­‐0.1948343	  
H	   1	   5.7032688	   2.1060004	   0.2516160	  
C	   6	   -­‐2.5586502	   0.0282472	   0.1754316	  
C	   6	   -­‐5.1533108	   1.0400719	   0.6278965	  
C	   6	   -­‐2.7455969	   1.3419436	   0.6438939	  
C	   6	   -­‐3.6893078	   -­‐0.7742876	   -­‐0.0635151	  
C	   6	   -­‐4.9668576	   -­‐0.2626744	   0.1644642	  
C	   6	   -­‐4.0294093	   1.8344226	   0.8645367	  
H	   1	   -­‐1.8710045	   1.9536050	   0.8256370	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H	   1	   -­‐5.8227922	   -­‐0.9035756	   -­‐0.0287253	  
H	   1	   -­‐4.1445891	   2.8521298	   1.2269159	  
H	   1	   -­‐6.1517268	   1.4282331	   0.8020086	  
O	   8	   -­‐1.5995240	   -­‐2.7140975	   -­‐0.7228374	  
	  
	  
Table	   3-­‐85.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐10anion	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   23	   0.02	   31	   767	   78.68	   61	   1358	   85.32	  
2	   30	   1.13	   32	   787	   25.05	   62	   1364	   25.98	  
3	   56	   3.46	   33	   807	   0.83	   63	   1366	   33.17	  
4	   80	   3.31	   34	   855	   0.02	   64	   1431	   68.17	  
5	   90	   2.46	   35	   859	   0.65	   65	   1461	   127.51	  
6	   165	   2.61	   36	   907	   4.90	   66	   1482	   6.70	  
7	   182	   2.19	   37	   927	   3.99	   67	   1496	   77.64	  
8	   192	   0.87	   38	   962	   0.13	   68	   1515	   18.17	  
9	   241	   0.42	   39	   965	   2.04	   69	   1518	   379.82	  
10	   264	   5.04	   40	   977	   54.29	   70	   1534	   36.86	  
11	   265	   1.94	   41	   978	   12.57	   71	   1536	   364.43	  
12	   287	   1.61	   42	   983	   1.00	   72	   1560	   47.56	  
13	   325	   26.81	   43	   1014	   9.71	   73	   1592	   582.92	  
14	   361	   2.42	   44	   1016	   0.34	   74	   1634	   14.54	  
15	   395	   10.61	   45	   1027	   70.91	   75	   1639	   40.39	  
16	   416	   4.75	   46	   1056	   3.08	   76	   1656	   287.35	  
17	   419	   0.42	   47	   1063	   5.42	   77	   1662	   5.37	  
18	   420	   0.86	   48	   1073	   1.64	   78	   3016	   146.13	  
19	   508	   4.23	   49	   1095	   12.10	   79	   3069	   46.62	  
20	   531	   3.06	   50	   1106	   38.44	   80	   3105	   41.48	  
21	   629	   19.03	   51	   1112	   37.47	   81	   3202	   14.01	  
22	   633	   0.16	   52	   1162	   39.01	   82	   3203	   0.48	  
23	   635	   16.90	   53	   1179	   0.98	   83	   3208	   32.52	  
24	   671	   13.25	   54	   1184	   0.10	   84	   3210	   13.70	  
25	   682	   11.48	   55	   1198	   21.34	   85	   3222	   31.88	  
26	   689	   19.35	   56	   1208	   3.84	   86	   3228	   42.54	  
27	   704	   10.82	   57	   1228	   108.56	   87	   3230	   32.71	  
28	   709	   25.68	   58	   1312	   7.95	   88	   3237	   20.69	  
29	   734	   30.88	   59	   1336	   70.24	   89	   3250	   5.94	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  	  	  -­‐933.372296	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  642.0662	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐585546.0586	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6850904	   -­‐1.4545779	   -­‐0.2182886	  
C	   6	   -­‐0.8513867	   -­‐1.4496239	   -­‐0.1897632	  
N	   7	   -­‐1.2322829	   -­‐0.1256317	   -­‐0.1167440	  
N	   7	   -­‐0.1319754	   0.7339636	   -­‐0.0702362	  
C	   6	   0.9628826	   0.0406611	   -­‐0.1070471	  
O	   8	   -­‐1.5872908	   -­‐2.4352332	   -­‐0.2214676	  
C	   6	   1.1636317	   -­‐2.0868864	   -­‐1.5354078	  
H	   1	   0.7536342	   -­‐3.0951320	   -­‐1.6183335	  
H	   1	   2.2527805	   -­‐2.1473983	   -­‐1.5798884	  
H	   1	   0.8204587	   -­‐1.4957583	   -­‐2.3903047	  
N	   7	   1.1245847	   -­‐2.1166907	   1.0346444	  
H	   1	   2.1285027	   -­‐1.9586819	   1.1440246	  
O	   8	   1.0462816	   -­‐3.5529657	   0.8786509	  
H	   1	   0.2487414	   -­‐3.7790549	   1.3868325	  
C	   6	   2.2684791	   0.7128273	   -­‐0.0503085	  
C	   6	   4.7395962	   2.0551694	   0.0855368	  
C	   6	   3.4796683	   0.0026086	   -­‐0.1220755	  
C	   6	   2.3217714	   2.1146356	   0.0918799	  
C	   6	   3.5417087	   2.7744032	   0.1564857	  
C	   6	   4.7028734	   0.6695156	   -­‐0.0531301	  
H	   1	   3.5605634	   3.8543372	   0.2654562	  
H	   1	   5.6249166	   0.1001397	   -­‐0.1112976	  
H	   1	   3.4826797	   -­‐1.0742238	   -­‐0.2419299	  
H	   1	   1.3941304	   2.6718797	   0.1519862	  
H	   1	   5.6912117	   2.5746515	   0.1384401	  
C	   6	   -­‐2.5355596	   0.4408332	   -­‐0.0386223	  
C	   6	   -­‐5.0806281	   1.6034625	   0.1264071	  
C	   6	   -­‐2.6679045	   1.8290255	   0.1069274	  
C	   6	   -­‐3.6806154	   -­‐0.3670378	   -­‐0.1039676	  
C	   6	   -­‐4.9411877	   0.2236066	   -­‐0.0203399	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H	   1	   -­‐1.7800972	   2.4447934	   0.1559613	  
H	   1	   -­‐3.5787873	   -­‐1.4369623	   -­‐0.2152150	  
H	   1	   -­‐5.8199457	   -­‐0.4121162	   -­‐0.0713553	  
H	   1	   -­‐4.0236929	   3.4752117	   0.3022628	  
H	   1	   -­‐6.0666718	   2.0520643	   0.1911934	  
	  
Table	   3-­‐87.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐10	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   18	   0.15	   35	   760	   20.39	   69	   1356	   10.14	  
2	   34	   1.10	   36	   775	   60.41	   70	   1365	   32.57	  
3	   49	   1.51	   37	   790	   14.26	   71	   1370	   2.08	  
4	   68	   1.22	   38	   803	   31.92	   72	   1375	   98.29	  
5	   78	   0.35	   39	   858	   0.20	   73	   1412	   195.60	  
6	   99	   4.89	   40	   859	   0.49	   74	   1430	   15.55	  
7	   120	   0.25	   41	   884	   46.68	   75	   1492	   7.80	  
8	   165	   4.60	   42	   901	   26.37	   76	   1504	   4.37	  
9	   187	   10.66	   43	   929	   5.12	   77	   1507	   16.11	  
10	   215	   12.99	   44	   943	   3.40	   78	   1513	   3.99	  
11	   232	   2.28	   45	   952	   42.81	   79	   1525	   18.14	  
12	   253	   45.76	   46	   976	   0.04	   80	   1541	   203.93	  
13	   260	   10.32	   47	   980	   0.52	   81	   1546	   21.97	  
14	   264	   0.32	   48	   999	   0.76	   82	   1612	   48.12	  
15	   277	   37.31	   49	   1007	   0.75	   83	   1639	   2.64	  
16	   303	   52.80	   50	   1015	   3.39	   84	   1649	   19.73	  
17	   329	   9.01	   51	   1017	   24.37	   85	   1658	   105.97	  
18	   346	   21.08	   52	   1018	   10.46	   86	   1663	   2.26	  
19	   373	   0.49	   53	   1023	   48.25	   87	   1700	   678.40	  
20	   411	   6.84	   54	   1060	   5.25	   88	   3084	   14.02	  
21	   415	   0.03	   55	   1063	   4.99	   89	   3157	   17.73	  
22	   419	   0.07	   56	   1101	   53.68	   90	   3177	   17.63	  
23	   495	   2.25	   57	   1113	   34.32	   91	   3208	   2.99	  
24	   501	   15.13	   58	   1119	   2.52	   92	   3208	   1.33	  
25	   531	   3.25	   59	   1141	   28.12	   93	   3216	   26.99	  
26	   631	   2.62	   60	   1170	   162.37	   94	   3217	   10.55	  
27	   631	   1.05	   61	   1190	   0.54	   95	   3227	   36.18	  
28	   638	   37.52	   62	   1196	   0.03	   96	   3230	   34.23	  
29	   674	   24.42	   63	   1198	   67.28	   97	   3236	   31.94	  
30	   675	   11.16	   64	   1212	   4.62	   98	   3239	   8.30	  
31	   681	   61.98	   65	   1219	   1.50	   99	   3263	   0.96	  
32	   705	   35.67	   66	   1254	   81.02	   100	   3272	   3.90	  
33	   708	   17.94	   67	   1323	   250.44	   101	   3467	   31.71	  
34	   741	   23.21	   68	   1349	   62.33	   102	   3721	   111.77	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   -­‐932.875214	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  598.8653	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   Not	  a	  ground	  state	  structure;	  HNO	  is	  dissociated	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6208385	   -­‐1.2860540	   0.6656423	  
C	   6	   -­‐0.8112153	   -­‐1.3671016	   0.6841239	  
N	   7	   -­‐1.2444588	   -­‐0.0938899	   0.2585264	  
N	   7	   -­‐0.1771051	   0.7648798	   0.0290382	  
C	   6	   0.9193137	   0.0612257	   0.2928946	  
O	   8	   -­‐1.5620971	   -­‐2.3170827	   1.0284011	  
N	   7	   0.6796230	   -­‐2.1687163	   -­‐1.6363697	  
H	   1	   1.1648782	   -­‐1.2484115	   -­‐1.8398544	  
O	   8	   1.5486646	   -­‐3.0650790	   -­‐1.6038462	  
C	   6	   -­‐2.5582049	   0.3835152	   0.0503369	  
C	   6	   -­‐5.1541459	   1.3879612	   -­‐0.3792844	  
C	   6	   -­‐3.6778669	   -­‐0.4515827	   0.2084836	  
C	   6	   -­‐2.7524241	   1.7240395	   -­‐0.3259289	  
C	   6	   -­‐4.0391680	   2.2132490	   -­‐0.5371203	  
C	   6	   -­‐4.9584101	   0.0578721	   -­‐0.0067834	  
H	   1	   -­‐3.5230971	   -­‐1.4813578	   0.4989275	  
H	   1	   -­‐1.8843208	   2.3586941	   -­‐0.4496016	  
H	   1	   -­‐4.1637464	   3.2522055	   -­‐0.8286242	  
H	   1	   -­‐5.8084707	   -­‐0.6065086	   0.1208261	  
H	   1	   -­‐6.1549597	   1.7735803	   -­‐0.5451710	  
C	   6	   1.4940225	   -­‐2.3292042	   1.2652167	  
H	   1	   2.3282155	   -­‐1.8969897	   1.8276544	  
H	   1	   1.9223784	   -­‐2.9959827	   0.4916114	  
H	   1	   0.9073198	   -­‐2.9630433	   1.9403888	  
C	   6	   2.2425797	   0.6976480	   0.1675166	  
C	   6	   4.7643040	   1.9264876	   -­‐0.0846158	  
C	   6	   2.3955678	   2.0779643	   0.3881807	  
C	   6	   3.3758414	   -­‐0.0546104	   -­‐0.1893711	  
C	   6	   4.6238540	   0.5571211	   -­‐0.3127798	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H	   1	   1.5199800	   2.6572093	   0.6622742	  
H	   1	   3.2684785	   -­‐1.1150869	   -­‐0.3976961	  
H	   1	   5.4839347	   -­‐0.0429939	   -­‐0.5949038	  
H	   1	   3.7383065	   3.7514281	   0.4426956	  
H	   1	   5.7371308	   2.3994048	   -­‐0.1775215	  
	  
Table	   3-­‐89.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐10anion	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   24	   0.20	   34	   714	   24.95	   67	   1359	   663.49	  
2	   37	   2.61	   35	   740	   68.67	   68	   1366	   359.05	  
3	   40	   4.61	   36	   764	   54.79	   69	   1372	   10.15	  
4	   59	   0.68	   37	   772	   104.57	   70	   1379	   472.29	  
5	   68	   2.60	   38	   786	   25.83	   71	   1454	   146.69	  
6	   91	   4.47	   39	   808	   2.19	   72	   1473	   22.88	  
7	   116	   7.08	   40	   856	   0.05	   73	   1487	   20.82	  
8	   140	   36.06	   41	   867	   1.00	   74	   1499	   7.83	  
9	   159	   5.47	   42	   912	   4.68	   75	   1510	   32.03	  
10	   168	   7.33	   43	   939	   5.26	   76	   1527	   172.23	  
11	   209	   5.17	   44	   966	   0.04	   77	   1536	   16.13	  
12	   225	   1.57	   45	   971	   101.83	   78	   1539	   306.12	  
13	   244	   6.36	   46	   976	   7.07	   79	   1550	   97.27	  
14	   262	   4.18	   47	   981	   1.02	   80	   1560	   19.45	  
15	   268	   7.48	   48	   994	   5.65	   81	   1604	   697.37	  
16	   287	   99.77	   49	   1015	   6.73	   82	   1636	   5.62	  
17	   324	   18.20	   50	   1016	   0.35	   83	   1640	   56.14	  
18	   332	   2.43	   51	   1032	   78.78	   84	   1658	   250.28	  
19	   379	   2.93	   52	   1058	   3.62	   85	   1663	   8.35	  
20	   394	   8.37	   53	   1065	   14.28	   86	   2937	   117.92	  
21	   420	   0.25	   54	   1079	   105.37	   87	   2951	   70.12	  
22	   420	   0.26	   55	   1096	   15.59	   88	   3077	   54.72	  
23	   445	   2.59	   56	   1110	   29.61	   89	   3126	   30.43	  
24	   509	   5.55	   57	   1120	   53.45	   90	   3198	   4.91	  
25	   528	   5.55	   58	   1152	   33.70	   91	   3203	   8.56	  
26	   631	   6.30	   59	   1181	   0.25	   92	   3206	   0.82	  
27	   631	   0.21	   60	   1185	   0.52	   93	   3210	   31.51	  
28	   637	   29.34	   61	   1203	   8.34	   94	   3214	   20.24	  
29	   666	   44.84	   62	   1215	   0.47	   95	   3222	   45.41	  
30	   679	   34.67	   63	   1233	   105.36	   96	   3228	   35.64	  
31	   684	   26.18	   64	   1325	   165.56	   97	   3231	   30.28	  
32	   697	   7.33	   65	   1339	   34.94	   98	   3253	   3.93	  
33	   705	   11.43	   66	   1344	   178.07	   99	   3258	   8.56	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Table	  3-­‐90.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐11	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1070.715916	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  430.195	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐671781.0547	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2518005	   -­‐0.5980621	   0.5122775	  
C	   6	   2.4249337	   0.1091910	   0.2888789	  
N	   7	   2.1298133	   1.2256819	   -­‐0.4223208	  
N	   7	   0.7950345	   1.3109130	   -­‐0.6762665	  
C	   6	   0.2645184	   0.2071882	   -­‐0.1224044	  
C	   6	   3.0448283	   2.2802394	   -­‐0.8311217	  
H	   1	   2.6728788	   2.7153555	   -­‐1.7587098	  
H	   1	   4.0334008	   1.8514617	   -­‐0.9975443	  
H	   1	   3.1152361	   3.0612414	   -­‐0.0679351	  
C	   6	   1.1243018	   -­‐1.8658631	   1.3041563	  
H	   1	   1.1179793	   -­‐2.7666788	   0.6773598	  
H	   1	   0.2065188	   -­‐1.8733620	   1.9004758	  
H	   1	   1.9560881	   -­‐1.9707971	   2.0110970	  
C	   6	   -­‐1.1898147	   -­‐0.0102012	   -­‐0.2084521	  
C	   6	   -­‐3.9619952	   -­‐0.3771073	   -­‐0.3807061	  
C	   6	   -­‐1.7523254	   -­‐1.2966452	   -­‐0.1777530	  
C	   6	   -­‐2.0587659	   1.0877278	   -­‐0.3387105	  
C	   6	   -­‐3.4361190	   0.9134118	   -­‐0.4270946	  
C	   6	   -­‐3.1317532	   -­‐1.4872732	   -­‐0.2593203	  
H	   1	   -­‐4.0953446	   1.7688897	   -­‐0.5225919	  
H	   1	   -­‐3.5524999	   -­‐2.4864577	   -­‐0.2368829	  
H	   1	   -­‐1.1117487	   -­‐2.1683842	   -­‐0.1125449	  
H	   1	   -­‐1.6395924	   2.0874155	   -­‐0.3676247	  
Cl	   17	   -­‐5.7125828	   -­‐0.6030888	   -­‐0.4773068	  
O	   8	   3.7175608	   -­‐0.1062282	   0.6623692	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Table	   3-­‐91.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐11	  	  	  	  	  	  	  	  
	  	  	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   41	   1.01	   25	   715	   9.45	   49	   1448	   46.20	  
2	   54	   0.62	   26	   743	   12.97	   50	   1454	   23.81	  
3	   78	   1.60	   27	   749	   44.35	   51	   1472	   29.57	  
4	   87	   0.88	   28	   823	   12.10	   52	   1480	   98.96	  
5	   133	   11.68	   29	   837	   6.80	   53	   1510	   34.40	  
6	   150	   9.99	   30	   851	   42.41	   54	   1518	   2.61	  
7	   174	   1.03	   31	   955	   1.68	   55	   1527	   29.72	  
8	   201	   116.27	   32	   975	   0.34	   56	   1530	   14.29	  
9	   227	   1.99	   33	   1016	   25.42	   57	   1550	   51.29	  
10	   238	   9.56	   34	   1024	   106.41	   58	   1565	   154.50	  
11	   275	   8.15	   35	   1046	   93.02	   59	   1605	   95.89	  
12	   283	   5.76	   36	   1073	   7.58	   60	   1631	   43.34	  
13	   296	   10.72	   37	   1080	   6.90	   61	   1651	   1.59	  
14	   319	   2.78	   38	   1097	   91.83	   62	   3046	   54.73	  
15	   359	   1.13	   39	   1139	   7.00	   63	   3089	   77.45	  
16	   409	   1.67	   40	   1150	   137.82	   64	   3098	   35.21	  
17	   422	   0.16	   41	   1185	   31.01	   65	   3124	   25.08	  
18	   481	   61.39	   42	   1209	   0.09	   66	   3168	   12.52	  
19	   519	   10.82	   43	   1264	   44.87	   67	   3202	   4.21	  
20	   578	   3.72	   44	   1281	   18.84	   68	   3226	   4.77	  
21	   612	   4.57	   45	   1308	   55.33	   69	   3231	   3.34	  
22	   644	   1.23	   46	   1331	   15.20	   70	   3240	   10.53	  
23	   661	   0.51	   47	   1337	   17.37	   71	   3245	   5.00	  
24	   706	   2.80	   48	   1402	   203.52	   72	   3687	   230.58	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1070.249995	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  400.0009	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.4250965	   -­‐0.6924571	   0.4543984	  
C	   6	   2.6377142	   0.0309382	   0.3114764	  
N	   7	   2.2488660	   1.2493368	   -­‐0.2427793	  
N	   7	   0.9009310	   1.3453544	   -­‐0.4538949	  
C	   6	   0.4038333	   0.1659918	   -­‐0.0304670	  
C	   6	   3.1195936	   2.3547442	   -­‐0.5736850	  
H	   1	   3.0771841	   2.5854211	   -­‐1.6439065	  
H	   1	   4.1352147	   2.0593725	   -­‐0.3052537	  
H	   1	   2.8412982	   3.2551339	   -­‐0.0152845	  
C	   6	   1.3870493	   -­‐2.0765982	   1.0287998	  
H	   1	   1.0197794	   -­‐2.8348430	   0.3224716	  
H	   1	   0.7681769	   -­‐2.1570887	   1.9333641	  
H	   1	   2.4079439	   -­‐2.3635767	   1.3073333	  
C	   6	   -­‐1.0509396	   -­‐0.0421594	   -­‐0.1247114	  
C	   6	   -­‐3.8398327	   -­‐0.3695892	   -­‐0.3197644	  
C	   6	   -­‐1.6754536	   -­‐1.2409101	   0.2635885	  
C	   6	   -­‐1.8787253	   0.9869129	   -­‐0.6192540	  
C	   6	   -­‐3.2564871	   0.8332999	   -­‐0.7189639	  
C	   6	   -­‐3.0576782	   -­‐1.4097020	   0.1703812	  
H	   1	   -­‐3.8721947	   1.6399439	   -­‐1.1017165	  
H	   1	   -­‐3.5162460	   -­‐2.3430436	   0.4784494	  
H	   1	   -­‐1.0788006	   -­‐2.0590494	   0.6460662	  
H	   1	   -­‐1.4123823	   1.9169838	   -­‐0.9243198	  
Cl	   17	   -­‐5.5872521	   -­‐0.5684468	   -­‐0.4350212	  
O	   8	   3.8533111	   -­‐0.2659694	   0.5926930	  
	  
	  
Table	   3-­‐93.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐11anion	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   20	   0.17	   24	   721	   0.37	   47	   1423	   79.97	  
2	   53	   0.16	   25	   748	   24.25	   48	   1438	   17.32	  
3	   57	   1.08	   26	   776	   35.56	   49	   1455	   42.29	  
4	   108	   0.20	   27	   835	   4.52	   50	   1461	   81.02	  
5	   122	   12.91	   28	   848	   17.85	   51	   1504	   534.06	  
6	   139	   0.05	   29	   850	   34.38	   52	   1517	   5.80	  
7	   235	   0.56	   30	   951	   0.02	   53	   1525	   20.50	  
8	   238	   0.38	   31	   976	   0.14	   54	   1530	   3.65	  
9	   250	   0.74	   32	   1014	   60.33	   55	   1541	   16.93	  
10	   255	   12.33	   33	   1025	   13.09	   56	   1554	   54.52	  
11	   290	   7.64	   34	   1044	   36.80	   57	   1568	   679.71	  
12	   306	   14.51	   35	   1053	   30.99	   58	   1622	   4.27	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13	   314	   0.57	   36	   1072	   0.38	   59	   1649	   4.75	  
14	   381	   5.06	   37	   1102	   66.37	   60	   3021	   132.30	  
15	   385	   4.72	   38	   1138	   16.65	   61	   3060	   49.26	  
16	   421	   0.08	   39	   1171	   1.49	   62	   3061	   167.52	  
17	   487	   89.03	   40	   1207	   8.22	   63	   3100	   46.68	  
18	   520	   4.91	   41	   1220	   45.96	   64	   3117	   41.89	  
19	   580	   18.84	   42	   1282	   105.10	   65	   3176	   7.67	  
20	   639	   3.48	   43	   1293	   55.23	   66	   3225	   3.37	  
21	   654	   4.14	   44	   1331	   4.96	   67	   3231	   4.32	  
22	   677	   2.80	   45	   1336	   8.76	   68	   3239	   11.57	  
23	   720	   14.72	   46	   1388	   73.42	   69	   3258	   7.60	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1201.230331	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  480.9956	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753667.8831	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.7456823	   -­‐0.6788200	   0.2144890	  
C	   6	   3.0286965	   0.1651453	   0.1129251	  
N	   7	   2.6149644	   1.4577745	   -­‐0.0133936	  
N	   7	   1.2340914	   1.5920486	   -­‐0.0521997	  
C	   6	   0.6923159	   0.4168513	   0.0551792	  
O	   8	   4.1984846	   -­‐0.2298326	   0.1391310	  
C	   6	   3.4487285	   2.6384016	   -­‐0.1566082	  
H	   1	   3.2792916	   3.1105660	   -­‐1.1275954	  
H	   1	   4.4880555	   2.3191341	   -­‐0.0811883	  
H	   1	   3.2254139	   3.3563943	   0.6357755	  
C	   6	   1.7097332	   -­‐1.3847856	   1.5798629	  
H	   1	   2.6020638	   -­‐2.0046604	   1.6856240	  
H	   1	   0.8281522	   -­‐2.0215208	   1.6798203	  
H	   1	   1.6922063	   -­‐0.6511661	   2.3919213	  
N	   7	   1.7149915	   -­‐1.5560907	   -­‐0.9819664	  
H	   1	   0.7932286	   -­‐1.9960883	   -­‐1.0315031	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H	   1	   3.3697030	   -­‐2.4596622	   -­‐1.3015316	  
C	   6	   -­‐0.7688461	   0.2716010	   0.0303977	  
C	   6	   -­‐3.5592270	   0.0693836	   -­‐0.0284572	  
C	   6	   -­‐1.4066537	   -­‐0.9696437	   0.1937991	  
C	   6	   -­‐1.5735207	   1.4121454	   -­‐0.1663263	  
C	   6	   -­‐2.9573688	   1.3185353	   -­‐0.1951346	  
C	   6	   -­‐2.7966755	   -­‐1.0775060	   0.1638517	  
H	   1	   -­‐3.5663170	   2.2022616	   -­‐0.3467142	  
H	   1	   -­‐3.2762776	   -­‐2.0409970	   0.2923746	  
H	   1	   -­‐0.8308444	   -­‐1.8724597	   0.3580895	  
H	   1	   -­‐1.0965560	   2.3764063	   -­‐0.2967558	  
Cl	   17	   -­‐5.3209297	   -­‐0.0516556	   -­‐0.0637007	  
	  
Table	   3-­‐95.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐11	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   22	   0.71	   28	   712	   5.66	   55	   1367	   68.06	  
2	   54	   1.08	   29	   729	   11.70	   56	   1432	   87.50	  
3	   69	   2.03	   30	   745	   27.42	   57	   1436	   85.10	  
4	   84	   3.70	   31	   763	   27.43	   58	   1448	   14.18	  
5	   92	   0.78	   32	   817	   37.51	   59	   1472	   10.30	  
6	   113	   6.46	   33	   836	   10.96	   60	   1509	   5.86	  
7	   133	   2.25	   34	   853	   35.56	   61	   1514	   12.71	  
8	   154	   2.92	   35	   884	   39.30	   62	   1517	   18.92	  
9	   208	   3.30	   36	   940	   44.65	   63	   1528	   7.14	  
10	   222	   3.08	   37	   960	   1.17	   64	   1538	   10.75	  
11	   234	   39.38	   38	   969	   44.45	   65	   1539	   81.29	  
12	   240	   1.80	   39	   988	   0.18	   66	   1596	   29.48	  
13	   280	   74.87	   40	   1020	   79.49	   67	   1629	   17.16	  
14	   289	   1.09	   41	   1035	   75.53	   68	   1649	   45.56	  
15	   294	   8.06	   42	   1039	   42.26	   69	   1684	   816.60	  
16	   319	   10.97	   43	   1068	   116.69	   70	   3088	   74.78	  
17	   350	   45.62	   44	   1097	   104.65	   71	   3092	   12.86	  
18	   357	   2.90	   45	   1130	   9.05	   72	   3160	   15.38	  
19	   376	   2.67	   46	   1150	   9.57	   73	   3161	   15.70	  
20	   420	   0.19	   47	   1175	   2.66	   74	   3199	   2.06	  
21	   427	   23.05	   48	   1195	   18.11	   75	   3205	   21.30	  
22	   481	   62.22	   49	   1220	   3.29	   76	   3235	   5.68	  
23	   513	   9.20	   50	   1249	   59.32	   77	   3237	   0.08	  
24	   620	   56.91	   51	   1264	   133.16	   78	   3249	   10.65	  
25	   637	   4.31	   52	   1330	   35.96	   79	   3250	   2.16	  
26	   662	   27.79	   53	   1341	   30.73	   80	   3464	   30.44	  
27	   669	   11.35	   54	   1355	   98.71	   81	   3721	   113.44	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B3LYP/6-­‐31G*	  Energy	  (E):	  	  	  	   	  	  	  	  	  -­‐1200.723566	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  449.1237	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753357.501	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2948369	   -­‐0.6741042	   0.4013380	  
C	   6	   2.5510678	   0.1403525	   0.1227574	  
N	   7	   2.1487305	   1.1913447	   -­‐0.6484319	  
N	   7	   0.7733111	   1.2562336	   -­‐0.8046996	  
C	   6	   0.2425771	   0.2445727	   -­‐0.1800840	  
O	   8	   3.7118643	   -­‐0.0733711	   0.4930840	  
C	   6	   2.9751961	   2.2545045	   -­‐1.1928803	  
H	   1	   2.6779548	   3.2200050	   -­‐0.7751465	  
H	   1	   2.8808814	   2.2895291	   -­‐2.2814557	  
H	   1	   4.0086214	   2.0384710	   -­‐0.9212023	  
C	   6	   1.1790899	   -­‐1.0345834	   1.8782796	  
H	   1	   1.8821904	   -­‐1.8565906	   2.0512189	  
H	   1	   0.1717026	   -­‐1.3667804	   2.1384257	  
H	   1	   1.4333279	   -­‐0.1928264	   2.5316034	  
N	   7	   1.4074698	   -­‐1.9193954	   -­‐0.5465835	  
H	   1	   0.4525575	   -­‐2.3157270	   -­‐0.4393963	  
O	   8	   2.3118557	   -­‐2.8649306	   -­‐0.0392392	  
C	   6	   -­‐1.2184887	   0.0976314	   -­‐0.1607725	  
C	   6	   -­‐4.0133177	   -­‐0.1134340	   -­‐0.1642467	  
C	   6	   -­‐2.0281232	   1.1635366	   -­‐0.6040221	  
C	   6	   -­‐1.8560979	   -­‐1.0735617	   0.2835377	  
C	   6	   -­‐3.2461754	   -­‐1.1848821	   0.2821598	  
C	   6	   -­‐3.4131302	   1.0653329	   -­‐0.6101957	  
H	   1	   -­‐3.7213462	   -­‐2.0972228	   0.6242933	  
H	   1	   -­‐4.0219523	   1.8944206	   -­‐0.9523826	  
H	   1	   -­‐1.5475368	   2.0737028	   -­‐0.9437378	  
H	   1	   -­‐1.2677857	   -­‐1.9191182	   0.6216110	  
Cl	   17	   -­‐5.7692809	   -­‐0.2431095	   -­‐0.1638320	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Table	   3-­‐97.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐11anion	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   45	   5.78	   27	   704	   33.21	   53	   1365	   123.57	  
2	   59	   0.92	   28	   715	   12.76	   54	   1415	   21.07	  
3	   76	   14.51	   29	   734	   8.13	   55	   1421	   46.59	  
4	   86	   5.27	   30	   759	   33.68	   56	   1446	   21.10	  
5	   113	   2.11	   31	   801	   68.36	   57	   1459	   72.74	  
6	   122	   9.83	   32	   839	   15.43	   58	   1509	   2.40	  
7	   159	   1.68	   33	   843	   14.23	   59	   1522	   12.15	  
8	   173	   17.87	   34	   852	   30.98	   60	   1534	   3.90	  
9	   180	   7.24	   35	   959	   131.63	   61	   1537	   23.06	  
10	   225	   2.97	   36	   970	   21.04	   62	   1538	   58.38	  
11	   243	   4.35	   37	   978	   1.00	   63	   1585	   44.72	  
12	   251	   8.41	   38	   991	   83.05	   64	   1625	   27.91	  
13	   286	   16.22	   39	   1021	   51.66	   65	   1647	   18.21	  
14	   300	   9.12	   40	   1037	   37.13	   66	   1650	   284.15	  
15	   324	   1.00	   41	   1047	   7.50	   67	   1685	   540.97	  
16	   359	   8.61	   42	   1096	   85.24	   68	   3061	   51.84	  
17	   377	   5.79	   43	   1101	   113.06	   69	   3098	   94.98	  
18	   408	   27.73	   44	   1126	   89.27	   70	   3122	   9.14	  
19	   424	   0.63	   45	   1144	   14.20	   71	   3150	   103.01	  
20	   459	   43.71	   46	   1184	   4.45	   72	   3169	   18.03	  
21	   501	   30.53	   47	   1205	   17.36	   73	   3190	   31.64	  
22	   509	   55.21	   48	   1216	   1.26	   74	   3205	   3.06	  
23	   553	   164.16	   49	   1258	   49.23	   75	   3221	   10.21	  
24	   617	   36.64	   50	   1299	   105.40	   76	   3235	   0.52	  
25	   638	   9.18	   51	   1335	   3.18	   77	   3241	   7.54	  




Table	  3-­‐98.	  	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  
for	  enol	  of	  PY-­‐12	  
	  
	  
B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  -­‐1070.710534	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  430.0694	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2687381	   -­‐0.6845066	   0.1740961	  
C	   6	   2.4040455	   0.1142365	   0.2069352	  
N	   7	   2.0374216	   1.3981192	   -­‐0.0316850	  
N	   7	   0.6897942	   1.5029493	   -­‐0.2132336	  
C	   6	   0.2332420	   0.2450688	   -­‐0.1018371	  
C	   6	   2.8908524	   2.5753940	   -­‐0.0612848	  
H	   1	   2.6800865	   3.1568968	   -­‐0.9607480	  
H	   1	   3.9305955	   2.2500359	   -­‐0.0733531	  
H	   1	   2.7173946	   3.2012915	   0.8183437	  
C	   6	   1.2095492	   -­‐2.1597120	   0.4349228	  
H	   1	   1.4419363	   -­‐2.7571421	   -­‐0.4549806	  
H	   1	   0.2124100	   -­‐2.4588550	   0.7716120	  
H	   1	   1.9108717	   -­‐2.4509551	   1.2268217	  
C	   6	   -­‐1.2251275	   0.0071254	   -­‐0.1759793	  
C	   6	   -­‐4.0272737	   -­‐0.3746367	   -­‐0.1991932	  
C	   6	   -­‐2.0733285	   0.7245014	   0.6876360	  
C	   6	   -­‐1.8384950	   -­‐0.8897698	   -­‐1.0655857	  
C	   6	   -­‐3.2187280	   -­‐1.0910967	   -­‐1.0791011	  
C	   6	   -­‐3.4529592	   0.5436595	   0.6804692	  
H	   1	   -­‐3.6487194	   -­‐1.7942695	   -­‐1.7833899	  
H	   1	   -­‐4.0752217	   1.1123322	   1.3638434	  
H	   1	   -­‐5.1009555	   -­‐0.5327519	   -­‐0.2098827	  
H	   1	   -­‐1.6148840	   1.4298166	   1.3725620	  
Cl	   17	   -­‐0.8825452	   -­‐1.7625516	   -­‐2.2715532	  
O	   8	   3.7150271	   -­‐0.1678176	   0.4452569	  
H	   1	   3.8162730	   -­‐1.1373627	   0.4993081	  
	  
	  
Table	   3-­‐99.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  enol	  of	  PY-­‐12	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   43	   1.76	   25	   724	   8.88	   49	   1448	   2.08	  
2	   44	   0.19	   26	   746	   23.37	   50	   1465	   13.12	  
3	   72	   2.89	   27	   752	   12.51	   51	   1477	   23.21	  
4	   90	   2.02	   28	   778	   45.69	   52	   1482	   132.11	  
5	   132	   5.38	   29	   825	   23.41	   53	   1510	   27.72	  
6	   136	   13.90	   30	   883	   0.47	   54	   1517	   11.95	  
7	   163	   1.16	   31	   957	   2.39	   55	   1521	   5.71	  
8	   182	   15.13	   32	   988	   0.06	   56	   1527	   35.01	  
9	   215	   104.55	   33	   1014	   13.45	   57	   1547	   4.34	  
10	   228	   2.29	   34	   1030	   60.36	   58	   1572	   155.87	  
11	   259	   8.57	   35	   1054	   125.21	   59	   1611	   85.55	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12	   292	   14.03	   36	   1072	   6.55	   60	   1623	   51.88	  
13	   298	   4.58	   37	   1078	   5.33	   61	   1654	   4.04	  
14	   314	   4.46	   38	   1088	   77.05	   62	   3049	   52.48	  
15	   357	   2.83	   39	   1149	   14.18	   63	   3093	   72.20	  
16	   421	   17.71	   40	   1161	   120.35	   64	   3100	   30.00	  
17	   453	   5.87	   41	   1185	   6.57	   65	   3130	   20.38	  
18	   473	   10.76	   42	   1192	   0.23	   66	   3165	   17.12	  
19	   522	   2.36	   43	   1256	   27.32	   67	   3205	   2.94	  
20	   576	   9.99	   44	   1288	   30.38	   68	   3214	   0.37	  
21	   615	   5.83	   45	   1294	   12.45	   69	   3223	   11.67	  
22	   654	   18.62	   46	   1308	   85.09	   70	   3234	   20.78	  
23	   662	   3.25	   47	   1333	   2.74	   71	   3241	   9.03	  
24	   707	   25.78	   48	   1408	   214.27	   72	   3690	   242.69	  
	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  -­‐1070.242766	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  399.4654	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐671491.4933	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.4297665	   -­‐0.7280154	   0.1634182	  
C	   6	   2.6149212	   0.0488761	   0.2374611	  
N	   7	   2.1806109	   1.3596018	   0.0499032	  
N	   7	   0.8227485	   1.4658153	   -­‐0.1409676	  
C	   6	   0.3855910	   0.1931895	   -­‐0.0742168	  
C	   6	   3.0180163	   2.5356561	   -­‐0.0124193	  
H	   1	   2.9909902	   2.9942252	   -­‐1.0077092	  
H	   1	   4.0387684	   2.2204458	   0.2115265	  
H	   1	   2.6975543	   3.2836594	   0.7204662	  
C	   6	   1.3895340	   -­‐2.2063190	   0.3924421	  
H	   1	   1.5828029	   -­‐2.7953073	   -­‐0.5159923	  
H	   1	   0.4166419	   -­‐2.5331395	   0.7781964	  
H	   1	   2.1559981	   -­‐2.4936633	   1.1240491	  
C	   6	   -­‐1.0719389	   -­‐0.0432802	   -­‐0.1509590	  
C	   6	   -­‐3.8863172	   -­‐0.4072599	   -­‐0.1659528	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C	   6	   -­‐1.6971193	   -­‐0.9591548	   -­‐1.0139833	  
C	   6	   -­‐3.0795610	   -­‐1.1527327	   -­‐1.0224326	  
C	   6	   -­‐3.3043341	   0.5343600	   0.6842625	  
H	   1	   -­‐3.5093976	   -­‐1.8735835	   -­‐1.7088584	  
H	   1	   -­‐3.9199002	   1.1300703	   1.3508681	  
H	   1	   -­‐4.9608276	   -­‐0.5598796	   -­‐0.1726420	  
H	   1	   -­‐1.4543899	   1.4257288	   1.3481327	  
Cl	   17	   -­‐0.7550505	   -­‐1.8676836	   -­‐2.2077211	  
O	   8	   3.8385088	   -­‐0.2759476	   0.4455808	  
	  
	  
Table	   3-­‐101.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  PY-­‐12anion	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   34	   0.98	   24	   736	   2.04	   47	   1436	   61.72	  
2	   55	   0.74	   25	   749	   27.75	   48	   1449	   113.42	  
3	   72	   0.46	   26	   769	   10.05	   49	   1461	   9.73	  
4	   92	   0.92	   27	   776	   67.65	   50	   1471	   17.52	  
5	   124	   0.08	   28	   852	   10.10	   51	   1503	   419.71	  
6	   133	   12.14	   29	   878	   0.93	   52	   1512	   15.06	  
7	   163	   1.23	   30	   947	   2.75	   53	   1522	   7.30	  
8	   178	   0.69	   31	   975	   0.21	   54	   1524	   24.77	  
9	   226	   0.83	   32	   1010	   12.77	   55	   1551	   159.30	  
10	   254	   2.59	   33	   1031	   26.05	   56	   1564	   269.46	  
11	   287	   9.44	   34	   1050	   101.13	   57	   1590	   177.55	  
12	   303	   11.69	   35	   1056	   26.17	   58	   1616	   9.37	  
13	   317	   11.82	   36	   1074	   2.95	   59	   1650	   4.57	  
14	   352	   2.44	   37	   1089	   42.89	   60	   3022	   134.55	  
15	   419	   18.92	   38	   1145	   8.52	   61	   3066	   62.38	  
16	   455	   17.71	   39	   1186	   0.22	   62	   3069	   138.62	  
17	   471	   11.45	   40	   1220	   55.00	   63	   3105	   46.12	  
18	   528	   0.72	   41	   1230	   8.34	   64	   3143	   49.99	  
19	   581	   28.23	   42	   1273	   86.46	   65	   3181	   15.45	  
20	   635	   2.09	   43	   1284	   3.70	   66	   3213	   2.54	  
21	   655	   20.92	   44	   1306	   56.17	   67	   3223	   13.37	  
22	   691	   4.95	   45	   1331	   2.35	   68	   3234	   22.73	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  -­‐1201.220982	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  481.3899	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753661.9222	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2191291	   -­‐0.8757850	   0.0806324	  
C	   6	   2.5003867	   -­‐0.0413677	   0.2509508	  
N	   7	   2.0972747	   1.1632027	   0.7498347	  
N	   7	   0.7147166	   1.2685746	   0.8905761	  
C	   6	   0.1790996	   0.1531967	   0.5204658	  
O	   8	   3.6624157	   -­‐0.3781222	   0.0053310	  
C	   6	   2.9339191	   2.3069961	   1.0667669	  
H	   1	   2.6840903	   3.1536684	   0.4223967	  
H	   1	   3.9698295	   2.0122475	   0.8992419	  
H	   1	   2.7982690	   2.5981430	   2.1109020	  
C	   6	   1.2911929	   -­‐2.1395399	   0.9487114	  
H	   1	   2.1717872	   -­‐2.7187327	   0.6637892	  
H	   1	   0.4040342	   -­‐2.7601559	   0.7983481	  
H	   1	   1.3693946	   -­‐1.8852040	   2.0106885	  
N	   7	   1.0128659	   -­‐1.1158829	   -­‐1.3672839	  
H	   1	   0.0789286	   -­‐1.5225818	   -­‐1.4733599	  
O	   8	   1.8748288	   -­‐2.1956326	   -­‐1.8046529	  
H	   1	   2.5431161	   -­‐1.7301722	   -­‐2.3356671	  
C	   6	   -­‐1.2899593	   -­‐0.0257394	   0.4982282	  
C	   6	   -­‐4.0845419	   -­‐0.4156443	   0.5093985	  
C	   6	   -­‐1.8855061	   -­‐1.0343100	   1.2782063	  
C	   6	   -­‐2.1444001	   0.7795207	   -­‐0.2791539	  
C	   6	   -­‐3.5250510	   0.5898983	   -­‐0.2769111	  
C	   6	   -­‐3.2637844	   -­‐1.2287637	   1.2895626	  
H	   1	   -­‐4.1498393	   1.2265665	   -­‐0.8927613	  
H	   1	   -­‐3.6923379	   -­‐2.0088390	   1.9095908	  
H	   1	   -­‐5.1603033	   -­‐0.5580134	   0.5067946	  
H	   1	   -­‐1.2516414	   -­‐1.6521557	   1.9031232	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Table	   3-­‐103.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐12	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   25	   0.48	   28	   704	   46.11	   55	   1370	   68.11	  
2	   55	   0.84	   29	   739	   22.31	   56	   1426	   12.59	  
3	   72	   3.93	   30	   745	   19.10	   57	   1432	   134.85	  
4	   86	   1.01	   31	   759	   34.30	   58	   1469	   6.97	  
5	   93	   0.77	   32	   776	   51.07	   59	   1473	   43.71	  
6	   116	   6.40	   33	   820	   23.69	   60	   1508	   5.85	  
7	   139	   1.32	   34	   884	   19.71	   61	   1513	   12.67	  
8	   154	   0.29	   35	   888	   17.28	   62	   1520	   14.44	  
9	   180	   13.14	   36	   936	   42.18	   63	   1527	   9.70	  
10	   233	   66.64	   37	   964	   5.40	   64	   1532	   18.53	  
11	   247	   24.96	   38	   967	   25.94	   65	   1542	   27.71	  
12	   258	   5.82	   39	   997	   0.16	   66	   1619	   4.12	  
13	   269	   18.32	   40	   1023	   60.47	   67	   1643	   17.46	  
14	   281	   7.98	   41	   1034	   57.59	   68	   1650	   18.67	  
15	   294	   5.30	   42	   1054	   76.73	   69	   1687	   658.97	  
16	   316	   19.37	   43	   1062	   89.02	   70	   3078	   15.61	  
17	   336	   3.31	   44	   1090	   14.36	   71	   3090	   62.15	  
18	   354	   17.69	   45	   1127	   8.45	   72	   3152	   15.92	  
19	   411	   17.74	   46	   1162	   6.34	   73	   3162	   15.84	  
20	   412	   7.39	   47	   1178	   2.14	   74	   3168	   15.31	  
21	   455	   10.88	   48	   1200	   3.15	   75	   3198	   2.12	  
22	   464	   12.86	   49	   1205	   8.80	   76	   3219	   2.05	  
23	   515	   1.60	   50	   1250	   99.47	   77	   3232	   13.69	  
24	   612	   43.58	   51	   1257	   50.85	   78	   3243	   8.51	  
25	   636	   8.31	   52	   1304	   6.33	   79	   3256	   5.41	  
26	   653	   21.57	   53	   1318	   25.10	   80	   3435	   23.83	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B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  -­‐1200.713193	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  445.1987	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐753351.93	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   1.2678813	   -­‐0.6989743	   -­‐0.2354491	  
C	   6	   2.5292334	   0.0969556	   0.0547601	  
N	   7	   2.1175863	   1.3808600	   0.2674859	  
N	   7	   0.7324748	   1.5103648	   0.3040883	  
C	   6	   0.2183360	   0.3409755	   0.0831598	  
O	   8	   3.7025328	   -­‐0.2962609	   0.0947223	  
C	   6	   2.9447879	   2.5293061	   0.5919196	  
H	   1	   2.7925998	   3.3268526	   -­‐0.1400153	  
H	   1	   3.9843059	   2.2016374	   0.5655375	  
H	   1	   2.7017690	   2.9065684	   1.5888003	  
C	   6	   1.2394100	   -­‐2.0391026	   0.4799732	  
H	   1	   1.9850129	   -­‐2.6691929	   -­‐0.0157334	  
H	   1	   0.2622363	   -­‐2.5181390	   0.3723935	  
H	   1	   1.4765982	   -­‐1.9560601	   1.5464223	  
N	   7	   1.2244901	   -­‐0.8711379	   -­‐1.8056417	  
H	   1	   0.2585456	   -­‐1.2601583	   -­‐1.8911308	  
O	   8	   2.1197043	   -­‐1.8624342	   -­‐2.2267148	  
C	   6	   -­‐1.2488857	   0.1630544	   0.0443132	  
C	   6	   -­‐4.0508320	   -­‐0.2145894	   0.0956645	  
C	   6	   -­‐1.8516645	   -­‐0.7734254	   0.9067195	  
C	   6	   -­‐2.1060999	   0.9079187	   -­‐0.7885184	  
C	   6	   -­‐3.4879794	   0.7222490	   -­‐0.7685295	  
C	   6	   -­‐3.2298558	   -­‐0.9636736	   0.9376613	  
H	   1	   -­‐4.1093499	   1.3122248	   -­‐1.4324461	  
H	   1	   -­‐3.6560395	   -­‐1.6896661	   1.6218398	  
H	   1	   -­‐5.1270949	   -­‐0.3526332	   0.1063234	  
H	   1	   -­‐1.2121141	   -­‐1.3347802	   1.5779229	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Table	   3-­‐105.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HAPY-­‐12anion	  	  	  	  	  	  	  	  	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   28	   3.36	   27	   700	   17.42	   53	   1353	   88.59	  
2	   49	   6.93	   28	   704	   63.01	   54	   1403	   20.11	  
3	   69	   7.36	   29	   743	   21.64	   55	   1425	   51.66	  
4	   74	   2.40	   30	   754	   36.49	   56	   1455	   69.44	  
5	   86	   11.16	   31	   773	   56.16	   57	   1466	   40.04	  
6	   119	   13.00	   32	   791	   25.81	   58	   1504	   2.19	  
7	   142	   13.15	   33	   836	   7.01	   59	   1508	   8.68	  
8	   148	   1.23	   34	   884	   0.20	   60	   1518	   20.09	  
9	   178	   0.45	   35	   958	   5.36	   61	   1524	   3.17	  
10	   196	   26.46	   36	   961	   121.91	   62	   1529	   19.66	  
11	   246	   2.74	   37	   984	   40.74	   63	   1586	   56.26	  
12	   251	   6.92	   38	   989	   41.89	   64	   1613	   15.15	  
13	   277	   2.66	   39	   1028	   76.77	   65	   1624	   46.87	  
14	   300	   21.30	   40	   1044	   11.10	   66	   1647	   7.71	  
15	   312	   2.98	   41	   1055	   49.67	   67	   1674	   666.74	  
16	   343	   0.69	   42	   1077	   44.26	   68	   3055	   49.35	  
17	   370	   48.33	   43	   1086	   27.25	   69	   3063	   129.14	  
18	   406	   20.66	   44	   1120	   30.48	   70	   3088	   83.27	  
19	   435	   5.01	   45	   1151	   6.68	   71	   3124	   6.92	  
20	   452	   8.11	   46	   1171	   2.36	   72	   3144	   32.70	  
21	   468	   4.29	   47	   1190	   1.12	   73	   3156	   19.19	  
22	   514	   46.17	   48	   1217	   13.27	   74	   3199	   3.48	  
23	   535	   153.02	   49	   1264	   93.62	   75	   3222	   0.43	  
24	   606	   51.78	   50	   1280	   28.01	   76	   3233	   8.45	  
25	   643	   26.57	   51	   1295	   10.08	   77	   3243	   10.71	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Chapter	  4.	  	  	  
Curtailing	  the	  Hydroxylaminobarbituric	  Acid	  –	  
Hydantoin	  Rearrangement	  to	  Favor	  	  	  	  	  	  	  	  	  





§ 4.1	  	  Abstract	  
Novel	   derivatives	   of	   the	   hydroxylamino-­‐barbituric	   acid	   (HABA)	   class	   of	  
nitroxyl	  (HNO)	  donors	  utilizing	  alkyl	  barbiturate	  leaving	  groups	  as	  unexpected	  HNO	  
donors	   have	   been	   synthesized.	   	   We	   previously	   reported	   the	   only	   example	   in	   the	  
HABA	  class	  of	  HNO	  donors	  that	  has	  an	  alkyl	  group	  in	  the	  R2	  position.	  	  However,	  this	  
particular	   example	   (R2	   =	   ethyl)	   produced	   negligible	   amounts	   of	   HNO	   due	   to	   a	  
competitive	   rearrangement	   mechanism.	   	   Herein,	   we	   identify	   new	   strategies	   to	  
circumvent	   this	   non-­‐HNO	   producing	   mechanism	   that	   allow	   the	   use	   of	   alkyl	  
substituents	   in	   the	  R2	  position.	   	  The	   timecourse	  and	   stoichiometry	   for	   the	   in	  vitro	  
conversion	  of	  these	  compounds	  to	  HNO	  (trapped	  as	  a	  phosphine	  aza-­‐ylide)	  and	  the	  
corresponding	   alkyl	   barbiturate	   byproduct	   were	   determined	   by	   proton	   NMR	  
spectroscopy	   under	   physiologically	   relevant	   conditions	   (pH	   7.4,	   37	   °C).	   	   HNO	   has	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§ 4.2	  	  Introduction	  
Heart	   failure,	  defined	  as	   the	   inability	  of	   the	  heart	   to	  pump	  enough	  blood	  to	  
supply	   the	   metabolic	   demands	   of	   the	   body,	   affects	   more	   than	   23	   million	   people	  
worldwide	  with	  total	  annual	  costs	  in	  2013	  of	  $32	  billion	  in	  the	  US	  alone.1-­‐3	  	  Nitroxyl	  
(HNO)	  therapy	  has	  recently	  been	  identified	  as	  a	  potential,	  alternative	  treatment	  for	  
congestive	   heart	   failure	   presumably	   due	   its	   ability	   to	   undergo	   a	   reversible	   direct	  
reaction	   with	   thiolates	   in	   selected	   target	   proteins	   causing	   increases	   in	   both	  
relaxation	   and	   contractility	   parameters	   in	   cardiovascular	   tissue.4	   	   Furthermore,	  
HNO	  treatment	  could	  also	  expand	  to	  alcoholism,	  vascular	  dysfunction,	  and	  cancer.5-­‐8	  
	   Limiting	   these	   efforts	   has	   been	   the	   lack	   of	   viable	   HNO	   donor	   platforms	  
amenable	   to	   structure	   activity	   relationship	   studies	   designed	   to	   optimize	  
physiochemical	   and	   physiological	   properties.	   	   A	   balance	   between	   reactivity	   and	  
stability	  is	  inherent	  for	  HNO	  donors,	  which	  are	  required	  to	  be	  stable	  enough	  to	  store	  
and	   handle,	   yet	   reactive	   enough	   to	   evolve	   HNO,	   a	   very	   reactive	   gas,	   under	   mild	  
conditions	  (i.e.,	  pH	  7.4,	  37	  °C).	  	  As	  such,	  HNO	  evolution	  from	  molecular	  architectures	  
with	   high	   reactive	   potentials	   is	   often	   in	   competition	   with	   alternative,	   undesired	  
decomposition	  pathways.	   	  Thus,	  most	   all	  HNO	  donors	   reported	   to	  date	  have	  been	  
restricted	  to	  examples	  with	  fast	  HNO	  release	  profiles.	  	  
Previously,	   we	   reported	   a	   new	   class	   of	   HNO	   donors	   based	   on	   the	   general	  
strategy	  shown	  in	  Scheme	  4-­‐1	  for	  N-­‐substituted	  hydroxylamines	  where	  X	  is	  a	  good	  
leaving	  group.9	   	  Piloty’s	  acid	  and	   its	  derivatives,	  with	  sulfinate	   leaving	  groups,	  are	  
classic	  examples	  of	  this	  strategy.	  10-­‐11	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Scheme	  4-­‐1.	  	  General	  Strategy	  for	  HNO	  Release	  
	  
	  
Piloty’s	   acid	   itself	   is	   quite	   stable	   at	   pH	   7.4	   (t1/2	   >	   1	   h),	   and	   under	  
physiological	  conditions	  is	  oxidized,	  presumably	  to	  the	  corresponding	  nitroxide,	  and	  
becomes	   an	  NO	  donor.12	   	   In	   order	   to	   favor	  deprotonation	   and	  HNO	   formation,	   vs.	  
oxidation,	  electron-­‐withdrawing	  groups	  were	  attached	  to	  the	  phenyl	  ring	  such	  that	  
the	   pKa	   of	   the	   N-­‐hydroxysulfonamide	   precursor	   was	   decreased	   along	   with	   an	  
increased	  stability	  of	  the	  sulfinate	  leaving	  group.10	  	  	  	  
We	   have	   also	   utilized	   this	   strategy	  with	   good	   carbon-­‐based	   leaving	   groups	  
(e.g.,	  barbiturate)	  such	  that	  HNO	  is	  released	  along	  with	  a	  stable	  carbanion	  at	  neutral	  
pH	   (Scheme	   4-­‐2).9	   	   Like	   the	   Piloty’s	   acid	   class,	   the	   hydroxylamino-­‐barbituric	   acid	  
(HABA)	  class	  also	  suffers	  from	  an	  alternative	  decomposition	  pathway,	  albeit	  by	  way	  
of	  an	  intramolecular	  rearrangement	  mechanism	  rather	  than	  oxidation.	  	  For	  example,	  
HABA-­‐2	   rearranges	   almost	   completely	   to	   the	   corresponding	   hydantoin,	  1,	   with	   a	  
half-­‐life	  at	  pH	  7.4,	  37	  °C	  of	  62	  minutes	  (Scheme	  4-­‐2).	  	  The	  only	  reported	  example	  of	  a	  
pure	  HNO	  donor	  in	  this	  class	  is	  HABA-­‐1,	  which	  has	  a	  short	  half-­‐life	  at	  pH	  7.4,	  37	  °C	  of	  
0.7	   minutes.9	   	   By	   exchanging	   the	   ethyl	   group	   in	   the	   R2	   position	   with	   an	   O-­‐
methyloxime,	  thus	  creating	  a	  more	  stable	  carbanion	  leaving	  group,	  HNO	  production	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Accessing	  longer-­‐lived	  HNO	  donors	  with	  half-­‐lives	  on	  the	  order	  of	  minutes	  to	  
hours,	  particularly	  within	  the	  same	  donor	  class,	  is	  expected	  to	  have	  a	  broad	  impact	  
on	   optimizing	   HNO	   release	   rate	   for	   the	   treatment	   of	   any	   number	   of	   potential	  
diseases,	   including	   congestive	   heart	   failure,	   alcoholism,	   vascular	   dysfunction,	   and	  
cancer.	   	  Furthermore,	  sustained	  release	  of	   low	  concentrations	  of	  HNO	  might	  be	  an	  
important	   step	   to	  mimic	   hypothesized	   endogenous	  HNO	  generation.13	   	   To	   expand	  
the	   HABA	   class	   of	   HNO	   donors,	   we	   need	   to	   (1)	   understand	   what	   favors	   the	  
rearrangement	   pathway	   and	   (2)	   create	   solutions	   that	   minimize	   or	   eliminate	   the	  
possibility	  of	  rearrangement.	  	  
Herein,	   we	   are	   pleased	   to	   report	   two	   independent	   strategies	   that	   protect	  
against	   rearrangement	   to	   favor	  HNO	  generation:	   	   (1)	   exchange	   the	   ethyl	   group	   in	  
the	  R2	  position	  with	  benzyl	  and	  (2)	  exchange	  the	  N-­‐Me	  groups	  of	  the	  barbituric	  acid	  
ring	   with	   N-­‐H	   groups.	   	   In	   both	   instances,	   we	   demonstrate	   that	   the	   non-­‐HNO	  
producing	   rearrangement	   pathway	   becomes	   kinetically	   unfavorable,	   thereby	  
allowing	   quantitative	   HNO	   production	   under	   physiologically	   relevant	   conditions.	  	  







t1/2 = 62 min
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enabling	   further	   optimization	   of	   physiochemical	   and	   pharmacological	   properties.	  	  
We	   have	   also	   prepared	   such	   substituted	   benzyl-­‐HABA	   compounds	   with	   electron-­‐
withdrawing	   and	   electron-­‐donating	   groups.	   	   Taken	   together,	  we	  have	   successfully	  
extended	   the	   HABA	   class	   of	   pure	   HNO	   donors	   with	   half-­‐lives	   on	   the	   order	   of	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§ 4.3	  	  Results	  and	  Discussion	  	  
4.3.1	  	  Synthesis	  
In	  order	  to	  protect	  against	  the	  hydantoin	  rearrangement	  (Scheme	  4-­‐2b),	  the	  
electrophilicity	   of	   the	   C-­‐2	   carbon	   of	   the	   barbituric	   acid	   ring	   and/or	   the	  
nucleophilicity	   of	   the	   hydroxylamine	   nitrogen	   must	   be	   tempered.	   	   We	   first	  
considered	   exchanging	   the	   ethyl	   group	   in	   the	   R2	   position	  with	   substituted	   benzyl	  
groups	   to	   give	   HABA-­‐3,	   HABA-­‐4,	   and	   HABA-­‐5	   (Table	   4-­‐1).	   	   We	   also	   considered	  
HABA-­‐6,	  the	  1,3-­‐unsubstituted	  derivative	  of	  HABA-­‐2.	  	  These	  new	  compounds	  can	  be	  
prepared	   from	   the	   corresponding	  byproducts	  of	  HNO	  release,	  BA-­‐3	  –	  BA-­‐6,	  which	  
are	  all	  known	  compounds	  and	  can	  be	  readily	  prepared	  (see	  Experimental).	  	  	  
Taking	  advantage	  of	  the	  chemical	  similarity	  between	  HNO	  and	  an	  aldehyde,	  
we	   have	   recently	   developed	   an	   HNO-­‐aldol	   procedure	   as	   an	   efficient	   synthetic	  
procedure	  for	  the	  expansion	  of	  the	  hydroxylamino-­‐pyrazolone	  (HAPY)	  class	  of	  HNO	  
donors,	  as	  discussed	  in	  Chapter	  3.	  	  Likewise,	  we	  wanted	  to	  apply	  this	  procedure	  to	  
the	  expansion	  of	  the	  HABA	  class.	  	  Fortunately,	  HABA-­‐3	  –	  HABA-­‐6	  can	  all	  be	  prepared	  
in	   excellent	   yields	   as	   shown	   in	  Table	   4-­‐1.	   	  Moreover,	   this	  HNO-­‐aldol	   procedure	   is	  
scalable,	  as,	  for	  example,	  HABA-­‐3	  can	  be	  readily	  prepared	  on	  the	  gram	  scale	  under	  
identical	  concentration	  and	  reaction	  time	  as	  the	  50	  mg	  scale	  without	  loss	  in	  isolated	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Table	  4-­‐1.	  	  HNO-­‐Aldol	  Reaction	  of	  Barbituric	  Acids	  
	  
	  
HABA	   R1	   R2	   %	  yield	  
3	   Me	   Bn	   99	  
4	   Me	   4-­‐OMeBn	   99	  
5	   Me	   4-­‐ClBn	   99	  
6	   H	   Et	   76	  
	  
4.3.2	  	  HNO	  Release	  from	  the	  Expanded	  HABA	  Class	  
The	   dimerization	   of	   HNO	   and	   subsequent	   dehydration	   gives	   nitrous	   oxide	  
(N2O).14	  	  Traditionally,	  HNO	  production	  from	  a	  potential	  HNO	  donor	  can	  be	  assessed	  
by	   the	   amount	   of	   N2O	   formed	   following	   donor	   decomposition.	   	   This	   assay	   is	  
performed	   using	   gas	   chromatographic	   headspace	   analysis	   at	   pH	   7.4,	   37	   °C	  with	   a	  
metal	   chelator,	   such	   as	   diethylenetriaminepentaacetic	   acid	   (DTPA),	   under	   inert	  
atmosphere	   to	   preclude	   reactivity	   of	   HNO	   with	   oxygen	   and	   trace	   metals.	  	  
Unfortunately,	   this	  assay	   is	  not	  applicable	   to	   the	  measurement	  of	  HNO	  production	  
from	  the	  extended	  HABA	  class	  series,	  since	  the	  byproduct	  of	  HNO	  release,	  BA,	  has	  a	  
strong	  affinity	  for	  HNO,	  as	  highlighted	  in	  the	  syntheses	  of	  these	  precursors.	  	  Thus,	  an	  
alternative	  method	  for	  evaluating	  HNO	  production	  must	  be	  utilized.	  
Angeli's salt (2 eq.)
DTPA (0.5 eq.)
50% v/v aq. ethanol
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As	  discussed	  in	  Chapter	  3,	  we	  have	  developed	  a	  1H	  NMR	  method	  utilizing	  the	  
selective,	   distinctive,	   and	   irreversible	   trap	   for	   HNO,	   tris(4,6-­‐dimethyl-­‐3-­‐
sulfanatophenyl)phosphine	  trisodium	  salt	  (TXPTS),	   for	  the	  extended	  HAPY	  class	  of	  
HNO	   donors.	   	   Moreover,	   this	   assay	   can	   be	   used	   to	   monitor	   the	   timecourse	   and	  
stoichiometry	  of	  the	  HNO	  donor,	  the	  released	  byproduct,	  as	  well	  as	  HNO	  itself.	  	  The	  
reaction	  scheme	  for	  the	  conversion	  of	  HABA-­‐3	  –	  HABA-­‐6	  to	  BA-­‐3	  –	  BA-­‐6	  and	  HNO	  
(trapped	  as	  one	  molecule	  of	  an	  aza-­‐ylide	  and	  one	  molecule	  of	  a	  phosphine	  oxide)	  is	  
shown	   in	   Table	   4-­‐2.	   	   Importantly,	   no	   other	   organic	   products	   arising	   from	  
compounds	   HABA-­‐3	   –	   HABA-­‐6	   are	   observed.	   	   Interestingly,	   when	   HABA-­‐2	   is	  
incubated	   in	   the	   presence	   of	   TXPTS,	   HNO	   release	   becomes	   comparable	   with	  
rearrangement;	   the	   yield	   of	   the	   expected	   byproduct,	   BA-­‐2,	   and	   the	   HNO-­‐derived	  
TXPTS	  aza-­‐ylide	  is	  59%	  relative	  to	  the	  corresponding	  hydantoin,	  compound	  1.	  	  	  
	  
Table	  4-­‐2.	  	  Incubation	  of	  HABA-­‐3	  –	  HABA-­‐6	  in	  pH	  7.4	  Phosphate	  Buffer	  at	  37	  °C	  Under	  
Argon	  with	  Added	  TXPTS	  
	  
	  
HABAa	   R1	   R2	   t1/2	  (min)	   k	  (s-­‐1)b	   %	  HNOc	   pKa	  of	  BAd	  
3	   Me	   Bn	   38	   3.1	  ×	  10-­‐4	   99	   4.2	  
4	   Me	   4-­‐OMeBn	   79	   1.5	  ×	  10-­‐4	   96	   4.3	  
5	   Me	   4-­‐ClBn	   19	   6.0	  ×	  10-­‐4	   92	   3.7	  
6	   H	   Et	   107	   1.1	  ×	  10-­‐4	   97	   4.1	  
aIncubation	  conditions:	  	  HABA	  (1	  mM)	  and	  TXPTS	  (5	  mM)	  in	  10%	  D2O,	  pH	  7.4	  phosphate	  buffer	  
(0.25	  M)	  with	  DTPA	  (0.2	  mM)	  at	  37	  °C	  under	  argon.	  	  bThe	  rates	  are	  calculated	  best	  fits	  to	  a	  single	  
exponential	   function	   of	   the	   integrated	   1H	  NMR	  data	   for	  HABA	  disappearance/BA	   appearance.	  	  
cHNO	  yields	  were	  determined	  from	  the	  final	  TXPTS	  aza-­‐ylide	  yield.	   	  dDetermined	  by	  titration	  in	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As	   an	   example,	   the	   complete	   decomposition	   of	   HABA-­‐3	   to	   give	   BA-­‐3	   and	  
HNO-­‐derived	   TXPTS	   aza-­‐ylide	   under	   physiologically	   relevant	   conditions	   following	  
the	  1H	  NMR	  assay	  described	  above	  is	  shown	  in	  Figure	  4-­‐1a,	  and	  the	  decompositions	  
of	  HABA-­‐3	  –	  HABA-­‐6	  are	  shown	  in	  Figure	  4-­‐1b.	  	  The	  acidity	  of	  the	  benzyl	  barbituric	  
acid	   byproduct,	   BA-­‐3,	   is	   comparable	   to	   benzoic	   acid.	   	   Like	   benzoic	   acid,	   the	  
substituents	   on	  benzyl	   barbituric	   acid	   affect	   the	   acidity;	   that	   is,	   their	   acidities	   are	  
increased	   by	   electron-­‐withdrawing	   groups	   and	   decreased	   by	   electron-­‐donating	  
groups.	  	  This	  substituent	  effect	  has	  been	  demonstrated	  to	  obey	  Hammett’s	  equation	  
on	  a	  series	  of	  5-­‐substituted-­‐benzyl-­‐1,3-­‐unsubtituted-­‐barbituric	  acid	  derivatives.15	  	  	  
Figure	   4-­‐1.	   	   (a)	   Timecourse	   for	   the	  disappearance	  of	  HABA-­‐3	  and	  appearance	  of	  BA-­‐3	  
and	   TXPTS	   aza-­‐ylide	  with	   added	   TXPTS.	   	   The	   solid	   curves	   are	   calculated	   best	   fits	   to	   a	  
single	  exponential	  function	  of	  the	  integrated	  1H	  NMR	  data	  (k	  =	  3.1	  ×	  10-­‐4	  s-­‐1	  for	  each	  fit).	  	  
(b)	  Disappearance	  of	  HABA-­‐3	  (black),	  HABA-­‐4	  (blue),	  HABA-­‐5	  (red),	  and	  HABA-­‐6	  (green)
under	  conditions	  outlined	  in	  Table	  2.	  
(a) 
(b)
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   As	  such,	  the	  rate	  of	  decomposition	  of	  HABA-­‐3,	  HABA-­‐4,	  and	  HABA-­‐5	  correlate	  
with	   the	   pKa	   values	   of	   their	   respective	   BA	   byproducts.	   	   As	   the	   stability	   of	   the	  
resultant	  carbanion	  increases,	  so	  too	  does	  the	  rate	  of	  HNO	  evolution.	  	  The	  pKa	  of	  the	  
resultant	  byproducts,	  BA-­‐3	  –	  BA-­‐5,	  also	  affects	  the	  pKa	  of	  the	  corresponding	  HABA	  
donors	   as	   well	   (Figure	   4-­‐2a),	   where	   the	   sharp	   increases	   in	   observed	   rate	   reflect	  
rapid	  BA	  formation	  as	  a	  result	  of	  HABA	  deprotonation.	  	  	  
	   In	  a	  similar	  fashion	  to	  the	  previously	  studied	  HAPY	  class,	  the	  decomposition	  
rates	   reach	   the	   time	   resolution	   limit	   (ca.	   0.15	   s-­‐1),	   precluding	   a	   complete	   pKa	  
analysis	   for	   each	  donor.	   	   Just	   as	   before,	  we	  believe	   these	   results	   indicate	   that	   the	  
barrier	   to	  HNO	  dissociation	  must	  be	   low	  once	  deprotonation	  of	   the	  donor	  occurs.	  	  
Yet,	   the	   longest-­‐lived	  HNO	   donor	   in	   this	   series	   is	   HABA-­‐6,	  which	   does	   not	   follow	  
same	  trend.	  	  As	  stated	  above	  and	  shown	  in	  Figure	  4-­‐2b,	  the	  ring	  nitrogen	  proton	  is	  
mildly	  acidic.	  	  With	  a	  measured	  pKa	  of	  ca.	  7.4,	  the	  pKa	  of	  HABA-­‐6	  as	  a	  whole	  is	  more	  
acidic	   than	   the	   other	   HABA	   compounds.	   	   The	   relatively	   slower	   decomposition	   of	  
HABA-­‐6	  is	  presumably	  due	  to	  slow	  tautomerization	  of	  the	  HOHN–BA-­‐6	  proton	  to	  the	  
ring	   nitrogen	   anion,	   since	   the	   difference	   in	   acidity	   of	   these	   two	   positions	   are	  
expected	   to	   be	   ca.	   3-­‐4	   pKa	   units,	   based	   on	   the	   pKa	   values	   of	   the	   other	   HABA	  
compounds.	   	   Figure	   4-­‐3c	   shows	   the	   initial	   spectra	   of	   HABA-­‐6	   in	   a	   variety	   of	  
phosphate	  buffers	  from	  pH	  5.0	  to	  pH	  9.5.	   	  As	  the	  pH	  of	  the	  buffer	  increases,	  a	  new	  
starting	   absorbance	   at	   242	  nm	   is	   observed,	  which	   is	   consistent	  with	   other	  mono-­‐
anion	  5,5-­‐disubstituted	  barbituric	  acids.	  	  For	  example,	  the	  λmax	  of	  the	  mono-­‐anion	  of	  
5,5-­‐diethylbarbituric	  acid,	  barbital,	  is	  238	  nm.16	  	  Also,	  we	  are	  confident	  the	  expected	  
byproduct	  of	  HNO	  release,	  BA-­‐6anion,	  is	  not	  observed	  in	  the	  initial	  spectra	  of	  HABA-­‐6	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in	  any	  of	  the	  buffers,	  and	  therefore,	  does	  not	  contribute	  to	  the	  absorbance	  of	  HABA-­‐
6anion	  in	  this	  UV-­‐vis	  spectral	  analysis.	  
Figure	  4-­‐2.	  	  (a)	  Plot	  of	  UV-­‐vis	  determined	  decomposition	  rates	  as	  a	  function	  of	  pH	  at	  25	  
°C	  for	  HABA-­‐3	  (black),	  HABA-­‐4	  (blue),	  and	  HABA-­‐5	  (red).	  	  (b)	  Plot	  of	  the	  concentration	  of	  
HABA-­‐6anion	  (purple,	  λmax	  =	  242	  nm)	  as	  a	  function	  of	  pH.	  	  The	  solid	  curve	  is	  a	  calculated	  
best	  fit	  to	  a	  sigmoid	  function	  (pKa	  =	  7.4).	  	  (c)	  Initial	  UV-­‐vis	  spectra	  of	  HABA-­‐6	  from	  pH	  5.0	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4.3.3	  	  Rearrangement	  Studies	  	  
The	  aminobarbituric	  acid–hydantoin	  rearrangement	   is	  a	  ring	  contraction	  of	  
5-­‐aminobarbituric	   acids	   and	   has	   been	   previously	   studied	   as	   a	   novel	   method	   of	  
producing	  hydantoins,	  which	  are	  important	  medicinal	  compounds.17,18	  	  When	  the	  R1	  
position	  is	  unsubstituted,	  the	  rearrangement	  follows	  a	  deprotonation–elimination–
addition	   mechanism	   (Scheme	   4-­‐3a).	   	   However,	   1,3-­‐disubstituion	   prevents	   the	  
formation	   of	   an	   isocyanate	   intermediate,	   and	   a	  mechanism	   involving	   a	   carbamate	  
intermediate	   becomes	   operative	   (Scheme	   4-­‐3b).	   	   These	   reactions	   are	   performed	  
under	  forcing	  conditions	  (i.e.,	  up	  to	  4	  equivalents	  of	  NaOEt	  and	  120	  °C	  in	  ethanol	  for	  
5	  h).	  	  	  






















































































































(a)  deprotonation-elimination-addition mechanism
(b)  nucleophilic-addition, ring-opening, ring-closing (ANRORC-type) mechanism
–
–
(c)  competitive pathways of the HABA class: rearrangement (Path A) and HNO 
production (Path B)
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In	  the	  same	  time,	  period	  but	  under	  much	  milder	  conditions	  (pH	  7.4,	  37	  °C,	  5	  
h),	   the	   rearrangement	   of	   HABA-­‐2	   is	   complete,	   and	   the	   measured	   half-­‐life	   is	   62	  
minutes	  (Scheme	  4-­‐3c,	  Path	  A;	  Figure	  4-­‐3).	  	  However,	  if	  the	  HOHN–BA-­‐2	  hydrogen	  is	  
replaced	  with	   a	  methyl	   group	   (compound	  2,	   Figure	   4-­‐3)	   then	   only	   approximately
4%	  of	  the	  corresponding	  rearranged	  hydantoin	  product	  is	  observed	  after	  5	  hours	  at	  
pH	  7.4,	  37	  °C	  (Figure	  4-­‐3).	   	  Thus,	   the	  relatively	   facile	  rearrangement	  of	  HABA-­‐2	   is	  
due	  in	  part	  to	  the	  ability	  of	  the	  free	  HOHN–BA-­‐2	  hydrogen	  to	  activate	  the	  barbituric	  
acid	   ring	   during	   the	   rearrangement,	   which	   likely	   follows	   a	   direct	   nucleophilic	  
addition	   of	   the	   hydroxylamine	   nitrogen	   prior	   to	   ring	   contraction	   rather	   than	  
formation	  of	  a	  carbamic	  acid	  intermediate,	  since	  no	  other	  product	  or	  intermediate	  is	  
observed	  throughout	  the	  rearrangement	  process	  for	  either	  HABA-­‐2	  or	  compound	  2.	  	  
On	   the	   other	   hand,	   this	   activation	   is	   also	   expected	   to	   facilitate	   HOHN–BA	  
deprotonation	  and	  HNO	  production	  (Scheme	  4-­‐3c,	  Path	  B).	  
	  
Figure	  4-­‐3.	  	  Hydantoin	  formation	  from	  HABA-­‐2	  (R	  =	  H)	  vs.	  compound	  2	  (R	  =	  Me).	  
Because	  the	  barbiturate	  ring	  of	  HABA-­‐6	  is	  approximately	  50%	  anionic	  in	  pH	  
7.4	  buffer,	  the	  electrophilicity	  of	  the	  C-­‐2	  carbon	  is	  substantially	  reduced,	  and	  attack	  
by	  the	  hydroxylamine	  nitrogen	  becomes	  exceedingly	  less	  likely.	  	  Ring	  opening	  to	  the	  
R = Me
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corresponding	   isocyanate	   intermediate	   is	   also	   evidently	   not	   possible,	   since	   no	  
rearranged	  product	   is	  observed	  during	  the	  decomposition	  of	  HABA-­‐6.	   	  Even	  under	  
conditions	  to	  disfavor	  HNO	  release	  (i.e.,	  no	  TXPTS	  and	  under	  argon),	  the	  rearranged	  
hydantoin	  product	  was	  not	  observed	  even	  after	  two	  days	  of	  incubation	  at	  pH	  7.4	  and	  
37	   °C.	   	   As	   with	   the	   aminobarbituric	   acid–hydantoin	   rearrangement	   of	   1,3-­‐
unsubstituted	  derivatives,	  the	  isocyanate	  intermediate	  likely	  requires	  more	  forcing	  
conditions	  for	  formation.	  
	   Similarly,	  when	  the	  benzyl	  derivative,	  HABA-­‐3,	  is	  incubated	  under	  conditions	  
to	  disfavor	  HNO	  release,	  again	  in	  the	  absence	  of	  TXPTS	  and	  under	  argon,	  the	  relative	  
rate	  of	  rearrangement	  is	  substantially	  slower	  when	  compared	  to	  HABA-­‐2.	  	  After	  one	  
day	  of	  incubation	  at	  pH	  7.4	  and	  37	  °C,	  the	  relative	  ratio	  of	  HABA-­‐3:BA-­‐3:hydantoin	  is	  
48:26:36.	  	  Given	  the	  high	  rate	  of	  HNO	  release	  in	  the	  presence	  of	  a	  good	  trap	  for	  HNO,	  
such	   as	   TXPTS,	   relative	   to	   the	   rate	   of	   rearrangement,	   the	   possibility	   of	  
rearrangement	   in	  the	  substituted-­‐benzyl	  derivatives	   is	  expected	  to	  be	  negligible	   in	  
vivo,	  where	  biological	  targets	  for	  HNO	  are	  in	  excess	  of	  HNO.	  	  	  
An	  explanation	  as	  to	  why	  rearrangement	  in	  HABA-­‐3	  is	  so	  much	  slower	  when	  
compared	  to	  HABA-­‐2	  is	  not	  yet	  fully	  understood,	  since	  the	  ability	  of	  the	  free	  HOHN–
BA-­‐3	  hydrogen	  to	  activate	  the	  barbituric	  acid	  ring	  during	  the	  rearrangement	  is	  also	  
possible	   with	   HABA-­‐3.	   	   Therefore,	   we	   employed	   computational	   investigations	   to	  
study	  the	  differences	  between	  HABA-­‐2	  and	  HABA-­‐3.	  	  	  
A	   potential	   explanation	   for	   the	  differences	  may	  be	  due	   to	   the	   ground	   state	  
structures	   of	   each	   donor.	   	   The	   lowest	   energy	   conformation	   of	   HABA-­‐3,	   both	  
determined	   computationally	   and	   in	   the	   crystal	   structure,	   is	   in	   a	   intramolecular	  π-­‐
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stacking	  motif,	  where	  there	  is	  a	  filled-­‐empty	  interaction	  of	  the	  HOMO	  of	  the	  phenyl	  
ring	   with	   the	   LUMO	   of	   the	   barbituric	   acid	   ring	   (Figure	   4-­‐4a).	   	   Specifically,	   the	  
dihedral	   angles	   of	   the	   benzyl	   group	   relative	   to	   the	   hydroxylamine	   in	   the	   lowest	  
energy	   calculated	   structure	   and	   in	   the	   crystal	   structure	   are	   177°	   and	   170°,	  
respectively,	   thus	   positioning	   the	   two	   rings	   in	   an	   overlapping	   conformation	  
(Supporting	  Information).	   	  Even	  though	  the	  two	  rings	  are	  not	  parallel	  with	  respect	  
to	   one	   another,	   there	   is	   evidently	   sufficient	   interaction	   to	   allow	   HABA-­‐3	   to	   exist	  
primarily	  in	  this	  π-­‐stacking	  conformation.	  	  
In	  order	  for	  nucleophilic	  attack	  of	  the	  hydroxylamine	  nitrogen	  to	  occur,	  this	  
π-­‐stacking	  interaction	  must	  be	  disrupted	  in	  order	  to	  form	  a	  tetrahedral	  intermediate	  
(Figure	   4-­‐4b),	   which	  may	   explain	   the	   kinetic	   unfavorability	   to	   rearrangement,	   as	  
rearrangement	  to	  the	  corresponding	  hydantoin	  is	  thermodynamically	  favorable	  for	  
both	  HABA-­‐2	  and	  HABA-­‐3.	  	  Although	  the	  calculated	  tetrahedral	  intermediates	  from	  
HABA-­‐2	   and	   HABA-­‐3	   are	   ground	   state	   structures,	   presumably	   they	   are	   relatively	  
similar	  in	  energy	  to	  the	  expected	  transition	  state	  of	  each	  reaction.	  	  Assuming	  this	  is	  
true,	  the	  activation	  barrier	  to	  the	  tetrahedral	   intermediate	  (Figure	  4-­‐3b,	  step	  1),	   is	  
approximately	  one	  kcal/mol	  higher	   in	  energy	   for	  HABA-­‐3	   relative	   to	  HABA-­‐2,	   and	  
the	  corresponding	  rate	  of	  hydantoin	  formation	  is	  then	  expected	  to	  be	  one	  order	  of	  
magnitude	  slower.	  	  In	  other	  words,	  if	  HABA-­‐2	  rearrangement	  occurs	  with	  a	  half-­‐life	  
of	  approximately	  one	  hour,	  a	  half-­‐life	  of	  approximately	  10	  hours	  is	  expected	  for	  the	  
rearrangement	   of	   HABA-­‐3,	   which	   is	   relatively	   consistent	   given	   the	   observed	  
propensity	   to	   rearrangement	   for	   these	   two	   compounds.	   	   Although,	   other	   factors	  
such	  as	  steric	  effects	  or	  hydroxylamine	  nucleophilicity	  may	  also	  be	  relevant.	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Figure	  4-­‐4.	  	  All	  calculations	  were	  performed	  with	  Spartan	  ’14	  at	  the	  B3LYP/6-­‐31G*	  level	  
with	   an	   SM8	   solvation	   model	   for	   aqueous	   solvation	   (Supporting	   Information).19
Optimized	  geometries	  and	  vibrational	  frequencies	  were	  calculated	  for	  each	  reactant	  
and	   product	   independently,	   and	   free	   energies	   are	   given	   for	   298.15	   K.	   	   (a)	   The	  
calculated	   structures	   of	   HABA-­‐2	   and	   HABA-­‐3	   and	   their	   respective	   HOMO	   and	   LUMO	  
orbital	   densities.	   	   (b)	   The	   stepwise	   scheme	   and	   energetics	   of	   the	   rearrangement	   of	  



























ΔG° = 21.1 kcal/mol ΔG° = -13.9 kcal/mol





















ΔG° = 22.1 kcal/mol
ΔΔG° = 1.0 kcal/mol
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4.3.4	  	  Barbiturates	  as	  HNO	  Donors	  	  
As	  shown	  in	  Table	  4-­‐2,	  the	  half-­‐lives	  of	  HABA-­‐3	  –	  HABA-­‐6	  are	  on	  the	  order	  of	  
an	  hour,	  making	  these	  compounds	  useful	  in	  a	  biological	  setting	  for	  comparing	  long-­‐
lived	  HNO	  donors	  with	   short-­‐lived	  HNO	  donors,	   such	  as	  Angeli’s	   salt.	   	   Ideally,	   the	  
byproduct	  of	  HNO	  release	  would	  be	   innocuous	  and	  readily	  cleared	   from	  the	  body.	  	  
Otherwise,	   the	   synergistic,	   or	   antagonistic,	   relationship	   between	   HNO	   and	   the	  
released	  byproduct	  must	  be	  taken	  into	  account	  when	  studying	  the	  pharmacology	  of	  
these	  HNO	  donors.	  	  For	  example,	  nitrite,	  the	  byproduct	  of	  HNO	  release	  from	  Angeli’s	  
salt,	   possesses	   its	   own	   biological	   activity,20-­‐21	   as	   does	   the	   pyrazolone	   byproducts	  
from	  the	  HAPY	  class	  of	  HNO	  donors,	  which	  are	  derivatives	  of	  edaravone,	  a	  potent	  
antioxidant	   already	   in	   clinical	   use	   for	   the	   treatment	   of	   stroke	   and	   cardiovascular	  
disease.22-­‐24	  	  	  
	   Barbiturates	   have	   clinical	   applications	   as	   sedatives,	   hypnotics,	   anesthetics,	  
and	  antiseizure	  drugs.	  	  Active	  barbiturates	  must	  be	  weak	  acids,	  meaning	  that	  at	  least	  
one	  of	  the	  barbituric	  acid	  ring	  nitrogens,	  whose	  pKa	  values	  range	  from	  7.1	  to	  8.1,	  is	  
unsubstituted.	   	   Also,	   active	   barbiturates	   must	   have	   a	   lipid/water	   partition	  
coefficient	  between	  certain	   limits	   in	  order	   to	   cross	   the	  blood-­‐brain	  barrier.	   	  Thus,	  
the	  substitution	  patterns	  are	   important	   for	   the	  biological	  activity	  described	  above.	  	  
The	   active	   substitution	   patterns	   are	   5,5-­‐disubstituted	   and	   1,5,5-­‐trisubstituted	  
barbituric	   acids.25	   	   Currently,	   there	   are	   several	   barbiturates	   used	   clinically,	  
including	   phenobarbital,	   a	   core	  medicine	   in	   the	  World	  Health	   Organization	   list	   of	  
essential	  medicines.26	  	  All	  other	  substitution	  patterns	  are	  considered	  to	  be	  inactive.	  	  
These	   include	   5-­‐monosubstituted,	   1,3,5-­‐trisubstituted,	   and	   1,3,5,5-­‐
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tetrasubstutituted	   barbituric	   acids.	   	   Therefore,	   the	   released	   byproducts	   of	   HNO	  
release	  in	  the	  extended	  HABA	  class	  of	  HNO	  donors,	  BA-­‐3	  –	  BA-­‐6,	  are	  all	  expected	  to	  
have	  minimal	  or	  negligible	  pharmacological	  effects.	   	  
For	   the	   HABA	   class	   as	   a	   whole,	   HNO	   release	   following	   HOHN–BA	  
deprotonation	   remains	   the	   most	   plausible	   mechanism	   in	   water	   (Scheme	   4-­‐4),	   as	  
was	  the	  case	  for	  the	  previously	  studied	  HAPY	  class	  of	  HNO	  donors.	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§ 4.4	  	  Conclusion	  
Compounds	  HABA-­‐3	  –	  HABA-­‐6	  are	  quantitatively	  converted	   to	  BA-­‐3	  –	  BA-­‐6	  
and	  HNO,	  trapped	  as	  a	  TXPTS	  aza-­‐ylide,	  with	  a	  half-­‐life	  range	  of	  approximately	  19	  –	  
107	   minutes	   in	   pH	   7.4	   phosphate	   buffer	   at	   37°C.	   	   The	   alternative,	   undesired	  
rearrangement	  mechanism	   that	   can	  occur	  with	   the	  HABA	   class	   of	   compounds	  has	  
been	   shown	   to	   be	   kinetically	   unfavorable	   for	   this	   expanded	   HABA	   series	   under	  
physiologically	  relevant	  conditions,	  including	  the	  O-­‐methylated	  model	  compound	  2,	  
which	  may	  suggest	  future	  pro-­‐drug	  strategies.	  	  Another	  potentially	  practical	  benefit	  
enjoyed	  by	  the	  HABA	  class	   is	   that	   these	  donors	  are	  achiral,	   removing	  the	  need	   for	  
any	  study	  into	  the	  differences	  in	  physiological	  effects	  between	  enantiomers.	  	  Taken	  
together	  with	  the	  HAPY	  class	  of	  HNO	  donors	  discussed	  in	  Chapter	  3,	  whose	  half-­‐life	  
range	   span	  minutes	   to	  days,	   the	  effects	   that	   long-­‐lived,	  pure	  HNO	  donors	  have	  on	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§ 4.5	  	  Experimental	  
4.5.1	  	  Methods	  and	  Materials	  
All	   starting	   materials	   were	   of	   reagent	   grade	   and	   used	   without	   further	  
purification.	   	   Compounds	   BA-­‐3	   –	   BA-­‐6,27-­‐28	   N-­‐(tert-­‐butoxycarbonyl)-­‐O-­‐methyl-­‐
hydroxylamine,29	  and	  5-­‐bromo-­‐5-­‐ethyl-­‐N,N-­‐dimethyl-­‐barbituric	  acid9	  are	  all	  known	  
compounds,	   and	   were	   prepared	   according	   to	   literature	   procedures.	   	   Angeli’s	   salt	  
(Na2N2O3)	  was	   prepared	   according	   to	   King	   and	  Nagasawa.30	   	  Tris(4,6-­‐dimethyl-­‐3-­‐
sulfanatophenyl)phosphine	   trisodium	  salt	   (TXPTS)	  was	  of	   reagent	  grade	  and	  used	  
without	   further	  purification.	   	   Synthetic	  TXPTS	  aza-­‐ylide	  was	  obtained	   through	   the	  
amidation	  of	  TXPTS	  using	  hydroxylamine	  O-­‐sulfonic	  acid	   in	  water.31	   	  NMR	  spectra	  
were	   obtained	   on	   a	  Bruker	  Avance	  400	  MHz	  FT-­‐NMR	   spectrometer.	   	   All	   chemical	  
shifts	  are	  reported	   in	  parts	  per	  million	  (ppm)	  relative	  to	  residual	  CHCl3	  (7.26	  ppm	  
for	  1H,	  77.23	  ppm	  for	  13C)	  or	  residual	  DMSO	  (2.50	  ppm	  for	  1H,	  39.52	  for	  13C).	  	  High-­‐
resolution	  mass	  spectra	  were	  obtained	  on	  a	  VG	  Analytical	  VG70SE	  magnetic	  sector	  
mass	  spectrometer	  operating	   in	  fast	  atom	  bombardment	  (FAB)	  mode.	   	  Ultraviolet-­‐
visible	   (UV-­‐vis)	   absorption	   spectra	   were	   obtained	   using	   a	   Hewlett	   Packard	   8453	  
diode	  array	  spectrometer.	   	  Buffered	  solutions	  (0.1	  M)	  for	  UV-­‐vis	  experiments	  were	  
prepared	   from	   NaPO3H2/Na2PO3H	   (pH	   5.0,	   5.5,	   6.0,	   6.5,	   7.0,	   7.5,	   8.0,	   8.5,	   9.0,	   9.5,	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4.5.2	  	  Incubation	  Procedure	  of	  HABA	  Donors	  at	  pH	  7.4,	  37	  °C	  with	  TXPTS	  
General	  
All	   1H	   NMR	   spectra	   were	   obtained	   in	   pH	   7.4	   solution	   containing	   0.25	   M	  
phosphate	  buffer,	  0.2	  mM	  of	  the	  metal	  chelator	  diethylenetriaminepentaacetic	  acid	  
(DTPA),	  and	  10	  %	  D2O	  on	  a	  Bruker	  Avance	  400	  MHz	  FT-­‐NMR	  spectrometer	  using	  a	  1	  
second	  presaturation	  pulse	  to	  suppress	  the	  water	  signal.	   	  The	  data	  were	  processed	  
with	  the	  academic	  version	  of	  ACDLabs	  NMR	  processor	  software:	  each	  free	  induction	  
decay	   was	   Fourier	   transformed,	   phased,	   baseline	   corrected,	   and	   integral	   areas	  
measured	  for	  the	  N-­‐methyl	  groups	  of	  compounds	  HABA-­‐3	  –	  HABA-­‐5	  and	  BA-­‐3	  –	  BA-­‐
5,	   the	   (-­‐CH2CH3)	   groups	   of	  HABA-­‐6	   and	  BA-­‐6,	   and	   the	   downfield	  methyl	   group	   of	  
TXPTS	   aza-­‐ylide.	   	   The	   1H	   NMR	   spectrum	   of	   the	   HNO	   derived	   TXPTS	   aza-­‐ylide	  
product	  matched	  that	  of	  synthetic	  TXPTS	  aza-­‐ylide.	  	  The	  HNO	  yield	  from	  compounds	  
HABA-­‐3	  –	  HABA-­‐6	  was	  determined	  from	  the	  final	  TXPTS	  aza-­‐ylide	  yield.	  	  	  
NMR	  Procedure	  
The	  NMR	  procedure	   used	  was	   based	   on	   an	  HPLC	  protocol	   developed	   by	  S.	  
Bruce	   King	   and	   co-­‐workers.32-­‐33	   	   To	   an	   argon-­‐purged	   NMR	   solution	   (1.00	   mL)	  
containing	  TXPTS	  (3.3	  mg,	  5	  mM)	  was	  added	  HABA-­‐3	  –	  HABA-­‐6	  (10	  µL	  of	  100	  mM	  in	  
methanol-­‐d4)	   to	  give	  1	  mM	  as	   the	   initial	   concentration	  of	  HABA-­‐3	  –	  HABA-­‐6.	   	  The	  
solution	   was	   briefly	   mixed,	   ca.	   0.5	   mL	   was	   transferred	   to	   an	   argon-­‐purged	   NMR	  
tube,	   and	   the	   sample	  was	   then	   internally	   incubated	   at	   37	   °C	   and	   1H	  NMR	   spectra	  
were	  collected	  using	  a	  canned	  Bruker	  pulse	  sequence,	  zg2d,	  modified	  to	  include	  a	  1	  
second	  presaturation	  pulse	  during	  the	  relaxation	  delay.	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4.5.3	  	  Experimental	  Procedures	  




5-­‐(N-­‐hydroxylamino)-­‐5-­‐benzyl-­‐N,N-­‐dimethylbarbituric	   acid	   (HABA-­‐3).	  	  
To	   5-­‐benzyl-­‐N,N-­‐dimethylbarbituric	   acid	   (BA-­‐3)	   (1.231	   g,	   5	   mmol),	   Angeli’s	   salt	  
(1.22	  g,	  10	  mmol),	  and	  powdered	  DTPA	  (0.983	  g,	  2.5	  mmol)	  under	  nitrogen	  at	  room	  
temperature	  was	  cannulated	  a	  degassed	  mixture	  of	  50%	  aqueous	  ethanol	  (25	  mL).	  	  
The	  reaction	  was	  allowed	  to	  vigorously	  stir	   for	  10	  minutes	   in	  order	  to	  dissolve	  all	  
solids	   followed	   by	   normal	   stirring	   under	   a	   gentle	   stream	   of	   nitrogen	   for	   an	  
additional	   1.5	   hours.	   	   At	  which	   time,	   precipitation	   of	   a	  white	   solid	  was	   observed.	  	  
The	  reaction	  was	  then	  diluted	  with	  ethanol	  (200	  mL)	  and	  concentrated	  to	  dryness	  in	  
vacuo	  with	  minimum	  heat	   (<30	   °C).	   	   The	   resultant	  material	  was	   then	   taken	  up	   in	  
dichloromethane	  (3	  ×	  20	  mL),	  filtered	  through	  cotton,	  and	  concentrated	  in	  vacuo	  to	  
give	  the	  title	  compound	  as	  a	  white	  solid	  (1.385	  g,	  99%).	  	  1H	  NMR	  (400	  MHz,	  CDCl3)	  
δ:	  7.26	  (m,	  3H),	  6.96	  (m,	  2H),	  6.28	  (d,	  1H,	  J	  =	  3.2	  Hz),	  4.98	  (d,	  1H,	  J	  =	  3.4	  Hz,	  1H),	  3.13	  
(s,	  6H),	  3.08	  (s,	  2H).	   	  13C	  NMR	  (100	  MHz,	  CDCl3)	  δ:	  170.01,	  150.02,	  131.75,	  129.19,	  
Angeli's salt (2 eq.)
DTPA (0.5 eq.)
50% v/v aq. ethanol
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128.95,	  128.71,	  73.64,	  42.89,	  28.78.	   	  HR-­‐MS	  (FAB):	   found	  m/z	  =	  278.11411	  (MH+);	  
calc.	  for	  C13H16N3O4:	  278.11408.	  
5-­‐(N-­‐hydroxylamino)-­‐5-­‐(4-­‐methoxybenzyl)-­‐N,N-­‐dimethylbarbituric	  
acid	   (HABA-­‐4).	   	   To	   5-­‐(4-­‐methoxybenzyl)-­‐N,N-­‐dimethylbarbituric	   acid	   (BA-­‐4)	   (55	  
mg,	   0.2	  mmol),	   Angeli’s	   salt	   (49	  mg,	   0.4	  mmol),	   and	   powdered	  DTPA	   (39	  mg,	   0.1	  
mmol)	   under	   argon	   at	   room	   temperature	  was	   added	   a	   degassed	  mixture	   of	   50%	  
aqueous	  ethanol	  (1	  mL).	  	  The	  reaction	  was	  allowed	  to	  stir	  for	  1.5	  hours,	  diluted	  with	  
ethanol	  (>5	  mL),	  and	  concentrated	  to	  dryness	  in	  vacuo	  with	  minimum	  heat	  (<30	  °C).	  	  
The	  material	   was	   then	   taken	   up	   in	   dichloromethane,	   filtered	   through	   cotton,	   and	  
concentrated	  in	  vacuo	  to	  give	  the	  title	  compound	  as	  a	  white	  solid	  (61	  mg,	  99%).	  	  1H	  
NMR	  (400	  MHz,	  CDCl3)	  δ:	  6.88	  (d,	  2H,	  J	  =	  8.6	  Hz),	  6.76	  (d,	  2H,	  J	  =	  8.7	  Hz),	  6.25	  (br.	  s,	  
1H),	   5.09	   (br.	   s,	   1H),	   3.76	   (s,	   3H),	   3.15	   (s,	   6H),	   3.03	   (s,	   2H).	   	   13C	  NMR	   (100	  MHz,	  
CDCl3)	  δ:	  159.73,	  150.11,	  130.32,	  123.47,	  114.27,	  73.70,	  55.43,	  42.08,	  28.82.	   	  HR-­‐MS	  
(FAB):	  found	  m/z	  =	  308.12476	  (MH+);	  calc.	  for	  C14H18N3O5:	  308.12465.	  
5-­‐(N-­‐hydroxylamino)-­‐5-­‐(4-­‐chlorobenzyl)-­‐N,N-­‐dimethylbarbituric	   acid	  
(HABA-­‐5).	   	  To	  5-­‐(4-­‐chlorobenzyl)-­‐N,N-­‐dimethylbarbituric	   acid	   (BA-­‐5)	   (56	  mg,	  0.2	  
mmol),	   Angeli’s	   salt	   (49	  mg,	   0.4	  mmol),	   and	   powdered	   DTPA	   (39	  mg,	   0.1	  mmol)	  
under	  argon	  at	  room	  temperature	  was	  added	  a	  degassed	  mixture	  of	  50%	  aqueous	  
ethanol	  (1	  mL).	  	  The	  reaction	  was	  allowed	  to	  stir	  for	  1.5	  hours,	  diluted	  with	  ethanol	  
(>5	  mL),	  and	  concentrated	   to	  dryness	   in	  vacuo	  with	  minimum	  heat	   (<30	   °C).	   	  The	  
material	   was	   then	   taken	   up	   in	   dichloromethane,	   filtered	   through	   cotton,	   and	  
concentrated	  in	  vacuo	  to	  give	  the	  title	  compound	  as	  a	  white	  solid	  (61	  mg,	  99%).	  	  1H	  
NMR	  (400	  MHz,	  CDCl3)	  δ:	  7.24	  (d,	  2H,	  J	  =	  8.5	  Hz),	  6.91(d,	  2H,	  J	  =	  8.5	  Hz),	  6.23	  (d,	  1H,	  J	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=	   3.3	  Hz),	   4.98	   (d,	   1H,	   J	  =	  3.3	  Hz),	   3.17	   (s,	   6H),	   3.06	   (s,	   2H).	   	   13C	  NMR	   (100	  MHz,	  
CDCl3)	  δ:	  169.96,	  149.93,	  134.71,	  130.60,	  130.31,	  129.19,	  73.14,	  41.74,	  28.88.	   	  HR-­‐
MS	   (FAB):	   found	   m/z	   =	   312.07483	   (MH+,	   35Cl),	   314.07293	   (MH+,	   37Cl);	   calc.	   for	  
C13H15ClN3O4:	  312.07511	  (MH+,	  35Cl),	  314.07246	  (MH+,	  37Cl).	  
5-­‐(N-­‐hydroxylamino)-­‐5-­‐ethyl-­‐barbituric	   acid	   (HABA-­‐6).	   	   To	   5-­‐ethyl-­‐
barbituric	   acid	   (BA-­‐6)	   (0.781	   g,	   5	   mmol),	   Angeli’s	   salt	   (1.22	   g,	   10	   mmol),	   and	  
powdered	   DTPA	   (0.983	   g,	   2.5	   mmol)	   under	   nitrogen	   at	   room	   temperature	   was	  
cannulated	  a	  degassed	  mixture	  of	  50%	  aqueous	  ethanol	  (25	  mL).	  	  The	  reaction	  was	  
allowed	  to	  vigorously	  stir	  for	  10	  minutes	  in	  order	  to	  dissolve	  all	  solids	  followed	  by	  
normal	  stirring	  under	  a	  gentle	  stream	  of	  nitrogen	  for	  an	  additional	  1.5	  hours.	   	  The	  
reaction	  was	   then	  diluted	  with	   ethanol	   (200	  mL),	   filtered	   through	   cotton,	   and	   the	  
clear	   filtrate	   was	   concentrated	   to	   dryness	   in	   vacuo	   with	  minimum	   heat	   (<30	   °C).	  	  
The	  resultant	  material	  was	  then	  triturated	  with	  diethylether	  and	  filtered	  to	  give	  the	  
title	  compound	  as	  a	  light	  yellow	  solid	  (0.707	  g,	  76%).	  	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  
δ:	  11.50	  (br.	  s,	  2H),	  7.95	  (s,	  1H),	  6.23	  (s,	  1H),	  1.66	  (q,	  2H,	  J	  =	  7.5	  Hz),	  0.73	  (t,	  3H,	  J	  =	  
7.5	  Hz).	  	  13C	  NMR	  (100	  MHz,	  DMSO-­‐d6)	  δ:	  172.07,	  149.96,	  70.88,	  26.92,	  7.79.	  	  HR-­‐MS	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Scheme	  4-­‐6.	  	  Synthesis	  of	  the	  Model	  Compound,	  2	  
	  
5-­‐(N-­‐(O-­‐methyl)-­‐hydroxylamino)-­‐5-­‐ethyl-­‐N,N-­‐dimethylbarbituric	   acid	  
(2).	   	  To	  a	  solution	  of	  N-­‐(tert-­‐butoxycarbonyl)-­‐O-­‐methyl-­‐hydroxylamine	  (0.294	  g,	  2	  
mmol)	   in	   dimethylformamide	   (25	   mL)	   at	   room	   temperature	   was	   added	   sodium	  
hydride,	   60%	   (0.088	   g,	   2.2	   mmol),	   and	   the	   reaction	   stirred	   for	   one	   hour	   under	  
nitrogen.	  	  To	  this	  solution	  was	  added	  5-­‐bromo-­‐5-­‐ethyl-­‐N,N-­‐dimethyl-­‐barbituric	  acid	  
(0.526	   g,	   2	   mmol),	   and	   the	   reaction	   proceeded	   at	   room	   temperature	   for	   an	  
additional	  24	  hours.	  	  The	  reaction	  was	  then	  diluted	  with	  ether	  (50	  mL)	  and	  washed	  
with	  ammonium	  chloride	  (×	  2),	  water,	  brine,	  dried	  over	  magnesium	  sulfate,	  filtered,	  
and	   concentrated	   in	  vacuo	   to	   give	   crude	  5-­‐(N-­‐(N-­‐(tert-­‐butoxycarbonyl)-­‐O-­‐methyl)-­‐
hydroxylamino)-­‐5-­‐ethyl-­‐N,N-­‐dimethylbarbituric	   acid	   (ca.	   50%	   pure	   by	   1H	   NMR,	  
contaminated	   by	   an	   unknown	   product),	   which	   was	   used	   without	   further	  
purification.	   	   This	   material	   was	   then	   taken	   up	   in	   dichloromethane	   (10	   mL)	   and	  
trifluoroacetic	  acid	  (10	  mL)	  and	  allowed	  to	  stir	  at	  room	  temperature	   for	  one	  hour	  
followed	   by	   concentration	   in	  vacuo	   to	   give	   a	  mixture	   of	   the	   title	   compound	   along	  
with	   unchanged	   contaminant.	   	   The	  mixture	  was	   dissolved	   in	   diethylether,	   diluted	  
with	   hexanes,	   and	   concentrated	   via	   rotary	   evaporation	   out	   of	   the	   water	   bath	   in	  
order	  to	  effect	  precipitation	  of	  the	  unknown	  product	  as	  an	  off-­‐white	  solid	  (0.125	  g).	  	  
The	  filtrate	  was	  concentrated	  in	  vacuo	  to	  give	  the	  title	  compound	  (ca.	  90%	  pure	  by	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(br.	  s.,	  1H),	  3.49	  (s,	  3H),	  3.38	  (s,	  3H),	  1.87	  (q,	  2H),	  0.82	  (t,	  3H).	  	  13C	  NMR	  (100	  MHz,	  
CDCl3)	  δ:	  170.27,	  150.91,	  71.42,	  62.94,	  29.72,	  29.03,	  7.92.	   	  HR-­‐MS	  (FAB):	  found	  m/z	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§ 4.7	  	  Supporting	  Information	  
4.7.1	  	  X-­‐Ray	  Crystallography	  Data	  
All	   reflection	   intensities	   were	   measured	   at	   110(2)	   K	   using	   a	   SuperNova	  
diffractometer	  (equipped	  with	  Atlas	  detector)	  with	  Cu	  Kα	  radiation	  (λ	  =	  1.54178	  Å)	  
under	   the	   program	  CrysAlisPro	   (Version	   1.171.36.32	  Agilent	   Technologies,	   2013).	  	  
The	   program	   CrysAlisPro	   (Version	   1.171.36.32	   Agilent	   Technologies,	   2013)	   was	  
used	   to	   refine	   the	   cell	   dimensions.	   	   Data	   reduction	   was	   done	   using	   the	   program	  
CrysAlisPro	   (Version	   1.171.36.32	  Agilent	   Technologies,	   2013).	   	   The	   structure	  was	  
solved	  with	  the	  program	  SHELXS-­‐2013	  (Sheldrick,	  2013)	  and	  was	  refined	  on	  F2	  with	  
SHELXL-­‐2013	   (Sheldrick,	   2013).	   	  Analytical	   numeric	   absorption	   corrections	  based	  
on	   a	   multifaceted	   crystal	   model	   were	   applied	   using	   CrysAlisPro	   (Version	  
1.171.36.32	   Agilent	   Technologies,	   2013).	   	   The	   temperature	   of	   the	   data	   collection	  
was	   controlled	   using	   the	   system	   Cryojet	   (manufactured	   by	   Oxford	   Instruments).	  	  
The	  H	  atoms	  were	  placed	  at	  calculated	  positions	  (unless	  otherwise	  specified)	  using	  
the	   instructions	   AFIX	   23,	   AFIX	   43	   or	   AFIX	   137	   with	   isotropic	   displacement	  
parameters	  having	  values	  1.2	  or	  1.5	  times	  Ueq	  of	  the	  attached	  C	  atoms.	  	  The	  H	  atoms	  
attached	  to	  N3X	  and	  O4X	  (X	  =	  A,	  B	  and	  C)	  were	  found	  from	  difference	  Fourier	  map,	  
and	   their	   coordinates	   were	   refined	   freely	   (but	   the	   N−H	   and	   O−H	   distances	   were	  
restrained	  to	  be	  within	  acceptable	  ranges	  using	  the	  DFIX	  instructions).	  	  	  
The	  structure	  is	  ordered.	  	  Some	  unresolved	  electron	  density	  −	  i.e.,	  most	  likely	  
a	   very	   disordered	   solvent	  DCM	  molecule	   (with	   at	   least	   3	   different	   orientations)	  −	  
has	  been	  taken	  out	  in	  the	  final	  refinement	  (SQUEEZE	  details	  are	  provided	  in	  the	  CIF	  
file).	  
283	  
HABA-­‐3: Fw	   =	   277.28,	   thick	   colorless	   plate,	   0.58	   ×
0.48	   ×	   0.14	   mm3,	   monoclinic,	   P21/c	   (no.	   14),	   a	   =	  
15.08539(16),	  b	  =	  22.7205(2),	  c	  =	  12.63479(12)	  Å,	  β	  =	  
95.2052(9)°,	  V	  =	  4312.69(7)	  Å3,	  Z	  =	  12,	  Dx	   =	   1.281	   g	  
cm−3,	  µ	  =	   0.811	  mm−1,	   abs.	   corr.	   range:	   0.751−0.907.	  	  
25707	  Reflections	  were	  measured	  up	   to	   a	   resolution	  
of	   (sin	   θ/λ)max	   =	   0.62	   Å−1.	   8452	   Reflections	   were	  
unique	   (Rint	   =	   0.0326),	   of	  which	   7495	  were	   observed	   [I	  >	  2σ(I)].	   574	   Parameters	  
were	   refined	   using	   6	   restraints.	   R1/wR2	   [I	   >	  2σ(I)]:	   0.0452/0.1284.	   R1/wR2	   [all	  
refl.]:	  0.0503/0.1333.	  S	  =	  1.057.	  Residual	  electron	  density	  found	  between	  −0.31	  and	  
0.47	  e	  Å−3.	  
	   284	  
4.7.2	  	  Density	  Functional	  Theory	  (DFT)	  Calculations	  
	  
All	   calculations	   were	   performed	   at	   the	   B3LYP/6-­‐31G*	   level	   with	   an	   SM8	  
solvation	   model	   for	   aqueous	   solvation	   using	   Spartan	   ’14	   modeling	   software.19	  	  
Optimized	  geometries	  and	  vibrational	  frequencies	  were	  calculated	  for	  each	  reactant	  
and	  product	  independently,	  and	  free	  energies	  are	  given	  for	  298.15	  K.	  	  	  
	  




B3LYP/6-­‐31G*	  Energy	  (E):	   	   	  	  	  	  	  	  	  -­‐777.830211	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  489.3164	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	  	   -­‐487978.5084	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.6049300	   0.8417058	   0.4349930	  
N	   7	   -­‐0.0984525	   -­‐0.6657865	   -­‐1.4894891	  
N	   7	   -­‐0.0411970	   -­‐1.5727172	   0.7351163	  
C	   6	   0.1705384	   -­‐1.7435236	   -­‐0.6359966	  
C	   6	   -­‐0.4511740	   -­‐0.3916519	   1.3217852	  
C	   6	   -­‐0.5300454	   0.5720091	   -­‐1.0633262	  
N	   7	   -­‐2.0156861	   1.2836506	   0.6784233	  
H	   1	   -­‐2.1106114	   1.3518565	   1.6937114	  
O	   8	   -­‐2.1938759	   2.6639788	   0.2659752	  
H	   1	   -­‐2.1722711	   2.5762678	   -­‐0.7061935	  
O	   8	   0.5512101	   -­‐2.8167159	   -­‐1.0835504	  
O	   8	   -­‐0.6847358	   -­‐0.3065386	   2.5248496	  
O	   8	   -­‐0.8530035	   1.4529791	   -­‐1.8634389	  
C	   6	   0.1816692	   -­‐2.7670242	   1.5764488	  
H	   1	   -­‐0.5153830	   -­‐3.5554505	   1.2907173	  
H	   1	   0.0157055	   -­‐2.4761208	   2.6098956	  
H	   1	   1.2014042	   -­‐3.1256746	   1.4385383	  
C	   6	   0.0517574	   -­‐0.9318365	   -­‐2.9351619	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H	   1	   1.0370686	   -­‐1.3562363	   -­‐3.1223527	  
H	   1	   -­‐0.0647327	   0.0132877	   -­‐3.4581450	  
C	   6	   0.4667668	   1.8918398	   0.8439986	  
H	   1	   0.3340905	   2.0597033	   1.9176854	  
H	   1	   0.2013473	   2.8189427	   0.3329428	  
C	   6	   1.9204494	   1.5154621	   0.5441506	  
H	   1	   2.5824359	   2.3141660	   0.8927911	  
H	   1	   2.1014350	   1.3949339	   -­‐0.5292235	  
H	   1	   2.2305006	   0.5966313	   1.0528481	  
	  
	  
Table	  4-­‐4.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  HABA-­‐2	  	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   29	   0.65	   27	   735	   34.66	   53	   1474	   60.94	  
2	   56	   0.37	   28	   752	   5.71	   54	   1490	   234.93	  
3	   67	   1.78	   29	   777	   10.85	   55	   1515	   26.84	  
4	   72	   1.98	   30	   816	   1.57	   56	   1525	   22.36	  
5	   97	   0.20	   31	   844	   38.74	   57	   1526	   4.54	  
6	   120	   3.92	   32	   933	   20.68	   58	   1531	   10.88	  
7	   141	   40.35	   33	   951	   26.65	   59	   1536	   10.55	  
8	   151	   5.20	   34	   989	   17.69	   60	   1539	   6.86	  
9	   187	   2.47	   35	   992	   44.26	   61	   1542	   54.27	  
10	   210	   3.78	   36	   1008	   13.12	   62	   1557	   8.11	  
11	   241	   1.43	   37	   1066	   99.45	   63	   1652	   1129.43	  
12	   269	   0.50	   38	   1088	   32.89	   64	   1666	   535.19	  
13	   297	   34.45	   39	   1104	   99.22	   65	   1745	   23.16	  
14	   311	   23.94	   40	   1111	   108.14	   66	   3068	   27.21	  
15	   328	   50.45	   41	   1186	   2.05	   67	   3089	   17.01	  
16	   348	   81.88	   42	   1186	   2.74	   68	   3119	   21.76	  
17	   368	   69.15	   43	   1203	   13.43	   69	   3120	   24.13	  
18	   385	   66.61	   44	   1226	   74.95	   70	   3127	   21.10	  
19	   397	   29.74	   45	   1267	   78.27	   71	   3136	   38.99	  
20	   405	   52.68	   46	   1314	   48.77	   72	   3154	   28.57	  
21	   436	   15.01	   47	   1324	   277.89	   73	   3196	   6.85	  
22	   467	   2.63	   48	   1356	   275.72	   74	   3198	   7.04	  
23	   493	   52.41	   49	   1380	   352.25	   75	   3236	   0.63	  
24	   595	   14.90	   50	   1410	   119.42	   76	   3237	   0.57	  
25	   672	   0.58	   51	   1421	   476.02	   77	   3470	   38.93	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Table	   4-­‐5.	   	   B3LYP/6-­‐31G*	  Optimized	   Geometries,	   Energies,	   and	   Entropy	   Corrections	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐777.794907	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	   	  	  	  	  	  	  	  	  	  484.8890	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	  	   -­‐487957.413	  kcal/mol	  
	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   0.6826550	   -­‐0.7093715	   -­‐0.2520754	  
N	   7	   -­‐0.6638236	   1.1747810	   -­‐0.4012703	  
N	   7	   -­‐1.5222246	   -­‐0.9329473	   0.3774277	  
C	   6	   -­‐0.8979778	   0.3314648	   0.8103178	  
C	   6	   -­‐0.6000347	   -­‐1.5750505	   -­‐0.3777609	  
C	   6	   0.3612552	   0.5797245	   -­‐1.0763558	  
N	   7	   0.4494646	   -­‐0.2058469	   1.1430580	  
O	   8	   1.3206431	   0.9286983	   1.3526051	  
H	   1	   1.5560453	   0.8394727	   2.2944745	  
O	   8	   -­‐0.7329593	   -­‐2.6064246	   -­‐1.0367486	  
O	   8	   0.9084712	   0.9658204	   -­‐2.1078447	  
C	   6	   -­‐2.9579868	   -­‐1.1824439	   0.4010370	  
H	   1	   -­‐3.3405700	   -­‐1.0059545	   1.4074358	  
H	   1	   -­‐3.1218680	   -­‐2.2265420	   0.1345554	  
H	   1	   -­‐3.4901284	   -­‐0.5499528	   -­‐0.3179059	  
C	   6	   -­‐0.9678759	   2.6021024	   -­‐0.4649829	  
H	   1	   -­‐0.5853145	   3.1176106	   0.4195906	  
H	   1	   -­‐2.0433129	   2.7739396	   -­‐0.5618622	  
H	   1	   -­‐0.4799754	   3.0020120	   -­‐1.3549919	  
O	   8	   -­‐1.5022385	   0.9617342	   1.8580946	  
H	   1	   -­‐2.3028962	   1.4311970	   1.5506580	  
C	   6	   1.9648948	   -­‐1.4526110	   -­‐0.5714643	  
H	   1	   1.8531246	   -­‐1.8182832	   -­‐1.5982688	  
H	   1	   1.9956406	   -­‐2.3446943	   0.0631897	  
C	   6	   3.2749579	   -­‐0.6676887	   -­‐0.4427477	  
H	   1	   4.1086776	   -­‐1.2996592	   -­‐0.7657019	  
H	   1	   3.4665574	   -­‐0.3591720	   0.5873357	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Table	  4-­‐6.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  Tetrahedral	  Intermediate	  from	  HABA-­‐2	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   64	   2.65	   27	   709	   5.40	   53	   1448	   30.37	  
2	   83	   5.37	   28	   771	   16.37	   54	   1454	   447.21	  
3	   91	   2.24	   29	   788	   5.14	   55	   1479	   112.57	  
4	   101	   4.52	   30	   810	   12.27	   56	   1487	   29.10	  
5	   129	   3.12	   31	   871	   3.18	   57	   1505	   9.17	  
6	   139	   12.35	   32	   900	   65.50	   58	   1526	   14.83	  
7	   144	   3.40	   33	   933	   45.67	   59	   1531	   5.13	  
8	   173	   1.41	   34	   953	   105.28	   60	   1533	   20.08	  
9	   209	   5.63	   35	   970	   106.74	   61	   1544	   6.05	  
10	   237	   82.42	   36	   993	   100.40	   62	   1546	   6.21	  
11	   250	   55.86	   37	   1019	   43.75	   63	   1555	   28.57	  
12	   261	   111.24	   38	   1034	   92.91	   64	   1699	   340.80	  
13	   266	   61.52	   39	   1067	   88.55	   65	   1728	   806.93	  
14	   278	   80.49	   40	   1146	   5.65	   66	   3072	   26.67	  
15	   288	   30.52	   41	   1162	   141.79	   67	   3076	   43.67	  
16	   296	   10.30	   42	   1175	   26.44	   68	   3078	   29.60	  
17	   320	   18.51	   43	   1189	   319.40	   69	   3090	   44.75	  
18	   348	   1.49	   44	   1200	   14.20	   70	   3107	   10.33	  
19	   390	   13.23	   45	   1239	   107.36	   71	   3138	   45.73	  
20	   471	   16.79	   46	   1257	   87.70	   72	   3159	   43.03	  
21	   473	   17.12	   47	   1307	   66.72	   73	   3163	   11.90	  
22	   519	   31.52	   48	   1326	   74.74	   74	   3163	   11.65	  
23	   564	   3.96	   49	   1335	   32.30	   75	   3182	   5.49	  
24	   596	   18.75	   50	   1375	   153.75	   76	   3197	   2.74	  
25	   615	   3.54	   51	   1381	   164.44	   77	   3673	   204.94	  
26	   650	   7.39	   52	   1410	   2.93	   78	   3702	   182.78	  
	  
	  
Table	   4-­‐7.	   	   B3LYP/6-­‐31G*	  Optimized	   Geometries,	   Energies,	   and	   Entropy	   Corrections	  




B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐777.851209	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	   	  	  	  	  	  	  	  	  	  486.2711	  kJ/mol	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Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.0923132	   -­‐0.2368749	   0.4267483	  
C	   6	   0.7843110	   0.8332527	   -­‐0.2507468	  
N	   7	   1.8410586	   0.1750048	   -­‐0.8351464	  
C	   6	   1.8269383	   -­‐1.2004694	   -­‐0.5413791	  
N	   7	   0.8327013	   -­‐1.3788250	   0.3949683	  
O	   8	   0.3357460	   -­‐2.6632163	   0.6304976	  
H	   1	   -­‐0.3725122	   -­‐2.7324241	   -­‐0.0604980	  
C	   6	   -­‐1.3065838	   -­‐0.5242424	   -­‐0.5075757	  
O	   8	   -­‐1.4574763	   -­‐1.6577741	   -­‐1.0169122	  
O	   8	   2.5912806	   -­‐2.0404216	   -­‐0.9992780	  
O	   8	   0.5681921	   2.0364942	   -­‐0.2901556	  
N	   7	   -­‐2.1552555	   0.4825832	   -­‐0.7081676	  
H	   1	   -­‐1.8902035	   1.4052629	   -­‐0.3761125	  
C	   6	   -­‐3.3356421	   0.3682620	   -­‐1.5636172	  
H	   1	   -­‐3.0568503	   0.3221934	   -­‐2.6202480	  
H	   1	   -­‐3.9650164	   1.2410281	   -­‐1.3943085	  
H	   1	   -­‐3.8929627	   -­‐0.5345995	   -­‐1.3094252	  
C	   6	   2.8994572	   0.8381860	   -­‐1.5957025	  
H	   1	   2.4473976	   1.5424362	   -­‐2.2944613	  
H	   1	   3.4533294	   0.0740824	   -­‐2.1390680	  
H	   1	   3.5740892	   1.3774046	   -­‐0.9268999	  
C	   6	   -­‐0.5420573	   0.1456049	   1.8509254	  
H	   1	   -­‐1.1951835	   -­‐0.6549214	   2.2144060	  
H	   1	   -­‐1.1521484	   1.0495159	   1.7766900	  
C	   6	   0.6015516	   0.3833344	   2.8369923	  
H	   1	   1.2520981	   1.2036314	   2.5140236	  
H	   1	   1.2150905	   -­‐0.5121467	   2.9708426	  
H	   1	   0.1909640	   0.6576385	   3.8136085	  
	  
	  
Table	  4-­‐8.	  	  B3LYP/6-­‐31G*	  Calculated	  IR	  Frequencies	  (cm-­‐1,	  uncorrected)	  and	  Intensities	  
for	  Hydantoin	  from	  HABA-­‐2	  (compound	  1)	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   16	   1.27	   27	   707	   7.98	   53	   1487	   100.04	  
2	   36	   7.25	   28	   759	   39.31	   54	   1498	   18.07	  
3	   61	   1.41	   29	   771	   25.07	   55	   1500	   122.82	  
4	   80	   0.62	   30	   809	   28.13	   56	   1519	   46.42	  
5	   102	   2.70	   31	   823	   1.68	   57	   1527	   7.51	  
6	   115	   1.59	   32	   905	   17.46	   58	   1536	   15.56	  
7	   132	   1.69	   33	   941	   20.89	   59	   1537	   4.44	  
8	   150	   20.66	   34	   984	   12.40	   60	   1537	   9.58	  
9	   158	   20.86	   35	   1011	   100.88	   61	   1542	   30.10	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10	   182	   2.91	   36	   1051	   22.41	   62	   1575	   237.76	  
11	   190	   1.32	   37	   1068	   171.69	   63	   1656	   184.52	  
12	   230	   10.32	   38	   1097	   18.81	   64	   1690	   1459.61	  
13	   260	   21.20	   39	   1122	   19.29	   65	   1775	   117.23	  
14	   277	   2.15	   40	   1173	   23.94	   66	   3065	   26.55	  
15	   280	   10.20	   41	   1187	   22.62	   67	   3084	   19.65	  
16	   314	   21.96	   42	   1202	   3.70	   68	   3091	   39.64	  
17	   325	   18.49	   43	   1214	   5.93	   69	   3105	   28.43	  
18	   377	   39.20	   44	   1240	   27.51	   70	   3125	   18.66	  
19	   397	   29.81	   45	   1282	   44.35	   71	   3136	   27.92	  
20	   415	   28.10	   46	   1294	   86.48	   72	   3148	   40.55	  
21	   534	   28.25	   47	   1303	   73.90	   73	   3163	   22.09	  
22	   553	   37.40	   48	   1343	   10.76	   74	   3185	   7.68	  
23	   576	   123.64	   49	   1379	   47.55	   75	   3206	   7.96	  
24	   605	   5.26	   50	   1415	   327.95	   76	   3213	   0.99	  
25	   668	   184.68	   51	   1440	   4.07	   77	   3352	   402.65	  








B3LYP/6-­‐31G*	  Energy	  (E):	  	   	   	  	  	  	  	  	  	  -­‐969.569250	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  622.8451	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐608264.5669	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐1.4148263	   0.6247761	   0.3800361	  
N	   7	   -­‐0.9742004	   -­‐0.8976144	   -­‐1.5490269	  
N	   7	   -­‐0.9003589	   -­‐1.8012850	   0.6754580	  
C	   6	   -­‐0.7295250	   -­‐1.9832829	   -­‐0.6996249	  
C	   6	   -­‐1.2474823	   -­‐0.6057805	   1.2692675	  
C	   6	   -­‐1.3285577	   0.3620266	   -­‐1.1193586	  
N	   7	   -­‐2.8343955	   1.0379468	   0.6104583	  
H	   1	   -­‐2.9449738	   1.1009460	   1.6248198	  
O	   8	   -­‐3.0387488	   2.4135406	   0.2004997	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O	   8	   -­‐0.4006397	   -­‐3.0704827	   -­‐1.1529572	  
O	   8	   -­‐1.4300681	   -­‐0.5039606	   2.4796402	  
O	   8	   -­‐1.5980966	   1.2649146	   -­‐1.9139484	  
C	   6	   -­‐0.6804412	   -­‐2.9958690	   1.5167346	  
H	   1	   -­‐1.3739723	   -­‐3.7840064	   1.2234202	  
H	   1	   -­‐0.8540530	   -­‐2.7061992	   2.5491599	  
H	   1	   0.3414716	   -­‐3.3521675	   1.3870168	  
C	   6	   -­‐0.8433367	   -­‐1.1686104	   -­‐2.9954580	  
H	   1	   -­‐1.5799466	   -­‐1.9122462	   -­‐3.3010751	  
H	   1	   0.1559919	   -­‐1.5490832	   -­‐3.2046696	  
H	   1	   -­‐1.0137365	   -­‐0.2333456	   -­‐3.5208156	  
C	   6	   -­‐0.3746770	   1.7091848	   0.8070813	  
H	   1	   -­‐0.5473907	   1.8830182	   1.8729592	  
H	   1	   -­‐0.6517544	   2.6195928	   0.2740368	  
C	   6	   1.0803261	   1.3671886	   0.5622397	  
C	   6	   3.7940664	   0.7600796	   0.1172980	  
C	   6	   1.8516439	   0.7527184	   1.5596992	  
C	   6	   1.6959238	   1.6808662	   -­‐0.6590690	  
C	   6	   3.0395190	   1.3773883	   -­‐0.8816871	  
C	   6	   3.1959216	   0.4500528	   1.3397052	  
H	   1	   1.3938920	   0.5171470	   2.5169891	  
H	   1	   1.1164719	   2.1706635	   -­‐1.4374423	  
H	   1	   3.4979254	   1.6317544	   -­‐1.8327907	  
H	   1	   3.7768082	   -­‐0.0220165	   2.1265470	  
H	   1	   4.8406339	   0.5285958	   -­‐0.0529168	  
	  
	  
Table	   4-­‐10.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  HABA-­‐3	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   32	   0.17	   34	   742	   26.24	   67	   1381	   341.81	  
2	   38	   0.21	   35	   752	   8.51	   68	   1411	   103.28	  
3	   65	   0.05	   36	   773	   31.94	   69	   1423	   525.50	  
4	   74	   1.05	   37	   781	   10.88	   70	   1473	   66.36	  
5	   76	   2.67	   38	   843	   4.81	   71	   1489	   254.49	  
6	   87	   5.07	   39	   871	   0.16	   72	   1501	   0.78	  
7	   104	   1.08	   40	   878	   24.21	   73	   1517	   26.69	  
8	   118	   35.16	   41	   898	   5.00	   74	   1524	   15.13	  
9	   127	   35.46	   42	   938	   10.22	   75	   1524	   15.99	  
10	   165	   0.42	   43	   959	   28.05	   76	   1533	   3.58	  
11	   173	   6.08	   44	   973	   10.30	   77	   1539	   63.64	  
12	   205	   5.64	   45	   978	   0.14	   78	   1547	   8.50	  
13	   237	   6.20	   46	   992	   42.25	   79	   1556	   6.31	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14	   282	   13.06	   47	   1002	   0.59	   80	   1643	   3.59	  
15	   286	   66.98	   48	   1018	   0.36	   81	   1656	   1171.51	  
16	   315	   3.80	   49	   1034	   5.67	   82	   1665	   12.83	  
17	   325	   93.67	   50	   1058	   162.92	   83	   1670	   515.39	  
18	   345	   53.46	   51	   1062	   2.07	   84	   1749	   18.50	  
19	   374	   44.43	   52	   1102	   125.30	   85	   3101	   15.60	  
20	   390	   29.88	   53	   1115	   17.44	   86	   3120	   20.66	  
21	   394	   33.30	   54	   1151	   74.71	   87	   3121	   22.21	  
22	   402	   37.38	   55	   1184	   1.36	   88	   3162	   4.54	  
23	   424	   0.29	   56	   1185	   1.09	   89	   3193	   12.72	  
24	   433	   15.05	   57	   1190	   2.33	   90	   3195	   8.17	  
25	   466	   9.86	   58	   1192	   0.21	   91	   3197	   6.44	  
26	   482	   37.22	   59	   1219	   2.08	   92	   3198	   7.75	  
27	   497	   32.19	   60	   1231	   0.93	   93	   3208	   5.14	  
28	   579	   14.09	   61	   1267	   82.96	   94	   3214	   56.13	  
29	   624	   8.15	   62	   1276	   50.88	   95	   3228	   28.99	  
30	   635	   0.05	   63	   1325	   328.24	   96	   3237	   0.60	  
31	   674	   1.94	   64	   1347	   169.28	   97	   3240	   0.67	  
32	   720	   40.70	   65	   1362	   9.25	   98	   3468	   47.65	  
33	   733	   20.18	   66	   1376	   39.93	   99	   3659	   152.10	  
	  
	  
Table	  4-­‐11.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  




B3LYP/6-­‐31G*	  Energy	  (E):	   	   	  	  	  	  	  	  	  -­‐969.531043	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	  	   	  	  	  	  	  	  	  	  	  615.0554	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐608242.4535	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.3427742	   -­‐0.6164885	   -­‐0.3472655	  
N	   7	   -­‐1.7098888	   1.2484088	   -­‐0.4628308	  
N	   7	   -­‐2.5194092	   -­‐0.8675358	   0.3495542	  
C	   6	   -­‐1.9000724	   0.4072400	   0.7611990	  
C	   6	   -­‐1.6134196	   -­‐1.5022917	   -­‐0.4302133	  
C	   6	   -­‐0.7007258	   0.6632307	   -­‐1.1671376	  
N	   7	   -­‐0.5369928	   -­‐0.1034517	   1.0540916	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H	   1	   0.8389397	   0.8135918	   2.0047001	  
O	   8	   -­‐1.7479128	   -­‐2.5451185	   -­‐1.0706060	  
O	   8	   -­‐0.1928524	   1.0461800	   -­‐2.2193422	  
C	   6	   -­‐3.9477418	   -­‐1.1457395	   0.4320903	  
H	   1	   -­‐4.2915614	   -­‐0.9846525	   1.4549900	  
H	   1	   -­‐4.1010789	   -­‐2.1909282	   0.1636579	  
H	   1	   -­‐4.5221183	   -­‐0.5188935	   -­‐0.2586696	  
C	   6	   -­‐2.0657555	   2.6618687	   -­‐0.5447626	  
H	   1	   -­‐1.6893930	   3.2049308	   0.3257873	  
H	   1	   -­‐3.1480604	   2.7936395	   -­‐0.6284639	  
H	   1	   -­‐1.6053830	   3.0644986	   -­‐1.4481676	  
O	   8	   -­‐2.4899514	   1.0345895	   1.8187620	  
H	   1	   -­‐3.3097450	   1.4811969	   1.5277412	  
C	   6	   0.9421954	   -­‐1.3535595	   -­‐0.6990596	  
H	   1	   0.9205801	   -­‐1.4986221	   -­‐1.7841385	  
H	   1	   0.8723837	   -­‐2.3519431	   -­‐0.2567094	  
C	   6	   2.2524503	   -­‐0.7088992	   -­‐0.2856689	  
C	   6	   4.7095564	   0.4285637	   0.4870530	  
C	   6	   2.8800902	   0.2517499	   -­‐1.0902291	  
C	   6	   2.8813536	   -­‐1.0972351	   0.9050960	  
C	   6	   4.0975251	   -­‐0.5320941	   1.2932827	  
C	   6	   4.0970928	   0.8154471	   -­‐0.7066315	  
H	   1	   2.4016941	   0.5617658	   -­‐2.0143798	  
H	   1	   2.4138765	   -­‐1.8543627	   1.5299078	  
H	   1	   4.5692095	   -­‐0.8497822	   2.2185716	  
H	   1	   4.5686040	   1.5570705	   -­‐1.3451162	  
H	   1	   5.6581530	   0.8675996	   0.7812166	  
	  
	  
Table	   4-­‐12.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  Tetrahedral	  Intermediate	  from	  HABA-­‐3	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   8	   63.69	   34	   717	   42.19	   67	   1370	   15.46	  
2	   40	   35.48	   35	   764	   17.19	   68	   1380	   225.16	  
3	   47	   2.55	   36	   774	   6.30	   69	   1388	   51.26	  
4	   63	   7.74	   37	   813	   11.63	   70	   1393	   4.27	  
5	   95	   4.33	   38	   837	   9.18	   71	   1457	   470.23	  
6	   113	   90.94	   39	   865	   1.40	   72	   1477	   73.15	  
7	   131	   17.03	   40	   867	   9.61	   73	   1483	   81.82	  
8	   140	   5.78	   41	   884	   6.53	   74	   1498	   4.72	  
9	   149	   3.52	   42	   909	   80.82	   75	   1504	   13.58	  
10	   163	   11.11	   43	   931	   11.70	   76	   1530	   10.40	  
11	   180	   3.85	   44	   952	   167.83	   77	   1536	   19.00	  
12	   193	   5.47	   45	   972	   2.08	   78	   1545	   10.32	  
	   293	  
13	   226	   14.61	   46	   996	   16.29	   79	   1549	   2.80	  
14	   240	   210.91	   47	   1000	   43.89	   80	   1556	   36.50	  
15	   254	   53.40	   48	   1001	   48.16	   81	   1643	   2.05	  
16	   271	   5.24	   49	   1019	   1.30	   82	   1664	   9.22	  
17	   279	   25.88	   50	   1033	   156.96	   83	   1702	   368.50	  
18	   293	   4.54	   51	   1043	   99.55	   84	   1731	   793.40	  
19	   334	   9.37	   52	   1060	   5.67	   85	   3079	   34.01	  
20	   345	   5.39	   53	   1070	   17.42	   86	   3081	   24.46	  
21	   387	   9.59	   54	   1116	   2.69	   87	   3084	   46.12	  
22	   421	   0.24	   55	   1171	   195.95	   88	   3123	   10.30	  
23	   462	   2.97	   56	   1186	   283.47	   89	   3160	   12.81	  
24	   469	   28.52	   57	   1188	   0.44	   90	   3164	   11.12	  
25	   480	   13.70	   58	   1203	   8.82	   91	   3180	   5.15	  
26	   519	   31.19	   59	   1213	   0.66	   92	   3192	   13.83	  
27	   567	   6.40	   60	   1227	   2.40	   93	   3196	   0.02	  
28	   604	   1.12	   61	   1238	   100.30	   94	   3197	   2.56	  
29	   609	   17.00	   62	   1257	   86.71	   95	   3207	   19.04	  
30	   616	   19.31	   63	   1266	   15.83	   96	   3213	   58.40	  
31	   635	   0.47	   64	   1307	   65.44	   97	   3224	   25.75	  
32	   659	   15.78	   65	   1329	   116.28	   98	   3671	   205.04	  




Table	  4-­‐13.	   	  B3LYP/6-­‐31G*	  Optimized	  Geometries,	  Energies,	  and	  Entropy	  Corrections	  




B3LYP/6-­‐31G*	  Energy	  (E):	   	   	  	  	  	  	  	  	  -­‐969.588678	  hartrees	  
Entropy	  Correction	  (Hv-­‐TSv):	   	  	  	  	  	  	  	  	  	  619.5569	  kJ/mol	  
G°	  =	  E	  +	  “entropy	  correction”:	   -­‐608277.5441	  kcal/mol	  
	  
Atom	   Atomic	  
Number	  
	  	  	  	  	  	  	  Cartesian	  Coordinates	  (Angstroms)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Y	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Z	  
C	   6	   -­‐0.5728124	   -­‐0.3925610	   -­‐0.4654126	  
C	   6	   0.2945958	   0.6820689	   -­‐1.1469397	  
N	   7	   1.3679730	   0.0344917	   -­‐1.7078855	  
C	   6	   1.3654973	   -­‐1.3424930	   -­‐1.4099210	  
N	   7	   0.3469391	   -­‐1.5300012	   -­‐0.5088406	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H	   1	   -­‐0.8621108	   -­‐2.8967473	   -­‐0.9005879	  
C	   6	   -­‐1.8064300	   -­‐0.6810948	   -­‐1.3729762	  
O	   8	   -­‐1.9987581	   -­‐1.8314813	   -­‐1.8254712	  
O	   8	   2.1553679	   -­‐2.1716769	   -­‐1.8439265	  
O	   8	   0.0528999	   1.8793996	   -­‐1.2096308	  
N	   7	   -­‐2.6249465	   0.3435873	   -­‐1.6058148	  
H	   1	   -­‐2.3248596	   1.2694655	   -­‐1.3132675	  
C	   6	   -­‐3.8219207	   0.2313936	   -­‐2.4381963	  
H	   1	   -­‐3.5622865	   0.1484151	   -­‐3.4975699	  
H	   1	   -­‐4.4299129	   1.1221482	   -­‐2.2847258	  
H	   1	   -­‐4.3932668	   -­‐0.6513532	   -­‐2.1478209	  
C	   6	   2.4311829	   0.7056765	   -­‐2.4540935	  
H	   1	   1.9822381	   1.4067382	   -­‐3.1579184	  
H	   1	   2.9976145	   -­‐0.0539708	   -­‐2.9906609	  
H	   1	   3.0930613	   1.2487810	   -­‐1.7758284	  
C	   6	   -­‐1.0136280	   -­‐0.0126943	   0.9727521	  
H	   1	   -­‐1.6605203	   -­‐0.8191389	   1.3319161	  
H	   1	   -­‐1.6291923	   0.8870064	   0.9018293	  
C	   6	   0.1231389	   0.2201962	   1.9448935	  
C	   6	   2.2141150	   0.6602418	   3.7717818	  
C	   6	   0.6519409	   -­‐0.8393271	   2.6941818	  
C	   6	   0.6572268	   1.5036175	   2.1249357	  
C	   6	   1.6960648	   1.7228613	   3.0302783	  
C	   6	   1.6888791	   -­‐0.6220647	   3.6010237	  
H	   1	   0.2510178	   -­‐1.8401618	   2.5588985	  
H	   1	   0.2575762	   2.3329778	   1.5487777	  
H	   1	   2.0959008	   2.7241574	   3.1602023	  
H	   1	   2.0850418	   -­‐1.4543736	   4.1753436	  
H	   1	   3.0190469	   0.8293737	   4.4807252	  
	  
	  
Table	   4-­‐14.	   	   B3LYP/6-­‐31G*	   Calculated	   IR	   Frequencies	   (cm-­‐1,	   uncorrected)	   and	  
Intensities	  for	  Hydantoin	  from	  HABA-­‐3	  
	  
	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	   	   cm⁻¹	   Intensity	  
1	   19	   0.52	   34	   718	   54.88	   67	   1377	   0.87	  
2	   39	   0.80	   35	   752	   51.71	   68	   1417	   339.55	  
3	   48	   4.83	   36	   774	   8.12	   69	   1473	   429.52	  
4	   56	   3.03	   37	   779	   8.28	   70	   1490	   53.91	  
5	   68	   1.86	   38	   814	   18.29	   71	   1493	   59.95	  
6	   95	   0.46	   39	   846	   7.21	   72	   1502	   40.70	  
7	   110	   0.69	   40	   862	   0.65	   73	   1504	   179.90	  
8	   115	   0.25	   41	   887	   1.82	   74	   1522	   50.21	  
9	   121	   2.33	   42	   921	   0.50	   75	   1532	   14.94	  
10	   157	   21.16	   43	   950	   11.10	   76	   1535	   5.85	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11	   167	   12.38	   44	   970	   1.53	   77	   1541	   37.64	  
12	   178	   3.24	   45	   987	   62.39	   78	   1547	   7.41	  
13	   197	   1.93	   46	   998	   1.03	   79	   1579	   271.93	  
14	   218	   4.27	   47	   1019	   0.48	   80	   1644	   3.31	  
15	   256	   18.11	   48	   1029	   26.79	   81	   1659	   166.19	  
16	   284	   1.55	   49	   1057	   114.57	   82	   1667	   4.81	  
17	   289	   33.67	   50	   1062	   27.19	   83	   1694	   1502.79	  
18	   312	   8.04	   51	   1073	   100.26	   84	   1778	   117.22	  
19	   339	   5.40	   52	   1104	   20.43	   85	   3090	   41.44	  
20	   378	   44.02	   53	   1127	   20.17	   86	   3093	   18.01	  
21	   389	   33.71	   54	   1181	   22.68	   87	   3105	   28.23	  
22	   405	   30.65	   55	   1192	   0.01	   88	   3150	   4.98	  
23	   418	   0.04	   56	   1201	   4.92	   89	   3163	   21.21	  
24	   469	   2.44	   57	   1215	   4.90	   90	   3185	   7.81	  
25	   542	   53.45	   58	   1218	   1.15	   91	   3192	   8.54	  
26	   554	   29.97	   59	   1229	   6.48	   92	   3200	   0.66	  
27	   586	   8.59	   60	   1237	   3.03	   93	   3206	   7.97	  
28	   608	   102.76	   61	   1252	   36.47	   94	   3208	   26.56	  
29	   628	   31.45	   62	   1295	   86.37	   95	   3214	   0.85	  
30	   635	   0.45	   63	   1297	   126.92	   96	   3215	   53.71	  
31	   665	   200.27	   64	   1322	   10.98	   97	   3224	   24.22	  
32	   680	   20.46	   65	   1361	   13.82	   98	   3359	   416.87	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Chapter	  5.	  	  	  
The	  HNO-­‐Aldol	  Screening	  Assay	  	  
Using	  1H	  NMR	  Spectroscopy	  
The	  hydroxylamino-­‐X	  (HAX)	  general	  class	  of	  nitroxyl	  (HNO)	  donors,	  where	  X	  
is	  based	  on	  Meldrum’s	  acid	  (HAMA),	  barbituric	  acid	  (HABA),	  or	  pyrazolone	  (HAPY),
is capable	   of	   releasing	   HNO	   quantitatively under	   nonenzymatic,	   physiological	  
conditions,	  with	   the	  rate	  and	  amount	  of	  HNO	  released	  being	  dependent	  mainly	  on	  
the	  nature	  of	   the	  carbon-­‐based	   leaving	  group.	   	  As	  shown	   in	  Figure	  5-­‐1,	   the	  rate	  of	  
HNO	  release	  can	  be	  varied	  over	  four	  orders	  of	  magnitude	  and	  is	  dependent	  on	  the	  
pKa	  of	  the	  carbon-­‐based	  acid	  byproduct,	  X–H,	  which	  can	  be	  varied	  over	  six	  pH	  units.	  	  
The	   most	   physiologically	   useful	   donors	   in	   terms	   of	   HNO	   release	   rate	   have	  
byproducts	  with	  pKa	  values	  ≤	  ca.	  8	  in	  50%	  v/v	  aq.	  ethanol	  (i.e.,	  ca.	  ≤	  7	  in	  water).	  
	  
Figure	  5-­‐1.	  	  Decomposition	  rates	  for	  the	  HAX	  general	  class	  of	  HNO	  donors	  as	  a	  function	  
pKa	  of	  X–H,	  the	  byproduct	  of	  HNO	  release.	  	  Each	  pKa	  value	  was	  determined	  by	  titration	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in	  50%	  v/v	  aqueous	  ethanol.	  	  Each	  rate	  is	  the	  calculated	  best	  fit	  to	  a	  single	  exponential.	  	  
The	  decomposition	  reaction	  was	  carried	  out	  in	  the	  presence	  of	  added	  TXPTS	  to	  minimize	  
contribution	  of	  the	  back	  reaction,	  save	  for	  the	  HAMA	  and	  HABA	  examples,	  which	  have	  
half-­‐lives	   around	   one	  minute,	  where	   there	   is	   negligible	   back	   reaction	   (see	   Table	   5-­‐1).	  	  
See	  Chapters	  2,	  3,	  and	  4,	  as	  well	  as	  Table	  5-­‐1,	  for	  compound	  structures.	  	  	  
	  
Moving	   forward,	  we	  will	   continue	   to	  broaden	   the	  scope	  of	   the	  HAX	  general	  
class	  by	  applying	  what	  we	  have	   learned	  about	  the	   inherent	  reactivity	  of	  HNO	  with	  
the	  carbon-­‐based	  byproduct	  of	   release,	  X–H/X–.	   	  That	   is,	  often	  what	  makes	  a	  good	  
leaving	   group	   so	   too	   makes	   a	   good	   nucleophile,	   particularly	   with	   the	   nitroso	  
functionality	  of	  HNO.	  	  	  
The	  HNO-­‐aldol	  screening	  assay	  using	  1H	  NMR	  spectroscopy	  was	  developed	  to	  
identify	   potential	   HNO	   donors,	   as	   well	   as	   potential	   HNO	   traps	   for	   detection	  
purposes.	  	  This	  assay	  predicts	  the	  success	  of	  the	  preparatory	  HNO-­‐aldol	  procedure,	  
as	   well	   as	   which	   functional	   groups	   to	   avoid	   since	   some	   scaffolds	   are	   prone	   to	  
hydroxylamine-­‐assisted	  hydrolysis	  and	  rearrangement	  mechanisms.	  	  As	  there	  exists	  
a	   large	   library	   of	   potential	   HNO	   donors	   that	   fall	   into	   the	   HAX	   general	   class,	  
efficiently	   screening	   out	   the	   possibilities	   are	   important	   as	   well.	   	   All	   of	   this	  
information	  can	  be	  obtained	  quickly	  and	  effectively	  without	  the	  need	  to	  synthesize	  
and	  isolate	  the	  potential	  HNO	  donor	  itself.	  	  Multiple	  experiments	  may	  be	  performed	  
in	  parallel.	  
HNO-­‐aldol	  screening	  assay	  procedure:	  	  Dissolve	  1	  mg	  of	  byproduct	  (X–H)	  in	  
1.2	   mL	   of	   10%	   D2O,	   pH	   7.4	   phosphate	   buffer	   (0.25	   M)	   with	   DTPA	   (0.2	   mM).	  	  
Transfer	   0.6	  mL	   to	   an	   NMR	   tube	   and	   take	   an	   initial	   1H	   NMR	   spectrum	   using	   a	   1	  
second	  presaturation	  pulse	  to	  suppress	  the	  water	  signal.	  	  To	  the	  remaining	  0.6	  mL	  of	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solution,	  add	  1	  mg	  of	  Angeli’s	  salt,	   transfer	  to	  a	  second	  NMR	  tube,	  and	  let	  stand	  at	  
room	   temperature	   under	   air	   for	   ca.	   30	   minutes,	   then	   take	   another	   1H	   NMR	  
spectrum.	   	  Signs	  of	  a	  new	  product,	  or	  products,	  will	  be	   evident	   if	  HNO	  trapping	   is	  
occurring.	  	  If	  a	  new	  product	  does	  form,	  then	  externally	  incubate	  the	  sample	  at	  37	  °C	  
and	   continue	   to	   check	   the	   reaction	  progress	   by	   1H	  NMR	  at	   regular	   time	   intervals.	  	  
Keeping	   the	   sample	   under	   air	   allows	   for	   the	   dissolved	   oxygen	   to	   serve	   as	   an	  
alternative	  trap	  for	  HNO	  such	  that	  the	  reaction	  may	  be	  reversible,	  albeit	  this	  reverse	  
reaction	  will	  be	  much	  slower	  than	  if	  a	  better	  trap	  (e.g.,	  TXPTS)	  were	  added	  following	  
the	   completion	   of	   Angeli’s	   salt	   decomposition	   (ca.	   2	   h).	   	   By	   not	   adding	   TXPTS,	  
potential	  alternative	  decomposition	  mechanisms	  may	  be	  observed;	  it	  is	  important	  to	  
be	  made	  aware	  of	  these	  pathways.	  	  Any	  new,	  undesired	  products	  that	  form	  may	  be	  
compared	  to	  the	  byproduct	  standard	  solution	  used	  for	  the	  initial	  spectrum	  in	  order	  
to	  identify	  decomposition	  pathways	  independent	  of	  HNO	  trapping.	  
HNO-­‐aldol	   screening	  assay	  observations:	   	  The	  observations	  may	  be	  divided	  
into	   five	   categories:	   (A)	   complete	   trapping	   of	   HNO	   and	   reversible	   reaction,	   (B)	  
incomplete	  trapping	  of	  HNO	  and	  reversible	  reaction,	  (C)	  complete	  trapping	  of	  HNO	  
and	  irreversible	  reaction,	  (D)	  incomplete	  trapping	  of	  HNO	  and	  irreversible	  reaction,	  
and	  (E)	  no	  reaction	  with	  HNO.	   	  Potential	  HNO	  donors	   fall	   into	  categories	  A	  and	  B,	  
and	  the	  HNO-­‐aldol	  preparatory	  procedure	  will	  be	  most	  successful	  with	  category	  A	  
compounds.	   	  The	  most	  successful	   traps	  for	  HNO	  detection	  will	   fall	   into	  category	  C,	  
particularly	  if	  the	  reaction	  is	  clean	  and	  the	  new	  product	  is	  distinctive;	  but	  category	  A	  
compounds	  may	  also	  serve	  as	  traps	  for	  HNO	  detection	  if	  it	  is	  later	  observed	  that	  the	  
reverse	   reaction	   is	   very	   slow	   in	   the	   presence	   of	   TXPTS.	   	   Compounds	   prone	   to	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alternative,	  non-­‐HNO	  decomposition	  mechanisms	   fall	   into	   categories	  C	  and	  D,	   and	  
the	   source	  of	   the	   instability	   in	  each	  scaffold	   should	  assessed	  as	   to	  whether	  or	  not	  
this	   may	   be	   curtailed	   to	   favor	   HNO	   generation.	   	   The	   compounds	   that	   fall	   into	  
category	  E	  will	  require	  synthesis	  and	  isolation	  of	  the	  corresponding	  HAX	  compound	  
in	  order	  to	  assess	  its	  fate.	  
This	  assay	  has	  already	  proven	   its	  usefulness.	   	  Upon	   its	   inception,	   the	  assay	  
was	   pivotal	   to	   the	   understanding	   of	   the	   decomposition	  mechanism	   for	   the	   HAPY	  
class	   of	  HNO	  donors	   discussed	   in	   Chapter	   3.	   	  Moreover,	   as	   the	   ethyl-­‐based	  HABA	  
compound,	   discussed	   in	   Chapters	   2	   and	   3,	   was	   known	   to	   rearrange	   to	   the	  
corresponding	   hydantoin	   product,	   it	   was	   expected	   that	   all	   alkyl-­‐based	   HABA	  
compounds	  would	  favor	  rearrangement.	  	  Thus,	  were	  it	  not	  for	  the	  efficiency	  of	  this	  
assay,	   the	  benzyl-­‐HABA	  compounds,	   discussed	   in	  Chapter	  4,	  would	  not	  have	  been	  
pursued.	  	  Shown	  in	  Scheme	  5-­‐1	  is	  the	  assay	  itself	  utilizing	  Angeli’s	  salt	  as	  the	  initial	  
HNO	  donor,	  and	  in	  Table	  5-­‐1	  are	  the	  current	  results	  of	  this	  assay,	  where	  most	  of	  the	  
successes	  are	  described	  in	  Chapters	  2,	  3,	  and	  4.	  	  
	  
	  
Scheme	  5-­‐1.	  	  The	  HNO-­‐Aldol	  Screening	  Assay	  Using	  1H	  NMR	  Spectroscopy	  
	  
	   	   	  
	  	  	  	  	  	  Categories:	  
	  	  	  	  	  	  (A)	  Complete	  trapping	  of	  HNO	  /	  Reversible	  
	  	  	  	  	  	  (B)	  Incomplete	  trapping	  of	  HNO	  /	  Reversible	  
	  	  	  	  	  	  (C)	  Complete	  trapping	  of	  HNO	  /	  Irreversible	  
	  	  	  	  	  	  (D)	  Incomplete	  trapping	  of	  HNO	  /	  Irreversible	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Table	  5-­‐1.	  	  The	  HNO-­‐Aldol	  Screening	  Assay	  Using	  1H	  NMR	  Spectroscopy:	  Results	  
Entry	   Starting	  Material	  	  (X–H)	  
Desired	  Product	  	  
(HAX)	   Category	   Notes	  
1	  






	   	  
D	  
Only	  get	  loss	  
of	  EtOH	  over	  
time	  
3	  












	   	  
C	  
Only	  get	  loss	  
of	  EtOH	  over	  
time	  
6	  
	   	  
D	  
Only	  get	  loss	  
of	  EtOH	  over	  
time	  
7	  






	   	  
D	  
Only	  get	  loss	  
of	  EtOH	  over	  
time	  
9	  
	   	  
E	   No	  reaction	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10	  







	   	  
C	  
Only	  get	  loss	  
of	  acetone	  
over	  time;	  	  
See	  Chapter	  2	  
12	  
	   	  
E	   No	  reaction;	  See	  Chapter	  2	  
13	  
	   	  
C	  











	   	  
E	   No	  reaction	  
16	  
	   	  
B	   ca.	  10%	  trapping	  
17	  
	   	  
E	   No	  reaction	  
18	  
	   	  
E	   No	  reaction	  
19	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20	  
 	  
A	   See	  Chapter	  3	  
21	  
 	  
B	   See	  Chapter	  3	  
22	  
 	  
A	   See	  Chapter	  3	  
23	  
 	  
B	   See	  Chapter	  3	  
24	  
 	  
A	   See	  Chapter	  3	  
25	  
 	  
A	   See	  Chapter	  3	  
26	  
 	  
A	   See	  Chapter	  3	  
27	  
 	  
A	   See	  Chapter	  3	  
28	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29	  
 	  
A	   See	  Chapter	  3	  
30	  
 	  












E	   No	  reaction	  
33	  
 	  
E	   No	  reaction	  
34	  
 	  
E	   No	  reaction	  
35	  
	   	  
E	   No	  reaction	  
36	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37	  









product	  likely	  	  
38	  
	   	  
C	   Get	  hydantoin	  formation	  
39	  






	   	  
C	   See	  Chapters	  2&4	  
41	  
	   	  
A	   See	  Chapter	  4	  
42	  
	   	  
E	   No	  reaction	  
43	  
	   	  
E	   No	  reaction	  
44	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45	  
	   	  
E	   No	  reaction	  
46	  
	   	  
A	   See	  Chapter	  4	  
47	  






	   	  
A	   See	  Chapter	  4	  
49	  






	   	  
A	   See	  Chapter	  4	  
51	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54	  



















yield	  is	  51%	  
57	  
	   	  
B	   ca.	  10%	  trapping	  
58	   K13CN	  
	  
D	  
pH	  10.0	  using	  
Piloty’s	  	  Acid	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